Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3547

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: date() [function.date]: It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected 'America/New_York' for 'EDT/-4.0/DST' instead in [path]/includes/functions.php on line 3734

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1181

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1182

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1183

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1184

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1185

Warning: Cannot modify header information - headers already sent by (output started at [path]/includes/class_core.php:3254) in /home/tebaselc/public_html/mkportal/modules/downloads/index.php on line 1186
╨╧рб▒с>■    ■   ыьэюяЁёЄєЇїЎў°∙·√№¤■                                                                                                                                                                                                                                                                                                                          ье┴q`°┐0`rbjbjqPqP:И::l}       джжжжжжж║вФвФвФвФ┤VЫ║│╞~Э~Э~Э~Э~Э~Э~Э~Эb└d└d└d└d└d└d└$╡╟h╩fИ└хж й~Э~Э й йИ└жж~Э~Эm╞└└└ йТж~Эж~Эb└└ йb└└└жж└~ЭrЭ └╦_ЛlБ╞вФЮо· └b└Г╞0│╞└Г╩Ш╕fГ╩└└6Г╩ж>└$~Э░.бв└╨гье ~Э~Э~ЭИ└И└■┐ ~Э~Э~Э│╞ й й й й║║║Д╚>╠d╚║║║>╠║║║жжжжжж    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л#(H C1'JF╗ 'D91BJ) H,1'( 'D491 #E' 7(B) E'DJJ,I A**CHF AJ 'D4G1 'D1'(9 EF 9E1 'D,FJF. ,D/ 'D7AD: ,D/ 'D7AD DG EDE3 F'9E HJ4(G ,D/ 'D('D: EF 'DF'-J) 'D*41J-J) DD#F3,) E9 (96 'DA1HB'* 'D(3J7). %F 7(B) 'D(41) EF 'D,D/ AJ 'D#7A'D GJ FA3G' AJ 'D('D:JF %D' #FG' #BD *E'3C'K H'DA1B 'D1&J3J H'DG'E GH 9/E 'DF6H, 'DC'ED DF3J, 'DCHD',JF H,1'( 'D491 H'D:// 'D/GFJ) AJ 'D#7A'D. CE' #F 'D(41) 'D37-J) E9 7(B) 'D#/E) 'D3ADJ) #BD *E'3C'K AJ 'D#7A'D HG0' JA31 -/H+ 'D#+1 'D#C+1 *A'9D'K F*J,) 'DE$+1'* 'D(3J7) AJ 'D#7A'D  -J+ #F D/:) 'D-41'* B/ *-/+ A#DJD ,D/J). CE' H#F 'D*:J1'* F*J,) 'D'.*D'A AJ F3() E3'-) 'D,D/ %DI ,3E 'D#7A'D HC0DC F3() F4'7 'D#H9J) 'D/EHJ) HC0DC 'DB'(DJ) DD*91B 'D2'&/  CD 0DC DG 9D'B) G'E) 9DI *F8JE -1'1) ,3E 'D#7A'D  -J+ #F (96 'DE$+1'* 'D(3J7) B/ *$/J %DI 'DE2J/ EF AB/'F -1'1) ,3E 'D#7A'D. HD0DC EF 'D#EH1 'DG'E) ED'-8) E+D G0G 'D8'G1)  %0 B/ *$/J *DC %DI E6'9A'* .7J1) 9DI -J') 'D7AD.B *:J1'* ,D/ 'D#7A'D( -/J+J 'DHD'/)) 'DA3JHDH,J) %F 'D9/J/ EF 'D9H'ED 'D*J *$+1 9DI ,D/ 'D7AD (9/ 'DHD'/) GJ 8H'G1 7'1&) H*2HD D'-B'K /HF 'D-',) %DI #J 9D', HEF G0G: (1/1)  'D7D'! 'D/GFJ: 'D:4'! 'D#(J6 'D/GFJ 'D0J J:7J 37- 'D,D/ (9/ 'DHD'/) J*D'4I (319) HJ*.D5 EFG 'D,D/ (9/ 3'9'* EF 'DHD'/). DHF 'D,D/: 'D*:J1'* 'D*J *-/+ AJ DHF ,D/ -/J+J 'DHD'/): *5(: 'D,D/ ('DDHF 'D/GFJ 'D#5A1: J-/+ AJ -'D'* 'D#E1'6 'DF'2A) AJ 'D#7A'D -/J+J 'DHD'/) CE' #F 'D,D/ J8G1 (DHF #5A1 F*J,) 5(:) 'D5A1'HJ) AJ (96 -'D'* '671'('* 'D7AD #+F'! 'D-ED HB(D 'DHD'/). CE' #FG AJ 'D#3(H9 'D#HD EF 'DHD'/) B/ JCHF DHF ,D/ 'D,2! 'D3ADJ DD7AD #-E1 H'D,2! 'D9DHJ ('G* H(JFGE' A'5D -'/ HJ-/+ 0DC 9F/E' JCHF H69 'D7AD B(D 'DHD'/) 9DJ %-/I ,F(JG. H*CHF 'D#71'A 0'* DHF E21B DA*1) (3J7) AJ (96 'D#7A'D .'5) %0' C'F GF'C *#.J1 H931) AJ 9EDJ) 'DHD'/) AJ 'D#7A'D C'EDJ 'DFEH. 8GH1 %-E1'1 9'E 9DI 'D,D/ AJ -'D'* E' J3EI %-E1'1J) 'DHDJ/ (Erythema neonatarum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tratum corneum)  'D7(B) 'D-(J(J)(Stratum granulosum) 'D4CD 1BE 1: ECHF'* 'D,D/ H2H'&/G 'D7(B) 'DE4HCJ) (Stratum malpighi , Prickle cell layer) 'D7(B) 'D4HCJ) - (Stratum spinosum) H'D7(B) 'DF'EJ) (Basal layer, Stratum germinativum) H*H,/ 7(B) #.1I AJ (7F 'DCA H(7F 'DB/E GJ 'D7(B) 'D5'AJ) (Stratium Lucidum) 'D7(B) 'DE*B1F)(Stratum corneum) : **CHF EF 9/) 5AHA EF 'D.D'J' 'DEF(37) H*-*HI 9DI E'/) 4E9J) .'DJ) EF 'D#FHJ). H37- G0G 'D.D'J' J(/H (G B4H1 ,'A) H1BJB). %F 3E'C) G0G 'D7(B) J.*DA EF EHB9 D".1 HC0DC ('.*D'A 'D9E1  %0 #FG' #C+1 3E'C) 9DI 37- 'D#CA H37- /'.D 'DB/E H'DC9(JF CE' #FG' #BD 3E'C) AJ ,D/ ,AF 'D9JF. 'D7(B) 'D5'AJ)(Stratum lucidum) : (1/3)  *B9 G0G #3AD 'D7(B) 'DE*B1F) H**CHF EF 41J7 D'E9 EF 'D.D'J' 'DEF(37) 'D.'DJ) EF 'D#FHJ) HG0G 'D7(B) EH,H/) AB7 CE' 0C1 3'(B'K AJ 'DCA H(7F 'DB/E. 'D4CD 1BE 2: 7(B'* 'D(41) 'D7(B) 'D-(J(J) (Stratum granulosum) *B9 G0G #9DI 'D7(B) 'D4HCJ) H**CHF EF 5AHA EF 'D.D'J' 'DEF(37) H(G' #FHJ) H*-*HJ 9DI -(J('*. 'D7(B) 'D4HCJ)(Stratum Malpighi, Prickle cell layer) #H 7(B) E'D(J,J *B9 #9DI 'D7(B) 'DF'EJ) H**(9 '*,'GG'. %F G0G 'D7(B) **#+1 (E98E 'DE$+1'* 'DE16J) 'D*J *-/+ DD,D/. 'D4CD 1BE 3: 7(B'* 'D(41) 'D7(B) 'DF'EJ)(Statum germinativum, Basal layer) GJ #3AD 7(B) EF 7(B'* 'D(41) H**CHF EF 5A H'-/ EF 'D.D'J' 'DE1*() 9EH/J'K 9DI ,/'1 'DB'9/) (Basement membrane) . %F .D'J' 'D7(B) 'DF'EJ) **-H1 H*CHF ,EJ9 7(B'* .D'J' 'D(41). *-*A8 .D'J' 'D(41) (H,H/G' H*9HJ6 E' *AB/G EF .D'J' (H'37) 'D.D'J' 'DF'EJ) H'D*J **-HD .D'D 3(9) #3'(J9 H*CHF 'D7(B) 'D37-J) DD(41). #FH'9 .D'J' 'D(41) 1. @ 'D.D'J' 'DE*B1F) (Stratum corneum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ytokines) : 'D*J DG' #GEJ) ('D:) 9DI H8'&A 'D.D'J' E+D 'D.D'J' 'DDEA'HJ) H'D-(J(J). *A12 9H'ED 'DFEH: 'D*J DG' #GEJ) AJ 9EDJ) 'F/E'D H4A'! 'D,1H-  CE' #F 'D9H'ED 'D*J **-CE AJ 8GH1 H*3'9/ 9DI %A1'2 G0G 'D9H'ED DG' /H1 G'E AJ 8GH1 (96 'D#E1'6 'D,D/J). 2. @ .D'J' D'F,1G'F2 (Langerhans cells) : G0G 'D.D'J' DG' /H1 EF'9J EGE -J+ #FG' *57'/ 'DEH'/ 'D:1J() 'D*J J*916 DG' 'D,3E H*B/EG' %DI .D'J' " T ". 3. @ .D'J' 'DEJD'FH3'J*3(Melanocytes) : HGJ 'D.D'J' 'D*J *97J 'D,D/ 'DDHF H*B9 G0G 'D.D'J' 9DI ,/'1 B'9/) 'D(41) (Basement membrane) *CHF G0G 'D.D'J' 'D5(:) 'D,D/J) EF 'DAJF'JD 'D#FJF (E3'9/) 'D*'J1H2JF (9EDJ) E9B/). 5(:) 'DEJD'FJF GJ 'D*J *97J 'D,D/ 'DDHF 'D.'5 (G. H*,/1 'D%4'1) %DI #F 4/) *DHJF 'D,D/ D' *9*E/ 9DI 9// G0G 'D.D'J' AJ 'D,D/ (D 9DI F4'7 *DC 'D.D'J' HEB/1*G' 9DI *CHJF 'D5(:). 'D#/E) (Dermis) **CHF 'D#/E) EF 7(B) #DJ'A C+JA) #3AD 'D(41). **CHF 'D#/E) EF #F3,) DJAJ) 1'3.) E1F) HC0DC EF 'D#F3,) 'D96DJ). 'D7(B) 'D9DHJ) EF 'D#/E) **CHF EF 'D7(B) 'D-DEJ) (Papillary layer) H*(12 'D7(B) 'D37-J) EF 'D#/E) C'D#5'(9 AJ 7(B) 'D(41)  H*-*HJ G0G 9DI FG'J'* 'D49J1'* 'D/EHJ) H'D#95'(. CE' #F '*5'D 'D(41) ('D#/E) *CHF 7(B) **/'.D E9 'D#/E) H*CHF G0G /9'E) BHJ) D7(B) 'D(41) H*-EJG' EF E98E 'DE$+1'* HC0DC EF 'D#E1'6 'D,D/J) 'D*J B/ *$+1 9DI EF7B) 'D-DE). 'D7(B) 'D3ADI EF 'D#/E) GJ 7(B) 'D4(CJ) (Reticular layer ) -J+ #F 'D%5'('* #H 'D%D*G'('* 'D,D/J) 'D*J *$+1 9DI G0G 'D7(B) B/ JF*, 9FG F/('*. *-*HJ 'D#/E) 9DI 'D#H9J) 'D/EHJ) H'DDJEA'HJ) @ 'D#95'( @ ,1'( 'D491 @ 'D:// H(96 'D#F3,) 'D96DJ). (1/5)  .D'J' 'D#/E) (Dermal cells) **CHF G0G 'D.D'J' H*F-/1 EF .D'J' 'D4(CJ) (Reticulum cells) H'D.D'J' HEF 'DF3J, 'D6'E (Mesenchymal cells). **6EF .D'J' 'D#/E) E' JDJ: 1. 'D.D'J' 'DDJAJ) (Fibrolasts) : *CHF G0G 'D.D'J' 'D#F3,) 'DDJAJ)(Fibrous tissue) H'D7D'! (Ground substances). H8'&A 'D.D'J' 'DDJAJ): *CHF 'DCHD',JF H'D#F3,) 'DE7'7J). *CHF 'D3C1J'* 'DE.'7J). *(FI 'DCHDH3*J1HD H'D3*J1HJ/'*. 2. 'D.D'J' 'DF3J,J) (Histiocytes) : G0G 'D.D'J' ,2! EF 'D,G'2 'D4(CJ 'D(7'FJ (Reticuloendothelial system ). 'D.D'J' 'DF3J,J) GJ .D'J' #CD) H**H',/ %E' E*,HD) #H E+(*) 9DI 'D#F3,). 3. 'D.D'J' 'D/BDJ)(Mastocytes) : GJ .D'J' E*.55) -J+ *CHF 'DG3*'EJF H'DGJ('1JF H**H',/ G0G 'D.D'J' (C+1) AJ 'D7(B) 'D-DEJ) DD#/E) HAI 'D49J1'* 'D/EHJ) H'D7(B) 'D4(CJ) H-HD 2H'&/ 'D,D/. 4. 'D.D'J' 'DDJEA'HJ) (Lymphocytes) : G0G 'D.D'J' DG' /H1 G'E AJ 'D*A'9D'* 'DEF'9J) ('D,3E. 5. .D'J' 'D(D'2E' (Plasma cells) : *CHF G0G 'D(1H*JF'* 'DEF'9J) 'DE6'/) (Immunoglobulins) 6. C1J'* 'D'J2JFHAJD (Eosinophils) : G0G 'D.D'J' *EF9 H*C(- *A'9D'* 'DG3*'EJF. E-*HJ'* 'D#/E) **CHF 'D#/E) EF: 1. #DJ'A 'DCHD',JF (Collagen) : **CHF 'D#/E) EF #DJ'A 'DCHD',JF 'D*J *F*,G' 'D.D'J' 'DDJAJ) H*9*E/ 3E'C) 'D#/E) 9DI 9/) 9H'ED #GEG' 'D9E1 H'D,F3 H'DEHB9. 7(B) 'DCHD',JF *CHF 7(B) F'9E) 37-J) *-* 'D(41) 9F/ 'D7(B) 'D-DEJ) H7(B) #.1I .4F) AJ 'D7(B'* 'D9EJB) EF 'D#/E). EF 5A'* #DJ'A 'DCHD',JF #FG' *$/J %DI *E'3C HDJHF) 'D,D/. 2. #DJ'A 'DE1F) (Elastic fibres): **/'.D G0G 'D#DJ'A E9 'DCHD',JF H,EJ9G' E-'7) ('D.D'J' 'DE.'7J) E*9//) 'D3C1J'*. (1/6)  3. 'DEH'/ 'DE7-HF) (Ground substance) : GJ 'D/9'E) DD#/E) H**CHF EF 'DEH'/ 'D(1HJ*JF) H'D3C1J'* E1*(7) E9 (96G' H*3'9/ G0G 9DI -A8 'DE'! H'D3H'&D AI 'D,D/. JH,/ FH9JF EF 'D#DJ'A 'D(1H*JFJ) GJ 'DCHD',JF 'D0J J4CD :'D(J) 'D#/E) H(96 'D#DJ'A 'DE1F). *-*HI 'D#/E) 9DI 'D#96'! 'D95(J) 'DE*.55) HC0DC 2H'&/ 'D,D/ E+D 'D:// 'D91BJ) H,1'( 'D491. #3AD 'D#/E) 7(B) /GFJ) *3EI 'D#F3,) *-* 'D,D/ (Subcutaneous tissue). *-*HI 'D#/E) 9DI 4(C) :FJ) EF 'D#H9J) 'D/EHJ) :J1 #F G0G 'D#H9J) 'D/EHJ) D' **9/I EF7B) '*5'D 'D(41) E9 'D#/E). CE' #F 'D#/E) *-HJ 4(C) EF 'D#DJ'A 'D95(J) HC0DC FG'J) 95(J) HC1'* 95(J) E*.55) *$/J H8'&A 95J() E.*DA). 'D*:0J) 'D95(J) DD,D/ GJ EF 'DFH9 'DE3*BD HJ*6EF 0DC *:0J) 95(J) %DI 'D:// 'D91BJ) (Cholinergic) HEF 'DFH9 (Adrenergic) %DI 'D:// 'D91BJ) л#(H C1'(JF╗ H'D96D'* 'DF'9E) H'D#H9J) 'D/EHJ). 'DFG'J'* 'D95(J) DD,D/ E.*DA) 'D#FH'9 AEFG' E' GH -1 H'D(96 JF*GJ AJ ,1'( 'D491 H'D".1 DG FG'J'* EF*A.). CE' #F GF'C FG'J'* 95(J) E*.55) AJ 'D#/E) EFG' C1J'* лA'*1╗ HлE3FJJ1╗ C1J'* лEJ1CD╗ 'D95(J) EH,H/) AJ 'DD3'F HC1J'* AJ ED*-E) 'D9JF #E' C1J'* л1AF2╗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air papilla): GJ 'D,2! 'D#3AD EF 'D491 H*8G1 9DI 4CD 'F*A'. HJ3EI (5JD) 'D491 (Hair bulb). ,01 'D491" Hair root" : GH 'D,2! EF 'D491) /'.D 'D,1'( HJ3EI EF(* 'D491 (Hair matrix) -J+ J*CHF 0DC EF .D'J' B1FJ). 'D4CD 1BE 6: ECHF'* 'D491 3'B 'D491 (Hair shaft): J*CHF 0DC EF .D'J' E*B1F) *3EI 'D:E/ @ 'DB41) H'DF.'9 AJ E1C2 'D491). :E/ 'D491) GH 'D,2! 'D.'1,J #E' 'D,2! 'D/'.DJ AJ*CHF EF 7(B'* лGC3DJ HGFDJ╗. JE*/ 'D,2! 'D.'1,J EF :E/ 'D491 EF 'D(41) -*I (5JD) 'D491 (CE' GH EH6- AJ 'D4CD 1BE 6). 'D#8'A1 'D#8'A1 E-/() D'E9) 'D37- H**CHF EF: 1. ,3E 'D8A1 (body) GH 'D,2! 'D8'G1 EF 'D#8'A1. 2. 'D71A 'D#E'EJ(Free edge) GH 'D,2! 'D#E'EJ EF 'D8A1. 3. ,01 'D8A1(Nail root) GH 'D,2! EF 'D8A1 *-* 'D(41). 4. 'D,2! 'D#(J6 'DGD'DJ EF 'D8A1 9F/ B'9/) 'D8A1 H*3EI G0G "Lanula" 5. EG/ 'D8A1(Nail bed) GH 'D,2! EF 'D(41) 'D*J J3*DBJ 9DJG' 'D8A1. 6. EF(* 'D8A1(Nail matrix) GH 'D,2! EF 'D8A1 #3AD ,01 'D8A1. 7. +FJ'* 'D8A1(Nail folds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лD' F,1G'F3╗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ameller" 'D-'HJ) 9DI 4-HE *D9( /H1'K G'E'K AJ -E'J) 'D,D/. 'DC+J1 EF 'DE1C('* E+D 'D4-HE /'.D 'D.D'J' @ 'D.D'J' 'DE*B1F) @ 'D-EH6 'D"EFJ(+)  H'D#ED'- 'D#.1I AJ 'D91B  H'DEA12'* 'D/GFJ)  'DEH'/ 'DF'*,) 9F *.1( 'D(1H*JF'* 'DB1FJ)  CD *DC 'DEH'/ *4CD -',2'K G'E'K DEF9 6J'9 'DE'! H'D-A'8 9DI pH 'D,D/ AJ -'D*G' 'DE+'DJ). 'D7(B) 'DB1FJ) *D9( 'D/H1 'D#GE C-',2 6/ 'D'D*G'('* 'DE.*DA). JD9( 'D,D/ C0DC /H1'K G'E'K C-',2 +F'&J 'D'*,'G DEF9 9(H1 'DE'! DD/'.D HAB/'F 'DE'! %DI 'D.'1, C0DC  %0 #F 'D(41) GJ 'D-',2 'D1&J3I A%0' #2JD* A%F 'D#/E) 'D('BJ) *CHF F'A0) (4CD C'ED. (1/9)  GF'C 71JB*'F E-*ED'F DE1H1 'D#/HJ) H'DEH'/ 'D#.1I HJ*E 0DC 9(1 'D(41) H9(1 'D.D'J' HG0G GJ 'D#C+1 '-*E'D'K DE1H1 'DEH'/ 'DE3*B7() %DI /'.D .D'J' 'D.D'J'. 'D9H'ED 'DE$+1) 9DI FAH0J) 'D,D/ %F FAH0J) 'DEH'/ 9(1 37- 'D,D/ *9*E/ %DI 9HED 9/J/) #GEG': 1. 'D9E1: 'DFAH0 #C+1 9F/ 'DHDJ/ EFG 9F/ 'DCGD. 2. -'D) 'D,D/: 'DFAH0J) #9DI AJ 'D,D/ 'DE*#0J 'D37-. CE' #F 'DEH'/ 'DCJEJ'&J) 1(E' *$0J 'D,D/ H*2J/ 'DFAH0J). 3. ,A'A 'D,D/ @ 'DFAH0J) #C+1 AJ 'D,D/ 'D17( EFG' AJ 'D,'A. 'D17H() *2J/ B'(DJ) 'D7(B) 'DE*B1F)  HJ9*(1 'DE'! 'DE-16 'DA9'D DDFAH0J). 'D4CD 1BE 8: 'D7(B) 'DB1FJ) H'DA1':'* 4. 'DE-*HI 'D/3E DD(41) DJ3 DG *#+J1 C(J1 9DI 'DFAH0J). 5. FE7 'D-'ED DDEH'/: %F 'DH3J7 #H 'DF'BD 'D0J J-*HJ (96 'DEH'/ 'DE$+1) B/ J2J/ 'DFAH0J) H'D'E*5'5 DD#/HJ) H:J1G' EF 9DI 37- 'D,D/  HG0' J9*E/ 9DI FE7 'D-'ED H-'D) 'D,D/. 9// EF 'D-H'ED FA3G' B/ *3(( 'D#0I DD,D/ -*I 'D(3J7) EFG' H('D*'DJ A%F G0G *3'9/ 9DI 'DE2J/ EF FAH0 #C+1 DD/H'! H'DEH'/ 'D#.1I 'DE7(B EH69J'K 9DI 37- 'D,D/. 6. 'D'-*B'F H*H3J9 'D#H9J) 'D/EHJ): 'D'-*B'F J2J/ EF '3*,'() 'D,D/ DDE-16'* 'DE.*DA) 3H'! C'F* EH69J) #H /'.DJ) H*DC *2J/ 'DFAH0J) 'D,D/J). 7. 'D9H'ED 'DAJ2JHDH,J) H'D/H'&J): FAH0 'DEH'/ 'DEH6H9) 9DI 37- 'D,D/ *9*E/ 9DI E$+1'* E.*DA) AE+D'K: 'FB('6 'D#H9J) 'D/EHJ) J92J %DI 'D3*J1H*J/'* 'DB41J). 'D*H39 'DH9'&J J92I %DI 'DFJCH*JF'*. 'D41J(Whealing) J92I %DI 'DGJJ3*'EJF'*. 'D*91B JCHF F*J,G 'D('JDHC'1(JF. 'D*./J1 J9H/ DDE./1'* 'DEH69J). (1/10)  8. 'DEH'/ 'DE0'() ('D4-HE *3'9/ 9DI FAH0 'DEH'/ 'DE7(B) 9DI 37- 'D,D/ H'DG1EHF'* H'D3*J1HJ/ HAJ*'EJF"D" H'D#ED'- 'DCDH1JF H'DC(1J*'* JECF #F *FA0 EF 37- 'D,D/. 'D:'2'* H'DEH'/ 'D7J'1) JECF C0DC #F *9(137- 'D,D/. 'DE1',9 Abraham W, Downing DT. Preparation of model membranes for skin permeability studies using stratum corneum lipids. J Invest Dermatol 1989; 93: 809-13 .1 Breathnach AS. Embryology of human skin. A review of ultrastructural studies. The Herman Beerman Lecture. J Invest Dermatol 1971; 57: 133 - 43 .2 Breathnach AS. An Atlas of the Ultrastructure of Human Skin. London: J. & A. Churchill, 1971 .3 Biochemistry and Physiology of the Skin Vol 2. New York and Oxford: Oxford University Press, 1983: 1255-95 .4 Blank IH. Cutaneous barriers. J Invest Dermatol 1965; 45: 249-56 .5 Elias PM. Epidermal lipids, membranes, and keratinization. Int J Dermatol 1981; 20: 1-19 .6 Deutsch TA, Esterly NB. Elastic fibers in fetal dermis. J Invest Dermatol 1975; 65: 320-3 .7 Farmer ER, Hood AF, eds. Pathology of the Skin. London: Prentice Hall International, 1990 .8 Goldsmith LA, ed. Biochemistry and Physiology of the Skin 2nd edn. New York: Oxford University Press, 1991 .9 Holbrook KA, Odland GF. Regional development of the epidermis in the first trimester embryo and the second trimester fetus (ages related to the timing of amniocentesis and fetal biopsy). J Invest Dermatol 1980; 74: 161-8 .10 Holbrook KA, Hoff MS. Structure of the developing human embryo and fetal skin. Semin Dermatol 1984; 3: 185-202 .11 (1/11)  Hashimoto K, Gross BG, Lever WF. The ultrastructure of the skin of human embryos. I. The intraepidermal eccrine sweat duct. J Invest Dermatol 1965; 45: 139-51 .12 Lever WF, Schaumburg-Lever G. Histopathology of the Skin 7th edn .13 Briggaman RA, Wheeler CE. Epidermal-dermal interactions in adult human skin. II. The nature of the dermal influence. J Invest Dermatol 1971; 56: 18-26 .14 Montagna W, Yun JS. The skin of primates. XVI The skin of Lemur mongoz. Amer J Phys Anthrop 1963; 21: 371-81. Philadelphia: Lippincott, 1990 .15 McKee PH. Pathology of the Skin. Philadelphia: Lippincott, 1989 .16 Scheuplein RJ, Bronaugh RL. Percutaneous absorption. In: Goldsmith LA, ed .17 Smith JG, Jr, Fischer RW, Blank H. The epidermal barrier: a comparison between scrotal and abdominal skin. J Invest Dermatol 1961; 36: 337-41 .18 Scheuplein RJ, Bronaugh RI. Percutaneous absorption. In: Goldsmith LA, ed Biochemistry and Physiology of the Skin Vol II. New York and Oxford: Oxford University Press, 1983: 1255-95 .19 Wertz PW. Lipids of keratinizing tissues. In: Bereiter-Hahn J, Matoltsy AG, Richards KS, eds. Biology of the Integument. Vol 2: Vertebrates. Berlin: Springer-Verlag, 1986; 815-23 .20 Yardley HJ. Epidermal lipids. In: Goldsmith LA, ed. Biochemistry and Physiology of the Skin. New York: Oxford University Press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л'D3J1JD'C╗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eroderma pigmentosum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occidomycosis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entostam I.M.60Mg.daily) DE/) 941) #J'E. 'DE1J6) E9*'/) 9DI #.0 5H1 EFA5D) DB1-) 'D3'B. HAJ 'DJHE 'D9'41 2'1*FJ AJ 9J'/*J HB/ 4AJ* (4CD 31J9 'DA5D Season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entian violet)  AGJ DJ3* *:7J 'D"A'* H%FE' B/ *3(( *3D.'K D,D/ 'D7AD .'5) %0' 7(B* E1C2G 9DI 'DEF'7B 'D*F'3DJ) H'D+FJ'* 'D,D/J). H1(E' *.*AJ 'D5H1) 'D31J1J) (4CD C'ED (3(( (96 'D#/HJ) 'DEH5HA)..CE' %F (96 'D#E1'6 E+D 'D#C2JE' 3HA F,/ #F 'D*:J1'* H'DE6'9A'* F',E) 9F 'DE9'D,) 'D:J1 EF'3() 'D*J *97I DDE16 'D,D/J AJ 'D(/'J). 9// C(J1 EF 'D#7A'D 'D169 B/ J5'(HF ('D.7H7 9DI 'D,D/  (+H1 *4(G -(H( 'D4('(  H,G 'D(/1  ,D/ -E'EJ (E-E1) H1BJB .'5) 9DI 'DH,G H0DC B/ JF,E 9F 3H! '3*9E'D #H '3*./'E E1C('* 'DCH1*J2HF ('D3*J1$J/'* 'DB41J)) 'DBHJ) 'DA9'DJ). 'D#/HJ) 'DEH69J) C0DC B/ *$/J %DI *-33 EH69J (3(( E-*HI 'DB'9/) 'D*J J-61 (G' 'DE1C( #H 'D/H'! FA3G #H EF 'DE4'1C) E9 #/HJ) #.1I E+D 'DFJHE'J3JF  'DE1C('* 'D*J *3*./E AJ 'D*./J1 'D,1'-J  E6'/'* 'DG3*'EJF H-*I 'D3*J1HJ*J/'*. HB/ J-/+ 'D*-33 'D/H'&J EF 'DE6'/'* 'D-JHJ) H'DEG/&'* H'DEBHJ'* H'DAJ*'EJF'* H'DEDJF'* HCE' #F 'D'F/A'9 'D/H'&J 'D+'(* 'DF',E 9F 'D3DAHFEJ/'* JECF #F J-/+ C0DC. (96 E17('* 'D,D/ 'D-'HJ) 9DI #94'( .'5) #H 'D*J *CHF 9DI 4CD 4'J 'D#94'( B/ *3(( '1*C'3'K ,D/J'K 4/J/'K. 'DA-5 'D31J1J (1/17)  J,( #F JCHF 'DA-5 *-* 6H! ,J/ HJA6D 6H! 'DFG'1 #H E5('- J4(GG. '3*./'E 'D9/3'* 'DEC(1) 'DE*-1C) JECF #F *3'9/ 'DC+J1. AJ C+J1 EF 'D-'D'* JECF *4.J5 'D-'D) 'DE16J) ('D9JF 'DE,1/) H0DC E9 'D.(1). HDCF 'DA-5 'D4'ED DJ3 AB7 E-5H1'K ('DEF7B) AJE' -HD 'D"A) H%FE' J,( #F J4ED 'DEF'7B 'D#.1I EF 'D,3E HJ,( 9/E %GE'D 0DC. 'D7(J( J,( #F J*GJ# HJBHE (9ED E' D#,D E1J6G  ('D%6'A) DD*-/+ E9G H%6'A) 1H- 'DE1- %DI 'DE1J6 CE' J,( #F J-'HD #F J(9+ AJG 'D+B) H'D*4,9 H'DH/. HJ3*7J9 -*I #F JB/E DD-'D'* 'D*4'$EJ) F81) *A'$DJ) D,9D E1J6G 39J/'K .'5) #HD&C 'DE5'(JF (#E1'6 ,D/J) E9B/) E2EF) #H 'DE5'(JF (#E1'6 FA3J). %0 J,( 9DI 'D7(J( #F J-'HD %/.'D 'D7E#FJF) H'D1'-) %DI FA3J) 'DE1J6. %F +B) 'DE1J6 #H #A1'/ 'D9'&D) ('D7(J( *9*(1 0'* #GEJ) B5HI  H'DH5A) H-/G' B/ D' *CAJ %0 J,( 9DI 'D7(J( #F D' J1C2 ,D 'F*('GG D*4.J5 H9D', 'D"A) 'D,D/J) AB7 (D J,( #F J*-1I 9F H,H/ 9D'B) (JF 'D"A) 'D,D/J) H1H'(7 #.1I  %0 #F (96 'D#E1'6 'D,D/J) *CHF E8'G1 D#E1'6 /'.DJ). CE' #F 'DA-5 'D31J1J 'D4'ED J,( #F D' J:AD #J 9D'E'* '67G'/ B/ *8G1 9DI 'D7AD 3H'! EF B(D 'D#GD #H 'D./E #H 'D3'&BJF #H EH8AJF ".1JF J9EDHF D#,D 'D#31). HJ,( C0DC A-5 'DEF'7B 'D*F'3DJ) 9F/ 'D7AD DDC4A 9F '-*E'D H,H/ 9D'E'* 'D%D*G'( 'DEH69J .'5) 'D+#DJD 'D*F'3DJ) H'D41,J)  3,-'* H'FA9'D'* ('DEF7B) 'D*F'3DJ) H'D41,J) %0 DJ3 EF 'DE3*(9/ #F JD'-8 'D7(J( 2H'D :4'! 'D(C'1) #H 3,-'* AJ 'DEF'7B 'D*F'3DJ) #H EA12'* EG(DJ) #H /'.DJ) #H 'DE8'G1 'D#.1I DD#E1'6 'DEF*BD) ('D,F3 9F/ 'D#7A'D. HJ,( C0DC ED'-8) 'D3DHC 'DFA3J H9D'B) 'D7AD (#GDG H'D#96'! 'D".1JF AJ 'D9'&D). #FH'9 'D"A'* 'D,D/J) 'D"A'* 'D,D/J) 'D#HDJ) ('D(/'&J)) (1/18)  HGJ 'D"A'* 'D#5DJ) 'D*J *8G1 (F*J,) E-16'* E.*DA). H*4ED G0G: 1. @ D7'.) (Macule): EF7B) E37-) E-/H/) EF DHF E.*DA 9F 'D,D/ 'DE-J7 (G'. B/ *5(- E1*A9) (3(( 'DH0E) -J+ *3EI 9F/&0 D7'.) -7'5J). 2. @ 'D-7'7) (Papule) : '1*A'9 EF 'D,D/ E-// 'D-H'A. 3. @ 'D9BJ/) #H 'D/1F) (Nodule) : '1*A'9 5D/ #C(1 EF 'D-7'7). 4. @ 'D(B9) (Plaque) : ,2! E1*A9 3EJC EF 'D,D/ 0'* -H'A H'6-) ,/'K H37- .4F #H ED3 #H EF(37). 5. @ 'D-E'EJ(Erythema) : '-E1'1 AJ 37- 'D,D/: HGJ #4J9 'D"A'* 'D,D/J) 'D(/'&J) *8G1 AJ E98E #E1'6 'D,D/ H*F,E 9F *H39 'D#H9J) 'D/EHJ) AJ 'D#/E). 6. @ FA7G (Blister) : -HJ5D ,D/J EEDH! 9'/) 3'&D. 7. @ 'D-HJ5D (Vesicle) : AB'9) 5:J1). 8. @ AB'9) (Bulla) : -HJ5D 6.E. 9. @ 'D(+1)(Pustule) : E1*A9 ,D/J EEDH! (3'&D ED*G(. 10. @ 'DH-E) (Nevus) : #E1'6 ,D/J) 9'&DJ) H1'+J) *F,E 9F 9H2 A17 AJ 'DE-*HI 'D7(J9J DD,D/ H9'/) *91A ('3E 'DH-E'* ('D4'E'*). 'D"A'* 'D,D/J) 'D+'FHJ) HGJ *9/JD'* #H *:J1'* AJ 'D"A'* 'D#HDJ) F',E) 9F #F*'F #H 16 #H 9H'ED #.1I. 'D"A'* 'D,D/J) 'D+'FHJ) GJ: 'D*-14A(Scales ) : 7(B) EF 'D.D'J' 'DB1FJ) 'DE37-) *F4# EF 'D7(B) 'DE*B1F). *B41 'D,D/ GH AJ2JHDH,J 9F/ 'D#4.'5 'D7(J9JJF JF,E 9F/E' J*E *CHJF .D'J' 'D(41) 31J9'K #H GF'C '671'( AJ *B1F 'D,D/ A%F 'D*B41 'DE16J 3HA JF*,. HB/ JCHF EH69J'K #H E9EE'K HJ3EI 'D*G'( 'D,D/ 'D*-14AJ. 'DB4H1 (Crust) : E5D ,'A JD'-8 AJ 'D#H9J) 'DE*E2B) #H 'D(+1'* #H 'DAB'9'*. 'D3-,'*Excoriation) ): 3,-'* ,D/J) JF,E 9'/) EF 'D#8'A1 CE-'HD) DEF9 'D-C. 'D4BHB(Fissure) : *G*C #H 'FA5'D AJ 'D(41). 'D*"CD #H 'D'FBD'9 (Erosion) : EF7B) AB/'F ,2&J EF 'D(41) 'D,D/J) #H 'D#:4J) 'DE.'7J). 'D6EH1 (Atrophy) : 6J'9 'D3E'C) AJ 'D(41) #H 'D#/E) #H 'D#F3,) 'D#.1I. (1/19)  'D*-22(Lichenification) : 2J'/) 3E'C) 'D,D/ HB/ J*(9 0DC 2J'/) AJ #5(': 'D,D/. 'D*DJA(Fibrosis) : *4CD F3J, DJAJ :2J1. 'D.1', (Abscess) : *,E9 EH69J DD5/J/ AJ ,HA (CGA) J*4CD EF *.1( #H *F.1 'DF3J,. 'D-E1) ('D*G'( 'DF3J, 'D.DHJ) (Cellulitis) : 'D*G'( AJ 'DF3J, 'D.DHJ .'5) 'DBJ-J EFG AJ 'D#/E) 'D9EJB) H'DF3J, E'*-* 'D,D/. 'D*BJ- 'D,D/J ('D/(JD)) (Pyoderma) : 'D*G'( ,D/J BJ-J. 'D-'5) ('D+9D()) (Alopecia) : 6J'9 'D491 'DEH69J #H 'D9'E HB/ JF,E 0DC 9F 9/) 9H'ED ,G'2J) #H EH69J). 'D+9D() B/ *CHF (/&J) #H +'FHJ) D#E1'6 ,D/J) #HDJ) E+D 'D#F*'F'* 'D,1+HEJ) #H 'DA71J). 'D'FA'B (Burrow): BF') 5:J1) AJ 'D,D/ *-*HJ 9DI H-J/'* 'D.DJ) E+D 'D,1(. 'D2$'F(Comedo) : 'F-('3 'DC1'*JF H'D/GHF AJ A*-) 'DBFH'* 'D/GFJ) 'DE*H39). 'DH1E 'D/EHJ(Hemartoma) : 4() H1E J-*HJ 9DI /E. 'DC/E'* (Ecchymosis) : EF7B) EF 'DF2A (B71 #C+1 EF 2 3E. 'DFE4'* (Petechiae ) : F2A FB7J -H'DJ 1 @ 2 EDE B71'K. 'D*5(:'* (Stains) : A17 *5(9 EH69J J*DH (96 #E1'6 'D,D/. 'D*B41 ('D*H3A) (Exfoliation) : HGJ 'F47'1 'DC1'*JF 'D#/EJ %DI B4H1. 'D5(': 'D/EHJ (Hemosedroses) : 'D'D*G'( 'D,D/ 'D5(':J J*(9 'D*,E9'* 'D/EHJ) *-* 'D,D/. 'DFH'3J1(Fistula) : HGJ EE1 EF 'D7(B) 'D9EJB) %DI 37- 'D,D/ #H (JF (FJ*JF HGJ E:7J 9'/) ((41) 4'&C). *B1F 'D,D/ (Keratoderma) : 2J'/) AJ 3E'C) 'D7(B) 'DB1FJ). 'D.7H7(Stria) : "A'* .7J) JF,E 9F 4/ 'D,D/ 3H'! AJ2JHDH,J'K #H E16J'K. 'D+AF (Callous) : 3E'C) B1FJ) AJ 'D,D/. 'D/.F (Milium) : CJ3) (J6'! 5:J1) *-*HJ 9DI E'/) CJ1'*JFJ). 'DF'(*G (Vegetations) : HGH FEH F3J, E16J J-*HJ 9// EF C*D -DEJ) E*B'1(). 'DH1E 'D-DJEI( Papilloma) : C*D) *4(G 'D-DE)  *(12 EF 37- 'D,D/. (1/20)  'DBD'9 (Aphthae) : B1- 5:J1) AJ 'D#:4J) 'DE.'7J). 8'G1) CH(F1 ('DC*H(J) 'D0'*J) (Koebners phenomenon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uerbach AD. Diagnosis of diseases of DNA synthesis and repair that affect the skin using cultured amniotic fluid cells. Semin Dermatol 1984; 3: 172-84 .1 Auerbach AD. Diagnosis of diseases of DNA synthesis and repair that affect the skin using cultured amniotic fluid cells. Semin Dermatol 1984; 3: 172-84 .2 Ahlstedt S, Eriksson N, Lindgren S et al. Specific IgE determination by RAST compared with skin and provocation tests in allergy diagnosis with birch pollen. Timothy pollen and dog epithelium allergens. Clin Allergy 1974; 4: 131-140 .3 Boyd AS, Neldner KH. The isomorphic reponse of Koebner. Int J Dermatol 1990; 29: 401-10 .4 Committee on Provocative Food Testing. Identification of food allergens. Ann Allergy 1973; 31: 375-92 .5 'DA5D 'D1'(9 71B '3*B5'! 'D#E1'6 'D,D/J) 71B 'D'3*B5'! E' B(D 'DHD'/) (Prenatal diagnosis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лGJE'*HC3JDJF╗ л'JH2JF╗ #H л,JE2'╗. G0G JECF #F *A-5 (9/3) BDJD) 'DBH) HEF +E (9/3) 9'DJ) 'DBH) D#.0 AC1) -HD E-*HJ'* 'DD7'.). 'D71B 'D9'EG D'3*B5'! 'D'E1'6 'D,D/JG D7'.) *2'FC(Tzank test) : 'DA-5 'DF3,J EF B'9/) 'DAB'9) DC4A 'D"A'* 'DAB'9J) AJ E98E 'D'F/A'9'* 'DAB'9J) A%F 'DD7'.) 3HA *(/J .D'J' 'D*G'(J) AB7 AJ 'DAB'9 HJECF #F JD'-8 .D'J' 4'&C) 0'* FHI 6.E) H3J*H(D'3E' C+JA) AJ 'D-D' 'D(3J7. /'! 'DEF7B) H,/1J 'DE'! 3HA *(/J 'DD7'.) .D'J' 917D) H-J/) HE*9//) 'DFHI H*FC3 ('DHFJ 'D4CD AJ 'DFHI. 'D*F8J1 'D.'1,J(Diascopy) : H3JD) (3J7) *AJ/ AJ %6'A) E9DHE'* DD*4.J5 AJ (96 #E1'6 'D,D/ E+D 'D0&() 'D4'&9) 'D0J J(/J 9BJ/'* E+D GD'E 'D*A'- 'D(FJ 'DE-E1 'DE'&D DD5A1) H*,1J G0G 'D*,1() (H'37) 41J-) 2,',J) #H .'A5 D3'F (D'3*JCJ 4A'A (6:7 (BH) 9DI 'D"A). 'D'F6:'* 'DE$B* DD/E 3HA J8G1 'D*:J1'* 'D,D/J). A-5 C4'7'* 'D,D/(Skin scrappings) : *3*./E 9'/) D*4.J5 'D"A'* 'DA71J)  *#.0 'DC4'7) EF 'DA1H) #H 'DEF'7B 'DE:(FJ)  'D#B/'E #H 'DEF'7B 'D#.1I H0DC J*E CE' JDJ: JF8A 'D,D/ (H'37) 'DC-HD +E J*1C -*I J,A. (1/23)  'D4CD 1BE 9: 'D*F8J1 'D.'1,J 'C47 'DEF7B) (H'37) 'DEC47) #H -'A) 'D41J-) 'D2,',J) 9DI 41J-) F8JA) H#6A FB7) H'-/) EF E1C( 10% @ 20% EF KOH #H SMS . 'D.JH7 H'D#(H': *8G1 (4CD #,3'E (J6'HJ) H*F9C3 6/ #16J) 'D.D'J' H'D4H'&(. H%+('* 'D*4.J5 H'D*#C/ EF 'DF*J,) J*E 9'/) (H'37) 219 'DC4'7) 9DI H37 .'5 E+D H37 л",'1 3'(H1HJ/╗. 'D5H1) 'D/EHJ) (Blood picture): *(/J (96 #E1'6 'D,D/ *:J1'* /EHJ) ,G'2J) #H EH69J) D0DC A%F 5H1) 'D/E B/ *3'9/ AJ 'DH5HD %DI 'D*4.J5  HD' J9FJ 0DC #F CD 'D-'D'* 'D,D/J) AJ -',) %DI B'&E) EF 'D'.*('1'* 'D*J 1(E' *,9D 'DE1J6 J5D %DI AB/'F +B*G ('D7(J(.B/ *8G1 5H1) 'D/E AJ (96 'D#E1'6 'D,D/J) E' JDJ: A17 'DE9/D'*(Neutrophilia) : *-/+ AJ 'D#E1'6 'D,D/J) 'D*'DJ): 1. 'D'F*'F E+D 'D-E1) @ 'D/ED. 2. '671'('* 'D*G'(J) E+D 'D(+1J) #H 'D5/'A 'D'D*G'(J  '-E1J'* 'D,D/ 'D/(JD) 'DF.1) (Pyoderma gangrenosum). 3. 'D.('+) 'D,G'2J) H'(J6'6 'D/E (Leukemia). 4. 'D'1*C'3 DDE9'D,) 'D,G'2J) ('D3*J1H&J/'*. A17 'D-E6J'* (Eosinophilia) 4'&9 AJ 'D-'D'* 'D*'DJ): 1. 'D#E1'6 'D'3*41'&J) .'5) 'D1(H H'D#C2JE'. 2. 'D-3'3J) DD79'E #H 'D/H'!. 3. 'D%5'() 'D7AJDJ): /J/'F (E9HJ) @ ,G'2J))  'D,1(. 4. #E1'6 'DCHD',JF 'DH9'&J): 'D*G'( 'D41'JJF 'D9/J/ 'D9B/J @ 'D*G'( 'D,D/ H'D96D'*. 5. 'D"A'* 'DAB'9J): 'D#C2JE'* 'D.DBJ)  'DAB'9 H'D/'! 'DAB9'FJ. 6. -E'EJ 'DHDJ/ (Erythema neonatarum). 7. 'D.('+) .'5) /'! GH/ ,CF2 H'(J6'6 'D/E ('D-E6J'*. A17 DDEA'HJ'* (Lymphocytosis) JECF #F JD'-8 AJ 'D-'D'* 'D*'DJ): 1. 'D'F*'F'* 'DAJ1H3J) .'5) 'D7AH- H/'! H-J/'* 'DFHI 'D'F*'FJ. 2. 'D'F*'F'* 'D,1+HEJ): 'D*/1F  'D2G1J ('D%A1F,J)  'D-EI 'DE'D7J) H-EI 'D*JAH&J/. 319) 'D*+BD " ESR " (1/24)  '.*('1 :J1 FH9J  '1*A'9 39) 'D*+AD JF,E 9'/) 9F 2J'/) 'D*5'B 'DC1J'* 'D/E 'D-E1 'DF',E 9F 40H0 (1H*JFJ'* 'D(D'3E' H'DAJ2JHDH,J) 'DE*1'AB E9 '1*C'3'* 'D7H1 'D-'/ #H 'DE2EF. (96 #3('( '1*A'9 319) 'D*+BD: 1. AJ2JHDH,J): 'D-ED  'D7E+  *B/E 'D9E1. 2. 'F*'F'*. 3. '671'('* 'D*G'(J) E+D 'D*G'( 'D#H9J). 4. 'D0&() 'D-E'EJ) 'D,G'2J) (SLE). 5. *.1( 'DF3J,. 6. 'D#H1'E 'D.(J+). 7. A17 F8'&1 'D(1H*JFJ'* 'D/EHJ). 8. A17 'DC1J'* 'D-E1 ('DC8G 'D/EHJ)). E9'J1) (1H*JFJ'* 'DE5D (Serum protein estimation) : G0' 'D'.*('1 J3*./E AJ (96 'D#E1'6 E+D 'D0&() 'D,G'2J HA17 (1H*JFJ'* 'D/E. '6/'/ 'DFHI "ANA" B/ *H,/ AJ: 1. #E1'6 'D:1'! 'DH9'&J) .'5) 'D0&() 'D-E'EJ) 'D,G'2J) " SLE ". 2. #E1'6 'DC(/ 'DE2EF). 3. 'D*G'( 'D/1B 'DG'4JEH*H @ 'DH1E 'D5B1J (+JEHE') @ 'DHGF 'D96DJ 'DH.JE. 4. AB1 'D/E 'D.(J+. 5. 'D*/1F. 6. 'D,0'E. 7. 'D*DJA 'D1&HJ 'DEF*41. 8. 'DDEAHE' H'D#H1'E 'D#.1I. 9. 'D*G'( 'DBHDHF. 'D'.*('1'* 'DE5DJ) G0G 'D'.*('1'* *C4A (96 'D#E1'6 'D,D/J) E+D 'D2G1J ('D%A1F,J) H/'! 'DDHD(J'* :J1 'D2G1J) E+D 'D(F*' H'D%A1F,J 'DE*H7F ('D(,D) (4CD 1&J3J. H8'&A 'DC(/ B/ **8'G1 #E1'6 'DC(/ (E8'G1 /'.DJ) H,D/J). 'DE9'J1'* 'DG1EHFJ): .7 EGE ,/'K AJ '3*B5'! (96 'D#E1'6 'D,D/J) .'5) 'DE*1'AB) E9 B5H1 H8JA) 'D:// 'D5E'!. '.*('1 'D:DHJHDJF'* 'DB1J)(Cryoglobulin tests) *(/J *13( 'D(1H*JFJ'* 9F/ 'D*(1J/ H%9'/) 0H('FG' 9F/ 'D*3.JF HG0G 'D:DHJHDJF'* D' *H,/ 9F/ 'D#4.'5 'D7(J9JJF. 'D#E1'6 'D,D/J) 'D*J *(/J '.*('1 %J,'(J GJ: @ 'D(1A1J) @ 'D21B) (3(( 'D-3'3J) DD(1/ @ /'! 1JFH @ 'D0&() 'D-E'EJ) @ 'D/'! 'D-(J(J DDEA'HJ 'D2G1J @ B1-'* 'D3'B @ (1A1J) 'D,D/ 'D71JB): (1/25)  J,E9 10 3E3 EF 'D/E 'DH1J/J AJ 31JF, E/A&'K HJA5D 'DE5D (/1,) -1'1) 37 E +E J(1/ AJ 'D+D',) D/1,) 5E. 'D*,1() 'D%J,'(J) *8G1 **4CD 13'() ,D'*JFJ) H*F-D 9F/ 'D*/A&). 9J'1 (H1AH(JDJFH,JF 'D(HD (Porphobilinogen test) HGH '.*('1 FH9J DD(H1AJ1J' 'D-'/) 'DE*B79) HGH (3J7 H0'* BJE) AJ *-1J 'DE16I 'DE*HB9 D/JGE (H1AJ1J'. 'D71JB): JE2, 5 ED EF (HD 7'2, E9 5ED EF 1J',JF л'1DJ4╗. H*E2, ,EJ9G' E9 10ED EF 5H/JHE '3*J'* E'&J)  HJ3*.D5 'DE-DHD (FA3 'D-,E EF 'DCDH1AH1E  'D(H1AH1(JDJFH,JF H'DJH1(JDJFH,JF J4CD'F E1C( л'D/GJ/ #-E1╗ ('D*A'9D E9 'D1J',JF. .29) 'D,D/ (Skin biopsy) 71JB) EGE) ,/'K D%+('* H/B) *4.J5 'D"A'* 'D,D/J). '.*('1'* 'D,D/ (Skin tests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atch test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pen patch test) : HG0' 'D'.*('1 J*-1I 'D1'*F,'* 'DF('*J). 'D71JB): *$.0 .D'5) 'DEH'/ E+D 'DF('*'*  'D(0H1 #H 'D#4,'1 (H'37) E0J( E+D 'D#3J*HF HJ7(B 9DI 37- 'D,D/ E9 E1'9') 'D-A'8 9DI ,A'A 'DEF7B) H*B1# 'DF'*, (9/ 48 3'9) . 2- '.*('1 'D(B9) 'DE.14 ('D*.14) (Provacative patch test) G0' 'D'.*('1 J3*./E D*-/J/ 'D-3'3J) EF 'DFJHEJ3JF H'DF(3JDJF H'D(F2HC'&JF. *7(JB E-DHD 10 % EF 3DA'* DH1JD 'D5H/JHE %DI EF7B) D'.*('1 DE/) 3'9)  'D'1*C'3 'DEGE 3HA J8G1 E('41). 3- '.*('1 'D(B9) 'D:'2'*J(Vapor patch test) AJ G0' 'D'.*('1 J7(B EF #,D E91A) 'DEH'/ 'D7J'1) E+D 'D97H1. HAJG J7(B 'D(.'1 #H 'D:'2 9DI 37- 'D,D/ *-* C#3 2,',J E:DB 9DI 'D,D/ DE/) 48 3'9). (1/27)  4- '.*('1 'D(B9) 9DI 'D#:4J) 'DE.'7J): J3*./E DE91A) 'D9H'ED 'DE-33) 'DEH69J) AJ 'DAE E+D :3HD'* 'DAE H'DFJCH*JF HE9',JF 'D#3F'F H*,1J *DC 'D*,1() (H'37) C#3 4A'7 J-*HJ 9DI E'/) 'D'.*('1 J7(B 9DI 'D:4'! 'DE.'7J DD4A) HJ*1C DE/) 3'9). 'D4'G/ 61H1J AJ G0' 'DFE7 EF 'D'.*('1. 5- '.*('1 'D(B9) 'D6H&J(Photopatch test) J3*./E D*-/J/ 'DEH'/ 'DE-33) 6J'&J'K E+D 'DAJFH+J'2JF  'D3DA'  H'DF('*'* 'DE-33) 6J'&J'K. '.*('1 'D(B9) J,1J ('D71JB) 'D'9*J'/J) DE/) 48 3'9) #.1I. EF7B) 'D4'G/ (Control) 61H1J'K DFAJ 'D%J,'(J) 'DC'0() #H 'D3D(J) 'DC'0(). 71B '.*('1 'D(B9) 'D'9*J'/J) G0' 'D'.*('1 E*HA1 'D"F (4CD ,'G2  -J+ JECF *7(JB 'DE3*6/ (Antigen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ntradermal test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rick test) GJ *9/JD 'D'.*('1 /'.D 'D#/E) HEF'3() DD'.*('1 'D1H*JFJ D9// EF 'DE$1,'*. J,( ED'-8) #F 'D-BF /'.D 'D#/E) AJ '.*('1 'DH.2 B/ JCHF 'DE-DHD .7J1'K. 'D71JB): CEJ) 5:J1) EF 'DE-DHD 'D'.*('1 *H69 9DI 'D,D/ HJ,1J H.2 9(1G' (%(1) -'/) *CHF 37-J) (/HF 8GH1 /E. -,E 'D'F*A'. H'D'-E1'1 JB'3 (9/ 15 /BJB). '.*('1 'D*47J( ( Scratch test ) J4(G '.*('1 'DH.2. 'D71JB): *47J( .7J (7HD -H'DJ 1 3E. DCF 37-J (/HF %.1', /E. 'D'.*('1 J97J F*'&, #BD /B) EF '.*('1 'DH.2. 'D4CD 1BE 11: *,1() 'D*47J( '.*('1 'DH.2 'DE9/D: G0' 'D'.*('1 #C+1 -3'3J) (BDJD EF '.*('1 'DH.2 'D9'/J DCFG D' JB/E F*'&, %6'AJ). 'D71JB): FB7) EF E-DHD 'D'.*('1 *H69 9DI 'D,D/ H*/.D %(1) 37-J) ,/'K H(4CD #ABJ /'.D 'D,D/ H*1A9 D*4CD '1*A'9 (3J7 EF 'D(41). '.*('1 'D*H1E 'DA,'&J: 'D'3*9E'D'* : J3*./E D*-/J/ #6/'/ IgE. B/ J3*./E D*-/J/ IgE 'D,H'D  DCF D' JF5- (G (3(( .71 'D*G'( 'DC(/ 'DE5DJ #H 'D%J/2 EF 'D#/H'* 'DE3*9ED) %0' *DH+*. J3*./E (4CD 1&J3J AJ *BJJE -EI 'D9DA H'D1(H HDG EHB9 E-// AJ E9'D,) 'D#C2JE' 'D'3*41'&J). J4'1 DG AJ *4.J5 'D41I. J,( ED'-8) %F 'DF*'&, 'D%J,'(J) H'D3D(J) 'DC'0() 4'&9). -'.*('1" ELISA, RAST" RAST) '.*('1 'E*5'5 'D1J',JF @ 'D49'9J) H (ELISA 'DEB'J3) ('D'E*5'5 'DEF'9J 'DE1*(7 ('D#F2JE) GE' H3'&D (/JD) D*-/J/ HBJ'3 'D#6/'/ 'D,H'D) AJ 'D/E. (1/30)  RAST J*9DB ,J/'K ('D'.*('1 'D,D/J  HE$G( D'.*('1 'D#7A'D 'D5:'1 ,/'K HJ*9DB #J6'K ('DE$1,'* 'D*J B/ *3(( 'DE.'71 'D*J B/ *-/+ AJ '.*('1 'DH.2 ('D#/HJ)). '.*('1'* 'D*.14 ('DE+'1)) (Oral provocation test ) J,( %,1'$G' (9F'J) HDG' BJE) AB7 %0' C'F 'D'.*('1 E1'B( (/B) H'DE1J6 E*,'H('K HEB*F9'K. %97'! 'D/H'! #H 'DE'/) 'DCJE'HJ) 9F 71JB 'DAE B/ J3*/9J #-J'F'K D%+('* *4.J5 'F/A'9 #H *-/J/ 3((G 'D1&J3J. 'D'3*7('( : 'D#C2JE' 'D'3*41'&J). 'D41I 'DE2EF #H 'DE*C11. 'D-3'3J) DD79'E: %9'/) %/.'D 'D79'E 'DFH9J #H 'D%6'A'* E+D 'D**1'2JJF- 'D(F2H'* H'DE6'/'* CD 9DI -/). '.*('1 'D-1E'F H'DFAJ (Elimination&Exclusion tests) G0G 'D'.*('1'* *3*./E D*-/J/ 'D79'E 'DED*GE DE/) 9/) #J'E HE1'B() 'D"A) 'D,D/J) 1(E' JECF #F *3'9/ *DC 'D*91A %DI *#+J1 'DE'/) 'DE3(() DD*-33. #49) HH/ (Wood's light) GH E5('- #49) AHB 'D(FA3,J) E9 E5'AJ (AD'*1) HH/. 7HD 'DEH,) -H'DJ (3650 AR). G0G 'D#49) GJ H3JD) '3*B5'&J) EGE) AJ *4.J5 HE9'D,) #E1'6 ,D/J) FH9J). HB/ *3*9ED AJ 'DE3'9/) AJ *4.J5 'D"A'* 'D*'DJ): 'D'D*G'('* 'DA71J): 39A) 'D1#3 'DF',E) 9F 3D'D'* 'D(HJ6'! (Micosporon ) *97J DE9'F'K #21B E.61 HJ,( ED'-8) #F A5'&D 'DA71J'* ( Trichophyton violaceum & Trichophyton tonsurans) 'D*J *3(( 'DB19 ('D'D*G'( 'DA71J) (A1H) 'D1#3) D' *97J DE9'F'K *-* *#+J1 E5('- HH/. 'D'-E1J'* (Erythrasma) *97J HE6'F #-E1 #1,H'FJ. 'DF.'DJG 'DE(1B4) (Pityriasis versicolor): 9F/E' *A-5 AJ :1A) E8DE) (#49) HH/ F8J1 'D6H! *8G1 'D-'D) 'DE16J) (4CD H'6- HE-/H/. 'D'F*'F'* 'D,1+HEJ) (Bacterial infections) 'D95J'* 'D21B *97J DHF #.61 E5A1 (3(( 'D3J'FJF (Pyocyanin). (1/31)  95J'* -(H( 'D4('( ('D9/) (Acne bacillus) *3(( HE6'F E1,'FJ 'DDHF AJ 'D#,1() 'D491J) HJ-*ED #FG F',E 9F %F*', 'D(H1AJ1JF. 'D'-E1J) (Erythrasma) *97J DHF #-E1 @ #1,H'FJ #H (1*B'DJ 2G1J. *-/J/ 'D"A'* 'D5(':J): #49) HH/ JECF '3*./'EG' D*-/J/ 9EB 'DEJD'FJF AJ 'D,D/ -J+ #F '.*D'A '57(': 'D(41) #C+1 8GH1'K *-* #49) HH/ EF 'D6H! 'D9'/J. #49) HH/ *8G1 (4/) 'DA1B (JF 'D,D/ 'DE57(: H:J1 'DE57(:. *A1B A17 'D*5(: 9F 'DD'*5(: 'DC'ED CE' AJ 'D(G'B H'DEGB ('DF5H9). *-/J/ 'D(H1AJ1FJ'*: 9F/ A-5 'D(H1AJF'* AJ 'D(HD *97J HE6'F *-* #49) HH/ (DHF #-E1 /'CF #H (1*B'DJ E'&D DD2G1J. 'D(H1AJ1JF'* ('D(HD @ 'D(1'2 @ H#-J'F'K 3'&D 'D(+H1 AJ 'D(H1AJ1J' ( Porphyria cutanea tarda) HAJ 'D#3F'F AJ 'D(H1AJ1J' 'DE4CD) DDC1J'* 'D-E1. (1H*HJHAJ1J' 'D/E JECF *4.J5G' #J6'K (H'37) HE6'F 'DC1J'* 'D-E1 %0 #F G0G *97J FA3 'DHEJ6 (#49) HH/. 'D**1'3CJF: *13( 'D/H'! AJ 'DEJF'! 'DF'EJ DD#3F'F 9F/ 'D#7A'D J$/J %DI DHF #5A1 DD#3F'F *-* #49) HH/. 'D#H1'E 'D.(J+): AJ 'D,D/ .'5) 'D317'FJ) 'DH3AJ) 3'&D (Squamous cell carcinoma ) *97J DHF HE6'F #-E1 A'*-. E*A1B'*: 'D#/HJ) @ 'DE1C('* 'D5F'9J) H'DEH'/ 'DB'(D) DDHE6'F JECF *-/J/G' (4CD .'5 (H'37) #49) HH/. 'DE1',9 Auerbach AD. Diagnosis of diseases of DNA synthesis and repair that affect the skin using cultured amniotic fluid cells. Semin Dermatol 1984; 3: 172-84 .1 Ahlestedt S. Eriksson N, Lindren S, et. Al., Specific IgE determination by RAST compared with skin and provacation tests in allergy diagnosis with birth pollen. Timothy pollen and dog epithelium allergens. Clin Allergy 1974; 4:131-140 .2 (1/32)  Boyd AS, Neldner KH. The isormorphic response of Koebner. Int. J. Dermatol 1990; 29: 131140 .3 Committee on Provocative Food Testing. Identification of food allergies. Ann Allergy 1973; 31: 375-92 .4 Caplan RM. Medical uses of Wood's lamp. J Am Med Assoc 1967; 202: 123 5 .5 Pepys J. Skin tests. Br J Hosp Med 1984; 32: 120-4 .6 Dutz W, Kohout E. Dermatologic diagnosis by using the hemocytometer and the dental broach. Int J Dermatol 1982; 21: 410-11 .7 Diagnosis. London: Royal College of Obstetricians and Gynaecologists, 1984: 147-58 .8 Eady RAJ, Rodeck CH. In: Rodeck CH, Nicolaides KH, eds. Prenatal Elias S. Use of fetoscopy for the prenatal diagnosis of hereditary skin disorders. In: Gedde-Dahl T, Jr, Whepper .9 Farmer ER, Hood AF, eds. Pathology of the Skin. London: Prentice Hall International, 1990 .10 Gosden CM, Ross A, Eason PJ. In: Sandler M, ed. Amniotic Fluid and its Clinical Significance. New York: Marcel Dekker, 1981: 37-103 .11 Harrison PV. A guide to skin biopsies and excisions. Clin Exp Dermatol 1980; 5: 235-43 .12 KD, eds. Prenatal Diagnosis of Heritable Skin Diseases. Current Problems in Dermatology. Basel: Karger, 1987: 1-13 .13 Kaback MM. In: Rodeck CH, Nicolaides KH, eds. Prenatal Diagnosis. London: Royal College of Obstetricians and Gynaecologists, 1984: 1-12 .14 Lehman CW. A double blind study of sublingual provocative food testing: a study of its efficacy. Ann Allergy 1980; 45: 144-9 .15 McKee PH. Pathology of the Skin. Philadelphia: Lippincott, 1989 .16 (1/33)  Marks R, Dawber RPR. Skin surface biopsy: an improved technique for the examination of the horny layer. Br J Derm 1971; 84: 117-23 .17 Mills OH, Kligman AM. The follicular biopsy. Dermatologica 1983; 167: 57 63 .18 Polani PE. Incidence of developmental and other genetic abnormalities. Proc Roy Soc Med 1973; 66: 1118-19 .19 Patrick AD. Inherited metabolic disorders. Br Med Bull 1983; 39: 378-85 .20 Serup J. Quantification of weal reactions with laser Doppler flowmetry. Allergy 1985; 40: 233-7 .21 Seltzer JM. Correlation of allergy test results obtained by IgE RAST and prick- puncture methods. Ann Allergy 1985; 54: 25-30 .22 Boyd AS, Neldner KH. The isomorphic reponse of Koebner. Int J Dermatol 1990; 29: 401-10 .23 Rothman S. Physiology and Biochemistry of the Skin. Chicago: University of Chicago Press, 1954 .24 Caplan RM. Medical uses of Wood's lamp. J Am Med Assoc 1967; 202: 123-5 .25 Gilchrest BA, Fitzpatrick TB, Anderson RR et al. Localization of melanin pigment on the skin with Wood's lamp. Br J Dermatol 1977; 96: 245-8 .26 Gottlieb PM, Stupniker S, Askovitz J. The reproducibility of intradermal skin tests: a controlled study. Ann Allergy 1960; 18: 949-60 .27 Lever WF, Schaumburg-Lever G. Histopathology of the Skin 7thedn. Philadelphia: Lippincott, 1990 .28 McKee PH. Pathology of the Skin. Philadelphia: Lippincott, 1989 .29 Pepys J. Skin tests. Br J Hosp Med 1984; 32: 120-4 .30 (1/34)  Ahlstedt S, Eriksson N, Lindgren S et al. Specific IgE determination by RAST compared with skin and provocation tests in allergy diagnosis with birch pollen. Timothy pollen and dog epithelium allergens. Clin Allergy 1974; 4: 131-140 .31 Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases. Philadelphia: Lea & Febiger, 1978 .32 Farmer ER, Hood AF, eds. Pathology of the Skin. London: Prentice Hall International, 1990 .33 Harrison PV. A guide to skin biopsies and excisions. Clin Exp Dermatol 1980; 5: 235-43 .34 Eady RAJ. Fetoscopy and fetal skin biopsy for prenatal diagnosis of genetic skin disorders. Semin Dermatol 1988; 7: 2-8 .35 Eady RAJ, Rodeck CH. In: Rodeck CH, Nicolaides KH, eds. Prenatal Diagnosis. London: Royal College of Obstetricians and Gynaecologists, 1984: 147-58 .36 Gosden CM, Ross A, Eason PJ. In: Sandler M, ed. Amniotic Fluid and its Clinical Significance. New York: Marcel Dekker, 1981: 37-103 .37 Auerbach AD, Adler B, Chaganti RSK. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 1981; 67: 128-35 .38 'DA5D 'D.'E3 E('/& 71B E9'D,) 'D#E1'6 'D,D/J) (1/35)  %F E9'D,) 'D#E1'6 'D,D/J) GJ AJ 'D-BJB) AF J2/'/ ('DEE'13) H'D.(1) 'D7HJD). DJ3 EF 'D-CE) #F JF/A9 'D7(J( 'DE9'D, AH1 ,DH3 E1J6G D(69) /B'&B AJ C*'() 'DH5A) 'D7(J) EDJ&) EF 'DH,GJF ('D#/HJ) 'D*J B/ *AJ/ #H D' *AJ/. %FG AJ 'DH'B9 JECF *5FJA 'D7(J( EF H5A*G 'D7(J) DE1J6G A'D7(J( 'D-'0B GH 'D0J J3'9/ E1J6G 9DI 'D4A'! (#BD 'D#/HJ) 'DEECF) 'D*J D' *3(( DG E6'9A'* H(*CDA) #BD. JECF *D.J5 0DC (#FG л%0' DE *3*7J9 E3'9/) 'DE1J6 AD' /'9J D#F *3(( DG 'DE2J/ EF 'D#61'1╗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л(#F D' /'9J DC*'() #J /H'! 7'DE' E1J6C DJ3 (-',) A9D'K %DJG╗. (96 'DE16I 'DD0JF J9'FHF EF '671'('* FA3J) E9JF) B/ J671 'D7(J( D(96 'D#/HJ) 'D(3J7) HB/ JCHF 0DC F*J,) D81A .'5. #E' (96 'D-'D'* AJECF *B/JE 'D*9DJE'* 'D9'E) 'D*J *3'9/ 'DE1J6 /HF 'D-',) %DI #/HJ) ECDA) AE+D'K: 0HJ 'D(41) 'D,'A) B/ J4CHF EF G14 E3*E1 ('D,D/ .'5) AJ A5D 'D4*'! AJECF F5- 'DE1J6 ('3*9E'D 'DE17('* DD,D/ H*.AJA A*1'* 'D'3*-E'E .'5) ((96 'D5'(HF 'D0J D' J-*HJ 9DI 'DBDHJ'* 'DBHJ). %F G0' B/ J.AA EF 4CHI E+D #HD&C 'DE16I. H('.*5'1 4/J/ A%FG AJ ,EJ9 'D#-H'D лD' /'9J D5J/ 'D7'&1 (B0JA)╗ HG0' J9FJ #F 'D#E1'6 'D(3J7) J,( E9'D,*G' (#BD 'D#/HJ) *1CJ2'K -*I DH '3*E1* A*1) 'D9D', DE/) #7HD. CE' #FG EF 'DEGE #F J41- 'D7(J( DE1J6G CJAJ) '3*9E'D 'D/H'! H.'5) 'D#/HJ) 'DEH69J) E+D 'DE1'GE H:J1G' H0DC 9F CEJ) 'D/H'! 'D0J JH69 9DI 'D,D/ H'DE/) 'D*J J,( (9/G' HBA 'D/H'!. AJB'D E+D'K 9DI 'DE1J6 #F J3*9ED 'D/H'! DE/) E-/H/) H0DC (H69 CEJ) EF 'DE1GE AJ CD E1) E+D'K E' J3'HJ (7HD 2/1 3E EF 'DE1GE #H #C+1 #H #BD -3( E3'-) 'DEF7B) 'DE5'(). %F (96 EF'7B 'D,D/ E+D 'DH,G H+F'J' 'D,D/ *-*', %DI E1C('* EH69J) #BD *1CJ2'K EF *DC 'D*J *3*9ED 9'/) %DI 'D#E'CF 'D#.1I EF 'D,D/ H0DC D#F ,D/ 'DH,G ('D0'* H'D+F'J' *8G1 9DJG' (319) #C+1 'DE6'9A'* E+D %-E1'1 'D,D/ H8GH1 'D#H1/) 'D/EHJ) *-* 37- 'D,D/ H:J1G' EF 'D#91'6 'D:J1 E1:H(). (1/37)  CE' #F 'D#/HJ) 'D*J *$.0 ('DAE .'5) (H'37) 'D#7A'D B/ JCHF DG' *#+J1 3D(J C0DC %0' DE J*BJ/ #GD 'DE1J6 ('D,19) 'DE-//) EF B(D 'D7(J( 'DE9'D,. G0G 'D9D','* %E' 9DI 4CD FB7 #H 41'(. H'DEB'JJ3 'DE*9'1A 9DJG' GJ : 'DFB7) = 0.05 3E3 ED9B) 'D4'J = 53E3 ED9B) 'D-DHJ'* = 8 3E3 ED9B) 'D79'E = 153E3 'DCH( 'D9'/J = 2503E3 %FFJ D' JECF #F #F3I *DC 'D-'/+) DE1J6 H5A* DG 'D*-'EJD D*3'9/G AJ *.AJA E' J4CH EFG EF 'D(H'3J1. DB/ #-61 %DJ 'DE1J6 AJ 'DJHE 'D*'DJ J-EDG (96 #B'1(G HGE AJ -'D) EF 'D59( H5AG' H(#F 'D/H'! 'D0J *F'HDG 'DE1J6 C'/ #F JB6J 9DJG. C'F 0DC A9D'K EA',#) HCJA JECF 0DC #F J-/+ 0DC EF 9/) *-'EJD '3*9EDG' 0DC 'DE1J6 HDE' ('/1*G ('D3$'D 9F CJAJ) '3*9E'D 'D9D', H9F 9// 'D*-'EJD 'D*J '3*9EDG' #,'( 'DE1J6 (#FG '3*9EDG' +D'+ E1'* JHEJ'K -3( 'DH5A) +E #1/A B'&D'K (#F 79E 'D/H'! J' /C*H1 C'F 4/J/ 'DE1'1) HDCFFJ '3*79* #F #*:D( 9DI 0DC H#F #.D7G E9 (96 'D4'J 'DE-DI C+J1'K H'3*79* AJ 'DFG'J) EF #.0 'D/H'! -3( 'D*9DJE'*. D' J3*:1( #-/ #F J5'/A 'D7(J( E+D G0G 'D-'D'* D0DC (69 /B'&B %6'AJ) B/ *CHF EGE) -*I J*H, 'D7(J( 9EDG ('D.J1  H0DC (41- EA5D 9F 71JB) '3*9E'D 'D/H'!. CE' #F 'D7(J( JD'-8 /'&E'K (#F EF (JF E16'G EF D' J3*H9( 'D41- EF #HD E1) HJ-*', %DI %9'/) H%9'/) AD' /'9J D6,1 'D7(J( EF 0DC . %F 'DE1C('* 'DEH69J) B/ D' J3*G'F (*#+J1G' HE6'9A'*G' .'5) AJ 'D#7A'D H0DC D319) 'E*5'5 'D#/HJ) 'DEH69J) EF 9DI 37- 'D,D/ HDBD) E3'-) 'D,D/ ('DF3() D,3E 'D7AD. E1C('* 'DE1'GE 'D,D/J): *3*9ED AJ -'D'* 'D,D/ 'DE*E'3C 'D,'A AJ -'D'* 'D#E1'6 'D,D/J) 'DE2EF). 'DC1JE'*: DD-'D'* 'D*J JCHF AJG' 'D,D/ E*3D. (96 'D4J! E9 'DBDJD EF 'D%A1'2'*. (1/38)  'DE1C('* 'D3'&D): E+D 'DCE'/'* H:J1G' A*3*9ED 9'/) D*,AJA 'DEF7B) 'DE5'() 'D17() 'D*J J.1, EFG' 'D3H'&D E+D 'D'D*G'('* 'D-'/). CE' #F 'DEF7B) 'DE5'() *-// FH9 'DE1C( 'DEH69J 'D0J J,( %3*9E'DG AE+D'K: 'DEF'7B 'D*J (G' 491 E+D A1H) 'D1#3 AJ,( '3*9E'D 'DE1C('* 'D3'&D) -J+ JECF '3*9E'DG' (71JB) #3GD HJECF *F8JAG' C0DC /HF 9F'!. H*C1'1'K DE' 0C1 3'(B'K A%F ,D/ 'DH,G H'D+F'J' E+D EF7B) 'D-A'&8 *-*', %DI E1C('* .AJA) 'D*1CJ2. %F (96 'DE1C('* E+D 'D3'D3JD'* @ 'D3JDJFJE 3DA'J/ HE1C('* 'DAJFHD 'D*J *3*9ED #-J'F'K D*.2JF 'DED'(3 'D4*HJ) B/ *$/J %DI E6'9A'* .7J1) HB/ 3,D* (96 'DHAJ'* AJ 'D#7A'D F*J,) 'D*3EE EF E+D *DC 'DE1C('*. %F 'DC+J1 EF 'D#7('! J5'/AHF (96 'DE16I 'DD0JF J3*9EDHF E1C('* 'DCH1*J2HF 'DE1C2) 9DI 'DH,G E+D'K H1:E 'DE6'9A'* 'D*J *-/+G' *DC 'DE1C('* E+D 'D%-E1'1 'D4/J/ H8GH1 'D#H1/) *-* 37- 'D,D/ H(96 'D(+H1 9DI 'DEF'7B 'DE5'() %D' #F 'DE1J6 J3*E1 AJ '3*9E'D 0DC 'DE1C( D#F ,D/G B/ #/EF 9DJG HD/JG 'D'9*B'/ 'D1'3. (#F G0' 'D/H'! AB7 'DH-J/ 'D0J JAJ/G -*I HDH 7D( EFG #F JHBAG H#F J97I 'D(/JD %D' #F 'DE1J6 D' JD*2E (0DC HJ9H/ %DI '3*9E'DG. %F G0G 8'G1) .7J1) HJ,( 'D*9'ED E9G' (-01 H-CE) (%BF'9 'DE1J6 (E6'1 0DC 'D/H'! H9DJG 'D5(1 H'D*9'HF E9 'D7(J( -*I J*.D5 EF *#+J1G H#F J3*9ED 'D/H'! 'D0J JH5A DG. 9F/E' J3'H1FJ 'D4C (*4.J5 /BJB D#J -'D) ,D/J) .'5) AJ 'D#7A'D AJ EF'7B 'DH,G H'D-A'&8 A%FFJ #5A DG /H'! (3J7 E+D ((JAHC3'E'C )"Droxaryl cream or Flogocid": (HG0' 'DE1C( .'DJ EF 'DCH1*J2HF HJ$/J 9'/) %DI F*J,) 7J() /HF 'D.HA EF 'DE6'9A'* -*I DH '3*9ED DE/) #7HD. (1/39)  %F G0G 'D71JB) #A6D (C+J1 EF 'D'F/A'9 AJ C*'() 'D#/HJ) 'D*J B/ *4HG 'D-'D) 'DE16J) -J+ D'JECF *4.J5G' (9/ 0DC ('D%6'A) %DI 'DE6'9A'* H'D.3'1) 'DE'/J) H'DFA3J) .'5) %0' DE **-3F -'D) 'DE5'(. CE' #FG EF 'DEGE *91JA 'DE1J6 (FH9 'DE16 'DE5'( (G: HE' GJ 'D9H'ED 'D*J J,( 9DJG #F J*,F(G'  HE/) '3*9E'D 'D9D', H'DA*1) 'DE*HB9) 'D*J J*E AJG' 'D4A'!. %F *HA1 E9DHE'* E7(H9) 9DI H1B) D/I 'D7(J( D*2HJ/ 'DE1J6 (G' *-*HJ 9DI 'DE$+1'* 'D/'.DJ) H'D.'1,J) 'D*J *$+1 9DI 8GH1 #H E6'9A'* 'D-'D) *3'9/ 'DC+J1 EF 'DE16I HDG' /H1 G'E H1&J3J AJ *-3JF -'D*G 'DE16J)  %0' #F '3*9E'D 'D#/HJ) DH-/G' /HF *,F( 'DE3(('* H'DE$+1'* DF *CHF DG' 'D#+1 'DE1,H EF 'D9D',. AE+D'K: -3'3J) 'D-A'&8 9F/ 'D#7A'D D' JCAJ #F F5A DDE1J6 'DE1'GE H'D9D','* 'D#.1I AB7 (D J,( #F F,/ 'DE'F9 'D0J JA5D (JF ,D/ 'D7AD H*DC 'D-A'&8 'D*J DG' /H1 G'E AJ 8GH1 'D-3'3J) 'D,D/J)  HJECF ((3'7) *-BJB 0DC (H69 4'4 F8JA #H E9BE 9DI 'D,D/ (9/ H69 'DE1'GE -*I JCHF GF'C 9'2D (JF 'DE$+1 H37- 'D,D/. H(9/ 'D'F*G'! EF CD E' 3(B 0C1G HC*'() 'DH5A) DDE1J6  J7D( EFG 'DE1',9) DE*'(9) 'D-'D) HD'JCAJ #F *BHD DDE1J6 JECFC 'D'*5'D *DAHFJ'K (G0' 'DEC*( %0' DE **-3F -'D*C .D'D .E3) #J'E E+D'K. %F 'DE1J6 'D0J D' J*'(9 ,J/'K DF JCHF 4'C1'K D7(J(G H3J4CH /HE'K (#F 7(J(G DE JB/E DG E' J3'9/G 9DI 'D4A'!. 'D#/HJ) 'DE3*9ED) (C+1) AJ 9D', 'D#E1'6 'D,D/J) E6'/'* 'D-3'3J) EB/E) *9*(1 #/HJ) E6'/'* 'D-3'3J) #C+1 'D#/HJ) '3*9E'D'K AJ 9D', 'D#E1'6 'D,D/J) HDG0' J,( 9DI 'D7(J( 'DE9'D, #F JCHF 0H /1'J) H'39) (E1C('* *DC 'D#/HJ) HA9'DJ*G' H'D,19) 'DEF'3() HC0DC 'D"+'1 'D,'F(J) 'DE-*ED). (1/40)  %F 'D,JD 'D#HD EF E6'/'* 'D-3'3J) *.*1B -H',2 'D/E': AB/ *-/+ AJ 'DC+J1 EF 'D#-J'F "+'1'K ,'FJ) E+D 'DF9'3 H:J1G' #E' 'D,JD 'D,/J/ EFG' A%FG #-3F -'D'K HE98EG' D' *$/J %DI E+D *DC 'D"+'1 %0' '3*9ED* AJ -/H/ 'D,19) 'DE-//). *.*DA E6'/'* 'D-3'3J) AJ *1CJ2G' HE/I *#+J1G': AEFG' EF DG 'D*#+J1 DA*1) B5J1) H#.1 DA*1) E*H37) H'D(96 'D".1 DG *#+J1 B/ J3*E1 %DI 9/) #J'E. E6'/'* 'D-3'3J) GJ .7 'D/A'9 'D#HD DE9'D,) 'DG14 AJ C+J1 EF 'D#E1'6 'D,D/J) -J+ #F (96G' J9'C3 *#+J1 E'/) 'DG3*'EJF AJ 'D,3E E('41) H'D(96 'D#.1 J9ED EF .D'D H3J7 J$/J AJ 'DFG'J) %DI FA3 'DF*J,). E6'/'* 'DG3*'EJF *-HJ 'DE,EH9) (CH2CH2N) HGJ *4(G ,2J! 'DG3*'EJF. J-*HJ ,3E 'D%F3'F 9DI 9// EF E3*B(D'* 'DG3*'EJF HGJ: 1. E6'/'* 'DG3*'EJF G@1: (H1 Receptors) H*#+J1 G0G 'D1&J3J 71AJ J6'/ *#+J1 'DG3*'EJF HJ(7D 'D*A'9D'* 'DF'*,) 9F 2J'/) 'DG3*'EJF AJ 'D,3E E+D 'D-C) - *H39 'D#H9J) 'D/EHJ) 'D5:J1) H*BDD EF FA'0 'D3H'&D 'DI 'D.'1, 'D0J J3(( 'F*A'. 'DEF7B) 'DH'B9) *-* 0DC 'DE$+1  ('D%6'A) %DI *.AA 'FB('6 'D96D'* 'DED3'!. 2. E3*B(D'* G@2: (H2 Receptors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rimeperazine) HJECF %97'&G' DD#7A'D 'D169. D' *97I (96 E1C('* E6'/'* 'DG3*'EJF %DI 'D#7A'D AJ 3F #BD EF '+FJ 941 9'E'K  HEF G0G 'D#FH'9 E+D : ( Azatidine, Pyrilamine,Clemastine). 'D,JD 'DB/JE EF E6'/'* 'DG3*'EJF #FH'9 C+J1) EF E6'/'* 'DG3*'EJF 'D*J C'F* *3*9ED EF0 A*1) 7HJD) B(D 'C*4'A 'D#FH'9 'D,/J/) E*FH9) HJ4ED (96G' E' JDJ : 1." Alkylamines" a) EF G0G 'DE1C('* (Chlorophenaramine maleate): HE*HA1) AJ 'D5J/DJ'* (#3E'! *,'1J) E+D: (Chlortrimaton, Polaramine..) 9DI 4CD -(H( #H 41'( H-BF. 'D,19) DD#7A'D EF G0' 'D#FH'9: GJ 35.,.E,E /C,E/ AJ 'DJHE H9DI +D'+) ,19'* AJ 'DJHE. (1/42)  #E' 'D('D:JF GJ 2-4 E,E 3-4 E1'* JHEJ'K #H 8-12 E,E CD 12-24 3'9). *97I ,19) H'-/) AJ 'DE3'! B(D 'DFHE *,F('K DD"+'1 'D,'F(J) 'D*J B/ *-/+ #+F'! 'DFG'1. ') "Bromopheneramine maleate" E*HA1 9DI 4CD -(H( (Dimetapp) (*1CJ2 4E,E #H -(H( 7HJD) 'D#E/ 12E,E *97I CD 12 3'9) HC0DC 9DI 4CD 41'( 2E,E/ ED9B) 4'J. HJ*HA1 EF G0' 'D5FA -BF (*1CJ2 10E,E/3E 3 #H 100 E,E DCD 3E3. ,) " Dexachlorophenarimine maleate " E*HA1 9DI 4CD (Polaramine) -(H( 4-6E,E H41'( 2 E,E DCD ED9B) 4'J EF 'D/H'!. ,19) 'D#7A'D EF G0' 'DFH9 *9*E/ 9DI 3F 'D7AD: J97I 'D#7A'D EF 3F 2 - 5 3FH'* ,19) 2/1 E,E +D'+ E1'* JHEJ'K. 'D#7A'D EF 9E1 6 3FH'* %DI #-/ 941 9'E'K AJ97HF 1 E,E 3 E1'* JHEJ'K. ,19) 'D('D:JF 4 - 6 E,E / AJ 'DJHE HJECF %97'! 'D,19) B(D 'DFHE. 2. E1C('* :"Ethanolamines " 'DE3*-61'* 'D*,'1J) EF G0' 'DE1C(: EF G0G 'DE1C('* (Diphenhidramine) : HJ*HA1 AJ 'D#3H'B ('3E  Benadryl capsules or syrup C(3HD'* (*1CJ2 10.25.50 E,E HC0DC 9DI 4CD 3'&D: (*1CJ2 12.5E,E / DCD E9DB) 4'J EF 0DC 'DE1C(. HJ*HA1 0DC #J6'K 9DI 4CD -BF (*1CJ2 50 E,E DCD -BF). 'D,19) DD#7A'D EF G0' 'D/H'!: GH 5 E,E /C,E/ AJ 'DJHE EH29) 9DI #1(9) ,19'* JHEJ'K  HJECF #F J97I E9DB*JF EF 'D4'J EF 'D/H'! B(D FHE 'D7AD ('DDJD #E' ,19) 'D('D:JF AGJ 25 - 50 E,E +D'+ E1'* JHEJ'K. 3. E1C('* :(Promathazines) EF G0G 'DE1C('* 'DE*HA1) AJ 'D#3H'B GJ: (Phenergan) HJ*HA1 0DC 9DI 4CD -(H( (*1CJ2 12.5E,E  25E,E  50E,E #H 9DI 4CD 41'( (*1CJ2 6.25 E,E DCD E9DB) 4'J EF 'D/H'!. ,19) G0' 'D/H'! DD#7A'D GJ 2/1 E,E /C,E/ AJ 'DJHE  *H29 9DI +D'+) ,19'*. 'D,19) DD('D:JF GJ 25E,E AJ 'DJHE. G0' 'D/H'! B/ J3(( -3'3J) 6H&J) HC0DC #D'E 96DJ) :'E6). (1/43)  4. (Piperadine) EF G0G 'DE1C('* GJ(Cyproheptadine; Periactin) J*HA1 G0' 'D/H'! 9DI 4CD 41'( H-(H(. 'D,19) DD#7A'D 4/1 E,E /C,E/ AJ 'DJHE  *H29 9DI +D'+) ,19'* %0 *-*HJ ED9B) 'D4'J EF 'D/H'! 9DI 2E,E . B/ J3(( G0' 'D/H'! 'DF9'3 DD#7A'D HC0DC J3'9/ 9DI A*- 4GJ) 'D7AD. H:'D('K E' F97J ,19) 'D/H'! B(D FHE 'D7AD H9F/ 9H/*G EF 'DE/13) *,F('K DD"+'1 'D,'F(J) #+F'! *H',/ 'D7AD (9J/'K 9F 'D(J*. H(5A) 9'E) J,( *-0J1 'DH'D/JF (E1'B() #7A'DGE 'DD0JF J*F'HDHF #FH'9 E6'/'* 'D-3'3J) .'5) *DC %0' C'F *#+J1 'D/H'! BHJ'K #H *F'HD ,19) 2'&/) AB/ J*916 'D#7A'D EF 'D3BH7 .'5) EF 'D41A'* #H AJ -E'E'* 'D3('-) A'DE1'B() 'D-01) 61H1J) 9F/ 'D(/! AJ '3*9E'D *DC 'DE1C('*. 5. (Hydroxazine HCL; Atarax) : Piperazine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tarax" HE1C( #.1 EF E6'/ DD-3'3J) EF A5JD) #.1I E+D 41'( #H -(H( "Benadryl,10 mgm. " B(D 'DFHE. (1/44)  %F G0G 'DE1C('* 0'* A'&/) C(J1) DD*.D5 EF 'DG14 .'5) #+F'! 'DDJD  H(0DC JECF E3'9/) 'D#7A'D H'D#31) 9DI FHE G'/& ('DDJD  9'/) *3'9/ E+D G0G 'DE1C('* 9DI 'D4A'! EF 'D#E1'6 'DE5-H() ('D-3'3J) 'D*I DE *3*,J( DC+J1 EF 'D9D','*. (Vistaril " : (Hydroxazine pomate " G0' 'DE1C( E*HA1 9DI 4CD -(H( @ 41'( (*1CJ2 25 H50 H100 E,E #H -BF 25 -50 E,E DCD 3E3. ED'-8'* G'E) 1. E1C('* E6'/ 'D-3'3J) EF 'D,JD 'DB/JE E+D E1C('* CyproheptadineD' *97I DD#7A'D 0HJ 'D9E1 #BD EF 3F*JF. 2.( Bromopheneramines, Chloropheneramines, Tripolidine &Phenindamine )D' *97I DD#7A'D #BD EF 9E1 6 3FH'*. 3. *-*HI #B1'5 " Hydroxazine " (*1CJ2 10E,E 9DI 'DF4' HC0DC E1C('* 'D*'1*1'2JF "Tartrazine " AJ 'D:D'A 'D.'1,J DD#B1'5 HB/ *3(( *DC -3'3J) EF *#+J1 G0G 'DEH'/ 'DEH,H/) AJ 'D:D'A. J,( E1'9') 0DC AJ -'D'* 'D*J JCHF 3(( -3'3J) 'DE1J6 EF 'DF4' #H E1C( 'D*'1*2JF. #E' -(H( "Atarax" (*1CJ2 25E,E H100 E,E A%FG' D' *-*HJ E+D G0G 'DE1C('*. 4. 'D#91'6 'D1&J3J) H'D"+'1 'D,'F(J) DD,JD 'DB/JE EF E6'/'* 'D-3'3J) GJ ,A'A 'DAE @ 9/E 'DB/1) 9DI 'D*1CJ2 @ 'DF9'3 HA*- 'D4GJ) H2J'/) 'DH2F %0' '3*9ED* DE/) 7HJD). 'D,JD 'D,/J/ EF E6'/'* 'D-3'3J) G0G 'D# FH'9 EF E6'/'* 'D-3'3J) **6EF E,EH9) EF 'DE1C('* 'D*J *.*DA 9F 3'(B*G' (#FG' D' *3(( 9'/) #+'1 ,'F(J) %0' '3*9ED* (71JB) 5-J-) HAJ 'DE1J6 'DEF'3( H('D,19) 'DE-//). *4ED *DC 'DE1C('*: 1." Teldane 60mg ):"Terfenadine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yrtec): GH /H'! JE*5 (319) E9 '3*BD'( BDJD HJ71- #:D(G (/HF *:JJ1 AJ 'D(HD EE' JH,( #F *.A6 'D,19) 9F/ E16I 'DCDJ). J(/# 'D*#+J1 .D'D 3'9) H'-/) H01H*G *(/# .D'D 4 @ 8 3'9'* HDG *#+J1 E/J/  -J+ #F ,19) H'-/) B/ JE*/ *#+J1G' %DI -H'DJ 243'9). DH-8 #F G0' 'D/H'! J3(( F9'3'K H'671'( H8JAJ ('DEB'1F) E9(Placebo) HG0' J(/H #FG E*9DB ('D,19) HD' JF5- ('3*9E'D G0' 'D/H'! #+F'! 'D-ED. 'D,19'*: 9F/ 'DC('1 5 @ 10ED: E1) H'-/) JHEJ'K. 3. @ 'DDH1'*'/JF(Clairatin) ,J/ 'D'E*5'5 HJ3*BD( (BH)  J3*E1 *#+J1G 9'/) %DI E' (9/ 5 #J'E. B/ J$/J %DI '671'( 'D#/'! ('3*9E'D 'D,19) 'D9'DJ). J,( %97'$G (-01 DDE16I 'DC('1 ,/'K ('DE3FJF) H'DE5'(JF ('D#E1'6 'DCDHJ) H'DC(/J). (1/46)  (/! 'D*#+J1 31J9 (.D'D 3'9)) H01H*G .D'D 4 @ 6 3'9'*  HDG *#+J1 E/J/ -J+ #F ,19) #H -() H'-/)10 ED: JECF #F J$+1 DE/) 24 3'9) HDJ3 DG *#+J1 EFHE #H -'D 'DF8J1 'DH/J(Anticholinergic) #H E-'0J1 E*9DB) ('D,19). AJ 'D-ED: *5FA 'DEF8E) 'D9'DEJ) DD*:0J) H'D#/HJ) (FDA)EF E,EH9G 'D#/HJ) 'DE3EH- (G' EF 'D/1,) 'D+'FJ) AJ 'D-ED. 'D,19): J*HA1 'D/H'! 9DI 4CD #B1'5 10 E,E H41'(. 'D,19) DD('D:JF: 10 E,E JHEJ'K. 4. Hismanal, 10mg) Astimazole) GH E6'/ BHJ DE3B(D'* "H1 "H('D*'DJ A%FG E6'/ BHJ DD-3'3J). 'E*5'5 'D/H'! JCHF (7J&'K E9 H,H/ 'D#79E) HG0' JA31 2J'/) 'DH2F 9F/ 'D(96. *5D BE) 'E*5'5 'D/H'! .D'D 3'9) H'-/) HB/ J3*E1 *#+J1G %DI -H'DJ 11 JHE'K H0DC (9/ ,19) B15 H'-/ 'D0J J3'HJ 10 E,E. %3*,'() 'D#91'6 (7J&) %0 *(/# (9/ -H'DJ JHEJF. G0' 'D9D', AJ -/H/ 'D,19) 'DE*AB 9DJG' D' J3(( 9'/) #91'6'K ,'F(J) HDCF %0' *E *,'H2 'D,19) A%FG B/ J3(( 'D%:E'! HE6'9A'* B/ *$/J %DI 'DHA'). *5FJA 'D/H'! D/I" FDA" (#FG EF 'DE,EH9G л,╗ .'5) AJE' J*9DB ('3*9E'D'*G #+F'! 'D-ED. 'D*/'.D'* 'D/H'&J) E9 'D'3*JE'2HD: 'DE3*HJ'* 'DE5DJ) DD'3*JE'2HD B/ *2/'/ (3(( 'D*/'.D E9 (96 'D/HJ) E+D 'DCJ*HCHF'2HD  HE+(7'* "H2 " H'D'1J+1H3JJF H'DE'C1HDJ/'*. 'D,19'* : 'D,19) 9F/ 'D#7A'D (AHB 40CD:) GJ 0.2 E:/C:/JHE  HDG *#+J1 %J,'(J 4/J/ ,/'K 9DI E3*B(D'* H1 H*#+J1'*G :J1 9CH3) (9/ %JB'A 'D9D', . ,19) 'DC('1 GJ: 10 ED:/JHE HGH #EF  E/J/ 'D*#+J1 ,/'K  A9'D H0H *#+J1'* ,'F(J) BDJD). 'D*1CJ('* 'DEH69J) DD9D','* 'DE.*DA) - 'D3*J1HJ/'* 'DEH69J) TOPICAL CORTICOSTEROIDS (1/47)  EF0 9'E 1925E 9F/E' #5(-* 'D3*J1HJ/'* 'DEH69J) E*HA1) *,'1J'K  '3*./E* AJ 9D', 'D9/J/ EF 'D#E1'6 'D,D/J) 'DE.*DA) (H'37) (96 'DE1C('* 'D*J *.*DA 9F (96G' ('DBH) H'D*1CJ(. 'D3*J1HJ/'* 'DB41J) GJ E6'/) DD'D*G'( HE6'/) DD-3'3J) HE6'/) D*C'+1 'D.D'J'. AJ 'D#7A'D: %F 'D*7(JB'* 'DEH69J) DD3*J1HJ/'* J,( '3*9E'DG' (-01 4/J/ H(CEJ'* BDJD) HJ,( '3*9E'D 'D#FH'9 'D.AJA) 'D*1CJ2 HDA*1'* #BD -*I D' *3(( *DC E6'9A'* :J1 E1:H(). 'D#7A'D H'D169 #C+1 *'+J1'K DE6'9A'* 'D3*J1HJ/'* 'DEH69J) .'5) 'D#FH'9 'DEADH1) 0DC D#FGE JEDCHF E3'-) ,D/ #C(1 DH2FGE. %F A9'DJ) 'D3*J1HJ/'* 'DEH69J) *9*E/ 9DI 'D(FJ) H'D*1CJ( 'D/H'&J H'DBH) H-'D) 37- 'D,D/ H'D9E1 HE/) 'D9D', H/1,) 'DFAH0J) %DI 'D,D/. 'D7AD AJ 'D5H1) 'D9DHJ) ('D4CD 1BE 13) 9HD, (E1C('* :J1 3*J1HJ/'* E1GE DE/) .E3 #J'E E9 2H'D 'D-3'3J) 'D,D/J) *E'E'K. 'D4CD 1BE 14: FA3 'DE1(6 (9/ 'D9D', (E1C( .'DJ EF 'DCH1*H2HF 'D4CD 1BE 13: #C2JE' /GFJ) 'D7AD 'D+'FJ ('D4CD 1BE 15): DH-8 (9/ '3*./'E 'D3*J1HJ/'* EH69J'K AJ E1'C2 #.1I DA*1) 7HJD) E-/+) '.*D'7'* #C+1 HE9'F') #C(1 H6J'9 DDHB* H'DE'D. 'D4CD 1BE 15: -3'3J) 'D'7A'D 9HD,* (E1C( BHJ EF 'DCH1*J2HF (JD'.8 'DE6'9A'* F*J,) D0DC) 'DCH1*J2HF H'DGJ/1HCH1*J2HF 0HJ *#+J1 E6'/ DD-3'3J) HB/ JCHF DG0G 'DE1C('* E6'9A'* #BD (JFE' 'DE,EH9'* 'DEADH1) *EDC *A'9D'* H*#+J1'* ,'F(J) #C+1 E+D 'D.7H7 'D#1,H'FJ)  *H39 'D491J'* 'D/EHJ) *-* 'D,D/ @ 6EH1 'D,D/ H(96 'D*#+J1'* 'D,'F(J) 'D#.1I :J1 'DE1:H(). E1C( 'DEHEJ*'2HF AH1J*(ELOCOM) GH 'D3*J1HJ/ 'DEH69J 'DH-J/ 'D0J '*AB 9DI '3*./'EG 9F/ 'D#7A'D AJ 'DHD'J'* 'DE*-/) 'D#E1JCJ) H-*I 0.5% H 1% GJ/1HCH1*J2HF 'DE*HA1) (/HF H5A) 7(J) DE J*AB 9DI '3*./'EG' 9F/ 'D#7A'D. (1/48)  GF'C 'D9/J/ EF 'D3*J1HJ/'* 'DE*HA1) AJ 'D5J/ DJ'* H'D*J *.*DA AJ *1CJ(G' HBH*G' H"+'1G' 'D:J1 E1:H() . 'D'3*7('('* ('D3*J1HJ/'* 'DB41J) EH69J'K #E1'6 'D,D/ 'D'1,J) H-3'3J) 'D,D/. 'D*#+J1'* 'DEB(6) DD#H9J) .'5) 'D#FH'9 'DEADH1). 'D"A'* 'D,D/J) 'D-'C): E+D 'D#C2JE'. 'D"A'* 'D*F4$J) 'D-7'7J) 'D4'&C) E+D 'D-2'2 'DE37- H'D5/'A. #/H'! 'D:1'! ('DCHD',JF) E+D 'D0&() 'D-E'EJ) 'DB1J5J). 'D#/H'! 'D-HJ5DJ) 'DAB'9J) E+D /'! 'DAB'9). 'D#E1'6 'D'1*4'-J) E+D 'D3'1CHJ/ H'DH1E 'D-(J(J 'D-DBJ. 71B 'D'3*./'E : 1. @ 'D*7(JB 'DE('41 9DI 'D"A) 'D,D/J). J7(B 'D/H'! 9DI ,D/ 17( (9/ -E'E #H :3D 'DEF7B) ('DE'! %F #ECF HJA1C 'D/H'! ,J/'K 9DI 37- 'D,D/ . ED'-8) : 'DE1'GE #C+1 A9'DJ) EF 'DC1JE'* H'DGD'E ('D,D). 'DE1C('* 'DEADH1) ((J*'EJ*'2HF A'DJ1'* 1, %  ADH3JF'DHF '3*JFHDHF '3*JH*J/ 025,%  *1'J'E 3JFHDHF '3J*HFJ/ 1H.%) #BHI (-H'DJ #DA E1) EF GJ/1HCH1*J2F 0.1%. 2. @ 71JB) 'D*:7J). :7J 'DEF7B) ('D3JDHA'F (9/ *7(JB 'D/H'! #H '3*./'E #:7J) .'5) *-*HJ %DI 3*J1HJ/ B41J A9'D(Cordran tape) J,( :3D 'DEF7B) #HD'K +E JA1C 'DE1GE 9DJG' H*:7I. H,/ #F A9'DJ) 'D3*J1HJ/'* 'DB41J) ('D*:7J) *2/'/ %DI -H'DJ E'&) E1) #C+1 EF 'D*7(JB 'D-1 9DI 'D,D/. G0' J9*E/ (4CD 1&J3J 9DI ,A'A EF7B) 'D*:7J) H2J'/) FAH0J) 'DE1C( HAJ FA3 'DHB* 'DCEJ) 'DE7(B) CE' J-'A8 H69 'D41J7 9DJG' CD 'DHB* 9DI '3*E1'1J) *E'3 'DE1C( E9 37- 'D,D/ HD' J2HD 'D/H'! F*J,) 0DC (#J H3JD). *3*9ED 71JB) 'D*:7J) (4CD 1&J3J DD#A'* 'DEA1/) #H 'DBDJD) 'D9// E+D 'D-2'2 'DE37- 'D6EH1J (Lichen planus)  'D(B9 'D5/AJ) 'DEA1/) (Psoriasis) HD' J3*9ED DDE37-'* 'DH'39) DCJ D' J-/+ *#+J1'* ,'F(J) EH69J) #H ,G'2J) :J1 E1:H(). #FH'9 'D3*J1HJ/'* 'DB41J) 'DEH69J) (1/49)  EHEJ*'J2HF AH1J* (Elocom): .AJA HDG *#+J1 ,J/  HGH EF 'D3*J1HJ/'* 'D#C+1 #E'F'K EF 'D3*J1HJ/'* 'DE*HA1) EH69J'K G0' 'DFH9 EF 'D3*J1HJ/'* 'DB41J) 'DEH69J) J3*./E AJ 'D#7A'D 'D5:'1. 'D3*J1HJ/'* 'DE9*/D) 'D69JA): GJ/1HCH1*J2HF @ CHD(J*'2HF (Eumovate). 'D3*J1HJ/'* 'DE9*/D) 'DBH) (Celestoderm)  ADH3JFHDHF (Synalar). 'D3*1HJ/'* 'DBHJ) ,/'K: CHD(J *'2HD (1H(JHF'* (Dermovate) . (96 'D3*J1HJ/'* 'DB41J) 'DEH69J) 'DE*HA1) AJ 'D#3H'B 1. @ EHEJ*' J2HF AH1J* : (Elocom) HGH E1C( "EF HE9*E/ EF B(D (FDA) DD'3*9E'D 9F/ 'D7AD. 2. @ GJ/1HCH1*J2HF  : (Eumovate)E*HA1 9DI 4CD E1GE  C1JE  E-DHD. 3. @ 'D3*J1HJ/'* 'DEADH1): #C+1 BH) DCFG' #:DI +EF'K EF 'DGJ/1HCH1*J2HF HDG #+'1 ,'F(J) :J1 E1:H(). HGF'C 9// EFG' E*HA1) E+D: DHCHCH1*JF (Fluromethazone) E1GE  C1JE  E-DHD #H E4'1C) E9 -E6 'D5A5'A (Salicylic acid) #H 'DB71'F(Tar) #H E6'/'* A71J) "Vioform" . (J*'E*J'2HF A'DJ1'* (Betnovate) E1GE  C1JE  HE-DHD DDA1H). 3DJ3*H/ J1E(Celestoderm) E1GE HC1JE CDG' B/ *CHF E*HA1) (4CD E4'1C E9 'DE6'/'* 'D-JHJ) C'D,F*'EJJF D9D', 'D#C2JE' 'DED*G(). (J*'EJ*'2HF /J (1H(JHF'* (Diprosone) E1GE  C1JE  E-DHD. / JC3'EJ+'2HF: E*HA1) (4CD Decoderm) C1JE) H(E4'1C) E9 E6'/ -JHJ: (Decoderm compound cream) #H E9 E6'/ (C*J1J HA71J(Decoderm trivalent) #H (.'. #H E1GE 9JFJ) #H E4'1C E9 -E6 'D55A'A E+D(Salidecoderm) E1GE. *1J'E 3JFHDHF ( Aristecort) E1GE HC1JE. CJF'DH, (Kenalog) E1GE C1JE  HE-DHD 'D"A'* 'DAE (Kenalog orabase) . (1/50)  "Dermovate"E1GE  C1JE HE-DHD  GH EF #BHI 'D3*J1HJ/'* 'DEH69J)  HJ,( #F D' J7(B (#J 71JB) 9DI ,D/ 'D16J9 #H 'D#7A'D 'D5:'1 #H 'DH,G #H 'D,D/ 'DE*E2B #H +F'J' 'D,D/ #H 'DEF7B) 'D*F'3DJ) AJ 'D('D:JF 9DI *DC 'DEF'7B 'DE0CH1). E1C('* DDEF'7B 'DE491) HA1H) 'D1#3 DHC'CH1*JF E-DHD" Lotion" DHCHJJ/ "Locoid " *7(JB 9DI 'DA1H). (J*FHAJ*" Betnovate" *7(JB 9DI 'DA1H). E-DHD"Diprosalic " (/J(1H2HF + -E6 'D5A5'A). "Dermovate" DD*7(JB 9DI 'DA1H) AJ 'D-'D'* 'DE2EF) DD('D:JF HD' J3*9ED DD#7A'D. G0G 'DE1C('* JECF :3DG' (3GHD) ('D4'E(HF'* 'D9'/J)  HAJ -'D'* E9JF) E+D 'D5/'A H'D*G'( 'D,D/ 'D2GEJ F3*./E 4'E(HF'* B71'FJ) 'D#C+1 A9'DJ) H*D9( /H1 %6'AJ AJ 9D', "A) 'DA1H). E-'DJD 'D3*J1HJ/ JECF '3*./'EG' E1*JF #3(H9J'K #H E1) JHEJ'K -3( BH) 'D3*J1H&J/ 'DEH,H/ AJ 'DE-DHD  H9E1 'DE1J6 HFE7 'D"A) 'DE1'/ 9D',G'. E-'DJD 'D3*J1HJ/ J,( #F J3*9ED #J6'K (-01 (-J+ D' *5D %DI 'D9JF H%DI FA3 'DE-'0J1 *F7(B C0DC DDE1C('* 'D3*J1HJ/J) J,( #F *$.0 (9JF 'D'9*('1. 'D*#+J1'* 'D,'F(J) DD3*J1HJ/'* 'DEH69J) *A'BE H'F*4'1'D'D*G'('* H'D'F*'F'* 'D,D/ 'DAJ1H3J) H'D,1+HEJ) H'DA71J). 'D3*J1HJ/'* 'DBHJ) B/ *3(( +H1'F H*H39 'F*4'1 'D"A) 'D,D/J) H'D#E1'6 D,G'2J) 'DEH,H/) 3'(B'K E+D 'D/'! 'D3C1J H'1*A'9 'D6:7 'D/EHJ. *1BJB 'D,D/ AJ 'DH,G H'D+FJ'* (3(( 6EH1 'D,D/. 8GH1 9D'E'* *4(G 'D*J *-/+ 9F/ 4/ 'D,D/ ('D.7H7 'D#1,H'FJ)). *H39 'D49J1'* 'D/EHJ). 8GH1 4CD 'DH,G E+D лH,G 'D(/1╗. 'F/A'9 4(JG ('D9/ E+D л-(H( ' D4('(╗ (9/J 'D4CD). B5H1 'DC81 (Adrenal failure) : F',E 9F 'D'E*5'5 'DEH69J #H 'D,G'2J DD3*J1HJ/ 'DBHJ 'DEH69J. G0G 'D*#+J1'* 'D,'F(J) *9*E/ 9DI FE7 'D3*J1HJ/ 'DE3*./E  EC'F HE/) 'D9D',  E3'-) 'D37- HCEJ) 'D3*J1HJ/ 'DE7(B. (1/51)  9/E F2HD .5J) 'D7AD 'DI EC'FG' 'D7(J9J ('D5AF DB/ H,/ #F 75,E EF 3*J1HJ/ 'DBHJ E+D 'DCH(J*'2HD(Dermovate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olbetasol, Dermovate ointment) DE/) 7HJD) '9*B'/'K (#F 'D3*J1HJ/ B/ J3(( (J'6'K AJ ED'E-GF 'D3H/'! HJCHF F*J,) 0DC 'DE6'9A'* 'D.71) H*4HJG (/D' EF *,EJD 'D(41) CE' J8FHF. 'D4CD 1BE 19: E6'9A'* 'DCH1J*2HF 'DEH69J) #A6D E' J3*./E 'D3*J1H&J/ E1*JF JHEJ'K EH69J'K HDE/) B5J1)  HEF 'D-CE) #F F41- DDE1J6 CE #F(H('K 3HA J3*./E H'DCEJ) AJ CD E1) EF 'D*7(JB 'DH'-/) H'DE/) 'D*J J3*9ED AJG' 'D9D',  HJ,( 'D'D*2'E 'D*'E (0DC H9/E '3*9E'DG E1) #.1I %D' (9/ E4H1) 'D7(J( 'DE9'D,. 'D4CD 1BE 21 :.7H7 ('D,D/ (E6'9A'* 'DCH1J*2HF) 'D4CD 1BE 20: 7A- J4(G -(H( 'D4('( (E6'9A'* 'DCH1J*2HF) 'D3*J1HJ/'* 'D,G'2J) (/'.D' Systemic steroids ) %F G0G 'DE1C('*"ACTHHCorticotropin" *-16 9DI %F*', 'DG1EHF'* 'DB41J) 'DC81J) GJ/1HCH1*J2HF @ CH1*J2HF H'DG1EHF'* 'D'F/1H,J) 'D*J *A12 '3*,'() D*-1J6 'D@ (ACTH). 'D3*J1HJ/'* 'DB41C81J) 'D7(J9J) %E' B41'FJ'* 3C1J) (,DHCH CH1*JCHJ/) #H 'F/1H,FJ). 'DCH1*JCHJ/'* 'D3C1J) E+D 'DCH1*J2HF GJ E6'/) DD'D*G'('*  *$+1 9DI '3*BD'( 'D3C1J'* HG/E 'D(1H*JF'*. (1/52)  'DCH1*JCHJ/'* 'D'F/1H,FJ): H*4ED /JHC3J CH1*JCH3*J1HF H'D'D/H3*J1HF DG' *#+J1 9DI 'D3J71) 9DI *H'2F 'D4H'1/ (Electrolytes) H'-*('3 'D5H/JHE. *#+J1 "ACTH": 2J'/) G0G 'DE1C('* J$/J %DI: @ 2J'/) 71- 17 GJ/1HC3J CH1*JCH3*J1HJ/. @ 2J'/) 'D*5(:'*. @ '1*A'9 'D*H*1 'D41J'FJ @ '-*('3 'D5H/JHE @ H0E) @ 6J'9 'D(H*'3JHE. @ 'F.A'6 'DCHDJ3*1HD. 'DE1C('* 'D*I *$.0 9F 71JB 'DAE #A6D 'E*5'5'K EF B(D 'DBF') 'DE9/J) 'DE9HJ). 'DE1C('* 'D.D'DJ): (*97I -BF'). (96 'D#7('! JA6DHF -BF 'D3*J1HJ/'* (3((: @ 3GHD) 'D%97'!. @ JECF 'D3J71) 9DI 'D,19'*. @ 0'* *#+J1'* ,'F(J) #BD EF 'DE3*-61'* 'DAEHJ). (96 #FH'9 'D3*J1HJ/'* 'DB41J) 'DAEHJ) 'D3*J1HJ/'* *.*DA -3( BH*G': CH1*J2HF 25 ED: = (1/ JF2HF 5 ED: = /JC'EJ+'2HF 0.75 ED: = *1J'E 3JFHDHF 4 ED: = (J*' EJ+'2HF 0.5 ED:. 'D3*J1HJ/'* 'DEADH1) HGJ E6'/ 'D*G'( BHJ) H0'* *#+J1 BDJD 9DI 'D4H'1/. (J*' EJ+'2HF #B1'5 ( Celestone0.5 ED:). /JC3' EJ+'2HF #B1'5 (0.5 ED: ). EJ+'JD (1/FJ2HDHF #B1'5 (Medrol 2-4 mg.). (1/ FJ2HDHF(Prednisone) #B1'5 1ED:  5ED:. *1J'E 3JFHDHF(Triamcinolone) #B1'5 1.2ED: H 5 ED:. (96 #FE'7 'D3*J1HJ/'* 'DB41J) 'DB'(D) DD-BF -BF 'D*1J'E 3JFHDHF (Kenacort 40 mg IM) *97I 9EJB'K 96DJ'K #3(H9J'K #H CD #3(H9JF. EJ+'JD (1/FFJ2HDHF (Depot medrol 40 mg IM): JECF %97'$G' #3(H9J'K  #C+1 #E'F'K H0'* *#+J1'* ,'F(J) #BD EF 'D*1J'E 3JFHDHF. 'DCH1*JCH3*J1HJ/'* 'DB'(D) DD-BF 'DEH69J (96 "A'* 'D,D/ 3H'! C'F* EA1/) #H E*9//) JECF E9'D,*G' ('D-BF 'DEH69J ('D3*J1HJ/'* 'DB41J). -BF 'D*1J'E 3JFHDHF (Leddercort / 25 mg / 4 ml ) GJ 'D#C+1 4JH9'K. 'DE-'0J1: (1/53)  JECF -BF 'DE-DHD (FA3 'D*1CJ2 'DE*HA1 CE' AJ 'D-BF) 'DE*HA1) #H J.AA #-J'F'K ('D3J1HE 'DAJ2JHDH,J H0DC '9*E'/'K 9DI FE7 'D"A) 'DE-BHF) HEC'F 'D-BF (EF'7B 'DH,G H'D+FJ'* *-*', *1CJ2 #BD). 'D*1'CJ2 'DBHJ) H'D-BF 'D37-J B/ *3(( 6EH1 EH69J HFB5 *5(: ,D/J EH69J. #+F'! 'D-BF J,( #F *CHF 'D%(1) 'DE3*9ED) DD-BF :J1 37-J) HD' 9EJB) ,/'K AJ 'DF3J, 'D,D/J. 71JB) 'D*7(JB : '3-( E-DHD EF 'DAD'CHF) -J+ #F CEJ) 'DE'/) 'DE3-H() *9*E/ 9DI -,E H9// 'D"A'* 'DE1'/ 9D',G'. 9F/ 'D#7A'D #H 'D#4.'5 'D-3'3JF ,/'K F'/1'K E' J3*./E D/JGE E./1'* EH69J) (Emla cream, ASTRA) B(D *7(JB 'D3*J1HJ/ -BF'K AJ 'D"A) (-H'DJ 40/BJB). *-BF ,H'F( 'D"A) EF 'DE-J7 HAJ CD E1) F-'HD #F F/.D #9EB BDJD'K *-* 'D"A). 'D-'D'* 'D*J JECF -BF 'D"A) ('D3*J1HJ/'* 'DB41J): 'D"A'* 'DEA1/) EF 'D-2'2 'DE37- 'D6EH1J (Solitary lesion of hypertrophic lichen planus). 'D"A'* 'DEA1/) EF 'D*G'('* 'D,D/ 'D95(J (Neurodermatitis) . 'D"A'* 'DEA1/) EF 'D0&(J) 'D-E'EJ) 'DB1(5J)(Discoid lupus erythematosus) . 'D"A'* 'DEA1/) EF 'D5/'A(Psoriasis) . 'D"A'* 'D,D/J) 'DE2EF) 'D*J B/ *8G1 D/I E16I /'! 'D3C1J (Necrobiosis diabeticorum) . 'D,/1'* (Keloids) . 'DA5D 'D3'/3 'D*G'('* ('F*'F'*) 'D,D/ 'D,1+HEJ) (Bacterial skin infections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acterial skin infections). 2. @ 'D#.E', 'DA71J)( Fungal skin infections) . 3. @ 'D#.E', 'DAJ1H3J) (Viral skin infections). 'D,1'+JE 'D*J **9'J4 7(J9J'K 9DI 37- 'D,D/ (Normal skin flora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ormal skin flora) GF'C 3D'D'* H#FH'9 E.*DA) EF 'DADH1' *BJE (4CD 7(J9J 9DI 37- 'D,D/ (/HF #F *-/+ #J *#+J1'* 6'1) AJ 81HA E9JF). 'DADH1' 'D,D/J) 'D/'&E) *4ED E' JDJ: @ ECH1'* %J,'(J) 'D,1'E GH'&J) E+D ('D9FBH/J'* @ 'DECH1'* 'D5:J1))  95J'* %J,'(J) 'D,1'E H'DEH*/J'* 'D.F'B'J). 'DD'GH&J'*: (Anaerobes) 'D3D'D'* 'D(1(JHFJ)(Propionobacterium species) **H',/ AJ 'D,2! 'D#9EB EF 'D#,1() 'D491J). 'DECH1'* 'DGH'&J) H'DF-'DJ'* 'DE(H:) H'D.E'&1 *H,/ 9DI 37- 'D,1'( 'D491J H'D:// 'D/GFJ). 'D(1(JHF'* 'DE9/J) H'D(1(JHF'* 'D-(J(J) *BJE AJ 'DH,G H#9DI 'D,09 AJ A*1G 'D(DH: H*D9( /H1'K G'E'K AJ 8GH1 -(H( 'D4('(. 'D9B/J'* 'DEBJE) E+D (Streptococcus pyogens) *3*9E1 EF7B) 'D-DB H*4CD G0G -H'DJ 10% EF 'DADH1' 'D7(J9) (JFE' **H',/ AJ A*-'* 'D#FA (F3() #BD. (1/56)  HEF 'DE91HA #F %F*', 'DE6'/'* 'D-JHJ) 'D7(J9J) EF B(D 9F'51 #.1I EF ADH1' 'D-DB B/ J3'GE AJ EB'HE) 'D'3*9E'1 (#FH'9 EF ,1'+JE 'D9B/J'*(Streptpyogens) HDCF 'D#4.'5 'D0JF J-EDHF E+D G0G 'D,1'+JE (5A) E2EF) D' JECFGE 'D*.D5 EFG' ('DE6'/'* 'D-JHJ). ED'-8): 1. @ D' JH,/ ADH1' 7(J9J) EBJE) 9'/) AJ 'D:// 'D91BJ). 2. @ 'DADH1' 'D,D/J) 'D7(J9J) DG' /H1 E-*ED AJ 'D"DJ) 'D/A'9J) 6/ 'D'F*'F'* 'D,1+HEJ). 'D(1(JHF'* 'D:/J) GJ ECH1'* %J,'(J) 'D,1'E *3(( 'F47'1 AJ 'D-EH6 'D/3E) %DI -EH6 -1) H:DJ31J/'* +D'+J). EE' J3(( *.1J4 ,D/J H'D*G'( CE' GH ED'-8 AJ 'D9/ #H -(H( 'D4('(. 3. @ 'D2GE ('D/GF) DH-/G #H 'D@ pH 'D-'E6J) D' *4CD 9'ED'K A9'D'K AJ 'D"DJ) 'D/A'9J) 6/ -/H+ 'D'D*G'('* CE' C'F E91HA'K 3'(B'K. 4. @ (96 3D'D'* 'DADH1' 'D,D/J) 'D7(J9J) B/ *F*, 5'/'* -JHJ) B'/1) 9DI *+(J7 'D96HJ'* 'D5:J1) 'D#.1I. 5. @ 'DC1JE'* 'DEH69J) EF 'DE6'/'* 'D-JHJ) E+D (Muperacin, Bactroban) B/ J2JD 'DADH1' 'D/'&E) EF 'D#FA H'D+FJ'* DE/) 6 4GH1 %0' 7(B* JHEJ'K DE/) #3(H9. 'D*G'('* 'D,D/ 'D,1+HEJ) ('D#7A'D('F*'F'*) (Bacterial skin infections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uperacin cream) 'D0J J7(B E1*JF JHEJ'K AJ A*-*J 'D#FA DE/) #3(H9 A%FG 3JB6J 9DI 'D,1'+JE 'DE3*9E1) DE/) 6 4GH1. (1/58)  '3*./'E 5'(HF E6'/ DD'F*'F E+D: " Cidal soap #H Dial soap " B/ JCHF DG *#+J1 ,J/. *,F( A17 'D*91B #H 'D*:7J) 'DC'*E) DDEF'7B .'5) EF7B) 'DA.0JF. 'D'9*F'! ('DF8'A) (71JB) 3DJE) -'5) D+F'J' 'D,D/ 9F/ 'DHD/'F H'D#7A'D 'D5:'1 ('D*GHJ) 'DE*C11) H*:J1 'D-A'&8 (4CD E*C11. :3D 'DJ/JF .'5) (9/ 'DFA H'3*./'E H1B 'DEF'/JD 'DF'9E) :J1 'DE971) D*F8JA 'D#FA. 'D'9*F'! ('D#0FJF H'D#FA EGE ,/'K HJ,( 9/E %GE'DG. J,( '3*./'E 'D#D(3) 'D/'.DJ) 'DB7FJ) H*:JJ1G' /H1J'K %0' #ECF 0DC. 'DH3'&D 'DFH9J) @ 'DCE'/'*: CE'/'* 'DE5D 'DAJ2JHDH,J(Normal saline) 'D/'A& JECF *7(JBG' 9DI 'D*G'( 'D#,1() 'D-'/) H'D4/J/). @ 5'/'* -JHJ) EH69J'K: E+D C1JE (Bactroban cream , Garamycine cream or Fucidine). (Bactropan cream)C1JE E1) JHEJ'K A9'D ,/'K HB/ J97J DH-/) %0' C'F 'D#F*'F .AJA'K #H ('DE4'1C) E9 E6'/'* -JHJ) AEHJ'K. @ 'D5'/'* 'D-JHJ) (Antibiotics) AEHJ'K HEH69J'K J$/J 9'/) %DI 'D4A'! 'D31J9 DD"A). 'D5'/'* AEHJ'K E+D ('DADHC3'3DDJF @ 3A'DH3(H1JF @ 3JA'DH1J/JF) A9'D AJ 'F*'F'* 'DF3, 'D1.H). 'D'1+J1H3JF :J1 A9'D AJ CD 3D'D'* 'D9FBH/J'*  'D3DA' GJ 'D/H'! 'D(/JD 'D+'FJ DDE1J6 'DE*-33JF DD5'/'* EF 'DE,EH9'* 'D#.1I. ED'-8) : EF 'DEGE ,/' #F D' F951 #H F4B 'D/ED 9F/E' JCHF ED*G('K (4/) #H EH,H/'K AJ 'DE+D+ 'D.71 AJ ('DH,G) 'DEF7B) 'DH'B9) (JF #9DI 'D#FA H#3AD 'D4A) 'D3ADI. %0' E' #5(- 'D/ED DJF'K EH69J'K H#8G1 *EH,'K 51J-'K. A%FG JECF %,1'! 'D4B H'D*A,J1 H*F8JAG H9ED 'D6E'/ 'DD'2E. /'! 'D/E'ED Carbunculosis 'D*G'( E-/H/ F',E 9F 'D9FBH/J'* 'DE0G() (Staph aureus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ypoglobulinemia). 71B 'D9D',: FA3 'DE9'D,) 'DE7(B) AJ 'D/ED 'D4'&9. 'D*G'( 'D#,1() 'DB41J) Folliculitis GH #F*'F ,1+HEJ AJ ,1'( 'D491 JF4# 9F/ 'D169 H'D#7A'D 'D5:'1  -J+ #F 'DA1H) GJ 'DEC'F 'D#C+1 %5'() (JFE' 9F/ 'DC('1 A%F #J EC'F E491 B/ J5'(. G0' 'DFH9 EF 'D'D*G'('* %E' #F JCHF 37-J'K #H 9EJB'K J$+1 9DI 'D#F3,) 'D3ADJ) H'D2H'&/ 'D,D/J). 'D4CD 1BE 24: 'D*G'( 'D#,1(G 'D4CD 1BE 25: 'D*G'( 'D#,1() H'D/E'ED 'D*G'( 'D#,1() 'D491J) 'D37-J : G0' 'DFE7 E91HA #J6'O ('3E лBH('! #H -5A (HC'1*"Bockhart impetigo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л'D*G'( #,1() /JC'DA'F╗ "Folliculitis Decalvans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ullous impetigo) G0' 'DFH9 EF 'D-5A 'D,D/J *3((G 'D9FBH/J'* (JFE' 'DBH('! #H 'D-5A 'D:J1 AB'9J) B/ *F,E 9F 'D9FBH/J'* 'DE0G() #H 'D9B/J'* #H CD'GE' E9'K. 'DE16 9'/) A1/J HDCF *,E9'* EF 'D-'D'* B/ *-/+ AJ 'D9'&D) 'DH'-/) H'D,E'9'* 'D#.1I EF 'DE9'G/ H'D-H'6F. 'D-5A 'DAB'9J J-/+ AJ CD 'D#9E'1  .'5) 'D#7A'D -/J+J 'DHD'/) -J+ *F41 (319) HC'F* *3EI 'DAB'9) 'DHDJ/J) (Pemphigus neonatarum) . 'D3-,'* #H 'DC/E'* 'D5:J1) H"A'* ,D/J) E*FH9) B/ *GJ! DD%5'() ('DE16 .'5) %0' C'F 'DE1J6 9DI *E'3 E9 A5'&D 'D,1'+JE 'D9FBH/J)  HB/ DH-8* 2J'/) E9/D 'D%5'() ('D-5A 'D,D/J D/I 9E'D 'DE4'AJ F*J,) 'D9/HI 'DE('41) (*DC 'D,1'+JE. 'DE8'G1 'D31J1J) DD-5A 'DAB'9J: J8G1 'DE16 9DI 4CD D7'.) E$DE) 9DI B'9/) -E'EJ) **-HD B1J('K %DI -HJ5D) #H AB'9) +E %DI (+1) J.1, EFG' EA12'* D*4CD B41) 'D*G'(J) 3EJC) 'D*J B/ *3(( .E,'K #H 'D*G'('K 0'*J'K .'5) (H'37) 'D#5'(9 %DI 'D,D/ 'DE,'H1 #H #J EF'7B #.1I EF 'D,3E. 9F/E' *CHF 'DAB'9) GJ 'DE8G1 'DE3J71 A%F 'D"A) *3EI 'D-5A 'DAB'9J. GF'C FH9 EF 'D-5A 'DAB'9J *3EI л'DAB'9) 'DHDJ/J)╗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eta-hemolytic sterptococci) B/ J5'-(G' 'D*G'( -'/ ('DCDJ*JF AJ -H'DJ 2% EF 'D#7A'D 'DE5'(JF. 3. @ *F'01 'D,D/ 'D3E7J (Scalded skin syndrome)  GJ E4CD) ,D/J) .7J1) *F,E 9F 'D0JA'F'* H3EHE 'D,1'+JE 'D9FBH/J) 'DE0G() E3(() *DA'K AJ 'D(41) -J+ *5(- 1.H) HE*B41) E.DA) H1'&G' 37- ,D/ E*3D. 9DI EF'7B H'39) EF 'D,D/. 'D-5A 'DHDJ/J Impetigo neonatrum GH E16 4/J/ 'D9/HI H'D31'J'F 9F/ 'DHD/'F HJ4CD E4CD) -BJBJ) AJ B3E 'DEH'DJ/ HJ8G1 9'/) E' (JF 'DJHE 'D3'(9 H'D9'41 (9/ 'DHD'/). JF,E 0DC EF 'D9FBH/J'* 'DE0G(). B/ J5'-( G0' 'DFH9 EF 'D-5A 'DAB'9J 9F/ 'DHDJ/ 'D*G'( 'D,D/ 'D3E7J 'D9FBH/J (Staphylococcal scalded syndrom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лFJCHDH3CJ╗ *CHF %J,'(J). 2. @ 'D%A1F,J ('D2G1J) 'D.DBJ: 'D"A'* 'DAB'9J) 9DI 'D1'-*JF H'D#.E5JF E9 H,H/ E8'G1 #.1I DD2G1J B/ *3'9/ AJ 'D*4.J5 'D*A1JBJ. H'D*#C/ JCHF ('D'.*('1'* 'DE5DJ) DD%A1F,J ('D2G1J). 71B E9'D,) 'D-5A 'D,D/J: 'DHB'J): EGE) ,/'K DEF9 'D'F*'F 'D0'*J H'F*4'1 'D.E, %DI 'D".1JF  %F 'D9F'J) 'D.'5) H'D'-*J'7'* 'D.'5) AJ 'DHD/'F EGE) DEF9 'F*4'1 'D'F*'F. 'DE9'D,) 'DFH9J): *F4JA 'DA*-) (H'37) (1EF,'* 'D(H*'3JHE (*1CJ2 1/9000 (4CD CE'/'* 17() E9 *7(JB E6'/'* -JHJ) EH69J) (4CD C1JE E+D (Bactroban, Muperacin). 'D5'/'* 'D-JHJ) AEHJ'K E+D 'DADHC3'3DJF  'EHC3J 3DDJF  3JA'DH3(H1JF  3JA'CDH1 (Zithromax; zithromycin) CDG' A9'D) AJ 4A'! 'D"A) 'D,D/J) .D'D HB* B5J1. 'D-'D'* 'D*J *9'D, AJ 'DE4'AJ 0'* *#+J1'* H'.*D'7'* 4/J/) HJ,( 92DG' H#.0 CD 'D'-*J'7'* DEF9 'F*4'1 'D.E, %DI 'D".1JF. *F'01 'D*G'( 'D,D/ 'D3E7J ' D9FBH/J (Staphylococcal scalded skin syndrome) GH #F*'F ,D/J ,1+HEJ -'/ F'/1 'D-/H+ 9F/ 'D#7A'D .'5) #HD&C 'DD0JF J9*E/HF 9DI 'D16'9) 'D7(J9J) EF 'D+/J. (1/64)  JF,E 'DE16 F*J,) DD3EHE 'D5'/1) 9F (96 3D'D'* 'D9FBH/J'* 'DE0G(J) (Staph.aureus ,phage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oxic epidermal necrolysis): J*4'(G G0' 'DE16 AJ 'DC+J1 EF 'D#91'6 H'D5A'* E9 *F'01 'D,D/ 'D3E7J (Staphylococcal scalded skin syndrome ) -J+ #F CD'GE' E*4'(G'F 31J1J'K DCF 'D#.J1 #C+1 E6'9A'* H.7H1) EF 'DE16 'D#HD 1:E #FGE' AJ 'DE'6J C'F' J9*(1'F FA3 'DE16 %D' #FGE' J9*(1'F 'D"F (#FGE' E.*DA'F HDCD .H'5G 'DEEJ2). 2. @ 'D'F/A'9 'D/H'&J(Drug reaction) : 'DB5) 'D3'(B) DD#/HJ) 'DE*F'HD)  H'DE8'G1 'D,G'2J) E+D 'D-EI H*-/J/ 'D(H&1 'D'F*'FJ) B/ JAJ/ AJ 'D*4.J5 'D*A1JBJ . (1/65)  3. @ 'D-5A 'DAB'9J(Bullous impetigo) : 8GH1 'D*3E7 H*3D.'* ('D,D/ B/ J3'9/ AJ *EJJ2 'DE16. 4. @ 'D-E'EJ 9F/ 'D7AD(Erythroderma) : 'D(/! 'D31J9 E9 'D#DE 'D,D/J 'D4/J/ *EJ2 'DE16 9F 'D-E'EI 9F/ 'D169. 5. @ 'D#E1'6 'DAB'9J)(Bullous diseases) : %F F/1) 'DE16 'DAB'9J AJ G0G 'D#9E'1 'DE(C1) H'DE8'G1 'D31J1J) JECF #F *-3E 'D*4.J5. 71B 'DE9'D,): 'D5'/'* 'D-JHJ) /'.D (Systemic antibiotics) J,( %,1'! 219 H*-33 D*-/J/ 'D5'/'* 'D-JHJ) 'DEF'3() H'D#C+1 A9'DJ) E+D 'D(F3DJF 'DEB'HE" DD(F3DJF(2" HE4'(G*G E+D "'DADHCDHC3' 3DDJF #H 'DEJ+J 3DDJF #H 'D3A'DH3(H1JF " 'DED'&E #H 'DAH3J/'* CDG' A9'D). %0' C'F* 'DG,E) -'/)  A%F 'D/H'! J,( %97'$G H1J/J'K AJ 'D(/!. 'D3*J1HJ/'* 'DB41J)(Corticosteroids) /'.D'K GJ E6'/ '3*7('( E7DB  HB/ *$/J %DI *A'BE 'DE16 H'F*4'1G D0DC J,( 'D-01 EF '3*9E'DG' AJ G0G 'D-'D'*. CE' J,( 'D'F*('G 'D.'5 EF #,D 9/E AB/'F 'D3H'&D EF 'D,3E -*I D' J-/+ ,A'A DD7AD H('D*'DJ B/ J$/J 0DC %DI *A'BE 'DE4CD) H2J'/) 'DE6'9A'*. 'D9D', 'DEH69J DD"A'* : -E'E'* HE:'73 E6'/'* 'D'F*'F E+D 1/9000 (1EF,F'* 'D(H*'3JHE. C1JE'* 'D5'/'* 'D-JHJ) *7(B (9/ *,AJA 'D"A'* (H'37) 'D4'4 'DF8JA 'D0J J:E3 AJ 3'&D 'D(1EF,F'* HJCE/ (G 'DEF7B) 'DED*G(). J,( A*- 'DAB'9'* H*A,J1G' (9/ *F8JA 'DEF7B) HJECF H69 6E'/ H5'/'* -JHJ)"C1JE": (Bactroban , Fucidine, Garamycine...). ED'-8'* : J,( ED'-8) #F 'DE16 E9/J  D0DC CD 'D6E'/'* H'DEH'/ 'D#.1I 'D/'.DJ) AJ 'D*E'3 E9 'D"A) J,( #F *-1B (9/ 'D'3*9E'D. H'D7'BE 'D7(J HE3'9/JG J,( ,EJ9GE 'D'F*('G H'D-01 EF #F JF*BD %DJGE 'D.E,. 'D.1','* Abscess GH 'F*'F ,D/J E-// J*1'AB E9 *.1( F3J,J EH69J. 'D4CD 1BE 29: .1', 'D4CD 1BE30: .1', 'DE8'G1 'D31J1J): (1/66)  *.*DA 'DE8'G1 'D31J1J) -3( 'D96HJ'* 'DE3(() H'DEC'F 'DE5'(. 'D.1', 'D,1+HEJ B/ J5J( 'D,D/ H'D#96'! 'D-4HJ). .1', 'D,D/ H'DF3J, *-* 'D,D/ B/ J5J( 'D"DJ)  'D'(7  'DA1H)  #H #J F'-J) EF 'D,D/ -J+ *(/# 'D"A) (4CD -7'7) -E'EJ) ED*G() **-HD (9/ 0DC %DI -HJ5D) HEF +E %DI (+1). 'D.1', 9'/) 0H E-A8) HG0' JA1BG 9F 'D'F*'F'* 'D,D/ 'D37-J) 'D#.1I E+D 'D*G'( 'DF3J, 'D.DHJ  HJCHF 'D.1', A*-) 9DI 37- 'D,D/ H*F2- BJ-'K. 'D#91'6 'D(FJHJ) 'D9'E) E+D 'D-1'1)  'D5/'9. 'D2HA'F H'D#DE %0 B/ *.*DA 4/) *DC 'D#91'6 -3( -,E HEC'F H9E1 'DE1J6 #H #J E16 E1'AB. B/ J*CHF 'D.1', EH69J'K AJ 'D1&) #H 'DC(/ #H #J EC'F  H*.*DA 'D#91'6 'DE1'AB) -3( 'DEHB9 'DE5'(. 'D#FH'9 'DE.*DA) DD.1','* 1. @ 'D.1', 'D,1+HEJ. 2. @ 'D.1', 'D('1/: J-/+ E9 'D*/1F 'D,F(J. 3. @ 'D.1', 'DE9BE: G0' 'DFE7 EF 'D.1','* J5J( 9'/) 'DF'-J) 'D#DJHJ) (3(( -BF (96 'DEH'/ 96DJ'K E+D 'DE3*-61'* 'D2J*J) 'D*J *H69 *-* 'D,D/ E-/+) .1','K E9BE'K HDJ3 ,1+HEJ'K H0DC (3(( 'D-BF 'D37-J DDEH'/ #H 'D-BF (71JB) .'7&). 4. @ .1','* 'D#-4'! : G0G 'D#FE'7 EF 'D.1','* B/ *CHF ,1+HEJ) #H #EJ(J) #H A71J). 'D.1', 'D0J J3(( #91'6'K H9D'E'* E.*DA) B/ JCHF C(/J #H CDHJ #H 1&HJ. 71B 'DE9'D,): *9*E/ E9'D,) 'D.1', (4CD 1&J3J 9DI FH9 'D,1+HE) 'DE3(() DG. 'D.1', 'D,1+HEJ JECF E9'D,*G ('D5'/'* 'D-JHJ) /'.D'K H.'1,'K HA*- H*A,J1 'D.1', 9F/E' JCHF E-//'K AJ 'D,D/. 'D#FE'7 'D#.1I *9'D, -3( 'D9'ED 'DE3((. 'D*G'( 'DF3J, 'D.DHJ Cellulitis GH #F*'F #H 'D*G'( EF*41 AJ 'D,D/ H'DF3J, *-* 'D,D/ HJF,E 9F 'D9FBH/J'* 'DE0G() H'D9B/J'* 'DEBJ-) #H 'DECH1'* 'DE9/J). 'D9'ED 'DEGJI! DE+D *DC 'D'D*G'('* 9'/) GH 16 'D,D/. 'D4CD 1BE 31: 'D*G'( 'DF3J, 'D.DHJ (1/67)  'D4CD 1BE 32: 'D*G'( 'DF3J, 'D.DHJ #91'6 'DE16 #C+1 'D#E'CF 916) DD%5'() GJ EF7B) 'DH,G H'D#71'A  -J+ J8G1 'D,D/ #-E1 'DDHF HED*G('K HE*H1E'K HE$DE'K. 'D'D*G'( B/ JF*41 HJF*BD %DI 'D#/E) H%DI 'DF3J, E' *-* 'D,D/ HB/ J$/J 0DC %DI 'D*B1- H'D*G'( 'D#H9J) 'DDEA'HJ) H'D*G'( 'D9B/ 'DDEA'HJ). 'D-'D'* 'D4/J/) EF 'D'D*G'( *5'-(G #91'6 9'E) E+D '1*A'9 AJ /1,) 'D-1'1) H"D'E ('D,3E. 'D*G'( 'DF3J, *-* 'D,D/ AJ 'DH,G 9F/ 'D#7A'D J-/+ (3(( E-('* 'D/E 'D'FADHF2J) (Hemophilus influenza). HGH 9'/) H-J/ 'D,'F( HJ*1'AB :'D('K E9 'D*G'( 'D#0F 'DH37I AJ FA3 'D,'F( HJ4CH 'DE1J6 9'/) EF #91'6 9'E) E9 *H1E H*:J1 DHF 'DEF7B) 'DE5'(). J8G1 0DC #-J'F'K ('DDHF 'D2G1J HDCF (4CD 9'E JCHF #21B #1,H'FJ  #E' 'DDHF 'D(FA3,J B/ J-/+ 9F/ 'D#7A'D AJ EF7B) E' -HD 'D-,', H'D4/B (3(( 'D*G'( 'DF3J, 'D.DHJ ('D9B/J'* 'D1&HJ). 71B 'DE9'D,): 'D-'D'* 'D4/J/) EF 'D'F*'F 'DEF*41 'DE*1'AB E9 #91'6 (FJHJ) 4/J/) B/ J-*', %DI '3*4A'! .'5) %0' DE JCF GF'C '3*,'() DD9D',. 'D-E1) (Erysipelas) GJ #F*'F #H 'D*G'( ,1+HEJ ,D/J H'DF3J, E' *-* 'D,D/ HJ-/+ 0DC (3(( 'D9B/J'* 'D-'D) DD/E (J*' (B-hemolytic streptococci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epticemia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uberculosis of skin 'D*/1F 'D.DBJ 9F/ 'DHDJ/: (1/69)  JF,E 9F 'F*B'D 'D'F*'F /'.D 'D1-E HGH F'/1 F3(J'K  J-*ED #F 'DBF') 'D*F'3DJ) 9F/ 'D#E GJ E5/1 'D'D*G'('*. #FH'9 */1F 'D,D/: DG 9/) E8'G1 31J1J) #H *41J-J) E16J) HJ9*E/ 0DC 9DI EB'HE) 'DE1J6 H9E1G. 1. @ E1J6 0H EB'HE) ,J/): 'D#FH'9: @ 0#( 4'&9 "Lupus vulgaris" @ 'D.F21) 'D,D/J) "Scrofuloderma" @ */1F 'D,D/ 'D+$DHDJ"Tuberculosis verrucosus cutis " @ 'D/1F'* "Tuberculids" @ "A'* 7A-J) "Exanthematous lesions " @ 'D*/1F 'D/.FJ 'DEF*41"Tuberculosis miliaris disseminatus" @ 'D0#( 'D/.FJ 'DEF*41 'DH,GJ"Lupus miliaris disseminatus " @ 'D/1F 'D-7'7J 'DF.1J "Papulonecrotic tuberculid " @ 'D.F21H 'D-2'2J) "Lichen scrofuloderma " 2. @ 'DE16I 'DE5'(HF (69A 'DEF'9) H'DEB'HE): 'D*/1F 'D/.FJ (Miliary tuberculosis) E1C( 'D*/1F 'D(/&J ('DB1-) 'D3DJ) Primary tuberculosis complex ). 'D0#( 'D4'&9 'D0&() 'D*/1FJ) 'D4'&9) Lupus vulgaris Fig. 50a Lupus Vulgaris Fig.50b. Lupus vulgaris GH 'DFH9 'D#C+1 4JH9'K EF 'D*/1F 'D,D/J. HGH EF 'DFH9 'DE/E1 DD#F3,) -J+ J5J( 'DEF'7B 'DE916) EF 'D,D/ E+D 'DH,G H'D#71'A. 'DE8'G1 'D31J1J) : *8G1 'D"A'* 'D(/&J) 'D,D/J) (4CD DHJ-'* (FJ) E-E1) 0'* E3J1) E2EF) 7HJD) 'D#E/ -J+ *4AI ((7! AJ EF7B) H*9'H/ 'D8GH1 AJ EF7B) #.1I. *4AI 'D*B1-'* E9 *F/( J$/J %DI *.1( H*G*C DDEF7B) 'DE5'(). 'D9B/ *8G1 (DHF GD'E 'D*A'- HAJ 'D*F8J1 'D2,',J J(/H 'DDHF H'6-'K *-* 'D41J-) 'D2,',J) E+D лGD'E 'D*A'- 'D(FJ 'DE5A1╗. 'D*41J- 'DE16J : J*EJ2 'DE16 *41J-J'K E16J'K (E' JDJ: 9B/J'* .D'J' (41'FJ) E-'7) (#CE'E EF 'DDEA'HJ'*. 'D95J'* 'D3DJ) F'/1'K E'*H,/ AJ 'DEB79. .D'J' D'F,1G'F3 *H,/ 9'/). *,(F E1C2J B/ JH,/ AJ E1C2 'D9B/J'*. E1C( 'D*/1F 'D#HDJ ('DB1-) 'D3DJ)) Primary tuberculosis complex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iliary tuberculosis G0' 'D4CD J-/+ 9'/) AJ 'D169 H'D#7A'D 'D5:'1. 'F*4'1 'DE16 J-/+ 9'/) (9/ 'D-5() H'D-EI 'DB1E2J) H'D#E1'6 'D7A-J) 'D#.1I. 'DE8'G1 'D31J1J) : 'DE8'G1 'D,D/J) E*FH9) :'D('K. *8G1 'D"A'* (4CD 'F/A'9 -'/ E9EE EF 'D-7'7'* 'DEBEE) 'D*J B/ **B1- E4CD) B1-'* E*9//) 5:J1)  G0G 'DB1-'* F.1J) @ 5:J1)  /'&1J) 'D4CD HE:7') (F*-) E5DJ) BJ-J). 'D*/1F 'D-7'7J 'DF.1J Papulonecrotic tuberculid Fig.51c. Paapulonecrotic tuberculid (Fresh lesion) Fig.51d. Paapulonecrotic tuberculid (Fresh lesion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ichen scrofulosorum) *-/+ 'D"A) AHB 'D,09 .'5) 9F/ 'D#7A'D 'DE5'(JF ('D*/1F 'D98EI #H 'DDEA'HJ. J5'( 'D,D/ (-7'7'* EA17) 'D*B1F 0'* BEE E37-)  B'3J) HE-'7) ((+1'* #H B4H1 FB7J)  **,E9 (4CD E,EH9'* H0'* 7(J9) E2EF). B/ *.69 'D"A'* DD2H'D HB/ *9H/ DD8GH1 E1) +'FJ). 'D*/1F 'D,D/J 'D+$DHDJ (Tuberculosis verrucosus cutis Fig.31d. Tuberculosis verrucosus cutis G0' 'DFH9 J-/+ 9F/ 'DCGHD H'D#4.'5 0HJ 'DEB'HE) 'D9'DJ) 'DF',E) 9F 'D-BF 'D.'1,J DD95J'* 'D/1&J). 'DE8'G1 'D31J1J) : *(/H 'D"A'* (4CD 1&J3J 9DI 'D#71'A  9DI 8GH1 'D#5'(9  'DJ/JF  'DC'-DJF. H'D#1/'A (4CD "A) EA1/) -E1'! EA17) 'D*B1F  H**EJ2 (CHFG' E2EF) ,/'K B/ J*1'AB 0DC E9 'D*G'( 'D#H9J) 'DDEA'HJ) H'D*G'( 'D9B/ 'DDEA'HJ) HF'/1'K E' J-/+ EH'* (:'F:1JF) ,D/J. 'D*4.J5 'D*A1JBJ : 'D-2'2 'DE37- EA17 'D*B1F (Hypertrophic lichen planus). 'D#E1'6 'DA71J) 'D9EJB): /'! 'DA7'1 'D(19EJ (Blastomycosis). 'D,D'/ 'D(1HEJ (Bromoderma). 'D-E'EI 'D,'3J) (/'! ('2F) (Erythema induratum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crofuloderma *-/+ 9'/) 9F/ 'D#7A'D H'DCGHD 'D5:'1 #E'CF 'D,D/ AHB 'D9B/ 'DDEA'HJ) 'D1B(J) #H AHB 'DEF'7B 'D98EJ). *-/+ 'D"A) (4CD +'FHJ DD9B/ 'DDEA'HJ) 'DE5'() (*/1F .AJ -J+ **E2B H*3(( 4/ EA17 AJ 'D,D/ EE' J$/J %DI *B1- H*4CD ,JH( HBFH'* 9DI 37- 'D,D/. 'DE8'G1 'D31J1J) : 'D,D/ 'DE:7J DD9B/ 'DDEA'HJ) 'DED*G() J5(- E-E1'K  #1,H'FJ'K J*DHG *B1-'K E9 *B41 HJ*-HD %DI F3J, -(J(J 4'-( :J1 EF*8E JF*GJ ('D*F/(. 'D*/1F 'D,D/J 'DE.'7J (Tuberculosis cutis orificialis) 'D('D:HF H'D#7A'D 'DA'B/HF 'DEF'9) #H 'DB/1) 'DC'ED) J5'(HF (G0' 'DFH9 EF 'D*/1F 'D0J J*1'AB 9'/) E9 'D*/1F 'D-4HJ. *5J( 'D"A'* 'D#:4J) 'DE.'7J) DDAE H'D-FC H'D-F,1)  'D#:4J) 'DE.'7J) DD#E9'! H'D1&). 'DE8'G1 'D31J1J): *(/# 'D"A'* (B1-'* (J6'HJ) E*B41) 37-J) *E*/ %DI 'DEF'7B 'DE,'H1) E9 3J1 E2EF. 'D*4.J5 GF'C 9/) #EH1 HE8'G1 .'5) *3'9/ 9DI *4.J5 'D*/1F 'D,D/J 'DE.'7J: 1. @ C4A 'D95J'* 'D3DJ) 'D5A) 'DE$C/) H'D-BJBJ) DD*4.J5. 2. @ 'DB5) 'DE16J) H'D9D'E'* 'DAJ2J'&J). 3. @ 'D5H1) 'D*41J-J) 'DE16J). 4. @ *A'9D 'D3DJF (Tuberculin test) %J,'(J. 5. @ A9'DJ) 'D#/HJ) 'DE6'/) DD*/1F. E9'D,) 'D*/1F 'D,D/J 9/) EF'G, *3*./E AJ E9'D,) 'D*/1F. '3*./'E 'DE6'/'* 'D*/1F DEF9 EB'HE) 'D95J'*. E/) 'D9D', 7HJD) 'D#E/ HB/ J3*:1B 0DC 9/) 4GH1. 1. @ 'D'J2HFJ'2J/ (Isoniazid ,INH): (1/73)  ,19) 'D#7A'D: 8 ED:/C:/JHE  450ED: D#HD&C 'D0JF H2FGE #BD EF 50C,E. J97I 'D9D', JHEJ'K DE/) 6 4GH1 C'ED) H9'/) J97I 'DE1J6 'D('D:: 300ED: JHEJ'K DE/) 6 4GH1 C'ED). 2. @ 'D(J1'2JF'EJ/ (Pyrazinamide) (.D'D 'D4G1JF 'D#HDJF) 1.5 :1'E JHEJ'K DD0JF JBD H2FGE 9F 50C:. 1.6 @ 2.0 :1'E JHEJ'K DD0JF JH2FHF (JF 50 @ 74C:. 1.7 @ 2.5 :1'E JHEJ'K DD0JF H2FGE #C+1 EF 75C:. 3. @ 'D+J'E(H*HD(Ethambutol) : .D'D 'D4G1JF 'D#HDJF ('D,19) 15ED:/C:/JHEJ'K). G0G 'D#/HJ) J,( #F *97J E9 (96G' E6'/'* 'D*/1F 'D#.1I *97I 9'/) E4'1C) E9 *DC 'D#/HJ). F8'E #.1 (,19'* 'DC('1) DE9'D,) 'D*/1F GJ: 'J2HFJ'2J/: 300ED:  1JA'E(J3JF: 600ED:  (J1'2JF'EJ/ 2:  H3*(1(*HE(JF 1:  #H 'J+'E(H*HD 15ED:/C: 4. E1'* JHEJ'K DE/) 4G1JF +E J6'A %DI *DC 'D9D','* H'-/ EE' JDJ: 'J2HFJ'2J/: 900ED: E9 1JA'E(JJF: 600ED: 4E1'* JHEJ'K DE/) 44GH1. ('1' 'EJFH3'D3JDJC '3J/ (PAS) J3*./E AB7 ('DE4'1C) E9 'D'J2HFJ'2'J/ (INH) #H 'D3*1(*HE'J3JF. J,( #.0 ,EJ9 'D#/HJ) 9DI E9/) A'1:) E1) H'-/) JHEJ'K. 'D*79JE : (BCG vaccination) 'D*79JE J-61 EF 'D95J'* 'D3DJ) 'DFE7 'D%F3'FJ DE9'D,) 'D*/1F 'D,D/J E9 F*'&, E4,9). J-EJ 'DDB'- 'DE1J6 (H'37) -51 'D'F*4'1 'D/EHJ 'D+'FHJ DD9'ED 'DE-16 HJ-// 'D'F*'F 'D#HDJ DJ,9DG 0H 5A'* :J1 E$+1 H:J1 B'(D DD9/HI (Subclinical). 'DA9'DJ) 'DHB'&J) DD@ "BCG" 9F/ 'D#7A'D EF 'DEECF #F *3*E1 -*I 15 3F) 9DI 'D#BD. 'D#4.'5 'DE916HF D.71 'D9/HI E+D (9E'D 'DE4'AJ @ 'DE3'A1JF DEF'7B EH(H!)) JF5-HF ('DDB'-. 71JB) 'DDB'- CE' JDJ: J,( #F JCHF 'DDB'- ,/J/'K AJ CD E1) H*97I 'D-BF) *-* 'D#/E) /'.D ,D/ 'D01'9 AJ 'DE3'A) AHB H*1 'D96D) 'D/'DJ) AJ 'DF'-J) 'DJ31I. J,( '3*./'E -BF) .'5) EB'3 (' ED) (D'3*JCJ) H0'* %(1) B5J1) BJ'3 25 DCD E1J6. (1/74)  ,19) 'D#7A'D 'D169 0.05 (F5A 'D941) ED  H'D#7A'D 'DC('1 J97I 'DDB'- (,19) E6'9A) 0,1 (941) ED . 'D'1*C'3 'DEH69J J-/+ 9'/) (9/ 'DDB'- (-H'DJ 2 @ 6 #3'(J9 9DI 4CD -7'7) 5:J1) B/ **6.E ((7! H*A12 E'/) BJ-J) -J+ **1C (9/G' B1-) 37-J) HF/(). 'DE1',9 Gracey DR. Tuberculosis in the world today. Mayo Clin Proc 1988; 63: 1251-5 .1 Capewell S, France A, Uzel N et al. The current value of tuberculin testing and .2 BCG vaccination in children. Br J Dis Chest 1986; 80: 254-65 .3 Rieder HL, Cauthen GM, Kelly GD et al. Tuberculosis in the United States. J .4 Am Med Assoc 1989; 262: 385-9 .5 Sehgal VN, Srivastava MD, Khurana VK et al. An appraisal of epidemiologic, .6 clinical, bacteriologic, histopathologic and immunologic parameters in cutaneous .7 tuberculosis. Int J Dermatol 1987; 26: 521-6 .8 Grosset JH. Present status of chemotherapy for tuberculosis. Rev Infect Dis 1989; 11 (Suppl. 2): 34752. .9 Goette DK, Jacobson KW, Doty RD. Primary inoculation tuberculosis of the skin. Arch Dermatol 1979; 114: 567-9 .10 Ramesh V, Misra RS, Jain RK. Secondary tuberculosis of the skin: clinical features and problems in laboratory diagnosis. Int J Dermatol 1987; 26: 578-81 .11 Kennedy C, Knowles GK. Miliary tuberculosis presenting with skin lesions. BrMed J 1975; 3: 356 .12 Duhra P, Grattan CE, Ryatt KS. Lupus vulgaris with numerous tubercle bacilli. Clin Exp Dermatol 1988; 13: 31-3 .13 Ramesh V, Misra RS, Jain RK. Secondary tuberculosis of the skin: clinical features and problems in diagnosis. Int J Dermatol 1987; 26: 578-81 .14 (1/75)  Voyce MA, Hunt AC. Congenital tuberculosis. Arch Dis Child 1966; 41:299-300 .15 Hassoun PM. Erythema induratum and active pulmonary tuberculosis. Am JMed 1988; 84: 784-5 .16 Grosset JH. Present status of chemotherapy for tuberculosis. Rev Infect Dis1989; 11 (Suppl. 2): 347-52 .17 Sensi P. Approaches to the development of new antituberculosis drugs. Rev Infect Dis 1989; 11 (Suppl. 2): 467-70 .18 Maruyama, C.: Studies on treatment of skin tuberculosis with extracts from tubercle bacilli.Jap..J.Derm.(ser. B) 74:70-88(Jan.)1964 .19 'DA5D 'D+'EF E16 'D,0'E (Leprosy) GH E16 ,G'2J 'F*'FJ E2EF  *-/+G 'DE*A71'* 'D,0'EJ). 'D9H'ED 'DEOGJ&): 'D#7A'D 0H *916 9'DJ DD'F*'F. 3H! 'D*:0J). 3H! 'D-'D) 'D5-J) ('D5-) 'D9'E)). 'D3CF :J1 'DEF'3(. 'DE3*HI 'DE*/FJ DD-J') H'D*1(J). 71B 'D9/HI : 1. @ E('41) 9F 71JB ED'E3) 'D#4.'5 'DE5'(JF. 2. @ 'D'F*'F EF 4.5 D4.5. 3. @ 'D*E'3 E9 'D"A'* 'D%F*'FJ) 'DE*B1-). 4. @ EA12'* 'D#:4J) 'DE.'7J) 'DE.EH,). 5. @ 'D-41'* E+D: 'D51'5J1 @ 'D(B @ 'DA1'4 H7AJDJ'* 'D,D/. 'D#FE'7 'D31J1J) : 1. @ 'D,0'E 'D,0'EJFJ (Lepromatous leprosy) . 2. @ 'D,0'E 'D/1FJ (Tuberculoid leprosy) . 3. @ 'D,0'E 'D-/J(Borderline leprosy) . 'D,0'E 'D,0'EJFJ (Lepromatous leprosy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acular type): 'D"A'* GJ : D7'.) /GFJ) D'E9) :J1 E-//) 'D-/H/ H'D#71'A HEF*41). 0'* *H2J9 E*F'71. 'D%-3'3 :J1 E*:J1. 'D,D/ AHB 'DD7'.) :'D('K E' JCHF 7(J9J'K. *:J1'* 'D491: *3'B7 AJ 491 'D-',(JF #H 'D,AHF (JFE' 491 A1H) 'D1#3 AD' J9*1JG *:JJ1. 2. @ 'D%1*4'- 'D,0'EJ (Lepromatous type) 'D"A) 'D,D/J) B/ *CHF DHJ-'* #H 9BJ/'* EF*41). 3. @ 'DFE7 'DEF*41 (Diffuse type) 'D#H1'E 'D,0'EJ) ('D,0'EJ'*): GJ 9BJ/'* '1*4'-J) 4E9J) DE'9) 0'* 37- -E'EJ E21B F',E 9F 'D*-'E 'DD7'.'*. 'DEF'7B 'D#C+1 %5'() GJ: 'DH,G H'D,(G) H'D'1*4'- GH 9BJ/'* 0'* -/H/ :J1 3DJE) 9/JE) 'D%-3'3 BDJD'K H:'D('K E' *CHF .'DJ) EF 'D491 .'5) 9DI 'D-H',( H'D,(G) H'D#0FJF H'DJ/JF H'D#1/'A. 'D*:J1'* AJ 'D491 GJ 6J'9 AJ 491 'D-'-(JF. *:J1'* 'DE8G1 'D9'E ('D4CD) *(/J 3-F) 'D#3/ (H,G 'D#3/) (Lion face). 3J1 'D'1*4'- : B/ J2HD 9AHJ'K. B/ J2/'/ -,E'K E4CD'K DH-'* C(J1). 'D,0'E 'DEF*41 D@ DH3J : (Diffuse leprosy of Lucio) FE7 :J1 4'&9 EF 'D,0'E 'DEF*41  *(/J 'D"A'* F.1'* E*9//) H*B1-'* *4AJ D'-B'K H**1C F/() C(J1) ,/'K. 4. @ 'DFE7 'D*B1-J (Ulcerating type): (1/77)  'DB1-) 9'/) .'ED) E:7') (EF7B) F*-J) E5DJ) BJ-J) H*4AI *'1C) H1'&G' /E'1 H*4HG'* ('DEF7B) 'DE5'(). 5. @ 'D,0'E -2'2J 'D4CD (Lichen leprosus): GH 0H 3J1 31J1J E2EF ,/'K  'D"A'* *5(- +'(*) (/HF *:J1'* DA*1) 7HJD). 'D"A'* 'D,D/J) GJ D7.'* B'3J) ,1'(J) 5:J1) H5A1'! 'DDHF 0'* -/H/ H'6-) H*97J 'D,D/ E8G1 4CD ",D/ 'D#H2)". 6. @ 'D%5'() 'D95(J) (Neural involvement): CD 'DE16I 'DE5'(JF ('D,0'E 'D,0'EJ J*8'G1HF (/1,) E.*DA) (%5'() 95(J) E+D 'D./1  *6.E 'D#95'(  *:J1'* ':*0'&J)  6EH1 ('D96D'*  4DD H69A HG2'D ('D96D'*. 'D*:J1'* 'D-3J) : 9/E 'DB/1) 9DI 'D*EJ2 (JF -3 'D(1H/) H-3 'D-1'1) HB/ *CHF G0G 'D9D'E) 'D#HDI DD,0'E 'D,0'EJ. .DD -3 'DDE3. ./1'F ('D,D/. 6J'9 'D%-3'3 ('D#DE. 'D*FEJD H-1B'F H'D%-3'3 ('DH.2 AJ 'DF'-J) 'DE5'() E+D 'DB/EJF H'DJ/JF H'D3'BJF H'D8G1. B1-'* ':*0'&J) (Trophic ulcers)AJ 'DB/EJF. 7. @ 'DE8'G1 'D9JFJ) DD,0E 'D,0'EJFJ 'FBD'('* 'DB1FJ) 'D*G'( 'DB1FJ) *B1-'* 'DC+'A) 'DB1FJ) *4CD D#D& (J6'! 'D*G'( 'DB2-J) H'D,3E 'DG/(J 8. @ 'DE8'G1 AJ 'D#:4J) 'DE.'7J): 'D#FA: 'D9BJ/'* H'D'1*4'-'* E9 'D*B1-'* AJ 'D-',2 'D#FAJ J$/J %DI 'D#FA 'D31,J. 'D-('D 'D5H*J): (-) 'D5H*. 9. @ 'D#3F'F 6J'9 AJ 'DBH'79 'D9DHJ). 10. @ 'D'-4'! 'DC(/ @ 'D7-'D @ 'DF.'9 'D98EJ @ 'D.5J*'F @ 'D9B/ 'DDEAJ) H'D,G'2 'D4(CJ 'D(7'FJ B/ *5'( ('DE16. 'D,0'E 'D3DJFJ (Tuberculoid leprosy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pigskin ). 8GH1 'D./1 AJ 'D"A'* 'DE*1'AB E9 FB5 'D*5(: HFB5 'D*91B H'DD7.) *CHF E./1) H:'D('K E' *H,/ AJ 'DH,G H'D#71'A. 'DE8'G1 'D95(J) : B/ *$/J %5'() 'D#95'( %DI: 1. @ 6.'E) 'D95( H3E'C*G. 2. @ 'D./1. 3. @ 4DD 96DJ: 6EH1 H69A ('D96D'*. 'D/1JF'* 'D-/J) (Borderline tuberculoid) 'D"A'* GJ FA3 'D"A'* AJ 'D,0'E 'D3DJFJ DCFG' #5:1 H#BD 9//'K HD' *H,/ 95J'* 'D,0'E AJ G0' 'DFE7 #H *CHF F'/1) ,/'K. G0' 'DFH9 :J1 E9/J 9'/). 'DE8'G1 'D,G'2J) E+D 'D%5'() 'D95(J) H%5'() 'D491 BDJD) ,/'K. 'D,0'E 'D3DJFJ 'D-/J (Borderline tuberculoid) 'D"A'* BDJD)  H:J1 E*F'81) H**#DA EF DHJ-'* 0'* 4CD E(GE :J1 EF*8E H:J1 E-//) 'D,H'F(. **(9 G0' 'DFH9 ('DB1( EFG' "A'* 5:J1) 'D-,E. 'D,D/ H'D#95'( GE' AB7 'DE5'('F  H./1'F 'D,D/ JCHF 9'/) E9*/D'K. 'DE8'G1 'D31J1J): "A'* 'D4CD 'D,0'EJ 'D-/J *CHF E*A1B) H1(E' *CHF D7'.J) #H -7'7J) #H DH-J). :J'( 'DE8'G1 'D,0'EJFJ) 'DG'E) E+D 'D*G'('* 'DB1FJ)  'D*B1- H'D*4HG'*. B/ J-/+ %5'() ('D#95'( HDCF JCHF E*#.1'K. 'D,0'E 'D:J1 E-// ('DD'-/J) (Indeterminate leprosy) (1/79)  'D"A'* 'D,D/J) GJ D7'.'* J*DHG' "A'* 6EH1J) H.'DJ) EF 'D%-3'3. 'DDHJ-'* #H 'D9B/J'* D'*-/+ AJ G0' 'DFE7. 'D*41J- 'DE16I DD,0'E : J8G1 'DF3J, 'DE5'( ('1*4'- 'D*G'(J E2EF -HD 'D#H9J) 'D/EHJ)  H'D#95'( H'D:// 'D,D/J)  E9 .D'J' 5:J1) E/H1) H#-J'F'K .D'J' EF 'DEF3,'* HE5H1'* 'DDJA 'D4CD. 'D*:J1'* 'D*41J-J) 'DE16J) *9*E/ 9DI FH9 'D,0'E: 1. @ 'D,0'E 'D,0JEJ(Lepromatous leprosy) "A'* -(J(J) **#DA (4CD 1&J3J EF .D'J' (.D'J' 1:HJ)) E-4H) ('D,1'+JE 'D95HJ) 'DE3(() DE16 'D,0'E. 6EH1 AJ 'D(41) H'D:// 'D91BJ). 95J'* EB'HE) DD-E6 EF*41) AJ 'DEB79. 2. @ 'D,0'E 'D3DJFJ (Tuberculoid leprosy) J(/J EB'HE) 9'DJ). 'D4CD 'D,1'(J: J(/J H1E -(J(J /1FJ AJ 'D(41) J*#DA EF .D'J' (41'FJ) H(96 'D.D'J' 'D917D) (Giant cells). 'D4CD 'D3'1CHJJ/J: J(/H (4CD H1E -(J(J J*#DA EF .D'J' 8G'1'FJ) ((41'JJF E9 DEA'HJ'*). 3. @ 'D3DJFJ 'D-/J (Borderline tuberculoid) 'D5H1) 'DF3.J) GJ EF3,'* (4CD 1&J3J E9 .D'J' (41'FJ) H'1*4'- DEA'HJ C+JA. (96 'D95J'* H(96 'D.D'J' 'D1:H). 4. @ 'D,0'E 'D,0'EJ 'D-/J (Borderline leprosy) @ 'F*4'1 4/J/ DD.D'J' 'D(41'FJ) .D'D 'DH1E 'D-(J(J. @ 95J'* 'D,0'E :2J1). @ 'F*4'1 'D.D'J' 'DDEA'HJ) AJ 'DEF7B). @ .D'J' 917D) #H 'D.D'J' (Giant cells) 'D9ED'B) :J1 EH,H/ ('DF3J,. 'D*4.J5 'D*A1JBJ DD,0'E : (96 'DC*'( J5AHF 'D,0'E (#FG "'DEBD/ 'D'98E" #J #FG J97J 5H1) *4(G #E1'6 ,D/J) E.*DA). 1. @ 'D4CD 'D,0'EJFJ : 'D0'( 'D4'&9. 'DD4E'FJ'. 'D41I. 'DA7'1 'DA71'FJ. 'D9/ 'DCJ3J (-(H( 'D4('(). 'D-E'EI 'DE2EF) 'DE3*E1) (Erythema chronicum migrans). 2. @ 'D4CD 'D3DJFJ : 'D'1*C'3 'D/H'&J. 'D-E'EI 9/J/) 'D#4C'D. 'D-E'EI 'D9B/J) ('D9,1J)) (Erythema nodosum). 'D-E'EI 'D,'3&) (Erythema induratum). 39A) 'D,3E. (1/80)  'D-2'2 'DE37-. 'D0&() 'D-E'EJ) 'DB1J5J) (Discoid lupus erythematosus). 3. @ 'D4CD 'D3DJFJ 'D-/J: 'DF.'DJ) 'D(J6'!. 'DF.'DJ) 'DE(1B4). 'D*G'( 'D,D/ 'D/GFJ. -3'3J) 'D97H1 (Berloque dermatitis) . 'D(D':1'. *A'9D 'D,0'EJF: (*A'9D E*3H/' (Lepromin test, Mistuda reaction) GH '.*('1J EF'9J J4J1 %DI EB'HE) 'DE5'( DDE*A71'* 'D,0'EJ). 'D*A'9D 'D,0'EJ (Lepra reaction) .D'D E9'D,) 'D,0'E GF'C *A'9DJF B/ J-/+': 'DFH9 'D#HD (3(( EF*,'* 'D,1'+JE #+F'! 'DE9'D,) (E1C('* 'D3DAHF'* #H (3(( *7H1 'DEF'9). 'D*A'9D B/ JCHF : 1. @ *A'BE -'/ DD"A'*: J-/+ 9'/) .D'D 'D#1(9 4GH1 'D#HDI DDE9'D,) HJ8G1 0DC 9DI 4CD *H1E H'-E1'1 AJ 'D"A'* 'DEH,H/). 2. @ -E'EI 9B/) ,0'EJ) (Erythema nodosum leprosum) : *9*(1 'D*G'( 'D#H9J) 'D*-33J HJ8G1 (4CD E*#.1 .'5) (9/ 6 4GH1 EF (/! 'D9D',. 'DE8'G1 'D31J1J) DD-E'EI 'D9B/) 'DE8'G1 'D9'E) : -EI  B491J1)  /9+  #DE 96DJ HEA5DJ. E8'G1 -4HJ). 'D*G'( 'DCDJ) @ 'D*G'( 'D.5J) @ 6.'E) C(/J) H*6.E C(/J 7-'DJ. 9D', 'D,0'E 1. @ 'D/'(3HF #H (/'J 'EJFH @ /J AFJD 3DAHF) (DDS) GH 'D/H'! 'DEA6D DE9'D,) CD #4C'D 'D,0'E. 'D,19'* : #HD #3(H9JF 25ED: E1*JF AJ 'D#3(H9. +'FJ #3(H9JF 50ED: E1*JF AJ 'D#3(H9. +'D+ #3(H9JF 75ED: E1*JF AJ 'D#3(H9. 1'(9 #3(H9JF 100ED: E1*JF AJ 'D#3(H9. 2. @ /J AFJJD +JHJH1J'( Ciba SU-1906) ,19) 'D('D:JF: 2:/JHE DE/) 3F*JF. G0' 'D/H'! B/ JCHF EAJ/'K AJ -'D'* 'DEB'HE) DD3DAHF'*. 3. @ 3DA' /'J EJ+HC3JF( Madribon) : A9'D DE9'D,) 'D,0'E 'D3DJFJ. 4.( Lampreme, Geigy) A9'D AJ E9'D,) -'D'* 'D,0'E 'D'1*C'3J. HJH,/ *A'9D ,0'E #BD 9F/ '3*9E'D G0' 'D/H'! HJ3*./E AJ 'D-'D'* 'DEB'HE) DD3DAHF'*. 9D', 'D'1*C'3 'D,0'EJ: (Lepra reaction) 'D-'D'* 'D.AJA) : 1. @ *.AJ6 'D,19) %DI 'DF5A. (1/81)  2. @ E6'/'* 'DGJ3*'EJF. 3. @ 'D#/HJ) 'DE6'/) DDED'1J'. 4. @ %0' '3*E1 G0' 'D'1*C'3 (9/ CD G0G 'DH3'&D  J,( %JB'A 'D/'(3HF. 'D-'D'* 'DE9*/D) H'D4/J/): 1. @ 'JB'A 'D/H'!. 2. @ EG/&'*. 3. @ E6'/'* 'DED'1J'. 4. @ E6'/'* 'DGJ3*'EJF. 5. @ 'D3*J1HJ/'*. 'DE1',9 Lara CB. Leprosy in children: general considerations; initial and early stages. WPR/LEP/24 Geneva: WHO, 1961. 1. Kaplan G, Cohn ZA. Regulation of cell mediated immunity in lepromatous leprosy. Lepr Rev 1986; 57: 199-207. 2. Neill MA, Hightower AW, Broome CV. Leprosy in the United States. J Inf Dis 1985; 152: 1064-9. 3. McDougall AC, Archibald GC. Lepromatous leprosy presenting with swelling of the legs. Br Med J 1977; i: 23-4. 4. Duncan ME, Melsom R, Pearson JMH et al. A clinical and immunological Study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy. Int J Lepr 1983; 51: 7-17. 5. Drutz DJ, Chen TSN, Lu W-H. The continuous bacteraemia of lepromatous leprosy. New Engl J Med 1972; 287: 159-64. 6. Dabholkar VR, Gaitonde BB. A study of autonomic functions in leprosy. Leprosy in India 1982; 54: 303-17. 7. Bryceson ADM, Pfaltzgraff RF. Leprosy 3rd edn. Edinburgh: Churchill Livingstone, 1990. 8. Pearson JMH. Dapsone resistant leprosy. Lepr Rev 1983; (Special Issue): 85S-89S. 9. Pedley JC, Harman DJ, Waudby H et al. Leprosy in peripheral nerves: histopathological findings in 119 untreated patients in Nepal. J Neurol Neurosurg Psych 1980; 43: 198-204. 10. Ridley DS. Reactions in leprosy. Lepr Rev 1969; 40: 77-81. 11. (1/82)  Ridley DS, Jopling WH. Classification of leprosy according to immunity, a five-group system. Int J Lepr 1966; 34: 255-73. 12. Ellard GA. Rationale of multidrug regimens recommended by a WHO Study Group on chemotherapy of leprosy for control programmes. Int J Lepr 1984; 52:394-401. 13. Duncan ME, Melsom R, Pearson JMH et al. A clinical and immunological Study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy. Int J Lepr 1983; 51: 7-17. 14. 'DA5D 'D*'39 #F*'F'* 'D,D/ ('DDHD(JJ'* Treponemal skin infections 'D'A1F,J ('D2G1J) 'D.DBJ Congenital syphilis 'DE8'G1 'D,D/J) DD'A1F,J 'D.DBJ *EJD DD8GH1 .D'D 'D#3'(J9 #H 'D#4G1 'D#HDI EF 'D-J'). JF*BD 'D#A1F,J EF 'D#E %DI 'D,FJF 9(1 'DE4JE)  D0DC J9*(1 'DE16 E'B(D 'D-ED #C+1 EE' GH .DBJ. 'DE8'G1 'D,D/J) DD'A1F,J 'D.DBJ 'D('C1 : 1. @ 'D3E)(Stigmata ) 'DE16 'D,D/J 'D'A1F,J 'D.DBJ JECF *4.J5G (3GHD) AJ -'D H,H/ 'D3E) HGJ EF 'D#EH1 'DG'E) 'D*J *3'9/ 9DI 'D*4.J5  HGJ *H,/ 9F/ 'D#7A'D 'D5:'1 F',E) 9F "A'* E.1() *$/J %DI 'D*F/( H*1C "+'1 ('D,D/. G0G 'D*:J1'* E91HA) ('3E +D'+J HE' J3EI G*4JF3HF2 *1'J/(Hutshinson's triad) HJ4ED : 'D#FA 'D31,J. "A'* ,D/J) (F/('* 49'9J) 'D4CD). B1-'* H*C+A'* 'DB1FJ) 'D9JFJ). #3F'F G*4JF3HF H*8G1 'D#3F'F (4CD л'D1-I 'D*H*J)╗ (Malbery moles). 2. @ AB'9'* 'DE16 'D'A1F,J: JCHF 'D%F/A'9 'DAB'9J E*F'81 HB/ J*H,/ AJ 'D1'-*JF H'D#.E5JF HJ-*HJ 9DI 3'&D BJ-J E5DJ J-*HJ 9DI 'DDHD(J'*  H#.J1'K A%F 'DB4H1 'D-E1'! 'D:'EB) *:7J 'DEF7B) 'DE5'(). 3. @ 'DH1E 'DBF(J7J ('DDBEJ) 'DE37- (Condyloma lata): B/ *5J( G0G 'D"A) 'D'*5'D 'D,D/J @ 'DE.'7J. (1/83)  'DE8'G1 'D31J1J): E8'G1 'D#:4J) 'DE.'7J): J-/+ *B1- H*.1J( 'D#:4J) AJ 'DEF'7B 'DED*G(). E.'7J) 'D#FA H'DAE H'D(D9HE H'D-F,1) *5'( 9'/) -J+ J-/+ 3JD'F E/EJ #H 3JD'F E.'7J BJ-J EF 'D#FA G0' J3EIлSnuffles╗ HJ5'( 'D16J9 ((C'! .'A* (3(( %5'() 'D-F,1). 'DE8'G1 'D,D/J): J5(- 'D,D/ #-E1'K  B/ *8G1 4BHB 49'9J) AJ 2H'J' 'DAE ('D5H1JF) H-HD A*-*J 'D#FA H'D41,. 4A'! G0G 'D"A'* J*1C F/('* 49'9J) 'D4CD *3EI "Rahgades" ('DD,E). 'DE8'G1 'D,G'2J): EF81 'D1,D 'DE3F: F',E 9F 'D#91'6 'D(FJHJ) E+D 'D*G'( 'DE9/) H'D#E9'!  0'* 'D1&). FB5 'DH2F H'D3AD  -J+ JCHF 'D,D/ #5A1  (FJ HEFCE4. 'D-'5) 'D#A1F,J) (Syphilitic alopecia ) 'D-'5): *8G1 AJ ,'F(J 'D1#3 H.DAG %0 *8G1 EF'7B .'DJ) EF 'D491 HJ97J 0DC EF81 EEJ2 J4(G л'D9+╗. :J'( 491 'D#,A'F H'D-',(JF. *C31 H*4HG 'D#8'A1. 'DE8'G1 'D,D/J) DDE16 'D'A1F,J 'D.DBJ 'DE*#.1 J-/+ 'D'A1F,J 'D.DBJ 'DE*#.1 9// C(J1 EF 'D9D'E'* H'D#91'6 AJ 'D-'D'* :J1 'DE9'D,). E8'G1 'D"A'* 'D+D'+J) лTertiary stage╗ *CHF 9'/) F'/1) 9F/ 'D#7A'D (9E1 #BD EF 5 3FH'*. G0G 'D9D'E'* EEJ2) ,/'K: 1. @ 'D5EH: (Gumma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on venereal Treponemas /'! 'DJH2 ('D/'! 'D9DJBJ) (Yaws) GH E16 ,G'2J :J1 'A1F,J J(/# 9'/) AJ 'D7AHD)  3J1 'DE16 9F/ 'D#7A'D #C+1 319) EFG 9F/ 'D('D:JF. DHD(J'* Pertunue GJ 'D9'ED 'DE3(( HGH E3*H7F AJ (96 'DEF'7B 'DE/'1J). 'DE3(('*: 'DDHD(J'* "Treponema Pertenue "GJ 'D9'ED 'DE3(( HE-//) 4CDJ'K E9 'DDHD(J'* 'DE3(() DD'A1F,J. 'D0('( EF ,F3 "Hippelates " *FBD 'D'F*'F %DI 'DC'&F'* 'D(41JG. 'D16 'D.AJA H-*I 'D3-,'* 'D,D/J) B/ *-16 9DI /.HD 'D,1'+JE 'DE3(() %DI 'D,D/. 'DE8'G1 'D31J1J): 1. @ 'D7H1 'D('C1 'D"A'* 'D(/FJ): *8G1 'D-7'7) #H E,EH9) 'D-7'7'* 'D(/&J) .D'D 4G1 #H #C+1 (9/ /.HD 'D9'ED 'DE-16 %DI 'D,D/. 'D"A) 'D#HDJ) *3EI 'D*H* 'D9DJB ('D*H* 'D(1J (Frambesiform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eriosteitis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inta) GH 'F*'F ('DDHD(J'*  :J1 #A1F,J HJ3EI л/'! 'D5(': 'D#21B (Blue stain disease ) . E' JEJ2 'DE16 GH 8GH1 EF'7B EDHF) (4CD :1J( AJ 'D,D/. J5J( 'DE16 9'/) 0HJ 'D(41) 'DEDHF) (4CD 1&J3J H*4CD G0G 'D9D'E'* 'DEEJ2) DDE16. 'D,1'+JE 'DE3(() GJ 'DDHD(J'* (Treponema carateum ) 'D*J D' JECF *EJJ2G' 4CDJ'K 9F 'D95HJ'* 'DE3(() DD'A1F,J H/'! 'D9DJBJ ('DJH2). J*H',/ 'D/'! 'DE3*H7F AJ 'DEF'7B 'DE/'1J) HE' *-* 'DE/'1J). 71JB 'D'F*B'D : 'D0('( EF ,F3 'D@ ( Hippelates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pirochetes) B/ *8G1 AJ 'D3'&D 'DE3-H( EF 'D9B/) 'DDEAJ). 'D4CD 1BE 57 '-: 'D(F*' 'D4CD 1BE 57(-: 'D(F*' 3. @ 'DE1-D) 'DE*#.1): G0G 'DE1-D) *-/+ (9/ 3J1 7HJD 7HJD ,/'K HB/ J3*:1B 3FH'* 9F/ 'D('D:JF H0H 3J1 E2EF ,/'K. *8G1 'D"A'* 9DI 'DH,G H'D1#3 H'D9FB H*$/J %DI *5(: FB7J) EF*41) #H EH69J) (DHF #21B /'CF  *3*(/D (9/ HB* 7HJD ((B9 A'B/) 'DDHF *4(G 'D(GB. D0DC *3EI G0G 'DE1-D) #-J'F'K ('3E лE1-D) 931 'D*DHF╗ %0 J8G1 9DI 'D,D/ (B9 21B'! ('D(F*' 'D21B'!) HEF'7B (J6'! ('D(F*' 'D(J6'!). 'D"A'* B/ *5(- EA17) 'D*B1F %0 *F*GJ (B1- 9EJB) H*.1( AJ 'DEF'7B 'DE5'() EF 'D,D/ H'D98E H'D#FA HF'/1'K 'D(D9HE E$/J) (0DC %DI *4HG'* H'39). %5'() 'D#-4'! 'D/'.DJ) H'D,ED) 'D95(J) F'/1) ,/'K. 71B 'DE9'D,): 'D(F3DJF ((F2J+JF (F3DJF) GH 'D/H'! 'DE.*'1. 'D,19) 'DEF5H- (G' DD('D:JF GJ -BF) ('D96D 1.200.000 H-/) CD #1(9 #J'E. 'DDHF 'D#21B H'DEF'7B .'DJ) 'D5(': H'D"A'* 'DE71A) 'D*B1F *(/# ('D2H'D (9/ 'DE9'D,). 'D(,D (Bejel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oot JM, Oranje AP, Menke HE et al. congenital syphilis in the Netherlands: diagnosis & clinical features. Genitourin Med 1989; 65: 300-3 1. Bradlaw RV. The dental stigmata of prenatal syphilis. Oral Surg Oral Med Oral Pathol 1953; 6: 147-58 2. Browne SG. Yaws. Int J Dermatol 1982; 21: 220-3 3. Bengali FS. Involvement of aortic valve and ascending aorta in congenital syphilis. Br J Vener Dis 1961; 37: 257-67 4. Dunlop EMC, Wink RB. Incidence of corneal changes in congenital syphilis. Br J Vener Dis 1954; 30: 201-9 5. Feign D, Glenn M, MacBride-Stewart G et al. Yaws in the Solomon Islands. J Trop Med Hyg 1990; 93: 52-7 6. Harter CA, Benirschke K. Fetal syphilis in the first trimester. Am J Obstet Gynecol 1976; 124: 705-11 7. Hackett CJ, Loewenthal LJA. Differential Diagnosis of Yaws. Monograph Series, No. 45. Geneva: WHO, 1960 8. Mascola L, Pelosi R, Blount JH et al. Congenital syphilis revisited. Am J Dis Child 1985; 139: 57-80 9. Medina R. Pinta. An Endemic Treponematosis in the Americas. WHO INT/VDT/204.65 10. Noordhoek GT, Cockayne A, Schouls LM et al. A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and Yaws.J Clin Microbiol 1990; 28: 1600-7 11. (1/89)  Robinson RCV. Congenital syphilis. Arch Dermatol 1969; 99: 599-610 12. Willcox RR. Njovera: an endemic syphilis of Southern Rhodesia. Lancet 1951; i: 558-60 13. Whittet HB, Quiney RE. Nasal manifestation of yaws. J Laryngol Otol 1988; 102: 1147-9 14. Hackett CJ, Loewenthal LJA. Differential Diagnosis of Yaws. MonographSeries, No. 45. Geneva: WHO, 1960 15. Mascola L, Pelosi R, Blount JH et al. congenital syphilis revisited. Am J Dis Child 1985; 139: 57-80 16. Noordhoek GT, Cockayne A, Schouls LM et al. A new attempt to distinguish serologically the subspecies of Treponema pallidum causing syphilis and Yaws 17. WHO. Treponemal infections. Technical Report Series No. 674. Geneva: WHO,1982 18. WHO. Expert Committee on Venereal Diseases and Treponematoses. Sixth Report. Technical Reports Series No. 736. Geneva: WHO, 1986 19. 'DB1-) 'DE/'1J) Tropical ulcer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лFrambesia╗: *-/+ AJ 'DEF'7B 'DEH(H!)  H0'* 3J1 31J9  HJECF 92D H*-/J/ 'DDH(J'* T. Pertenue EFG'. 71B 'DE9'D,): 'DH3'&D 'DHB'&J) EGE) ,/'K 6/ D/: 'D-41'* H'D9H'ED 'DEGJ&) 'D#.1I. 5'/'* -JHJ) /'.D'K H.'1,'K. E9'D,) 'D9'ED 'DE3((. /'! C'1JHF (Carrion's disease) GH E16 (FJHJ #F*'FJ *3((G 'D('1*HFJDD' 'D95HJ) (Bartonella) 'D*J B/ *5J( 'D#9E'1 'D5:J1) H'D169 H(9/ 0DC J-/+ EF'9) 7HJD) 'D#E/. 'DE16 E3*H7F AJ (96 'D#H/J) AJ 'D,2! 'DE1C2J EF ,FH( #A1JBJ' .'5) AJ 'DA5HD 'DE'71). 0('( 'D1ED 'DA'5/) 'DFH:H4J)(Phlebotomus noguchi) H'D0('() (P.verrcarum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driaans B, Hay RJ, Drasar B et al. The infectious aetiology of tropical ulcer - a study of the role of anaerobic bacteria. Br J Dermatol 1987; 1616: 31-7 1. Robinson DC, Adriaans B, Hay RJ et al. The epidemiology and clinical features of tropical ulcer. Int J Dermatol 1988; 27: 49-53 2. J Clin Microbiol 1990; 28: 1600-7 3. Wilkinson M, Agett P, Cole TJ. Zinc and acute tropical ulcers in Gambian children and adolescents. Am J Clin Nutr 1985; 41: 43-51 4. 'DA5D 'D9'41 #F*'F'* 'D,D/ 'DA71J) Fungal skin infections 'D'F*'F'* 'DA71J) 'D37-J) Superficial fungal infections 39A) 'D1#3 Tinea capitis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canes "*(/H #FG' BDJD) H9DJG A%FG J3E- DD7AD #F J9H/ DDE/13) AH1 'D(/! ('DE9'D,). #FE'7 'DA7H1 'DE3(() DD'F*'F: 1. @ 'D(HJ:'! 'D'H/HJFJ) (Micosporon auduini) : GJ #4J9 'D#FH'9 %-/'+'K D39A) 'D1#3. 2. @ 'D(HJ:'! 'DCD(J)(M.Canis) : *F*BD 9'/) EF 'D-JH'F'* HB/ *3(( "A'* #4/ 'D*G'('K. 3.( Trichophyton mentagrophyte): *3(( 39A) 1#3 4/J/) 'D'*G'(. 4.( Trichophyton tonsurans ): *3(( 'F*'F E2EF H'D'F*'F 'DA71J :'D('K E' JCHF 9'&DJ'K. 5.( T.Vioaceum ): *3(( "A'* 31J1J) *3EI (B9 3H/'! "Black dot type". 6.( T.schoenleini ): *3(( 39A) 'D1#3 E' J91A ('3E 'DB19). 'DE8'G1 'D31J1J) : *.*DA 'D#91'6 ('.*D'A 'DA71 'D,D/J 'DE3((. (96 'D3D'D'* E+D 'D(HJ:'! 'DCD(J) H'DFH9"T.Mmentagrophyte" *3(( #91'6'K H'D*G'('* 4/J/) (JFE' "T.Tonsurans " *3(( "A'*'K 0'* 3J1 E2EF ,/'K. (1/93)  'D5H1) 'D31J1J) B/ *CHF :J1 H'6-) HD' JECF *4.J5G' (3GHD) E' 9/' (A-5 'DA7H1 (H'37) D7.'* GJ/1HC3J/ 'D(H*'3JHE"KOH ". #FE'7 EF 39A) 'D1#3: 1. @ 'DFH9 'D,'A: 'D"A) -'A) HE*B41) H*4(G B41) 'DA1H)  H'D5/'A H'D-2'2 'DE37-. 2. @ 'DFH9"Blackdot ": 9'/) *CHF 'D"A) ,'A) H'D491 EB7H9 EF 'D,0H1 H#33 'D#49'1 'DE5'() EH,H/) H*8G1 'DEF7B) 'DE5'() .'DJ) EF 'D491 'D7HJD HJ(/H 'D491 C#FG EB5H5 9DI E3*HI 37- 'D,D/ HJ(/H CFB7 9DI 37- A1H) 'D1#3. H*H,/ /1,) E.*DA) EF 'D'-E1'1  -C) H*B41. B/ *3*E1 'D"A) A*1) 7HJD) #H *2HD 9AHJ'K. 3. @ 'DFH9 'DE3EI 'D4G/) "Kerion" : "A'* #.1I B/ *CHF #C+1 'D*G'('K A*8G1 *H1E'K HF2'K H*B41'K AJ 4CD 'D*G'( 'F*A'.J AJ 'DA1H) *3EI "'D4G/)" HB/ *-/+ 'D*('3'K AJ *4.J5G' HB/ *9'D, 9DI #FG' .1', AJ 'DA1H). B/ J-5D 6J'9 'D491 H5D9 /'&E ('DEF7B) 'DE5'(). 4. @ 'DB19) "Favus" : **EJ2 (B4H1 5D() **4CD AHB 'DEF7B) 'DE5'() HB/ *F*41 D*:7J CD 'DA1H) HB/ *3(( 1'&-) C1JG) ,/'K DDA1H) HB/ *F*GJ (-'5) D' 9CH3) H5D9 /'&E  'D'F*'F B/ JF*41 %DI EF'7B #.1I (9J/'K 9F 'DA1H) E+D 'D(7F H'D#71'A. 71B 'D*4.J5 : *4.J5 39A) 'D1#3 B/ JCHF (71B E.*DA): 1. @ 'D5H1) 'D31J1J): 'DA7H1 'DE3(() *(/# (4CD E*EJ2 DE8'G1G' 'DE16J) %0 *(/# 'DA7H1 F4'7G' AJ 'DE1C2 E*:0J) 9DI 'DE'/) 'DB1FJ) H(9/ 0DC *F*41 E-J7J'K (9J/'K 9F 'DE1C2 %0 J-/+ 4A'! AJ 'DH37 (JFE' E-J7 'D"A) J(/J -H'A F4J7) 3H'! -7'7J) #H -HJ5DJ) #H -7'7J) -HJ5DJ) E9 37- E*B41. 2. @ #49) HH/: *97J DHF HE6'F #.61 BHJ. 'D491J'* 'D-'2) E+D 'D4HFD'JFJ) *97J HE6'F #.61 *-* 'D#49) AHB 'D(FA3,J) 'DEAD*1) (H'37) #49) HH/ AJ :1A) E8DE)  HG0' JAJ/ ,/'K AJ 'D*4.J5 'D31J9 D9// EF 'D#7A'D AJ 'DE/'13. (1/94)  3. @ 9JF) B4H1 EF -H'A 'DEF7B) 'DE5'(): GJ 71JB) (3J7) HJECF %,1'$G' (3GHD) AJ 'D9J'/)  'DA-5 'DE,G1J DD9JF) ('D(H*'3JHE GJ/1HC3J/ (KOH) JECF #F J-// 'D.JH7 'DA71J) DDA71 'D,D/J 'DE3((. 'D71JB): ,E9 'DC4'7'* EF 'D,D/ 'DE5'( J,( #F J$.0 EF 'D-H'A 'DF4J7) DD"A'* (H'37) E417 C'47 CDJD #H -'A) 'D41J- 'D2,',J). 'D491 'DE5'( J,( F29G EF ,0H1G .'5) AJ -'D'* 'D@ FAVUS. *H69 'D9JF) 9DI 'D41J-) 'D2,',J) E9 FB7) EF "KOH 30%". H*:7I ('D3'*1) 'D2,',J). +E *3.F (D7A DCJ *5(- 71J) H*5AJ 'DE'/)  J,( 'D-01 EF *3.JF 'D9JF) C+J1'K -*I D' *:DJ H('D*'DJ B/ *$/J %DI F*J,) 3D(J). 'D9JF) *A-5 ('DBH) 'D5:J1) (9/3) 'DE,G1 (/HF *DHJF. 'DF*J,) 'D%J,'(J) *8G1 .JH7 A71J) EA5HD) HE*A19). :2H 'DA7H1 DD491 GH .'1, 'D491)" Ectothrix "AJ( 'D(HJA'!Micosporon H'DA7H1 memenentagrophytes H T.verrucosum ). (JFE' GH" Endothrix" /'.D 'D491) AJ( T.Tonsurans H T. violaceum )'D491J) 'D,'2) 'D(FA3,J). 4. @ 'D219: AJ 9D() (*1I #H E'3-) B7FJ) AJ #F'(J( '.*('1 *-*HJ H37" 3'(H1HJ/ /HC3*1H2" H9DI "5'/'* -JHJ)" D*+(J7 'D,1'+JE H'DA7H1 'D1EJ). *-A8 G0G AJ 'D-'6F) AJ /1,) -1'1) 26 @ 30 DE/) #3(H9 #H #3(H9JF. 'DF*J,) 'D%J,'(J) *8G1 'D9/J/ EF 'DE3*9E1'* 'D*J JECF 'D*A1JB (JFG' H('D*'DJ *-/J/ FH9 'DA71 'DE3(( H JECF *-/J/G' 4CDJ'K HE,G1J'K. 'D*4.J5 'D*A1JBJ: 1. 'D-'5) 'D(B9J) "Alopecia Areata ": 'DEF7B) 'DE5'() @ F'9E)  .'DJ) EF 'D#49'1 #H %0' C'F GF'C (96 'D#49'1 'DF'EJ) *8G1 H(/HF B4H1. 9D'E) -1A 'D'3*AG'E 'D@" exclamation" D(96 'D#49'1 'DF'EJ) 'D*J *8G1 9DI E-J7 'D(B9) H*DC EF 'D9H'ED 'DE3'9/) AJ *4.J5 'D-'5) 'D(B9J). *-/J/ FH9 'DA7H1 'DE3(() ('DA-5 'DE,G1J #H 'D21'9) GE' 'DA'5D AJ *4.J5 39A) 'D1#3. (1/95)  2. 'D*G'( 'D,D/ 'D/GFJ: 'D"A) #C+1 'F*4'1'K H0'* B4H1 /GFJ)  6J'9 'D491 'DEF*41 H'DA-5 'DE,G1J 'D3D(J GE' E9J'1'F EGE'* DD*A1JB. 3. 'D-5A 'D,D/J H'D/E'D: AJ 'DA1H) B/ J4(G 'D4G/) (kerion) 'D"A'* 'D,1+HEJ) #C+1 'D*G'('K  H0H 3J1 #B51  H'D491 :J1 6'&9 HD' J8G1 HC#FG EB5H5'K 9DI 37- 'D(B9). 4. 'DA7H1 'D,D/J): JECF *-/J/G' ('DA-5 'DE,G1J #H ('D21'9). 5. 'D0&() 'D-E'EJ) 'D,G'2J)(Discoid lupus erythematosus) : 0'* 3J1 E2EF JF*GJ (-/H+ F/('* ('D,D/ H5D9 D' 9H/) (9/G H'DB4H1 ED*5B) H'DEF'7B 'DEC4HA) 'D#.1I E+D 'DH,G JECF #F *5'(. 'DA-5 'DE,G1J DDA7H1 JCHF 3D(J. 6. 'D-2'2 'DE37- (Lichen planus) : -7'7'* (FA3,J) E37-) B/ *4'G/ AJ 'D"A) 'D*J *F*GJ %DI -'5) D' 9CH3) #H 5D9 /'&E ('DEF7B) 'DE5'(). 'D#71'A H'D4/B B/ *CHF E5'() ("D'A'* 'DEEJ2) DD-2'2 'DE37-. 71B 'DE9'D,) : H3'&D HB'&J). E9'D,) EH69J). E9'D,) ,G'2J). 1. @ 'D,1J2HAHDAJF(Griseofulvin) : 'C*4A AJ #H'.1 'D#1(9JF'* H'3*./'E (9/ 1958 DE9'D,) 'D"A'* 'DA71J) 9F/ 'D%F3'F  HGH #HD E6'/ A71J %D' #FG #BD A9'DJ) EF CD 'DE6'/'* 'DA71J) 'DE*HA1) -'DJ'K  CE' #F DJ3 DG *#+J1 9DI 'D,1'+JE. 71JB 'D*#+J1: %FG J+(7 ,2&J'K *4CJD H*CHJF 'D#F'(J( 'D/BJB)(Microtubules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zoles) 'D"2HD'* 'DAEHJ) GJ 'DE1C('* 'D-/J+)  .'5) 'D' J*1'CHF'2HD  A9'D C(/JD DD,1J2HAHDAJF DCFG #C+1 :D'! EFG. '3*7('('* .'5) DD"2HD'* : @ 'D39A) 'D,3EJ) 'DH'39) 'DF',E) 9F 'DA7H1 'D491J) 'D-E1'!"T. rubrum" A%F 'D#2HD'* GJ 'DE9'D,) 'DE.*'1). @ 'D-'D'* 'D*J *A4D AJ 'D'3*,'() #H AJ -'D) 9/E *-ED 'D,1J2HAHDAJF. @ #FH'9 'D'2HD'* AJ 'D3HB: 'D'J*1'CHF'2D"itraconazole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llylamine" : GJ #/HJ) E6'/) DDA7H1 *9ED 9DI *+(J7 H*4CJD .EJ1)" Squalene epioxidase" AJ 'D:4'! 'D.DHJ 'DA71J. GF'C E1C(JF 1&J3JF GJ (Naftifine, Terbenifine ) CD'GE' A9'D 6/ 'DA7H1 'D,D/J). 'D@( Terbinifine -Lamisil ) JECF #F J97I AEHJ'K. ,19) 'D#7A'D AHB 20C:: JECF %97'$GE 62.5 ED: /JHE. 'D#7A'D 20 @ 40 C:: J97I 125ED: JHEJ'K. AHB 'D@ 40C: : 250 ED: /JHE. ,19) 'D('D:JF: GJ 250 ED: /JHE. HGH E*HA1 #J6'K (4CD E3*-61 EH69J (C1JE) HJ-/+ GH'/) 31J9) H7HJD) 'D#E/ AJ #E1'6 'D#8'A1 H39A) 'D,3E 'DE3*E1). GF'C (96 'D'/D) *4J1 %DI H,H/ 'DFC3 'DE*C11 E9 "'D*1(JF'AJF " #BD EF 'DE3*-61'* 'DE6'/) DDA7H1 'D*G'('* 'D#8'A1 'DA71J) 'D#.1I A7'1 'D#8'A1 )Onychomycosis): (1/98)  'D'F*'F 'DA71J DD#8'A1 0H 3J1 E2EF  (7J!  HB/ J3*:1B 9/) #4G1 -*I J8G1 %0 #F 4/) 'D*#+J1 9DI 'D#8'A1 #C+1 E' *9*E/ 9DI FH9 'DA71 'DE3((. 9/) #FH'9 EF 'DA7H1 *3(( A7'1 'D#8'A1: 1. @ 'DA7H1 'D491J) 'D-E1'!(T. Rubrum) : *-/+ E16'K E2EF'K 0H '1*C'3 'D*G'(J BDJD. 'DE8'G1 'D31J1J): 3J1 'DE16 E2EF  H**8'G1 'D"A'* (DHF #5A1 D71A 'D8A1 HB/ JF*41 0DC %DI CD 'D8A1. DHF 'D8A1 J*:J1 HJ(/J (B'J' /'CF) *-*G  H(4CD E*#.1 J5(- 'D8A1 C'E/ 'DDHF HG4 HJFBD9 E.DA'K (B'J' 3H/'!. 'D,D/ 'DE,'H1 B/ *:2HG 'DA7H1 H*3(( EF'7B -E'EJ) E-//) 'D-H'A F.'DJ) HE*B41). 2. @ 'F*'F (T. Mentagrophtes): *3(( 'F*'F 37-J HEH69J AJ 'D8A1. 3. @ #F*'F 'D8A1 'DEHFJDJ'&J (('DE(J6'* (Candidal nail infection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inea corporis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inea circinata "A) A71J) *8G1 (4CD -7'7) 5:J1) J2/'/ -,EG' (9J/'K 9F 'DE1C2 'D0J (/' AJG 'D'D*G'( -J+ #F 'DA7H1 *3*GDC 'DE'/) 'DB1FJ) AJ 'DE1C2 +E **-1C DDE-J7 D*(-+ 9F EF7B) ,/J/) *'1C) H1'&G' E1C2 E*B41 F'B5 'D5(': H-H'A F47) E1*A9). 'DE8'G1 'D31J1J) : 'D"A'* B/ *D*-E E9 (96G' E4CD) DHJ-'* C(J1) #H "A'* EA5A5) 'D-H'A. 'D#91'6 BDJD) AJE' 9/' -C) .AJA). H'D-'D) E9/J) (4CD .AJA. 'D"A'* *4CD 9/) #FE'7 31J1J): 1. @ 'DFE7 'DDH-J (Plaque type): 9'/) *3((G 'DA7H1 'D491J) 'D-E1'! -J+ *8G1 DHJ-'* C(J1) E*B41) 9DI 'D,D/ 'D.'DJ EF 'D491. 2. @ 'DFE7 'DE*B41 (Crusted type) : 'D"A'* 'DE*B41) *:7J EF'7B H'39) EF 'D,D/ H'DA1H) E9 1'&-) A'1J). 'D5A'* 'DEEJ2) DG0' 'DFH9 GJ "Scatula" H'D"A'* 'DE*B41) (C+'A) C*DC 'D*J *-/+ AJ 'DB1'9. (1/100)  'D4CD 1BE 71: 'D39A) 'D-DBJ) 'D4CD 1BE 72: 'D39A) 'D-DBJ) 'D39A) 'D9EJB) Tinea profunda GJ 'D*G'( 'F*A'.J AJ 'D,D/ :J1 'DE491 E+D 'D4G/) 'D*J *-/+ 9DI 'DA1H). 'D-'D) *-/+G' 'DA7H1 'D,D/J) 'DEF*BD) EF 'D-JH'F'* E+D " Trichophyton verrucosum". 'DE8'G1 'D31J1J) : GF'C 9/) FE'0, 31J1J): 1. @ 'D4CD 'D'C2JE'&J: GH 4CD 'D*G'(J 4/J/ H'6- 'D-/H/ E9 (+1'* ,1'(J) *F*, EA12'* E5DJ) /EHJ) #H E/E'). 'D'F*'F 'D,1+HEJ 'D+'FHJ B/ J-/+ C'.*D'7 (G0G 'D-'D) HB/ JCHF 'D*F/( GH 'DE1-D) 'D#.J1) DG0' 'DE16. 2. @ 'D4CD 'D,'A: 'D"A'* *CHF /'&1J) (/HF 4A'! E1C2J  HG0' 'DFE7 J-/+ (3(( 'DA7H1 'D491J) "Trichophyton". 3. @ 'D4CD 'D9B(HDJ : GH 4CD -HJ5DJ EF 'DA7H1 'D,3EJ) F',E 9F 'DA71J'* 'D,D/J) 'DEF*BD) EF 'D-JH'F'* @ C'DB77 H'DCD'(. 'D"A'* 'D-HJ5JDJ) *8G1 +E **E2B H**1C 37-'K E*#CD'K. 'DA7H1 'D-(J(J) (Majochi's Granuloma) GH 4CD F'/1 EF 'DA7H1 'D-(J(J) 'D,1'(J) H-HD 'D#,1() HGH 0H 3J1 E2EF. 'DE8'G1 'D31J1J) : *8G1 'D"A) 9DI 'D,D/ 'D.'DJ EF 'D491 'D'-D3 .'5) 9DI 'D0BF (4CD "A) -DBJ) E*B41) H'6-) 'D-/H/ E1*A9) HEF*A.) -J+ 'D#,1() 'D491J) **H39 E9 H,H/ E'/) BJ-J) E.'7J) D2,). 'D39A) 'D'1*H'2J) Tinea imbricata 'F*'F A71J 37-J J5J( 'D,D/ :J1 'DE491 H*8G1 'D"A) (4CD (B9 H'39) (4CD -DB'* E*-/) 'DE1C2 H-H'A 9/J/) 'D-DB'* HEB41). 'D3J1 B/ J#.0 HB*'K 7HJD'K -J+ *3(( A17 'D*5(F9 HC0DC (B9 A'*-) 'DDHF 'D*J *8G1 (9/ 4A'! 'D"A'*. 'DB1'9 Favus GH 'F*'F A71J AJ A1H) 'D491  HJ3((G' 'DA71" Trichophyton schoenleini "'D4HFD'JFJ)  'D#7A'D GE 'D#C+1 %5'() ('DB1'9. 'D#F*'F F'/1'K E' J5J( 'D,D/ :J1 'DE491 E+D 'D9FB H'D,09. 'D"A) B/ *8G1 (4CD (B9 E*B41) H3EJC). 'D*4.J5 'D*A1JAJ D39A) 'D,3E: GF'C 9/) "A'* ,D/J) *4(G 'D39A): (1/101)  1. @ 'DF.'DJ) 'DH1/J): GJ #C+1 'D#E1'6 'D,D/J) 'D*I B/ **4'(G H0'* 5H1) 31J1J) *4(G 4CDJ'K 39A) 'D,3/. "A) 'D39A) 'D,3/J) *CHF E1*A9) H-7'7J) -HJ5JDJ) F47) (JFE' 'DF.'DJ) 'DH1/J) -H'AG' 5:J1) HF'9E). ((B9) 'D7DJ9) (Herald patch) HGJ DHJ-J) -E'J) C(J1) *3*(B 8GH1 'D'F/A'9 'D,D/J) JECF (3GHD) #F *3'9/ 9DI *4.J5 'DF.'D) 'DH1/J). *H29 "A'* 'DF.'DJ) 'DH1/J) 9'/) ('*,'G .7H7 'D#6D'9. 9F/E' JCHF GF'C E4CD) AJ 'D*4.J5 'D*A1JBJ A%F E3-'* 'DE9'D,) (E-DHD 'D(H*'3JHE G'J/1HC3J/"KOH" JECF #F *-// 'DA7H1 AJ 'D39A) 'D,3/J). 'D4CD 1BE73: 'DB1'9 2. @ 'D'C2JE' 'DB15J)(Discoid eczema) : 'D"A'* #C+1 *B41'K  -E'EJ) E/H1) H0'* -H'A E1*A9) A9'D) E+D 39A) 'D,3/ HD' JH,/ 9F'51 A71J) ('DA-5 'DE,G1J 'D6H&J. 3. @ 'D0&() 'D-E'EJ) 'DB15J) (Discoid lupus erythematosus): 'D#E'CF 'D#C+1 %5'() GJ 'DEF'7B 'DE916) DD4E3. D' *8G1 'D-7'7'* 'D-HJ5DJ) 9DI 'D-H'A  H'D"A'* AJ 'D0&() 'D-E'EJ) 'DB15J) 9('1) 9F B4H1 ED*5B) ('D,D/ EF #3ADG' H'DB4H1 7DJB) EF #9D'G'. *4AI 'DEF7B) 'DE5'() *'1C) F/('* ('D,D/ H*DJA H*/EJ1 (5JD'* 'D491 %0' #5'( 'D'D*G'( A1H) 'D1#3. 4. @ 'D5/'A(Psoriasis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olnaftate "#H( Imadizole, Miconazole , Econazole ) CDH1 *1JE'2HD HCDH1 EJ/'2HD: ,EJ9G' A9'D) AJ 9D', 39A) 'D,D/ .'5) 'D-/J+) 'D*CHJF  HG0G *3*,J( (4CD ,J/ DE6'/'* 'DA7H1 'DEH69J). *7(B *DC 'DE1C('* E1*JF JHEJ'K DE/) 4G1 *B1J('K. 'D"A'* 'DA71J) 'D4/J/): *9'D, ('3*9E'D E6'/'* 'DA7H1 'DAEHJ) H'DEH69JJ). J,( 'D-01 EF '3*./'E 'D3*J1HJ/'* 'DB41J) AJ 'D"A'* 'DA71J) AGJ B/ *.AA 'D'D*G'( H'D*.1J4 E$B*'K  DCFG' B/ *.AJ 'D5H1) 'D31J1J) %DI ,'F( #FG' B/ *3(( E6'9A'* E+D 'D.7H7 H6EH1 'D,D/ .'5) 9DI ,D/ 'DE1J6 AJ 'DEF'7B 'D+FJ'* 9F/E' J3*./E 'D3*1HJ/'* 'DE1C2) DA*1) 7HJD). 'DE3*-61'* 'D,G'2J) 'D*J *97I /'.D'K: 'D,1J2HAHDAJF: #H 'D,JD 'D,/J/ EF 'D#/HJ) 'DE6'/) DDA7H1 'D#.1I %D' #F E,EH9'* 'D"2HD J,( #F *3*./E DD"A'* 'DH'39) 'D'F*4'1 #H 'D-'D'* :J1 'DE3*,J() DD9D', 'DEH69J #H AJ 'D"A'* 'D,1'(J). 'D,1J2HAHDAJF JA6D (4CD 9'E AJ 9D', 'D'F*'F'* 'DH'39) 'D'F*4'1 H'D"A'* -/J+) 'D9G/ -J+ J*HB9 4A'! 'D-'D) .D'D -H'DJ 4 #3'(J9. 9F/E' *CHF 'D"A) 7HJD) 'D(B'! E+D @ 9F/E' *-/+ (3(( A7H1 'D491 'D-E1'!( T.Rubrum)@ AEF 'D#A6D %97'! #C+1 EF CH13 9DI E3'A'* 2EFJ) EFA5D) H7HJD) 'D#E/ AI CD E1) EF 3 - 4 #3'(J9 H0DC D9/) 9/) #4G1. 'DCJ*HF'2HD J(/H #FG #BD A9'DJ) EF 'D,1J2HAHDAJF AJ 'D39A) 'D'1*H'2J). JAJ/ E1C(( Itraconazole )'D*G'('* 'DA71J) 'DH'39) 'D'F*4'1 H-/J+) 'D9G/ C0DC . 39A) +FJ'* 'D,D/ D'1(J) Tinea cruris GH 'D*G'( A71J 37-J J5J( 'D+FJ'* .'5) 'DF'-J) 'D'1(J)  H'D'DJHJ)  H'D'(7J). #C+1 #FH'9 'DA7H1 'D*J *3(( 'D'D*G'('* 'DA71J) GJ: (Epidermophyton floccosum & Trichophyton rubrum) "A'* 'D*G'(J) 4/J/) F'/1) H*F,E 9F . (T. Mentagrophytes) (1/103)  (T. verrucosum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pidermophyton flocossum" GJ -'/) 'D(/! 9'/) #C+1 'D*G'(' H(/&J) :'D('K. (1/104)  'DA7H1 'D491J) 'D-E1'!"T. Rubrum" : 9'/) E2EF)  'D'E*/'/ EF 'DA.0JF %DI EF'7B #.1I 4'&9. "A'* A7H1 'D491 'D-E1'! *E*/ %DI 'D#1/'A H#3AD 'D8G1 H'D(7F. E' (JF 'D#5'(9: 'D'F*'F'* B/ *CHF -HJ5DJ) H'D*G'(J). 'D4CD 1BE 74: 39A) +F'J' 'D,D/ 'D4CD 1BE 75: 39A) +F'J' 'D,D/ 'D4CD 1BE 76' : 39A) +F'J' 'D,D/ -H'A 'D7A- *47G HE1*A9G 'D4CD 1BE 76(:-E'EJ 'D'1A': -H'A :J1 E1*A9) 'D*4.J5 'D*A1JBJ : 'D*G'( 'D,D/ 'D2GEJ: *(/H 'D"A'* (4CD (B9) -E'EJ) .'DJ) EF 'D4A'! 'DE1C2J HDJ3 DG' -H'A A9'D) CE' AJ 39A) 'D+FJ'*  B4H1 /GFJ) *:7J 'D"A) AJ 'D*G'( 'D,D/ 'D/GFJ. D' JH,/ 9F'51 A71J) AJ 'DA-5 'DE,G1J. l'DF.'DJ) 'DH1/J) (Pityriasis rosea) : 'D"A'* *CHF (B9 E/H1) HE*F'+1) E9 (96 'DB4H1 AJ 'DE1C2. 'D-H'A :J1 E1*A9) H(B9) 'D7DJ9) B/ *EJ2 9F/ H,H/G' AJ #J EC'F 9DI 'D,3E. -E'EJ 'D'1A'9(Erythrasma) : 'D"A'* *:7J 'DF'-J) 'DE5'() (/HF 4A'! E1C2J HD' -H'A E1*A9) CE' AJ 39A) 'D+FJ'*. H-E'EJ 'D'1A'9 *97J DHF #-E1 ,H1J ('49) HH/. 'DA-5 'DE,G1J DC4'7) EF 'D"A) *(/J 'D,1'+JE 'DE3((). /'! 'DE(J6'*(Candidiasis ): "A'* ED-B)(Satellites) *8G1 9DI ,H'F( 'D"A) 'D#5DJ). 39A) 'DB/E T. pedis GH 'F*'F A71J J5J( 'D,D/ E' (JF 'D#5'(9  H'D7J'* *-* 'D#5'(9 H'D#.E5JF HEF'7B #.1I EF 'D,3E. 'DA7H1 'D,D/J) 'D-E1'! @ E' (JF 'D#5'(9 (Epidermophyton floccosum) 'D.E'&1 H'D7-'D(@(Moulds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p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aktarin powder ). 3. @ E3*-61'* E6'/) DDA7H1 EH69J'K DH-/G' #H ('DE4'1C) E9 E6'/'* 'D,1'+JE 9F/E' J*HB9 -/H+ 'D'F*'F'* 'D+'FHJ) E+D ( Lamisil cream, Dektacort). E3-HB 'D@ (Tolnaftate) B/ +(** A9'DJ*)  H'DJEJ/'2HD 0H A9'DJ) E3'HJ) DG EH69J'K. E-DHD (1EF,F'* 'D(H*'3JHE 1/9000 AJ *3'9/ *,AJA 'D"A'* 'D17() 'DF'2) #H 'D'DHEFJHE CDH1'J/ 20-30% J7(B E1*JF JHEJ'K 0H AH'&/ G'E) AJ *.AJA 'D*91B. 4. @ %0' C'F GF'C #J /DJD 9DI 'F*'F ,1+HEJ A%F 'DE3-) J,( #F *$.0 D#,1'! 'D219 H'D*-33 D*-/J/ FH9 'D,1'+JE H'DE6'/ 'D-JHJ 'DEF'3(. 5. @ 'D,1J2 HAHDAJF: '3*9E'D 'D,2J2 HAHDAJF AJ E9'D,) 39A) 'DB/E 59( *BJJEG FH9'K E' AJ 'DFH9 'DE2EF 'D0J 9'/) JF,E 9F 'DA7H1 'D-E1'! %D' #FG 0H BJE) 9'DJ) DCFG B/ J-*', %DI 'D'3*E1'1 DE/) 2 - 3 #4G1 . 6. @ 'D"2HD'*: 'D'JEJ/'2HD @ 'D'*J1'CHF'2HD H'D*1(JF'AJF GJ #/HJ) A9'D). 319) 'D4A'! #C+1 HE9/D 'DFC3 #BD E9 G0G 'DE1C('*. 'DE1C('* 'D#.1I AJ G0G 'DE,EH9): EJCHF'2HD @ 'J2HCHF'2HD @ *JHCHF2HD H'D3'DCHF'2HD 0'* A9'DJ) E*3'HJ) E9 (96G' 'D(96. 'D-'D'* 'DE5-H() (A7'1 'D#8'A1 B/ *-*', %DI A*1) #7HD EF 'DE9'D,). 'D,19'* GJ: 'D#7A'D -*I 9E1 1 3F): 10ED:/ C:/ JHE #H 125ED: / JHE. EF 9E1 1 - 5 3FH'*: 187ED: / JHE. EF 6 - 123F): 250 - 375ED:/ JHE. 'D'J*1'CHF'2HD GH E6'/ A71J ,/J/ A9'D HJ97I DD('D:JF (,19) 200ED: / JHE HJ,( /'&E'K #F J97I (9/ 'DH,('*. 'D,19) 'DJHEJ) 'DH-J/) #H JECF '3*9E'DG' (4CD E1*JF JHEJ'K HGH 'D#A6D. (1/107)  E1C('* 'D'JEJJ/'2HD *9*(1 9'/) E6'/'* ,1+HEJ) ('D%6'A) DCHFG E6'/ A71J A9'D. 'DF.'DJ) 'DE(B14) Tinea versicolor GJ 'F*'F A71J 3EJ7J *-/+G 'DED'3J2J' 'DF.'DJ) "Malassazia furfur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l 'D"A'* 'DF.'DJ) 'DE(B14) *97J DHF #5A1 ('49) HH/. 'D*4.J5 'D*A1JBJ : 39A) 'D,D/: 'D"A'* #C+1 'D*G'('K E9 -H'A E1*A9) A9'D) H'DA7H1 'D,D/J) JECF %8G'1G' ('DA-5 'DE,G1J. 'D(GB Vitilligo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elsun shampoo ) #H 4'E(H(Nizoral) J3*9ED E1) CD JHEJF) JA1C (G 'D,D/ 'DE5'( HJ*1C DE/) 1(9 3'9) 9DI 'D,D/ +E J:3D. B/ J97J 0DC F*J,) 7J() H3GHD) AJ 'D'3*9E'D .'5) 9DI 'DEF'7B 'DH'39) #H *DC 'DEF'7B EF 'D,D/ 'D*J J59( 'DH5HD %DJG' (H'37) 'DE5'( DE/) #3(H9JF 3J2JD 0DC :'D('K E98E 'D"A'*. J,( 'D'G*E'E ('DEF'7B 'D*F'3DJ) H'D9JHF (3(( %EC'FJ) 'D*.1J4 'DEH69J. 'D'2HD'* 'DEH69J) E+D "'D'JCHF'2HD (Pevaryl spray) " HE6'/'* 'DA7H1 'D#.1I A9'D) #J6'K DCFG' :'DJ) 'D+EF. 'DE3*-61'* 'D10'0J) #H 'D4'E(H #3GD '3*./'E'K EF 'DC1JE'* #H 'DE1'GE. E1) #H E1*JF JHEJ'K J7(B 'D/H'! GH CD E' J7D( 9'/) DE/) #3'(J9. 'D3*J1HJ/'* 'DB41J) EH69J'K  B/ *-3F 'D-'D) E$B*'K  HDCF D'JF5- (G' #(/'K. 9D', -'D'* 'DA4D AJ 'DE9'D,) 'DEH69J) J9H/ 3((G %DI E9'H/) 'D9/HI 3H'! ('D'F*'F 'D0'*J #H EF E5'/1 #.1I. (1/109)  'D9D', ('3*9E'D 'D'JCHF'2HD 3*J1'* (Pevaryl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evaryl sachets ) 9(H) H'-/) JA1C (E-*HJ'*G' 'D,D/ E1*JF #3(H9J'K DE/) 4G1 H'-/ +E E1) H'-/) #3(H9J'K DE/) 3 4GH1 #H #C+1. J,( #.0 'D-J7) H'D-01 DEF9 'D'F*'F 'D0'*J #H 'DE*C11 EF 'DE*E'3JF. 'DA7'1 'D491J 'D9BJ/J Piedra 'F*'F A71J J5J( 'D491) HJ$/J %DI *4CJD 9BJ/'* 37-J) 9DI 'D491) 'DE5'(). #C+1 E' *5J( G0' 'DFH9 'DA*J'* 'D5:J1'* HB/ J-/+ 'F*4'1 DDE16 (JF #A1'/ 'D9'&D) #H 'D#4.'5 'DED'E3JF DGE. G0' 'DFH9 J-/+ AJ 'D(D/'F 'DE/'1J) HJ5J( 'DB1H/ ('D%6'A) DD%F3'F. 'DE8'G1 'D31J1J) : JH,/ FH9'F EF 'DA7'1: 'DA7'1 'D491 'D3H/'! (Black piedra) H'D(J6'!(White piedra)  'DF,EJ) 'D4CD (Asteroid). #FH'9 'DA7H1 'D*J *3(( 'DE16 GJ: (Piedra hortae &Trichosporon beigelii ). (1/110)  A7'1 'D491 'D3H/'!: J*EJ2 G0' 'DFH9 (H,H/ 9BJ/'* 3H/'! ED*5B) HB'3J) **#DA EF C*D) 'D.D'J' 'DA71J) 9DI ,09 'D491)  -J+ J3(( 0DC %DI *A** H*B5A 'D491. J*1H'- -,E 'D9B/ E' (JF 'DFH9 'D/BJB %DI 1/ EDE #H #C+1. A7'1) 'D491 'D#(J6 " White piedra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erpes Simplex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eonatal herpes simplex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incents angina) "#H 'DBD'9 'DAEHJ(Aphthous stomatitis) #H 'DE16 'DAB'9J 'DE*B1- (Ulcerating bullous disease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ig.100.d&e.The same child after 10 days(she was given mupericin cream (Bactroban cream) applied once daily for the exfoliated area) 'D4CD 100 /-G FA3 'D7ADG H5A* DG' C1JE ('C*1H('F DE9'D,) 'D*3D.'* 'H 'J 'D*G'('* +'FHJG 'D4CD 1BE 100 H : 4A'! *'E (9HF 'DDG H'DEF7BG 7(J9JG /HF F/('* 'H 'J E6'9A'* (2/4)  ED'-8G G'EG : DB/ 9'F* G0G 'D7ADG 'DC+J1 .D'D 'D'1(9) '4G1 HGJ **1// EF 9J'/G 'DI '.1I HB/ *916* DC+J1 EF 'D9D','* HC'F '.71G' 'D9EDJG 'D,1'-JG D'2'D) 'DAJ1H3!!!!!!! EE' F*, 9F 0DC 'F*4'1 'DE16 'DI C'ED 'DEF7BG 'D*F'3DJG H'E*/ 'DI 'D.DA DJ4ED EF7B) 'D41, ('CEDG' . H('D'6'AG DDE9'F'G 'D5-JG H'DFA3JG H'D',*E'9JG DG' HDH'D/JG' A'F 'D9D', CDAG' 'C+1 EF +D'+) 'D'A /HD'1 (CE' 0C1* H'D/*G'). G0G 'D7ADG 1',9*FJ HA9D' G'DFJ 'DEF81 'D0J .D'D 'D+D'+HF 9'E' DE J5'/AFJ G0' 'DH69 D7AD) AJ G0' 'D9E1 HDD'E'FG HBA* -'&1' '0 ,'&FI 'DH'D/JF (1,'! '2'D) 'D'D*G'( ('DDJ21 (F'! 9DI F5J-G EF '-/ 'D'7('!. 7(9' 'AGE* 'DH'D/JF ('F 0DC 3J2J/ 'D'E1 *:BJ/' ('D'6'AG 'DI 'DF/('* 'D*J B/ *F4'R AJ G0G 'DEF7BG 'D-3'3G ('D'6'AG 'DI 'D*CDAG 'D('G8G. H(A6D H*HAJB EF 'DDG H5A* DG' E1C( 'D(H/HAJDJF AJ 'D(F2HJF H7D(* EFG 'F J1',9 'D5J/DJG D*1CJ( 'D/H'!(('DEF'3(G C'F +EF 'D/H'! DE J*,'H2 (69) /HD'1'*) HB/ E3-* 'DEF7BG H'AGE* 'D'E 'F *:3D 0DC (9/ '1(9 3'9'* H'F *9J/ '3*9E'D 'D9D', CD JHEJF. (9/ '3(H9 1',9*FJ 'D7ADG(-3( 'D5H1G 'DEH6-G '9D'G) HCE AH,&* ('DF*J,G H'D*HAJB H'D4A'! EF 'DDG . E' 'H/ 'F 'HC/ 9DJG H'0C1 FA3J /HE' H'D2ED'! 'D'A'6D 'FG J,( 9DJF' 'F F*-ED G0G 'D'E'FG H'FF' H'DDG DE3&HDJF HE-'3(JF 9DJG'. 9DJF' 'F F(0D CD E' F3*7J9 EF ',D 'DE1J6 DE9'D,*G ('J31 H'1.5 'DH3'&D. 3'&DJF 'DEHDI 'D9HF H'D4A'!.........................................(.'DE$DA : 'D/C*H1 E-EH/ -,'2J) 'D9B(HD 'D*F'3DJ J3((G 'DAJ1H3 'D'C+1 'F*4'1' (--Human papillomavirus HPV) ('D'6'AG DE1C('* 'D(H/HAJDDJF AJ*HA1 AJ (96 'D'3H'B E1C('* '.1I B/ *H/J FA3 'DF*J,G HDCFG' ':DI +EF' G0' '0' *HA1*. (2/5)  EF G0G 'DE1C('*(Immiquinol--Aldara cream and Podofilix--Condylox gel0.5% 4. @ 'D#C2JE' 'D9B(HDJ) 'D%F/A'9 -E'BJ 'D4CD 'DC'(H2J : (Eczema herpeticum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atal viraemia" . GH E16 AJ1H3J ,G'2J J(/# AJ 'D#3(H9 'D#HD EF 'D-J')  HG0' J*8'G1 (-EJ H-1'1) *-* 'D/1,) 'D7(J9J)  21B)  6.'E) C(/J) 7-'DJ)  %5'() CDHJ) HC81J) %DI ,'F( 'D%5'() 'D,D/J). GJ "A) 9B(HDJ) 4/J/) HB'*D) 9F/ 'DHDJ/ *-/+ (3(( AJ1H3 'D9B(HD FE7 " II " (3(( 'F*'F 'D#E ('D9B(HD 'D*F'3DJ. 9F/E' *CHF 'D#E E5'() ('D9B(HD 'D*F'3DJ #+F'! 'DE.'6 A%F GF'C '3*7('( BHJ DDHD'/) ('DBJ51J). 6. @ 'D@ "Whitlow "'D9B(HDJ : B/ J/.D 'DAJ1H3 'D9B(HDJ EF 'D,1-. *-H5D H*B1- J8G1'F 9DI 'DEF7B) 'DE5'(). J,( 'D-01 H0DC (9/E 4B 'D,1- (3(( #F 'D*E'3 E9 'D-HJ5D'* E9/J H'D-'D) E-//) DFA3G' H*3(( #91'6 BDJD). 7. @ 'D*G'( 'DB1FJ) H'DED*-E) 'D9B(HDJ:"Herpetic kerato-conjunctivitis" (2/6)  B/ J5J( 'D9B(HD 'D(3J7 'D9JFJF E3(('K B1-'* B1FJ) #H 'D*G'( B1FJ) #H 'D*G'( ED*-E) HB1FJ). 'D,D/ 'DE,'H1 AJ 'D#,A'F B/ J(/J -HJ5D'* 9B(HDJ) H*B1-'*. 8. @ 'D9B(HD 'D*F'3DJ: "Herpes progenitalis" GH E16 AJ1H3J @ EF*BD ('D,F3. *(/# 'D-'D) ('D%-3'3 ('D-1B'F HH.2 9DI 'D,D/ 'DE5'( J*DHG 8GH1 -HJ5D'* 5:J1) *EJD DD*B1-. 'D3J1 B5J1 DCF 'D*C1'1 4'&9 AJ FA3 'DEHB9 #H B1J( EF 'DEF7B) 'D*F'3DJ). 'DEC'F 'D#4J9 %5'() GH 'DB6J( H'D5AF 9F/ 'D0CH1  'DA1, #H 'DEG(D 9F/ 'D%F'+. 'D#EG'* 'DE5'('* B/ JFBDF 'DE16 %DI #HD'/GF #+F'! 'DE.'6. 9. @ 'D9B(HD 'D41,J 'D*F'3DJ 9F/ 'D169 H'D#7A'D" Ano-genital herpes" : DG 9/) #3('( E-*ED). J,( 'D#.0 (9JF 'D'9*('1 %EC'FJ) 'DED'E3) 'D,F3J) -*I HDH C'FH' #7A'D'K  -J+ #F 'DB5) 'DE16J) 'D4'ED) H'D'3*B5'!'* 61H1J) D*-/J/ 71JB) 'D'F*'F. 'D'F*'F 'DE('41 EF B3E 'DEH'DJ/ @ EF 'D#EG'* EF 'D.'/E'* #H :J1GE :J1 E3*(9/ HB/ *CHF *DC H'-/) EF 'D#3('( 'DE-*ED). 10. @ 'F*'F 'D,ED) 'D95(J) 'DE1C2J) 'D9B(HDJ: (Central nervous system herpetic infection) F'/1'K E'J/.D AJ1H3 'D9B(HD %DI 'D,ED) 'D95(J) 'DE1C2J) E-/+'K 'D*G'( 'D/E': #H *.1J4 3-'&J H"A'* 'D95( 'DB-AJ E9 9D'E'* 95(J) ($1J) H3('*. 'D-'D) B/ *CHF B'*D). 11. @ 'D9B(HD 'D(3J7 'DE*C11(Recurrent herpes simplex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cyclovir)EH69J'K: (Zovirax cream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ovirax tablets, 200, 800 mgm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erpes Zoster GH 'F/A'9 AJ1H3J -HJ5DJ JF,E 9F 'DAJ1H3 'D-E'BJ Varicella - Zoster Virus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angrane" 'D"A'* 'DF7'BJ) .'5) AJ 'DE1J6 'DEFGC. 'D*G'( F3J, .DHJ H"A'* (+1J) F',E 9F 'D'F*'F 'D,1+HEJ 'D+'FHJ. 'D*G'( 'DB1FJ) 'DED*-E) AJ 'D"A'* 'D9JFJ): 'D*F/( H'D9EI JF,E'F 9F %5'() 'D9JF 'DE*1BJ). 'D*G'( 'D/E': H'D1J. " Ataxia" 'DF',E 9F '671'( 'DE.J. GH '.*D'7 F'/1. 'D*G'( 'D1&): 39'D  'D2D) 'D*FA3J). 'D21B)  9B/ *CD3J) E*F'+1) AJ 'D1&). 'D#DE 'D95(J E'(9/ 'D4A'!: GH '.*D'7 :J1 4'&9 #-J'F'K JCHF 4/J/ #H J3*E1 DA*1) 7HJD) E3(('K #DE'K E9B/'K. 71B 'DE9'D,): (1EF:F'* 'D(H*'3JHE CE'/'* 1/8000 JECF #F *,AA 'D"A'* 'DF'2). '3JCDHAJ1 EH69J (Zovirax) C1JE J7(B CD 4 3'9'*. J,( '3*./'E 'DBA'2'* 'D*J *3*9ED DE1) H'-/) 9F/ *7(JB 'DC1JE ('D#5'(9. '3JCDHAJ1 AEHJ: ,19) 'DC('1 200 ED: 5 E1'* JHEJ'K DE/) .E3 #J'E #H 800 ED: E1*JF JHEJ'K. 'DA'3JCDHAJ1 (Faciclovir) 250 ED: 3 E1'* JHEJ'K A9'D #J6'K. 'DE3*-61'* 'DE6'/) DDAJ1H3'* 'D#.1I E+D 'DA'D'3JCDHAJ1 (Valacyclovir) 1000ED: +D'+ E1'* JHEJ'K DE/) #3(H9. CD G0G 'D,19'* 'D3'(B) GJ ,19'* 'D('D:JF. ,19) 'D#7A'D: *9*E/ 9DI H2F 'D,3E  'D#9E'1 'D#5:1 JECF %97'!GE '3JCDHAJ1 (,19) 5 ED: / CD: / JHE. 'DE3CF'* 'DBHJ): B/ *CHF 61H1J) DEF9 'D#DE 'D4/J/. ,19'* C(J1) EF AJ*'EJF'* B B/ *AJ/ AJ EF9 -/H+ 'D#DE 'D95(J D'-B'K. -BF 'D3*J1HJ/ E+D ( Depot Medrol 40mg ) : J9*B/ #FG J.AA 'D#DE 'D95(J E'(9/ 4A'! 'D'D*G'('* 'D,D/J DD-2'E 'DF'1J %0' #97J ('C1'K . 'D#7A'D B/ J97HF 10ED: /J(HEJ/1HD C,19) H-J/) AJ 'DE1-D) 'D('C1) EF 'DE16. 'D3*J1HJ/'* EH69J'K JEF9 (*'*'K '3*9E'DG' AJ #E1'6 'D,D/ 'DAJ1H3J). 'D-D# 'DF7'BJ 'DHD'/J (2/11)  (Congenital herpes zoster) 'D-D# 'DF7'BJ 'DEC*3( HD'/J'K 9F/ 'DEH'DJ/ J-/+ (3(( 'D'F*B'D 9(1 'DE4JE) DDAJ1H3 'D-E'BJ 'DF7'BJ Varicella zoster virus. *DC E4CD) .7J1) B/ *$/J %DI *4HG'* .DBJ) %0 B/ J9(1 'D-E'B 'DF7'BJ 9(1 'DE4JE). 'DE8'G1 'D*J *(/H (9/ 'DHD'/) E('41) GJ 'DF/('* 'D,D/J)  *4HG'* 'D#71'A H'D9JF  'DE8'G1 4/J/) %0' C'F 'D'F*'F J-/+ AJ #H'.1 'D-ED. 71B 'DE9'D,): J97I 'D#3JCDHAJ1 (,19) 1000 ED:/ JHE AEHJ'K DE/) .E3 #J'E. 'D'3JCDHAJ1 EH69J'K J7(B 9DI 'D,D/ #H 'D"A'* 'D9JFJ) (4CD E*C11. ,/1J 'DE'! / 'D,/J1J Chicken Pox GH E16 AJ1H3J 4/J/ 'D'F*4'1 J-/+ (3(( AJ1H3 'D-E'B 'DF7'BJ"Varicella zoster virus" HJ5J( 'D#7A'D 9DI 'D#.5 (/1,) C(J1). 'D7A- 0H *H29 E1C2J H*DC EF EEJ2'* 'DE16 %0 J-/+ 9DI 4CD 'F*'F'* EF*41) #H (4CD ,'F-'* .'5) AJ 'DE/'13 H'D#E'CF 'DE2/-E). 9'/) J97J 'D-E'B /'! 'DEF7B) EF'9) /'&E) -J+ %F /'! 'DEF7B) J-/+ EF'9) (9/ 'D%5'() ('D-E'B. 'D5H1) 'D31J1J): /H1 'D-6'F) EF 1- 2 #3(H9. 'D9/HI *-/+ ('DB7J1'* #H 'D10'0 'D5'/1 EF 'DE5'(JF 9F/ 'D973 #H 'D39'D HC0DC ('DED'E3) 'DE('41) E9 'D"A) #H EF #/H'* 'DE1J6 'D4.5J) 'DEDH+). 'DE8'G1 'D,G'2J) : J*8'G1 'DE16 (G,E) .AJA) E9 '-*B'F 'D(D9HE @ 'D-EI H'D5/'9 H*3*E1 *DC 'D#91'6 EF 2@3 #J'E %0 J8G1 'D7A- 'D,D/J 'DEEJ2 (9/G' 9DI ,D/ 'D,09 H'D#:4J) 'DE.'7J) HJ5(- (9/ 0DC E9EE'K. 'DE8'G1 'D,D/J): J*8'G1 'DE16 (D7.'* -E'EJ) H-HJ5D'* H(+H1 -J+ **E2B E.DA) H1'&G' "A'* EF*41). 'D7A- 9/J/ 'D#4C'D %0 #F 'DE1'-D *CHF E.*DA) 'D#FH'9 EF 'D7A-: D7'.J  -HJ5DJ H(+1J H(#-,'E E.*DA) *H,/ AJ FA3 'DHB*. 'DB4H1 JECF #F *FA5D (9/ #3(H9 *'1C) H1'&G' F/('* 4/J/) HA17 'D*5(: .'5) AJ 'DE16I 0HJ 'D(41) 'D/'CF). (2/12)  'D"A'* 0'* *H29 E1C2J EEJ2 9DI 'D,09 #C+1 EF 'D#71'A. 'D-C) .AJA) HB/ *CHF 4/J/) AJ (96 'D-'D'*. 'D'.*D'7'*: 'D5H1) 'D31J1J) B/ *CHF .AJA) DCFG' B/ *CHF 4/J/) .'5) 9F/ 'D('D:JF  %0 *5J( 'D,D/ H'D#:4J) 'DE.'7J) 'DE*1'AB) E9 -EI H#91'6 (FJHJ) 4/J/) E+D: 'D*G'( 'D/E': - 'D*G'( 'D3-'J' H0'* 'D1&) HCDG' '.*D'7'* :J1 4'&9) HDCFG' B/ *-/+ AJ (96 'D-'D'*. 'D4CD 1BE 92: 'D-E'B (,/1J 'DE'!) 'D4CD 1BE 93: 'D-E'B 'D4CD 1BE 94: 'D-E'B 'D4CD 1BE 95: 'D-E'B 'D*4.J5: J9*E/ *4.J5 'D-E'B 9DI 9/) E9'JJ1 #GEG': 'D5H1) 'D31J1J) 'DFEH0,J). 'D*H29 'DE1C2J DD"A'*. 'D'F/A'9 E.*DA 'D#FH'9 H'D#4C'D H'D#-,'E. 'D'3*B5'&'* 'DE.(1J). 'D*4.J5 'D*A1JBJ: 'D,/1J 'D'C2JE' 'D9B(HDJ) 'DBH('! 'DAB'9J) 'D'F/A'9 'D/H'&J 71B 'DE9'D,): J,( 9/E 0G'( 'D7AD %DI 'DE/13) %DI #F J*E 'D4A'! 'D*'E HD'J8G1 #J B4H1 9DI 37- 'D,'/. 'D-'D'* 'D.AJA) JECF E9'D,*G' (71B (3J7): E-DHD C'D'EJF'(Calamin lotion) : J3*9ED (4CD 4'&9 D*.AJA 'D"A'* H'D-C)  HDCF '3*./'EG 'DEA17 B/ J3(( E2J/'K EF 'D,A'A DD,D/ H('D*'DJ J6'9A EF 'D-C). FA6D '3*9E'D E1C( (HAJC3'E'C" Droxaryl cream" HJ97J 9'/) F*'&, ,J/). 'D"A'* 'D17(): *9'D, (CE'/'* (1EF,F'* 'D(HF'3JHE 1 :9000 E1*JF JHEJ'K HC1JE 'D/1HC3'1JD J7(B (9/ 'D(1EF,F'*. G0' 'DE3*-61 H,/F' #FG 0H *#+J1 A9'D. E6'/'* 'DG3*'EJF ('DAE DE9'D,) 'D-C) B/ *D2E AJ (96 'D#-J'F: AJ 'D-'D'* 'D4/J/) .'5) 9F/ 'D('D:JF: B/ J*7D( 'D#E1 D92D 'DE5'( H'D'3*4A'! -*I **E 'D3J71) 9DI 'D'.*D'7'* H'D#91'6 'D4/J/) 'DE1'AB). 'D-E'B 'DHD'/J Neonatal Varicella %F .7H1) 9/HI 'DEHDH/ 'D*J B/ *CHF EEJ*G *-/+ 9F/E' *5'( 'D#E 'D-'ED B(D +D'+) 4GH1 EF 'DHD'/). 'DE8'G1 'D31J1J): (2/13)  *9*E/ 4/) H#91'6 HE6'9A'* 'DE16 9DI (/'J) 8GH1G ('D#E H'D7AD: 1@ 'D'F*'F B(D 'DHD'/) #. 'F*'F 'DHDJ/ 'D.AJA: 'D'F*'F 9'/) .AJA %0' C'F* 'D(/'J) 9F/ 'D#E AJ 'D#3(H9 'D#HD B(D 'DHD'/) H.D'D 'D#J'E 'D#1(9) 'D#HDI EF 'D9E1 9F/ 'DHDJ/. (. 'F*'F 'DHDJ/ 'D4/J/ H'DEF*41: B/ J-/+ %0' #5J(* 'D#E ('D'F*'F AJ .D'D 'D#J'E 'D#1(9) B(D 'DHD'/) H'DHDJ/ J5'( ('D'F*'F AJ 'D#J'E 5@10 EF 'DHD'/). 'D'F*'F J-*ED #F JCHF EF*41'K H4/J/'K E9 %5'() 'D1&*JF H'DC(/ H'D/E': AJ G0G 'D-'D'* JH,/ 9'/) E9/D HAJ'* 9'DJ. ,. *F'01 'D-E'B 'DHD'/J: 'F*'F 'D-E'B /'.D 'D1-E AJ 'D+D+ 'D#HD EF 'D-ED B/ J$/J %DI *1'AB E*EJ2 EF 'D*4HG'* 9F/ 'DHDJ/ J91A ('3E "*F'01 'D-E'B 'DHD'/J" %0 B/ J8G1 FB5 *5F9 'D#71'A H*F/( ,D/J J4(G /'! 'DEF7B) HGJ E8'G1 4'&9). 2. @ 'D'F*'F (9/ 'DHD'/): 'D-E'B 'DEC*3( (9/ 'DHD'/) B/ JCHF #C+1 4/) AJ 'D-'D'* 'D*'DJ): %0' -/+ *916 DDE16 AJ 'D#J'E 'D#HDI EF 'D-J') .'5) 9F/ 'D#7A'D 'D169 D#EG'* DE J5(F 3'(B'K HD0DC DCHFG' D' *EDC EF'9) EFA9D). 'DHD/'F 'D./, 'DD0JF DE JCEDH' A*1) 'D-ED B/ JCHF D/JGE EF'9) EFA9D) BDJD) B/ %F*BD* %DJGE. 'DE8'G1 'D9'E): 5/'9 @ :+J'F @ %BJ'! @ -EI @ 5D'() ('D1B() HF'/1'K *4F,'*. %5'() 'D,ED) 'D95(J) 'DE1C2J) *-/+ AJ #BD EF 1% EF 'D-'D'* AJ 'D-E'B 'D13. 'DE.J.J HE8'G1 4(G @ ('1CF3HF GJ 'DE8'G1 H'D9D'E'* 'D95(J) 'D#C+1 4JH9'K. 'DE8'G1 'D,D/J): CE' AJ 'D-E'B 'D9'/J AJ 'D#9E'1 'DE.*DA)  'D"A'* B/ *CHF -'/) H'D7A- #C+1 'F*4'1'K H*H29'K. 'D*4.J5: 'D*A1JB (JF -E'B 'DHDJ/ H'F*'F 'D9B(HD 'D(3J7 J$C/ AB7 ('D219 'DAJ1H3J. *'1J. E16J ('D9B(HD 'D*F'3DJ 9F/ 'D#E. H,H/ 'D*G'( B1FJ) HED*-E) ('D9JF. 'D"A'* 'DAEHJ) 'D9B(HDJ) 'DFEH0,J). 'DE9'D,): B/ *CHF 'D-'D) .7J1) H*G// -J') 'D16J9. (2/14)  FBD 'DE1J6 %DI 'DE3*4AI H'D*E1J6 ('D9F'J) 'DEF'3() 0'* #GEJ) B5HI. 'D:DH(JF 'DEF'9J 'DFH9J (Zoster-immune globulin ) #H:'E' :DH(JF(Gamma globulin) J,( #F J97I DDHDJ/ 'D0J JHD/ D#J #E #5J(* ('D-E'B .D'D 'D#1(9 #J'E 'D#.J1) EF 'D-ED. 'D7AH- 'D'F*'FJ) The Infectious Exanthemas *4ED 'D7A-J'* 'D'F*'FJ) 'D#E1'6 'DAJ1H3J) 'D*J **EJ2 ("A'* 7A-J) ,D/J) H-EI HE8'G1 ,G'2J). B/ *E1 'D-'D) (/HF #F *$+1 9DI 5-) 'D7AD #H B/ *CHF 4/J/) H*G// -J'*G ('D.71. *4ED 'D7A-J'* (4CD 1&J3J 'D-5() @ 'D-5() 'D#DE'FJ) @ 'DH1/J) @ /'! H-J/'* 'DFHI 'D'F*'FJ. 'D-5() Measles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oplik's spots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ubella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ongenital rubella 'D#E 'DE5'() ('D-5() 'D#DE'FJ) #+F'! 'D+D+ 'D#HD EF 'D-ED B/ *D/ 7AD'K E5'('K (*F'01 +D'+J J*#DA EF: 3'/ .DBJ(Congenital cataract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oseola GJ E16 AJ1H3J 7A-J J5J( 'D#7A'D 'D5:'1 H'DHD/'F. 'DE8'G1 'D31J1J) : 'DE8'G1 'DE(C1): J8G1 'DE16 (E8'G1 E.*DA) 5'.() E+D 'D-EI @ 'D'.*D','*. H'9*D'D 'D9B/ 'DDEAJ). H'D7AD B/ JCHF E1J6'K (4/). AJ 'DJHE 'D1'(9 H'D.'E3 *G(7 'D-1'1) A,#) H**-3F -'D) 'D7AD 'D9'E) -J+ J5(- F4J7'K H*2/'/ 4GJ*G DD79'E . 'DE8'G1 'D,D/J): *8G1 D7'.'* E*F'+1) H1/J) 'DDHF (9/ G(H7 'D-1'1). 'D#E'CF 'D4'&9) DD7A- GJ 'D,09  'D9FB  'D#1/'A  'D#71'A H#BD 'F*4'1'K 9DI 'DH,G. B/ J3*E1 'D7A- D9/) #J'E -J+ J2HD */1J,J'K. D'*5'( 'D#:4J) 'DE.'7J) . 'DH1/J) 'D7ADJ) Roseola infantum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mall Pox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omplement fixation test) . 'DE9'D,): D'JH,/ 9D', FH9J DD,/1J *92D 'D-'D'* AJ E4AI 'D,/1J 'DFH9J 'D-'D'* 'DE.*D7) (#F*'F +'FHJ *3*AJ/ EF 'DE6'/'* 'D-JHJ). 'D3*J1HJ/'* 'DB41J) B/ JCHF DG' BJE) AJ 'D*G'( 'D/E':. E9'D,) 'D#91'6: 'DH3'&D 'DHB'&J) (DB'- 'D,/1J 9DI CD -'D A%F *DBJ- 'D#7A'D :J1 61H1J AJ 'DEF'7B 'D*J '3*$5D EFG' 'DE16 (JFE' AJ (96 'DEF'7B 'DEH(H!) ('D,/1J A%F 'DDB'- 61H1J. 'DDB'-J) Vaccinia AJ1H3 'DDB'-J) GH AJ1H3 ,/1J 'D(B1 'DE69A 'D0J J-61 AJ E.'(1 'DDB'- 'D,/1J. "A'* 'D,D/ *F,E 9F AJ1H3 'DDB'-J) 'DF',E 9F '.*D'7'* 'DDB'- 6/ 'D,/1J. *8G1 'DE8'G1 (5H1 31J1J) E*9//): '3*,'() EA',&) #H '3*,'() EF'9J): "Immediate response or immune response "'D-7'7) *8G1 E('41) (9/ 'DDB'- H*2HD (9/ 'DJHE 'D+'D+ EF 'DDB'-. (2/19)  'D'3*,'() 'D(/'&J): "Primary response "AJ 'DJHE 'D+'D+ EF 'DDB'- *8G1 -7'7) H*5(- -HJ5D'* AJ 'DJHE 'D*'39 +E **-HD %DI (+1)  H**1'AB E9 '9*D'D 'D9B/ 'DDEAJ) 'DE,'H1). '3*,'() 31J9):"Accelerated response" *8G1 -7'7) AJ 'DJHE 'D.'E3 H+E *4CD -HJ5D) 5:J1) *2HD 9'/) AJ 'DJHE 'D*'39. 'DDB'-J) 'DE9EE):" Generalized vaccina "'F/A'9 -7'7J -HJ5DJ E9EE (9/ 10 #J'E EF 'DDB'- +E **-HD %DI 4CD (+1J HB/ J2HD .D'D 3 #3'(J9 -J+ J*DHG' #-J'F'K E,EH9'* E**'(9). 'D*G'( 4(CJ) 'D9JF: 'D#C2JE' 'DDB'-J):" Eczema vaccinatum "GJ FA3 'D#C2JE' 'D9B(HDJ) 'D*J *-/+ E9 'D9B(HD 'D(3J7 'DF',E) 9F -BF 'DDB'- AJ EC'F 'D*DBJ-. 8GH1 'D%5'() ('DDB'-'* 'DE*9//):"Multiple vaccination" 9/) #E'CF ,D/J) B/ *5'( (3(( *E'3 'D,D/ EF EC'F 'DDB'- 9F/ FA3 'D4.5 #H 'D*E'3 E9 'DEDB-JF 'D".1JF. 'DH1/J) 'DDB'-J): "Roseola vaccination "'D169 H'D#7A'D 'D5:'1 J5'(HF (4CD 4'&9. 'D7A- 'D,D/J GH 'F/A'9 -5(J 'D4CD J5(- EC'F 'DDB'- EF*41'K HE-'7'K (G'D) -E'EJ) H*2HD .D'D 9/) #J'E. 'DDB'-J) 'DF.1J):"Vaccinia necrosum" *-/+ 9F/ 'D169 (9E1 #BD EF 6 4GH1 'D0JF D'J3*7J9HF %F*', 'D#6/'/ '3*,'() DDB'-  'F*B'D'* 'DF.1J) *-/+ AJ CD 'D,3E H'D-'D) B'*D) 9'/). DH1/) 'DDB'-J):"Roseola vaccinia " 'F/A'9 -7'7J D7'.J -5(J 'D4CD E*F'+1 E*F'81 J8G1 (9/ 'DDB'- (#3(H9JF (DB'- 'D,/1J %0 J5(- EC'F 'DDB'- EF*41'K HE-'7'K (G'D) -E'EJ). /'! 'DJ/ @ 'DAE @ 'DB/E Hand-foot-mouth disease GH E16 AJ1H3J J-/+ (AJ1H3 "CHC3'CJ 16 " HJ5J( (4CD 1&J3J 'D#7A'D. 'DE8'G1 'D31J1J): 'D#91'6 'D('/1J): -EI *3(B 8GH1 'D7A-. 'DE8'G1 'D,D/J): 'DE8'G1 'DH'3E) DDE16 GJ 8GH1 'F/A'9 D7'.J -7'7J .7J #H GD'DJ #H (J6HJ 'D4CD J5(- E('41) -HJ5DJ 9DI 'DJ/JF #H 'DB/EJF H'DAE. (2/20)  'D'F/A'9 'D0J J8G1 9DI 'DJ/JF H'DB/EJF 9'/) JH'2J .7H7 'D,D/. 'D4A'! 9'/) J-/+ .D'D #3(H9JF HD'-',) DDE9'D,) #-J'F'K. /'! 'DB/E @ 'DAE Foot - and mouth disease GH E16 AJ1H3J 4/J/ 'D9/HI. /H1 'D-6'F) EF 2 @ 10 #J'E. JF*BD 'DE16 %DI 'D%F3'F E('41) EF 'D-JH'F'* 'DE5'() E+D 'DEH'4J H'DE'92 H0DC (*F'HD 'D-DJ( 'DEDH+. 'DE16 B/ JCHF DG '.*D'7'* .7J1) H#-J'F'K B/ JCHF B'*D'K .'5) 9F/ 'D#7A'D. 'D5H1) 'D31J1J): 'D#91'6 'D('/1J) .AJA). H*4ED -EI @ /9+ @ -1B'F H,A'A 'DAE E9 A17 'DD9'(. 'D'F/A'9 'D,D/J J8G1 E9 'F.A'6 'D-1'1) H:J'( 'D#91'6 'D('/1J). E8'G1 'D,D/ H'D#:4J) 'DE.'7J): *H1E H-C) H'D%-3'3 ('D-1B'F AJ 'D#5'(9 B/ *CHF 'DE8'G1 'D,D/J) GJ 'D#(C1  +E *8G1 'D-HJ5D'* AJ 'DAE H'D(D9HE 'DAEHJ H'D1'-*JF H'D#.E5JF H#5'(9 'DJ/ H'DB/E. 'DE9'D,): E9'D,) 'D#91'6. 'D%J/2 9F 'D#7A'D Hiv disease in childhood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ell " GH E8G1 ('C1 EGE. 2. E6/'* 'DAJ1H3 "HIV " 'D,H'D): B/ *CHF E.AJ) (3(( 'DE6'/'* EF 'D#E. (2/21)  3. .DD H8JAJ DD.D'J' 'DDEA'HJ) 'D*'&J) "T. Cell " EEJ2 DD/'! 9F/ 'D('D:JF HGH 9'/) E8G1 E*#.1 9F/ 'D#7A'D 'D5:'1. 4. #6/'/ 'DAJ1H3: "HIV" H,H/ #6/'/ 'D@ "HIV " EF 'DFH9 "IgG " 9F/ 'D169 JE+D ((3'7) 'D#6/'/ 'DEC*3() EF 'D#E (4CD E*FBD HD'J9*(1 /DJD'K D'F*'F" HIV" . 71B 3J1 'DE16: (96 'D#7A'D 'DE5'(JF J-/+ D/JGE 'D%J/2 (AIDS) AJ 'D3F) 'D#HDI EF 9E1GE AJ E98E 'D-'D'* J*1BJ 'D'F*'F ((7! 4/J/. E9'D,) 'F*'F" HIV " AJ 'D7AHD): E9'D,) 'D%.*D'7'*. E9'D,) 'D#F*'F 'D,1+HEJ 'D+'FHJ 0'* 'D1&) 'DE*CJ3 'DC'1JFJ'J. 'DE9'D,) ('D#/HJ) 'DE6'/) DDAJ1H3'* -'DJ'K D'*4AJ 'D'F*'F. 'D/H'! 'D1&J3J GH" Retrovir , AZT, (Azidothymidine) Zidovodine" 1:E 'D*-3F AJ (96 'D-'D'* DCFG J,( EH'2F) 'DAH'&/ E9 'D"+'1 'D,'F(J) DD/H'! H*4ED: AB1 'D/E. FB5 'DC1J'* 'DE9*/D) @ 'D*G'( 'D96D'* @ 'D5/'9 @ 'D*,D7 @ AB/'F 'D0'C1) ('D*HG'F) 'D-EI @ 'D7A- H*5(: 'D#8'A1. J97I 'D@" Zidovudine "9'/) AEHJ'K DA*1'* 7HJD)  AJ (96 'D-'D'* 'DEB'HE) B/ 3,D* E3*HJ'* #6/'/" HIV " AJ 'DE5D #H 'D3'&D 'D/E':J 'D4HCJ"CSF " JECF #F JF.A6 (4/) HB/ *5(- EGED) 'D*1CJ2. 'D*31J( 'DH1J/J 'D7HJD 'D#E/ ('D9D', (Zidovudine) B/ J$/J D*-3F 'D40H0'* 'D*7H1J) 'D95(J) 9F/ 'D#7A'D. D'JH,/ DB'- #H E9'D,) FH9J) DD@" HIV " -'DJ'K %D' #F ,GH/'K C+J1) ,'1J) AJ 9/) E1'C2 /HDJ) D%J,'/ E9'D,) 4'AJ). 'DHB'J): 'DHB'J) EF 'F*B'D 'DAJ1H3 'D@ "HIV "GH 0H #GEJ) C(J1) H'D.7H) 'D1&J3J) GJ *,F( 'D*E'3 (JF EA12'* 'DE5'(JF H'D#:4J) 'DE.'7J) #H 'D,D/ 'DEE2B. 'DA5D 'D+'FJ 941 'D'F*'F'* 'D7AJDJ) 'D,D/J) Parasitic skin infestations 'DE8'G1 'D,D/J) D'F*'F'* 'D#H'DJ / H-J/'* 'D.DJ) / Skin manifestations due to Protozoa /'! 'DD'J4E'FJ' (2/22)  (Leishmaniasis) GH E16 7AJDJ *3((G 7AJDJ'* 'DD'J4E'FJ) 'DE/'1J) 'D*J *F*BD (H'37) 0('() 'D1ED 'DA'5/)(Phlebotomus sand fly) 'D*J *9*(1 'DCD'( E3*H/9' DG'. JC+1 'DE16 AJ EF7B) 41B 'DE*H37 H'D41B 'D#H37 #E' AJ "3J' H#A1JBJ' A%F 'DA&1'F 'DB'16) B/ *CHF GJ E5/1 'D9/HI. 'D/'! 0H +D'+) #4C'D E.*DA) GJ: 'DD'J4E'FJ) 'D,D/J). 'DD'4E'FJ) 'D,D/J) 'DE.'7J) H'DD4E'FJ' 'D-4HJ). /'! 'DD'J4E'FJ' 'D,D/J: (Cuutaneous leishmaniasis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riental sore" 'D"A) 'D(/'&J) GJ -7'7) 9DI 'DEF'7B 'DEC4HA) E+D 'DH,G H'D#71'A. 'D-7'7) **6.E (9/ 9/) #3'(J9 D*4CD DHJ-) E/H1) H#.J1'K %DI B1-'* *F*- EA12'* D2,) H*4CD B41) ED*5B) 3EJC) (FJ) 'DDHF. (2/23)  'D'F*'F 'D,1+HEJ 'D+'FHJ DDB1-'* 4'&9 E3(('K *.1( #F3,) #C+1 H*4HG'* ,D/J) H*DC H'-/) EF 'D5A'* 'DEEJ2) D"A) 'DB1-) 'DE/'1J) GJ 3J1G' 'DE2EF 'D7HJD HFH9 'D"A'*. G0G 'D"A'* *4CD B1-'* E1*A9) HE/H1) (J6'HJ) 'D4CD B/ *4AI (9/ 9/) 4GH1 E3(() F/('* E4HG). 'D4CD 'DE,G6 Abortive type : (96 'D"A'* ,'A) -J+ **-HD 'D-7'7) %DI 9BJ/) B/ **6.E -,E'K (/HF *B1-. 'D4CD H-J/ 'DF'C3"Abortive type ": GH F'C3 -J+ J-/+ 'D'F*'F E1) +'FJ) (9/ 4A'! 'D"A) 'D(/&J). 'D4CD 'DEF*41"Disseminated type" : "A'* E*9//) B/ *5J( 'D#71'A. 'D4CD 1BE 118: /'! 'DD'J4E'FJ' 'D,D/J 'DE,G6 'D4CD 1BE 119: /'! 'DD'J4E'FJ' 'D,D/J (H-J/ 'DF'C3) 'D4CD 1BE 120: /'! 'DD'J4E'FJ' 'D,D/J ('D4CD 'DEF*41) 'DE8'G1 'D,D/J) 'DE.*DA): /'! 'DD'J4E'FJ' 'D,D/J 'DF',E 9F 'DD'J4E'FJ' 'D7AJDJ) /'D5:1I /"L. infantum ":'D169 'DE5'(HF (G0' 'D7AJDJ B/ J5'(HF (E16 'DD'J4E'FJ' 'D-4HJ (JFE' 'D('D:JF 9'/) J5'(HF ('D"A'* 'D,D/J) AB7. 'D/'! 'DD'J4E'FJ' 'D,D/J 'DF',E 9F 'DD'J4E'FJ' 'DC(1I:"L. Major "G0' 'D4CD E3*H7F AJ 'DEF'7B 'D17() AJ 'D(/'H) .'5) (JF 19') 'D-JH'F. 'D"A'* 'D,D/J) GJ 9BJ/) /EDJ) 'D4CD -E1'! *8G1 9DI EC'F 'D/.HD -J+ (9/ #3(H9JF **4CD B41) E1C2J) J*DHG' 'DB1-) 0'* G'E4 #-E1 E1*A9  *C(1 .D'D 2 @ 3 4GH1 'D*'DJ) -J+ *5D %DI B71 3 @ 63E HB/ *8G1 9/) "A'* 9B/J) +'FHJ) (*'(9)) B1J('K EF 'D"A) 'D(/&J). 'D4A'! 'D9AHJ -*I (/HF 9D', 9'/) J-/+ .D'D 6 #4G1 E.DA'K H1'&G F/(). /'! 'DD'J4E'FJ' 'D,D/J 'DF',E 9F 'DD'J4E'FJ' 'DE/'1J)" L. tropica ": /H1 'D-6'F) #C+1 EF 2 4G1  *8G1 'D"A) (4CD 9BJ/) (FJ) 5:J1) **6.E */1J,J'K %DI DHJ-) (B71 1 @ 23E AJ -H'DJ 6 4GH1 E4CD) *B1- 37-J 6-D E9 B41) ED*5B). 'D"A'* 'D+'FHJ) ('D*'(9)) BDJD) (G0' 'DFE7. (2/24)  /'! 'DD'J4E'FJ' 'D,D/J 'DF',E 9F 'DD'J4E'FJ) 'D#+JH(J) "L. Ethiopia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ucocutaneous Leishmaniasis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aws" / H / 'D# A1F,J 'D2G1J/ 71B E9'D,) 'DD'J4E'FJ': E98E 'DB1-'* :'D('K E' *4AI 9AHJ'K .D'D 3F) H'-/). 9D', /'! 'DD'J4E'FJ' 'D,D/J H'D,D/J 'DE.'7J GJ FA3G'  (JFE' J-*', 'D#.J1 E9'D,) E4//) #C+1 (3(( 'D'.*D'7'* 'D#C+1 4/) H'DE.1(). 'D#F*EH'F 'D.E'3J" Pentavalent antimony" J3*9ED DDB1-'* 'D*J *3(( *F/('K H*4HG'* AJ 4CD 'DH,G #H 9DI #3AD 'D3'B #H AHB 'DEA5D  #H 9DI 'D#:4J) 'DE.'7J) #H 'D:6'1JA #H 'DB1-) 'D*J B/ *CHF F',E) 9F 7AJDJ DD'J4E'FJ' 'D(1'2JDJ). " D3H! 'D-8 AI (96 -'D'* /'! 'DD'J4E'FJ' B/ *4'G/ E9'D,) ('D3*J1HJ/'* 'DB41J) EH69J'K HG0G *:J1 'D5H1 'D31J1J) H*,9D 'D"A'* E.*D7) 'D*J *5(- #.J1'K #C+1 %2E'F'K H*FB5 '3*,'(*G' DDE9'D,) 'DFH9J)". DD('D:JF F97J 63E3 EF 'D(F**H3*'E (Pentostan) 96DJ'K CD JHE DE/) 941) #J'E  G0' 9'/) J97J F*'&, ,J/) HJ$/J D4A'! 31J9 DDB1-'* HJECF *9/JD 'D,19) -3( 9E1 'DE1J6. DB/ 3,D 'D/C*H1 'D8H'G1J F*'&, ,J/) ('3*9E'D E1C('* GJ/1H'JE*JF -(*'F JHEJ'K DD('D:JF DE/) 4G1 H'-/. FJH3*J(H2'F (Neostibosan ,Bayer) GH #J6'K /H'! A9'D. 'D,19) 'DJHEJ): GJ 5/ ED: /CD: ,19) EF 200 @ 300 ED: JECF %97'!G' JHEJ'K DD#7A'D 'DC('1 H'D('D:JF DE/) 16 JHE #+(* #FG A9'D #J6'K. 'D#/HJ) 'D#.1I E+D" 'DCDH1HCJF" H'DA$'/JF (Fouadin) H'DE6'/'* 'D-JHJ) E+D "'D**1'3CDJF "H,/* %FG' A9'D). 'D(F*'EJ/JF 'J2H+JHF'*(Pentadine isothionate) : DE9'D,) 'DD'J4E'FJ' 'DE/'1J) (,19) 4 ED:/ CD: E1) H'-/) #3(H9J'K DE/) 7HJD) -3( 'D-',). 'DE1J6 'DE5'( (/'! 'DD'J4E'FJ' 'D,D/J B/ J-*', %DI E9'D,) DA*1) #7HD. (2/26)  'DD'J4E'FJ' 'DF'C3) B/ J3*,J( DD-BF 'DEH69J #H 'D'97'! 'D,G'2J DD#F*EH'F'*. 'D*41( 'DEH69J (@ 1 @ 2 EDE 5H/JHE 3*J(H:DHCHF'* (Sodium stibogluconate) DD"A'* 'DEA1/). +D, :'2 +'FJ #HC3J/ 'DC1(HF (Co2 snow) D9D', 'DB1-'* 'D5:J1) **,E/ H*,1A *-* *./J1 EH69J. "A'* 'D*F/( 'D4/J/ B/ *-*', ,1'-) *5FJAJ) (*,EJDJ)). F-F F3*./E 'DDJ21" CO2 "D%9'/) 37- H%2'D) 'DD4E'FJ' 'D,D/J). AJ 'DE1C2 'D7(J 3,DF' F*'&, E4,9) .'5) 'D"A'* 'DE.*D7) ('D*F/( . 'D4CD 1BE 121: 'DD'J4E'FJ' 'D,D/J) (F/()) 'D4CD 1BE 122: 'DD'J4E'FJ' 'D,D/J) (F/() E9'D,) ('DJ21) /'! 'DD'J4E'FJ' 'D-4HJ Visceral leishmaniasis J91A ('3E 'DC'D' "2'1 #H -EJ /E /E" Dum-Dum Fever" : 'DE16 EF*41 ,/'K AJ "3J' H,FH( #H1H('  -HD 'DE*H37  #A1JBJ' H'DE,*E9'* 'DABJ1) H'D1JAJ). 'D5H1) 'D31J1J): 'D-EI EEJ2) H#-J'F'K E4.5) DDC'D' "2'1. *1*A9 'D-1'1) AJ HB* 'D951 H*F.A6 B1( 'DE3'! H*1*A9 #C+1 -H'DJ EF*5A 'DDJD. 6.'E) C(/J) 7-'DJ). G2'D HF-HD. AB1 /E HFB5 'DC1'* 'D/EHJ) 'D(J6'!. E8'G1 -4HJ)  6.'E) C(/J) 7-'DJ). E8'G1 ,D/J): ,D/ (DHF 1E'/J :1J( .'5) 9DI 'DJ/JF H'D#8'A1 H'D,(G) H'D.7 'DF'5A DD(7F D0DC 3EJ "'D/'! 'D#3H/ ". /'! 'DD'J4E'FJ' 'D,D/J E'(9/ 'DC'D' "2'1 Post kala azar leishmaniasis 'DE8'G1 'D31J1J): 8GH1 9BJ/'* (DHF GD'E 'D*A'- E-'7) (F/('* .'5) 9DI 'DH,G -J+ *8G1 9/) 3FH'* (9/ 'D4A'! EF 'D"A) 'D(/&J). B/ *8G1 (B9 F'B5) 'D5(': .'5) 9DI 'DH,G H'D9FB H'D37H- 'D('37) EF 'D3'9/ H'D,'F( 'D/'.DJ DDA./JF J4(G 'D,0'E 'D,0'EJFJ. "A) 9B/J) H-(J() B/ *8G1 9DI 'D,D/ HF'/1'K E'*CHF -DJEJ) 9DI 'D#,A'F H'D4A'G HA*-'* 'D#FA. 'DE1',9 Bryceson A. Therapy in man. In: Peters W. Killick-Kendrick R, eds. The 1 (2/27)  Leishmaniases in Biology and Medicine Vol 2. London: Academic Press, 1987: 848-907 2 Ho M, Koech DK, Iha DW et al. Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol 1983; 51: 207-14 3 Kumar PV, Sadeghi E, Torabi S. Kala azar with disseminated dermal leishmaniasis. Am J Trop Med Hyg 1989; 40: 150-3 4 Rashid JR, Chunge CN, Oster CN et al. Post kala-azar dermal leishmaniasis occurring after long cure of visceral leishmaniasis in Kenya. E Afr Med J 1986; 63: 365-71 5 WHO. The leishmaniases. Report of WHO Expert Committee. Technical Report Series 701. Geneva: World Health Organization, 1984 6 Ballou WR, McClain JB, Gordon DM et al. Safety and efficacy of high dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 1987; ii: 12-16 7 Bryceson A. Therapy in man. In: Peters W. Killick-Kendrick R, eds. The Leishmaniases in Biology and Medicine Vol 2. London: Academic Press, 1987: 848-907 8 El-On J, Weinrauch L, Livshin R et al. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzathonium chloride. Br Med J 1985; 291: 704-5 9 Kumar PV, Sadeghi E, Torabi S. Kala azar with disseminated dermal leishmaniasis. Am J Trop Med Hyg 1989; 40: 150-3 10 Montalban CK, Martinez-Fernandez R, Calleja JL et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989; 11: 655-60 11 /'! 'DE+B(J'* 'D%F3'FJ Human Trypanosomiasis (/'! 4':'3) Chigas diseae (2/28)  /'! 'DE+B(J'* 'D,FH( #E1JCJ(South American trypanosomiasis) : GH /'! ,G'2J *3(( 'DE+B(J'* 'DC1H2J) 71B 'D'F*'F: @ 'D'F*'F 'DE('41: 'D'F*'F EF 'D-JH'F'* 'DE5'() EF 'DE3*H/9'* 'D-JH'FJ) E+D 'DB77  'DCD'(  H'DA&1'F 'DB'16). @ 'D'F*'F :J1 'DE('41: EF %F3'F %DI %F3'F (H'37) "'D(B 'DEB(D "(Kissing bugs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leeping sickness /'! 'DE+B(J'* 'D'A1JBJ 'D9'ED 'DF'BD DD7AJDJ GH 0('() 'D*3J @ *3J 'D*J 9F/E' *D/: 'D%F3'F A%FG' *-BF ('DE+B(J'* 'D7AJDJ'* 'DEH,H/) AJ ://G' 'DD9'(J) /'.D 'D,D/ ('DE+B(J'* 'D1H/J3J) H'DE+B(J'* 'D,'E(J)). 'D5H1 'D31J1J): 'DE1-D) 'D-'/): **EJ2 G0G 'DE1-D) (@: #91'6 (FHJ) 4/J/) -EJ H'D*G'( 9B/ DEAJ) 'D*G'( #H9J) DEAJ) 37-J F'-J HH0E) 9'(1) *EJ2 G0G 'DE1-D). 'DE8'G1 'D,D/J): 'DB1-) (Chancre): GJ 9B/) *8G1 EC'F 'DD/:)  *CHF -E1'! @ E$DE). H**1'AB E9 'D*G'( #H9J) DEAJ) H9B/ DEA'HJ) F'-J). -C) HH0E) E$DE): *5J( 'DJ/JF H'DB/EJF H'D9JFJF H*(/H 'DEA'5D E*H1E). 'DE1-D) 'DE*#.1): *-/+ (9/ 7H1 E2EF -J+ JCHF GF'C '671'( /E':J J-/+ */1J,J'K E$/J'K %DI 5H1) 31J1J) GH "E16 'DFHE". D' JH,/ E8'G1 ,D/J) AJ G0G 'DE1-D). 'D*4.J5: (2/29)  *-/J/ 'D7AJDJ AJ 'D3'&D 'DE(2HD EF 'D9B/ 'DDEAJ). 'D7AJDJ'* F'/1) 'DH,H/ AJ 'D/E. /'! 'DEBH3'* Toxoplasmosis /'! 'DEBH3'* GH E16 -JH'FJ J-/+ (H'37) 7AJDJ EF 'D#H'DJ (H-J/ 'D.DJ)) *3EJ 'DEBH3'* 'D,HF/J) (Toxoplasma Gonadi). 'DE16 HD'/J  JF*BD %E' EF 'D#E 'DE5'() %DI 'D,FJF 9(1 'DE4JE) #H JC*3( EF 'D-JH'F ('DE3*H/9) E+D 'DB77  'DCD'( H'D7JH1. /'! 'DEBH3'* 'DHD'/J Congenital Toxoplasnosis 'D'F*'F AJ 'E1#) -'ED B/ J$/J %DI 'D%3B'7 #H HD'/) ,FJF *'E 'DF6, E9 E8'G1 +D'+J) GJ: '3*3B'! 'D1#3 @ 'D*G'( 4(CJ) HE4JE) 'D9JF @ *CD3'* /E':J). 'DE8'G1 'D,D/J): 7A- ,D/J J8G1 (4CD D7'.J H'F/A'9 F2AJ. 'DE8'G1 'D,G'2J): 6.'E) C(/J) 7-'DJ) HJ1B'F. E9/D 'DHAJ'* -H'DJ 10%. 'D0JF JF,HF B/ J8G1H' '.*D'7'* E+D '3*3B'! 'D1#3  *.DA 9BDJ H'671'( 'D1$J'. AJ 'D-EHD 'D*'DJ) D'J5'( 9'/) 'D,FJF. /'! 'DEBH3'* 'DEC*3( "Acquired Toxoplasosis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gM H IgG . 'DHE6'F :J1 'DE('41: 71JB) (3J7) H"EF) HJECF '3*./'EG' D*EJJ2 #6/'/ "IgM "9F #6/'/" IgG". (2/30)  -BF 'D3'&D 'D/E':J 'D4HCJ DA#1): GH DJ3 '.*('1 1H*JFJ HF'/1'K E'J3*9ED AJ 'DEE'13) 'D31J1J). 71B 'DE9'D,): E4'1C) 'D3DAHF'EJ/'* (,19) 'D('D: 3:/JHE) H'D(J1JEJ+'EJF (Daraprim) *97I (,19) 1 ED:/ CD: JHEJ'K DE/) 4G1 H'-/. J,( ED'-8) #F 'D/'1'(1JE GH EF E9'C3'* -E6 'DAHDJC D0DC JF5- (%97'! AHDJC #3J/ E9 'D9D',. 'D@" Rovamycine" EECF #F J97J F*'&, ,J/). 'D@" Spiramycin "/ ,19) 'D('D: 2 : / JHE/ HGH A9'D #J6'K. G0G 'D#/HJ) *.A6 E9/D -/H+ 'D'671'('* 'DB'*D) . 9F/E' *97J 'D#/HJ) 'DEF'3() DD#E 'D-'ED A%F *DC *3J71 9DI 'D#91'6 'D(FHJ) E+D 'D-EJ H*-3F 'D"A) 'D9JFJ) 9F/E' *41C E9 'D3*J1HJ/'* 'DB41J). 'DE1',9 McCabe RE, Remington JS. Toxoplasma gondii. In: Mandell GL, Douglas RG. 1. Bennett JE, eds. Principles and Practice of Infectious Disease 2nd edn. New York: John Wiley, 1983: 1540-9. 2. Beverley JKA. Congenital toxoplasma infections. Proc Roy Soc Med 1960; 53:111-13. 3. Topi GC, D'Alessandro L, Catricata C et al. Dermatomyositis - like syndrome due to toxoplasma. Br J Dermatol 1979; 101: 589-91. 4. 'D/'! 'D-JH'FJ Zoonosis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rombidiosis" (*-* 'D-5'/ #H 'D9DA): GH /'! -JH'FJ .'1,J 'DEF4#. J-/+ EF 9+ 'D*1'( 'D0J B/ *1*(7 #H **9DB J1B'*G 9DI 'D,D/ E+J1) D*A'9D ,D/J (4CD "A'* -E'EJ) -7'7J) -HJ5DJ) #H 7A-J) E9 *3-,'* H'F*'F ,1+HEJ +'FHJ E+D 'D/E'D #H 'DBH('!. 'D'F/A'9 'D2'-A "Creeping Eruption ": GH E16 ,D/J JF,E 9F 'D/J/'F 'DEG',1) #+F'! E1-D) *7H1G' E+D 'DEDBH'* (Ancylostom)  'D/J/'F 'D4HCJ) H/H/) 'D'3C'1J3. *G',1 'DJ1B'* *-* 'D,D/ E4CD) 'FA'B *3(( 'D-C) H'D'F/A'9'* 'D41HJ). 'DE8'G1 'D,D/J) 'DF',E) 9F ('DB'1E'*) 'D,1( 'D(41J Human scabies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nimal scabies ,1( EFBHD EF 'D-JH'F'* E+D 'DCD'( H'DB77 B/ JCHF 0H 5H1) 31J1J) 4/J/) E+D: '1*C'3'* -7'7J) @ D7'.J) (+1J) @ BH('! #H 4(G 41HJ. 'D-C) 4/J/) HB/ *,9D 'DE1J6 E+(7'K (J'&3'K) HJ3(( '671'('* ('DFHE. 'D4CD 1BE 125: ,1( ('FA'B #E'E 'DE1AB) 'D4CD 1BE 126: ,1(('D31) H'D-4A)) "A'* EEJ2) 'D.HA EF E16 'D7AJDJ'* Parasitophobia (2/33)  (96 'DE16I 'D95(JHF 'D0JF J5'(HF ('D,1( B/ J3*E1HF ('D'9*B'/ (#F 'D,D/ E'2'D E5'('K 1:E CD 'DE9'D,'* 'D4'AJ) 'D*J #.0G'. GH J9*(1 #F #J -C) .AJA) -*I D/: 'D-41'* GJ G,E) EF 'D,1(  HJF*BD EF 9J'/) %DI #.1I H#-J'F'K J-ED E9G (B'J' ,D/J) AJ H9'! DCJ JBF9 'D7(J( (#FG E'2'D D/JG 'DE16. 1:E #FG EF 'D59( %BF'9 G$D'! 'DE16I  %D' %FG J,( (0D CD 'D,G/ 'DEECF DCJ J7E&F 'DE1J6 HFB/E DG 'D*-3F 'DFA3J H'D31J1J. 'D,1( 'DF1HJ,J Norwagian scabies GH 4CD F'/1 EF 'D,1( 0H 5H1) 31J1J) #4/ EF 'D,1( 'D9'/J  HJH,/ AJ 'DE,*E9'* 'DABJ1) H-'D'* FB5 'D9F'J) 'D5-J) H(JF 'D#4.'5 3J! 'D*:0J). 'DE8'G1 'D31J1J): *8G1 "A'* BJ-J) E*B41) 9DI 'DH,G H'DEF'7B 'D*F'3DJ). *8G1 "A'* EA17) 'D*B1F 9DI 'D1'-*JF H'D#.E5JF E9 931 *5F9 'D8A1 HE' *-* 'D8A1. *8G1 "A'* EF*41) *4(G 'D5/'A 9DI 'D,09 H'D#71'A. 'D,1( 9F/ 'D#7A'D Scabies in Babies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urax #H Kwell " E-DHD H%F JH69 'D9D', 9DI CD ,2! E5'( EF 'D,3E .'5) 'D+FJ'* 'D#AH'*( E'(JF 'D#5'(9 ) HJ*1C 'DE-DHD #H 'DC1JE 9DI 'D,D/ HJ:3D AJ 'DJHE 'D*'DJ HJA6D CHJ 'D#D(3) 'DE:3HD) -/J+'K EF CD' 'D,'F(JF. :DJ HCHJ 'DED'(3 EF 'D,'F(JF 9'/) DDB6'! 9DI 'DB'1E'* #H 'D9+. (96 'D#D(3) B/ **#0I ('D:DJ'F  A%F 'D:3JD 'D,'A H'D71JB) 'D9'/J) D:3JD H951 #:7J) 'DA1'4 B/ JCHF C'AJ'K DB*D 'DB'1E). *9BJE 'D#D(3) H'D#31). 'DE9'D,) 'DFH9J): (F2JD (F2H'* (Benzyl benzoate) : E*HA1 (*1'CJ2 25%  HJ,( *.AJAG (@ 2 @ 3 #-,'E EF 'DE'! 9F/ '3*9E'DG DD#7A'D 'D5:'1 H'D169 HJ,( *,F( *C1'1 #H *7(JB 'DE*C11 DD(F2JD (F2H'* #H "Lindane". E9'D,) 'D,1( A9'D) (H'37) A1C 'D,D/ EF 'D9FB -*I #.E5 'DB/EJF (H'37) "Kwell" E-DHD #H E-DHD (Eurax) (9/ %,1'! -E'E -'1 HA1C 'D,3E (H'37) 'D%3AF,). E-DHD(Crotamiton) HC1JE: B/ JAJ/ AJ E9'D,) 'D'FA'B AJ 'D1#3 H'D9FB. 'D*#+J1'* 'D,'F(J) DG0G 'D#/HJ) B/ *CHF #C2JE' *E'3 H'F-D'D 'D(41) 'D3EJ 'DF.1J E-16 ('DEHFH3DAH1'E. E6'/'* 'DGJ3*'EJF 61H1J) D'JB'A 'D-C). (2/35)  'DE6'/'* 'D-JHJ). AEHJ'K B/ F-*', %DJG' DD3J71) 9DI 'D'F*'F'* 'D,1+HEJ) 'D+'FHJ) "'D#1J+1H3JF @ 3JA'DH3JH1JF @ 'DADHC3'3DDJF AEHJ'K " A9'D) AJ 'D3J71) 9DI 'D/E'ED #H 'D"A'* 'D(+1J) 'D*J *.*D7 AJ (96 -'D'* 'D,1(. 'DE8'G1 'D,D/J) D"A'* 'D9+ #H 'DB'1E'* 'D#.1I Skin Manifestations of Other Mites 1. @ #C'D 3H*3 'DBE-(Grain itch ) 2. @ #C'D 'DJ3'1J9( Chiggers mite) 3. @ #C'D 'D(B'DJF 'D,10'F ( Rat mite itch) 4. @ #C'D 3H/ ( Grocer's itch) 5. @ #C'D :('1 'DEF'2D (House dust mite ) 'D'F/A'9 'D0J J+'1 (G0G 'DB'1E'* J*#DA (4CD 4'&9 EF -7'7'* 5:J1) -'C) (4/) #H -7'7'* -HJ5DJ) 9DI 'D#,2'! 'DEC4HA) EF 'D,3E .'5) 'D1#3 H'D9FB H'D3'9/JF  DCF #-J'F'K JCHF #C+1 'F*4'1'K. 8GH1 'D'F/A'9 9DI 'DH,G B/ J8G1 'D*G'( ,D/J *E'3J -'/. 9+ :('1 'DEF'2D "Dermatophygoides pteronyssinus ": EF*41 (4CD H'39 AJ 'D(J&) 'DEF2DJ) (:('1 H#31)) HJ-/+ 9'DEJ'K AJ 'D#E'CF 'DE#GHD). 'D9// 'D6.E EF 'DB'1E'* H,/* AJ 'D(JH* 'D17() :J1 C'AJ) 'D*/A&). J.*DA 'F*4'1 'DE16 -3( 'DA5HD 'D3FHJ) H*2/'/ AJ (/'J) 'D5JA H*5D #B5'G' AJ (/'J) 'D.1JA. 'D:0'! 'D1&J3J DD9'ED 'DEE16 GH B4H1 'D,D/ 'D(41J  'D9+ 'D'C3J1HAJDC .'5) 'D14'4J'*"Asperigellus penicilloides " 'D3(1J,D'3 GH EGE DDFEH H'DE9J4) DD9+ 9DI 37- 'D,D/. 'D9AF *G6E 'D/3E AJ 'DB4H1 'D*J GJ 3'E) ('DF3() DDB'1E'* #H 'D9+. 'D4CD 1BE 127: B'1E) 'D-5' / ( Harvest) 'D4CD 1BE 128: B'1E) 'DA&1'F /H1 9+ :('1 'DEF2D AJ 'D"DJ) 'DE16J) DD'C2JE' 'D*#(*J) (Atopic dermatitis) E'2'D* :J1 H'6-). (2/36)  DB/ DH-8 %F (JH* 'DE16J 'DE5'(JF (#C2JE' 'D*#(*J) 'DE9*/D) %DI 'D4/J/) J*H',/ AJG 9+ :('1 'DEF'2D #C+1 EF 'D#4.'5 'D7(J9JJF. 9DI CD -'D  GF'C 'D/DJD 'DE('41 H'DE+(* (#F 'D*916 D9+ :('1 'DEF'2D J+J1 'D#C2JE' 'D*#(*J) :J1 EBF9 /'&E'K. 'DH3'&D D*.AJ6 9// B'1E'* 9+ :('1 'DEF'2D J4ED 'D*F8JA 'DE-DJ DDGH'! 'DEF*8E HDCD 3,'/'* :1A 'DFHE H'D41'4A H'3*./'E #:7J) 'DA14'* *CHF (D'3*JC) HJECF C0DC *,1() E6'/'* 'DA7H1 E+D Natamycin . G0G 'D#FH'9 EF 'DB'1E'* *G',E 'D169 H'D#7A'D AJ A1'4GE  -J+ *+J1 #H *A'BE 'D#C2JE' H'D1(H 'DB5(J 'D*-33J AJ (96 'DE16I. JECF *-/J/ G0G 'DB'1E'* 'D9+J) (H'37) '.*('1'* 'D,D/. B/ *AJ/ 'D*79JE 'D*-33J AJ (96 'DE16I. 3H3) 'DBE- Pyemotes mites Grain itch mites 'D"A) 'D,D/J) *F,E 9F 'D*E'3 E9 'D*(F 'DEDH+ (G' @ 'D*G'( 'D,D/ J91A ('3E "-C) 'DBE-" #H "-C) 'D49J1" #H "#C2JE' (0H1 'DB7F". 'D"A'* GJ -7'7'* 41HJ) E-'7) (-HJ5D'* H#-J'F'K *CHF AB'9J) HGJ 9'/) 0'* 9// C(J1 H*H29G' J9*E/ 9DI 71JB) 'D*916. 'D9+ 'DB7JAJ Trombidosis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sutsu gammushi". 9+ 'D-5'/ Harvest Mites -C) 'DF.'D) (2/37)  'D*G'( 'D,D/ JF,E 9F 'DJ1B'* 'D7AJDJ) #H 'D41'FB ('D-H1'!) 'D*J *9J4 -1). B/ *3(( 'DJ1B'* 'D*G'( ,D/ E29,  H(96G' F'BD D#E1'6 'D1C*3J'"Rickettesia ". 'D(JH6 *9J4 AJ 'D*1'(  'DJ1B'* 3/'3J) 'D#1,D 'D*J *:13 #1,DG' AJ 'DF('* 'DB5J1 EF*81) 'DE6JA 'DEF'3(. AJ 'DE6JA *F*BD 'DJ1B'* %DI 'DEF'7B 0'* 'D,D/ 'D1BJB E+D 'D#0FJF H'D%(7JF H'D.'51*JF H'DF'-J) 'D*F'3DJ) +E *.1B 'D,D/ (E.'D(G' H*-BF D9'(G' 0H 'DEJ2) 'D-'D) DD.D'J' /'.D 'D(41) H**:0I 9DI 'D3H'&D H(B'J' 'D.D'J'  H9F/E' *4(9 H*E*D# *3B7 9DI 'D#16. *CHF 'DJ1B'* #C+1 9//'K EF 4G1 #J'1 (E'JH) %DI *41JF 'D#HD (#C*H(1) E9 01H) AJ #JDHD (3(*E(1). H'DE6JA 'D#C+1 *A6JD'K GJ 'D#1'F(. J9*(1'D@ Eutrombi cula GJ #C+1 'DJ3'1J9 (Chiggers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heyletiella FH9 EF B'1E'* (Cheyletiella) D'*-/+ #FA'B'K HGJ 7AJDJ'* *9J4 9DI (96 'D+/J'* .'5) 'DCD'( H'DB77 H'D#1'F( -J+ *CED /H1*G' 'D-J'*J) AJ 'DE6JA. **8'G1 'D"A) 'D,D/J) 9F/ 'D*E'3 E9 'D-JH'F'* 'DE5'(). 'DE8'G1 'D31J1J): (2/38)  'D5H1) 'D31J1J) 'DFEH0,J) GJ 9// C(J1 EF 'D-7'7'* 'D-'C) (4/) 'DE-'7) (-HJ5D)  *-/+ 9DI 'DEF'7B 'D*J *CHF 9DI *E'3 E9 'D-JH'F'* 'DE.EH,) #+F'! E/'9() *DC 'D-JH'F'*. G0G 'D"A'* *5(- F.1J) H'D'F/A'9 B/ J5(- E:7J'K H'39'K DD5/1 H'D(7F E*8'G1'K (-C) 4/J/). 'D'F*'F 'D,1+HEJ 'D+'FHJ B/ JCHF '.*D'7'K DD"A'* 'D,D/J) (3(( 'D*.1J4 'D4/J/. 9+ 'D7JH1 @ 'DBH'16 @ 'D2H'-A Dermanyssid GJ 7AJDJ'* ('D9) DD/E 9F/ 'D7JH1 H'D+/JJ'* (9+ 'D/H',F) HG0' 'D7AJDJ 4'&9 AJ 'D7JH1 'D#GDJ) H'DE*H-4). 'D'F*'F J-/+ #+F'! 'DD9( #H 'D*9'ED E9 'D7JH1 'D#GDJ) E+D 'D((:'H'*  'D/,', #H #BA'5G'  'DB'1E) */.D 'D(JH* EF #94'4 'D7JH1 9(1 'DFH'A0 #H 'DECJA'* E-/+) 'D*G'('K ,D/J'K. Liponyssoides Sanguineus: B'1E) A&1'F 'DEF2D GJ 7AJDJ G',1 EF 'DBH'16 'D5:J1)  HGJ 0'* #GEJ) 7(J) D#FG' E3*H/9 'D1C*3J' 'D"C'1J) 'D*J *FBD E16 'D1C*3J'. 9'&D) 'DE'C1HF3J/J' Family Macronyssidae G0G 'DE,EH9) *4ED 7AJDJ'* ('D9'* DD/E H*F*BD EF 'D7JH1 H'D+/JJ'* H'D2H'-A. 'D5H1 'D31J1J): B/ *9*E/ *DC 9DI 71JB 'F*B'D H4/) 'D'F*'F H/1,) '3*,'() 'DE6JA. 'DE8'G1 'D,D/J): "A'* 41HJ) #H -7'7J) -'C). JH,/ 'F/A'9 EF*41 HC+JA EF 'DDH-'* 'D41HJ) ('DD-()) #H -7'7'* -'C) (4/) B/ **,E9 H:'D('K :J1 E*F'81)  HB/ JH,/ FB7) EF.A6) AJ H37 'D"A'* H#-J'F'K 8GH1-HJ5D'* AJ E1C2 'D-7'7'* .'5) 9F/ 'D#7A'D. 'D'F*'F 'D+'FHJ B/ J-/+ (3(( 'D-C) 'D4/J/). 'D4.5 'D0J *G',EG 'DB'1E'* AJ 'DA1'4 JCHF D/JG 96'* HD/:'* C+J1) HEF*41) **,E9 'D"A'* #-J'F'K E,'H1) DEF'7B 'D+J'( 'D6JB) 'DE4/H/) -HD 'D.51. AJ 'D'F*'F 'D4/J/ B/ *8G1 'DB'1E'* 'DE3(() AJ EHB9 D/: 7AJDJ. 'DE8'G1 'D,D/J) 'DF',E) 9F 'D0('( (2/39)  'D0('( GH F'BD G'E D#E1'6 'F*'FJ) E9JF). 'DE8'G1 'D,D/J) B/ *CHF F',E) 9F D/:) 'D0('() #H 9F 'DJ1B'* /'.D 'D,D/ E3(() "'DFAB 'D,D/J". 'D5H1) 'D31J1J): 1. D/:) 'D0('() 4/) 'DE8'G1 **FH9 -3( FH9 9'&D) 'D-41). 9'&D) 'D.JDJ'* Family Tambidia: GJ 0('() 'D-JH'F'* E+D 'D.JHD H'D:2D'F H*3(( D/:) E$DE) (4/). 9'&D) 'D-D2HFJ'* Helediae : H*3EI #J6'K 'D0('() 'D/BJB) "No see ums"(3(( 5:1 -,EG' AHB 'D9'/)  HGJ **EJ2 (D/:) .7J1) H*3(( -C) H"A'* EBDB) B/ *3*E1 9/) #J'E. 'D4CD 1BE 129:'D0('( 'D#0FA 'D#3H/ (Simuliides) 'D4CD 1BE 131: J1B) 'D0('() 'D2,',J) 'D4CD 1BE 130: 0('() 'D:2'D 'D0('( 'D#0FA 'D#3H/ (Simuliides) E3*H7F AJ 'DEF'7B 'D1JAJ) 'D-'1) 'D17() HGJ 0('() .7J1) H.(J+). 'DE8'G1 'D31J1J): 'D0('() 'D3H/'!: *3(( D/:) E$DE)  *A6D 'D9JF'F HA*-'* 'D#FA H'D#0F'F H*-/+ E8'G1 ,G'2J) HEH69J) 4/J/). 'DE8'G1 'D,G'2J): -EI @ '671'('* G6EJ) (E9/J) E9HJ)). '1*C'3 EH69J  *8G1 "A'* -E'EJ) H0EJ)  *H1E AJ 'DH,G HB/ J3(( *B1- H*E2B. 9'&D) 'D@ "Psyclodidae " 'D0('() EF ,F3 'DA'5/'* HGJ F'BD D/'! 'DD'J4E'FJ' 'D,D/J H'DC'D' @ "2'1  H/'! C'1JHF  /'! 'D+"DJD 'D9DJBJ  H:J1G'. *G',E 'DA'5/) 6-J*G' E3'!'K H*A6D 'DC'-DJF H'DE95E H'D1C(*JF H'DE1ABJF. 9'&D) 'D.61'! 'DEDHF)(Chloropidae) GJ E3*H7F) AJ 'DEF'7B 'D1JAJ) H:J1 'D1JAJ) 0'* 'D9F'J) 'D5-J) 'DEF.A6). **:0I 9DI 'D/E HEA12'* 9JF 'D%F3'F E3(() 'D*G'( ED*-E) H('&J H,1H- EA*H-) HE$DE). 2. 'DF9A 'D,D/J (Cutaneous myiasis) : GH E16 ,D/J F',E 9F 'F*'F 'D,D/ (J1B'* 'D0('( H#C+1 #FH'9 'D0('( 'DE3(() D@ 'DF9A 'D,D/J GJ 'D0('() 'D.(DJ) 'D-D2HFJ) ( Screw Worm). (2/40)  J1B'F 9/) #FH'9 EF 'D0('( *3(( E8'G1 ,D/J) E.*DA) E8G1) .7H7 E*91,) H0'* -'A) -D2HFJ) 'D*A'AJ) #H .7 J-// G,1*G'. 'D(JH6  'DJ1B'* 'D-J)  #H CD'GE' B/ **E1C2 ('D,D/ H'DBF') 'DG6EJ) #H 'DBF') 'D*F'3DJ) 'D(HDJ)  'D9JF'F @ 'D#0F'F H-*I 'D#FA. 'DE8'G1 'D31J1J): 1. @ 'DF9A 'D(/&J" Primary myiasis": JECF DDJ1B'* #F *5F9 DG' FAB'K AJ 'D,D/ 'DE5'(. 'D#91'6 H'D'.*D'7'* *9*E/ 9DI FH9 'D0('(). 'D4CD 1BE 132: 'DF9A 'D,D/J #. (96 3D'D'* 'D0('( *+B( 'D,D/ H*69 'D(JH6 *-* 37- 'D,D/ HFH9 ".1 */.D (JH6G' AJ 'D,1- 'DEA*H- #H 'DB1-'*. (. 'D3D'D'* 'D#.1I E+D 'D@ (Walfahrtia)'DHDH/) *DBJ (JH6G' 9DI 'D,D/ H(9/ #F *AB3 *G',1 'DJ1B'* %DI 7J'* 'D,D/ E+D 'DF'-J) 'D#1(J) E3(() 'D*G'('K (4CD -7'7'*  /E'ED H-*I (+H1. *. 9'&D) 0('() 'D2,',) 'D(41J) "Human bottle fly H D.Hominin " J3*./E H3J7 (H6JA H3J7) D*69 (JH6G' 9DI ,3E 'D(9H6)  H'DB1'/ #H "Stable Fly". +. 9F/E' *D/: 'D(9H6) 'D,D/ A%F 'DJ1B'* 9DI 'D(9H6) */.D 'D,D/ 9(1 EHB9 'DD/:) E3(() 'DF9A 'D,D/J. 0('()"Tumbu" AJ #A1JB' 'DE/'1J) *69 (JH6G' 9DI 'D#16 H(9/ 8GH1 'DJ1B'* *G',E H*FA0 %DI 'D,D/ AJ 'D5AF #H 'D#71'A E3(() H1E 'D*G'(J -J+ *.1, 'DJ1B'* EF 'D"A) (9/ #3(H9. 2. @ 'DF9A 'D+'FHJ "Secondary myiasis ": J9*E/ G0' 'DFH9 9DI 3DHC (96 'DJ1B'*. #. 'DJ1B'* 'DEG',1): -J+ *9J4 'DJ1B'* AJ 'DF3, E-/+) 'D*G'('K AJ EHB9 G,1) 'DJ1B) HJ91A ('3E 'D'F/A'9 'D2'-A"Creeping eruption " . (. 'DJ1B'* 'DD'EG',1): *H69 'DJ1B'* AJ 'D,D/ +E *5(- E3*H7F) AJ 'DEC'F 'D#HD. 'DF9A 'D,D/J 'D0J J-/+ (3(( J1B'* 'D0('( EF FH9 (Genera Casterophillus) H (Hypoderma ) B/ J3(( 'F/A'9 2'-A J4(G 'D0J JF,E 9F 'D/J/'F 'D.7'AJ). E9'D,) 'DF9A: (2/41)  'DF29 'D,1'-J: DDJ1B'* (%(1) -'/) H*41J( 'D,1- (E-DHD CDHAH1E AJ 2J* F('*J (*1CJ2 15%. *./J1 'DJ1B'* ('DB7F 'DE(DD ('DCDH1AH1E JECF #F *9'D, (G 'DF9A 'D#FAJ HEF +E %:D'B A*-) 'D#FA DE/) 2 @ 3 /B'&B H%2'D) 'DJ1B'* ('DEDB7. 'DHB'J) ('DB6'! 9DI 'D0('(. 'DE1',9 Poindexter HA. Cutaneous myiasis. Arch Dermatol 1979; 115: 235. .1 Reames MK, Christensen C, Luce EA. The use of maggots in wound debridement. Ann Plast Surg 1988; 21: 388-91. .2 Spigel CT. Opportunistic cutaneous myiasis. Arch Dermatol 1988; 124: 1014-15. .3 Wildy GS, Clover SC. Myiasis due to tumbu fly larva. Lancet 1982; i: 1130-1. .4 'DA5D 'D+'D+ 941 'DE8'G1 'D,D/J) D0JA'* /3EHE/ 'D3EC H(96 'D-41'* 'DE8'G1 'D,D/J) 'DF',E) 9F 3EHE 'D3EC 9/) #FH'9 EF 'D3EC B'/1) 9DI %+'1) H.2'* E$DE) H-*I .71) (H'37) 29'FAG' 'D8G1J) #H 'D(7FJ) 'DE2H/) (:// 3'E) E9B/). 'D#FH'9 'D*J *9J4 AJ 'DEJ'G 'D-'1) 'DD'/:): 3EC 'D9B1( @ 3EC 'DB7) @ 3EC 'D#1F( @ 3EC 'D5.1 H3EC "Stargazers " .71) ,/'K. 'DE8'G1 'D31J1J): H.2 'D3EC J*8'G1 9'/) (*3D.'* H*G*C ('D,D/ J5'-(G #91'6'K E$DE) #H ,1H- FB7J) B/ J3*E1 'D#DE 'D4/J/ D9/) 3'9'*. B/ J4(G 0DC 'D-E'EJ H'D*H1E 'D*G'( 'DF3J, 'D.DHJ 'D'F*'FJ. 'DE9'D,): 1 @ 'DE'! 'D-'1: GH A9'D ,/'K AJ E9'D,) D/: 3EC" Weaver HStingrays " "H3EC 'D#3/ H#3E'C 'D9B1(" 'D#.1I. 'D,2! 'DE*#0J J,( #F J:73 AJ E'! #C+1 3.HF) JECF #F J*-EDG 'DE5'( DE/) 30 /BJB). 2 @ E6'/'* 'DGJ3*'EJF. 3 @ 'D3*J1HJ/'* 'DB41J). 'D-'D'* 'D4/J/) B/ *-*', D3*J1HJ/'* B41J) EH69J) H,G'2J). 'D4CD 151 ': -3'3J) 3EHE 'D3EC 49() 'DD'E9'&J'* Phylum Coelentrata (2/42)  G0G 'D9'&D) *4ED 'D3EC 'DGD'EJ @ 'DGJ/1J'*" Hydroids ' H#FH'9 #.1I *9J4 AJ E'! 'DE-J7. "Potuguese Man-of-War" H'D3EC 'DGD'EJ 'D'C2JE' F*J,) 'DED'E3) DDE,3'* DD-JH'F 'D0J B/ JCHF #21B #H #-E1 'DDHF HDG 'D9/J/ EF 'DE,3'* 7'AJ) 'D*J *-*HJ 9DI 3'&D J-HJ 'D0JA'F'* H'D3EHE 'D*J *5D 'D,D/ 9(1 'DE,3'* 9DI 7HD #71'AG'. 'D3E GH 95(J B/ J3(( AJ 'D#7A'D 'D-3'3JF #C2JE' 4/J/) HB/ *H/J %DI 'DEH*. 'D#E'CF 'D#C+1 %5'() GJ 'D3'9/JF  'DB/EJF H'DA./JF H,'F(J 'D,09. 'D4CD 1BE 151( : BF/JD 'D(-1 Portuguese man of war 'DE8'G1 'D31J1J): 'DE8'G1 'D,D/J): "A'* -E'EJ) #H 41H1J) H#-J'F'K F2AJ)  .7J) 'D4CD *8G1 AJ EHB9 'D*E'3 E9 'D2H'&/ Barbs H'DE,3'*" Tentacles "'D96HJ'*. %-3'3 ('D#DE 'D4/J/ H'DH.2 'D-'/ GE' E8'G1 4'&9). 'DE8'G1 'D,G'2J): :+J'F @ %BJ'! @ H#DE (7FJ. 59H() 'D*FA3 H*9( H.H'1. GJ', H'671'('* 9'7AJ). 'DE9'D,): JECF '3*./'E 71B E.*DA)  HGJ *9*E/ 9DI %2'D) 'D2H'&/ "Tentacles" EF 'D,D/. 'DE9'D,) 'DEH69J): :3D 'DEF7B) 'DE5'() ('DE'! HA1CG' ('D1ED 'D,'A HC47 'DEF7B) (3CJF -'/. :3D 'DEF7B) +'FJ) H*7(JB E1GE 3*J1HJ/ EH69J. 'D:'2'* 'D#1HE'*J) E+D 'D#EHFJ' 9DI 'DEF7B) 'DE5'() B/ *3(( 4A'! 'D#91'6. 'DE9'D,) 'D,G'2J): 'D-'D'* 'D.AJA): *3*,J( (4CD ,J/ DE6'/'* 'DGJ3*'EJF 'DAEHJ). 'D-'D'* 'D4/J/): B/ *97J -BF) 96DJ) EF" ACTH " #H -BF EF 'D3*J1HJ/'* 'DB41J) E+D (3DHEJ/1HD)" Solu - Medrol " HE6'/'* 'DGJ3*'EJF H1J/J'K. G0G 'D#/HJ) *3(( 9'/) *-3F'K EA',&'K H/1'E'*JCJ'K. #C2JE' 'D3('-JF (E3*-EI 'D(-1) Seabathers dermatitis 'D"A'* 'D41HJ) 'D-E'EJ) B/ *8G1 (9/ 9/) 3'9'* EF 'D'3*-E'E AJ EJ'G 'DE-J7 #H 'D#E'CF 'D#.1I. 'D#E'CF 'D#C+1 %5'() GJ 'DEF'7B 'DE:7') (D('3 'D3('-). (2/43)  'D4CD 151 ,: -3'3J) 'DE3'(-(EF E1C('* 'DCDH1 HE6'/ 'DA7H1) (Fig.151c.Swimming pool dermatitis(Due to Chlorine&Algicid) 'D4CD 1BE 151 /: -3'3J) 'D3('-) AJ 'DJ-1 Fig. 151d. Seabather's dermatitis AJ 'D#7A'D *8G1 'D'A'* (4CD 1&J3J 9DI 'D#1/'A H-HD 'D-2'E 9DI EF'7B 'D6:7 DD('3 'D3('-). B/ JF,E 'D7A- 9DI 'DEF4B'* Schistosoma #H 'D3EC 'DGD'EJ HC'&F'* #.1I. 'DE9'D,): E1GE 3*J1HJ/'* B41J) EH69J'K. E6'/'* 'DGJ3*'EJF AEHJ'K B/ JCHF A9'D'K AJ EF9 'D-C). 3*J1HJ/'* ,G'2J) F'/1'K E'J-*', %DJG'. D/:'* 'D#A'9J Snake Injuries *#+J1'* 96) 'D#A'9J *9*E/ 9DI *1CJ( 'D3E. 4/) 'DE6'9A'* *9*E/ 9DI FH9 'D0JA'F 'DEH,H/ AJ 3EHE 'D#A'9J 'DE.*DA). 96'* 'D@" Spitting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corpoin Sting 'D9B'1( EF*41) ,/'K AJ 'DEF'7B 'DE/'1J) HE'*-* 'DE/'1J)  D/:*G' 'D3'E) GJ 'DE3$HD) 9F 'DE6'9A'* H'DHAJ'* 'D9'DJ)  .'5) AJ 'D169 H'D#7A'D 'D5:'1. J-ED 'D3E AI 'DEC'F 'DE9BHA AJ 71A 'D0JD H**,G AHB 1#3 'D9B1( D*57'/ A1J3*G'. 'DE1C( 'D1&J3J AJ 'D3E GH 9'ED 3EJ 95(J 0H *#+J1'* H/J)(Adrenergic) HF8J1) H/J) (Cholinergic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lexander JO D. Scabies. In: Arthropods and Human Skin. Berlin: Springer-Verlag, 1984: 227-92. 1 Bartley WC, Mellanby K. The parasitology of human scabies (women and children). Parasitology 1944; 35: 207-8. 2 Van Neste DJJ. Human scabies in perspective. Int J Dermatol 1988; 27: 10-15. 3 Alexander JOСD. Scabies. In: Arthropods and Human Skin. Berlin: Springer-Verlag, 1984; 227-92. 4 Funaki B, Elpem DJ. Scabies epidemiology, Kauai, Hawaii, 1981-1985. IntJDermatol 1987; 26:5902. 5 Dahl MV. The immune system in scabies. ln: Orkin M, Maibach HI, eds. Cutaneous Infestations and Insect Bites. New York: Marcel Dekker, 1985:75-83. 6 Van Neste DJJ. Human scabies in perspective. Int J Dermatol 1988; 27: 10-15. 7 Bean SF. Bullous scabies. J Am Med Assoc 1974; 230: 878. 8 Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126: 226-8. 9 Clayton TM. Treatment of scabies by T.E.T.M.S. Br Med J 1943; 1: 443-5. 10 Cubela V, Yawalkar SJ. Clinical experience with crotamiton cream and lotion in the treatment of infants with scabies. Br J Clin Pract 1978; 32: 229-31. 11 Ginsburg CM, Lowry W, Reisch JS. Absorption of lindane (gamma benzene hexachloride) in infants and children. J Pediatr 1977; 91: 998-l000. 12 Hewitt M, Barrow GI, Miller DC et al. Mites in the personal environment and their role in skin disease. Br J Dermatol 1973; 89: 401-9. 13 Alexander JOСD. Reactions to Dipterous biting flies. In: Arthropods and Human Skin- Berlin: Springer-Verlag, 1984: 115-33. 14 (2/46)  Matusow RJ. Oral inflammatory responses to a sting from Portugese man-oX war. J Am Dent Assoc 1980; 100: 73-5. Hoeffler DF. Swimmers itch. Cutis 1977; 19: 461-7. 15 Bernhardt MJ, Mandojana RM. Sea bathers eruption. Clin Dermatol 1987; 5: 101-2. 16 Hoeffler DF. Swimmers itch. Cutis 1977; 19: 461-7. 17 Kettle DS. Medical and Veterinary Entomology. London: Croom Helm, 1984. 18 Medley S. A dog bite wound infected with Pasteurella pneumotropica. Med J Australia 1977; 2: 224-5. 19 Brenner DJ, Hollis DG, Fanning GR et al. Capnocytophaga canimorsus sp. nov. (Formerly CDC group DF-2), a cause of septicaemia following dog bite, and C. cynadegmi sp. nov., a cause of local wound infection following dog bite. J Clin 20 Stawiski MA. Insect bites and stings. Emerg Clin North Am 1985; 3 (4): 785-808. 21 Burns DA. The investigation and management of arthropod bites acquired in the home. Clin Exp Dermatol 1987; 12: 114-20. Microbiol 1989; 27: 231-5. 22 Warrell DA. Animal poisons - scorpion stings. In: Manson-Bahr PEC, Bell DR, eds. MansonСs Tropical Diseases 19th edn. London: BalliEre Tindall, 1987: 889-90. 23 Alexander JOСD. Scorpion stings. In: Arthropods and Human Skin. Berlin: Springer-Verlag, 1984: 199-207. 24 Medley S. A dog bite wound infected with Pasteurella pneumotropica. Med J Australia 1977; 2: 224-5. 25 Gueron M, Yaron R. Cardiovascular manifestations of severe scorpion sting. Clinicopathologic correlations. Chest 1970; 57: 156-62. 26 (2/47)  Pearn J, Morrison J, Charles N et al. First-aid of snake bite. Efficacy of a constrictive bandage with limb immobilization in the management of human envenomation. Med J Aust 1981; 2: 293-5. 27 'DA5D 'D1'(9 941 'D*8'G1'* 'D,D/J) DD/J/'F 'D7(J) 'D/J/'F 'D7(J) 'D#C+1 4JH9'K 'D*J 0'* HD9 ('D,D/  HJ*1'AB E9 E8'G1 ,D/J) GJ: 'D/J/'F 'DE/H1) 'D.J7J) ('D-(DJ'*Nematode ): 'D#C3JH1) ( Oxyrius'D-1B5) 'DA*'C) 'D#EJ1CJ) @ 'DEDBH'* 'D9A,J) "Strongyloides " H'DJ1B) 'DG',1). 'D/J/'F 'DE/H1) 'DF3,J): 'DF-J7J'* @ 'DDH'DH' H/H/) 'DE/JF). 'D41J7J'*" Cestoda" 'D41J7J) 'DH-J/) H'DE4HC) 'D-(J(J). 'DE+BH('* "Trematoda " 'DEF4B'* 'D-4HJ) H'DEF4B'* 'D,D/J). 'DE8'G1 'D,D/J) DD/J/'F 'D.J7J) 'D/J/'F 'DE9HJ) (Enterobiasis) 'D/J/'F 'D.J7J) @ 'D/J/'F 'D/(H3J) " Entrobius Vermicularis " 'D/J/'F 'D/(H3J) GJ #4J9 'D/J/'F 'D(41J) H*5J( 9'/) 'D#7A'D. 'D9/HI JF,E 9F '(*D'9 'D79'E #H 'D41'( 'DEDH+ ((JH6 'D7AJDJ'* #H 9(1 'D#5'(9 'DEDH+). 'D4CD 1BE 153: (J6 'D/J/'F 'DE9HJ) (Entrobius Vermicularis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ntepar) GH 'D/H'! 'DE.*'1. J97I ,19) JHEJ) H'-/) EF 65 ED:/C: #H ,19) EA1/) C(J1) (D' **,'H2 2500 ED:)  HJ$.0 B(D 'DA7H1 (3'9) H'-/) EE2H,'K E9 EDJF E+D ('D3F'EC)) DE/) +E'FJ) #J'E E**'DJ). 'D/H'! "EF DCFG J,( 9/E %97'!G AJ -'D'* 'DB5H1 'DCDHJ #H -'D'* 'D519 :J1 'DE3J71 9DJG'. ((J1'2JF 100 ED:/C: H((J1'F*'D ('EH* Pyrental pamoate; 10) ED:/C: A9'D #J6'K. EJ('F/'2HD: (Mebendazole) /H'! A9'D J97I (,19) H'-/) 100 ED:. AJ -'D) 9H/) 'D'F*'F JECF *C1'1G (9/ #3(H9JF (%97'! 100 ED: EJ(F/'2HD E1*JF JHEJ'K DE/) 3 #J'E E**'DJ). (J1JAJHE ('EH'*:(Pyrivium pamoate) J97I (,19) H-J/) 5 ED: / C: . JECF *C1'1G' (9/ #3(H9 HJ,( 'DED'-8) #F 'D(1'2 .D'D 'DE9'D,) J5(- #-E1 A'*- . 'D+J'(F/'2HD: (Thiabendazole) 'D,19) 25ED:/ C: (,19*JF E*3'HJ*JF DJHE H'-/ JECF *C1'1G' (9/ #3(H9. (2/49)  E6'/'* 'DGJ3*'EJF (41'() JECF '3*./'EG DE9'D,) 'DG14 HJECF 2J'/) 'D,19) ('DDJD -*I *3'9/ 'DE5'( 9DI 'DFHE. 'D-C) 'DEBDB) 'D4/J/) B/ *-*', %DI 'D3*J1HJ/'* (C1JE) EH69J'K JECF '3*./'EG' %0' C'F* 'D-C) 4/J/) HE3*E1). 'D/J/'F 'D*FJFJ) /J/'F 'DE/JFJ) Dracunculosis GJ 'D*G'( E2EF JF,E 9F /J/'F *3EI /J/'F :JFJ'  #H /H/) 'DE/JF). GJ /J/'F .J7J) -J+ 'D#F+I B/ *5D %DI 7HD #C+1 EF E*1 H'-/. J-/+ 'DE16 AJ 'DGF/  :1( #A1JBJ' H41B H37 #A1JBJ'  EF7B) 'D.DJ,  'DJEF  %J1'F H('C3*'F H:1( 'DE-J7 'DG'/J. J-/+ 'D9/HI (41( E'! EDH+ ('DB41'FJ'* 'D5:J1) 'D*'(9) D,F3 'D@"Cyclops" (1':J+ 'DE'!. 'D#F+I 'D('D:) *F6, .D'D A*1) 3F) AJ 'D%F3'F H*A12 'DJ1B'* 9(1 "A) ,D/J) E*B1-)  "D'A 'DJ1B'* *F*, @ .'5) 9F/E' *5(- 'DEF7B) 'DE*B1-) 9DI *E'3 E9 'DE'! 'D*J JECF #F *(BI EF 3 @ 4 #J'E H**7H1 #C+1 AJ (1':J+ 'DE'!. 71B 'D9/HI: %5'() 'D%F3'F **DH 41( E'! EF 'D(1C H'D"('1 'DEDH+) H'D-'HJ) 9DI #FH'9 (1':J+ 'DE'! 'DE5'(). **-11 'DJ1B'* H*+B( 'D#E9'! H'DF6, 'D%6'AJ J-/+ AJ 'DE3'A) .DA 'D(1J*HF #H #E'CF #.1I -J+ J-5D 'D*2'H,( Mating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yclops" . :DJ 'DE'! AJ 'DEF'7B 'DEH(H!) B/ JB*D (1':J+ 'DE'! . 'D4CD 1BE 154: 7A- /H/) 'DE/JF) 'DE9'D,) 'DFH9J): 'DE9'D,) 'DE.*'1) GJ -BF 'DAJFH+J'2JF (Phenothiazine)AJ 2J* 'D2J*HF 9'/) *B*D 'D/J/'F. J,( 'D-01 'D4/J/ DCJ D'*3-( 'D/H/) (4CD BHJ -*I D'*-/+ 'FA5'D :J1 E7DH( DD/H/) *'1C'K ,2!'K ('BJ'K AJ 'DF3J, *-* 'D,D/. (F2JEJ/'2HD AEHJ E+D 'DE*1HFJ/'2HD (Benzomidazole, Metronidazole) J97I JHEJ'K DE/) #3(H9  JECFG B*D 'D/H/) 'D*J JECF '3*.1',G' EF 'D,D/ (D7A. 'D71B 'D*BDJ/JG DD9D',: "(96 'DEH'7FJF AJ 'DEF'7B 'DEH(H!) D/JGE 71BGE 'D.'5) DD*.D5 EF 'D/H/)". -'DE' J5(- ,2! EF 'D/H/) 8'G1'K EF .D'D 37- 'D,D/ A%F 'D3'B 'DE5'( J:73 AJ E'! DA*1) E9JF) %0 *E/ 'D/H/) ,3EG' (9/ 0DC #C+1 AJ 'DE'! 'DEH,H/. 'DE1J6 D/JG .(1) D3-(G' (D7A HDAG' 9DI 9H/  HJC11 G0G 'D9EDJ) JHEJ'K (-01 H('F*('G 4/J/ H5(1 -*I J*E F29 'D/H/) C'ED). 'D(DG'13J' Bilharziasis /'! 'DEF4B'* GH E16 ,G'2J .7J1  J-/+ (9/) #FH'9. 'DEF4B'* 'D/EHJ) ('DADHC 'D/EHJ) "Schistosoma or blood fluke ": 'D7AH- B/ *-/+ #+F'! 'DE1-D) 'D:'2J) AJ 'DE16 (9/ +B( 'D,D/ H'D#:4J) 'DE.'7J) ('DE0F('* (Cercaria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auliflower" HB/ J8G1 #J6'K FH9 DHJ-J #H 9BJ/J B'3 EF 'DH1E 'D-(J(J 'D(DG'13J 9DI 'D,09 HJ5(- E*B41'K HE57A'K (4CD :'EB. 4 @ /'! 'DEF4B'* 'D,D/J) 'DG',1): #E'CF 'DG,1) D%/.'D 'D(JH6 *8G1 9'/) #+F'! G,1) 'D/H/) 9(1 'D6AJ1) 'DH1J/J) ,'F( 'DAB1J). %5'() 'D,D/ B/ *-/+ %E' CF*J,) DD/.HD 'D#HDI DDE0F('* 'D-J) 'D-1) 'DE'&J) #H AJ 'DE1'-D 'D#.J1) EF 'D'D*G'( 'D*'DJ DDH69 'D(9J/ DD/H/) #H 'D(JH6. AJ /'! 'D(DG'13J' 'D,D/J) 'DG',1) B/ *5(- 'D(JH6 E*13(G #H E1C2) AJ 'D,D/ H#E'CF (9J/) #.1I E+D 'DED*-E) H'D,09 H'D1&*JF H'D,G'2 'D95(J 'DE1C2J. (2/52)  'DEF7B) -HD 'D31) GJ EC'F 4'&9 DCF 'DEF'7B 'D#.1I B/ *5'(. AJ (96 'D-'D'* 'D"A'* *CHF 0'* *H29 B79J #H F7'BJ 'D4CD (J4(G /'! 'DEF7B)). 'DE8'G1 'D9'E) DD(DG'13J' 'DG',1): 'D"A) 'D(/&J) GJ -7'7) EC*F2)  15'5J) 'DDHF E*HG,) *5D D-,E 2 @ 3 EDE 'D4CD DHJ-'* E1*A9) BDJD'K E9 -H'A :J1 EF*8E) H37- 0H -DE'*. 'D,D/ AHB 'D9BJ/'* 'DB/JE) *5(- E57(:'K (4/)  HE*B41'K HB/ JCHF #.J1'K (4CD E*B1-  B/ J-/+ (B9) F'B5) 'D5(': (9/ 'D4A'!. ( @ 'DE8'G1 'D9'E) DD(DG'13J': -EI @ (1A1J) @ /9+ @ #DE EA5DJ @ E:5 (7FJ @ H%3G'D. 6.'E) C(/J) 7-'DJ). 'D#91'6 *2HD .D'D -H'DJ 4 @ 6 #3'(J9. , @ 'DE8'G1 'D,G'2J) DD(DG'13J': *4E9 C(/J. %5'() E9HJ). %5'() 'DE,'1J 'D(HDJ). 'F*'F 'DCDJ) H'DE+'F) B/ J$/J %DI C'13JFHE' AJ 'DE+'F). B/ J5'( 'DBD( H'D,G'2 'D95(J 'DE1C2J H'D4(CJ) ('D7AJDJ H-J/ 'D.DJ). E9'D,) 'D(DG'13J': 71B 'DHB'J): EF9 'D*E'3 EA12'* 'D%F3'F E9 'DE'!. 'DB6'! 9DI 'DBH'B9 AJ 'DEJ'G. 'D71B 'DFH9J): 'JE*JC *'1*'1 (Tartar emetic ) #H 'D3*J(HAJF"Stibophen"  'D*1JH2'F" Triostan" H'D'3*J('F CDG' #/HJ) E*FH9) *3*9ED AJ 9D', 'D(DG'13J'. 'DFJ1J/'2HD (Ambibhar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etronidazole) : ,19) 'D('D:JF 'DEF5H5 9DJG' GJ 800 ED: AEHJ'K +D'+ E1'* JHEJ'K DE/) 10 #J'E. B/ J4'1C G0' 'D/H'! E9 'D/JDHC3'FJ/ AJH1J* (Diloxanide 500) ED: 3 E1'* JHEJ'K #H J*(9 (@ /J JH/HGJ/1HC3J CJFJF: 650 ED: +D'+ E1'* JHEJ'K DE/) 21 JHE'K DDB6'! 9DI 'DE*CJ3'* 'DE9HJ). 'D*F8JA 'DEH69J DDB1-) 'D,D/J) ('DE7G1'* B/ *CHF 61H1J). 'D.1', 'DC(/J J-*', D*A,J1  HJ,1J (#E'F #C+1 (H'37) 'D(2D ('D%(1). 'DE9'D,) 'DA9'D) **(9 9'/) ('D4A'! 'DC'ED DD"A) 'D,D/J) (/HF -',) DDE9'D,) 'D*,EJDJ). /'! 'DE491'* ('D*1JCHEHF'3) Trichomonasis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etronidazole 400 ) ED:/ JHE DE/) 5 #J'E. 'D,19) 'DH-J/) (#1(9 -('* 500 ED:) JECF #F *97J (4CD ,19) H-J/) HGJ A9'D) #J6'K. (2/55)  'DE:'73 'D(3J7) B/ *AJ/ AJ %2'D) 'D#91'6 'DEG(DJ) 20 ED "Vinegar "%DI DJ*1 H'-/ EF 'DE'! 'D/'A& . 'D'F/A'9 'D2'-A Creeping Eruption GH 'F/A'9 ,D/J J-/+ (4CD 1&J3J (J1B'* 'D/J/'F 'D45J)  'DEDBH'* 'D(1'2JDJ) H(4CD #BD ('DJ1B'* 'D#.1I E+D 'DEDBH'* 'DC1'FJ)  0('() 'D.JD #H J1B'* 'D-(DJ'* (Strongyloides) 'D*J *FA0 9(1 'D,D/ #+F'! 'DE4J -'AJ'K .'5) 9F/ 'D'7A'D. 'D#E'CF 'D#4J9 %5'() GJ 'DB/EJF H'D#1/'A H'D#96'! 'D*F'3DJ) H'DJ/JF 'D-'D) 4'&9) AJ CD 'DEF'.'* 'D/'A&). 71B 'D9/HI: 'D/H/) 'D.7'AJG (Hook worms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ig.156b.Creeping eruption 'D4CD 156(. 'D'F/A'9 'D2'-A 'DE9'D,): E9'D,) 'D#91'6: E6'/'* 'DGJ3*'EJF H3*J1H&J/ EH69J .AJA DEF9 'D-C) 'D4/J/). 'DE6'/'* 'D-JHJ) AJ 'D-'D'* 'DE.*D7) ('F*'F ,1+HEJ +'FHJ. *,EJ/ 'DJ1B'* (%10'* %J+JD CDH1'J/ GJ 71JB) B/JE) HA9'D). 'D+J'(F/'2HD (EF*J 2HDMentezole-Merk Sharp &Dohome): ,19) 25 ED: E1*JF JHEJ'K DJHEJJF E**'DJJF. 'D/H'! 'DE.*'1 GH 'D*7(JB 'DEH69J DD+J'(F/'2HD 10%. (2/56)  3H'! J3*./E 'DE3*-61 'DAEHJ 'DE*HA1 *,'1J'K E('41) #H -(*'F 0.5: EF 'D+'(F/'2HD *E2, AJ 10 : EF 'D(*1HD'JHE ('DA'2DJF)  HJ7(B E1*JF JHEJ'K. -J+ #F 95% EF 'D-'D'* *4AJ .D'D #3(H9. "'DE+J'(F/'2HD" 'DAEHJ #BD A9'DJ) H#C+1 3EJ). -C) 'D*1'( Ground Itch -C) 'D*1'(" Dew itch" GH 'F/A'9 9DI 'D'.E5JF H'D#AH'* 9'/) H'DC'-DJF (3(( '.*1'B 'D,D/ (J1B'* 'D/J/'F 'D4-J) H'DEDBH'F 'D9A,J) H'DA*'C) 'D#EJ1CJ) H'D/J/'F 'DE/H1) 'D-(DJ) Round worm #H Strongeloides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lcopar) B(D '3*./'E **1'CDH1'J+JDJF. /'! 'DEDBH'* (/'! 'D/J/'F 'D45J)) Ancylostomiasis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lgart ML. Onchocerciasis and dracunculosis. Dermatol Clin 1989; 7: 323-30. Morbidity and Mortality Weekly Report. Regional workshop on dracunculiasis in Africa. MMWR 1987; 35: 797. 1 Watts SJ. Dracunculiasis in Africa in 1986: its geographic extent, incidence and at-risk population. Am J Trop Med Hyg 1987; 37: 119-25. 2 (2/58)  Broadbent V. Children's worms. Br Med J 1975; i: 89. Pearson RD, Irons RP, Irons RP Jr. Chronic pelvic peritonitis due to the pinworm Enterobius vermicularis. J Am Med Assoc 1981; 245: 1340-1 3 Burke JA. Strongyloidiasis in childhood. Am J Dis Child 1978; 132: 1130-6. von Kuster LC, Genta RM. Cutaneous manifestations of strongyloidiasis. Arch Dermatol 1988; 124: 1826-30. 4 Katz R, Ziegler J, Blank H. The natural course of creeping eruption and treatment with thiabendazole. Arch Dermatol 1975; 91: 420-4. 5 Beaver PC, Jung RC, Cupp EW, eds. Clinical Parasitology, Philadelphia: Lea & Febiger, 1984: 340. 6 Davis A. Recent advances in Schistosomiasis. Quart J Med 1986; 58: 95-110. El-Zawahary M. Schistosomal granuloma of the skin. Br J Dermatol 1965; 77: 344-5. 7 Gonzalez E. Schistosomiasis, cercarial dermatitis and marine dermatitis. Dermatol Clin 1989; 7: 291-300. 8 Mahmoud AAF, ed. Schistosomiasis. In: Clinical Tropical Medicine and Communicable Diseases. London: Bailliere Tindall, 1987. 9 Mahmoud AAF. Praziquantel for the treatment of helminthic infections. In: Stollerman GH, ed. Advances in Internal Medicine 32. Chicago: Year Book Medical Publishers, 1987: 419-34. 10 Torres VM. Dermatological manifestations of Schistosomiasis mansoni. Arch Dermatol 1976; 112: 1539-42. 11 World Health Organization. Atlas of the global distribution of Schistosomiasis. Parasitic Diseases Programme. WHO, 1987, Geneva. 351 12 Baird JK, Wear DJ. Cercarial dermatitis. The swimmers itch. Clin Dermatol 1987; 5: 88-91. 13 (2/59)  Bernhardt MJ, Mandojana RM. Sea bathers eruption. Clin Dermatol 1987; 5: 101-2. 14 Hoeffler DF. Swimmers itch. Cutis 1977; 19: 461-7.Medical Letter. Drugs for parasitic infections. Med Let 1988; 30: 15-24. 15 Fujita WH, Barr RJ, Gottschalk HR. Cutaneous amoebiasis. Arch Dermatol 1981; 117: 309-10. 16 Martinez-Palomo A. The pathogenesis of amoebiasis. Parasitol Today 1987; 3: 111-18. 17 Knight R. The chemotherapy of amoebiasis. J Antimicrob Chemother 1980; 6: 577-93. 18 Fouts AC, Kraus SJ. Trichomonas vaginalis. Reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141: 137-52. 19 Honigberg B. Trichomonads of importance in human medicine. In: Kreier JP, ed. Parasitic Protozoa 2. New York: Academic Press, 1978: 275-86. 20 Lossick JG. Treatment of Trichomonas vaginalis infection. Rev Infect Dis 1982; (Suppl.): S801-8. 21 Foulkes JR. Human trypanosomiasis in Africa. Br Med J 1981; 283: 1172-4. 22 Greenwood BM. African trypanosomiasis. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine 2nd edn. Oxford: Oxford University Press, 1987. 23 Gallerano RH, Marr JJ, Sosa RR. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease. Am J Trop Med Hyg 1990; 43: 159-66. 24 'DA5D 'D.'E3 941 'D-3'3J) H'DEF'9) 'D31J1J) Allergy and clinincal immunology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acrophages) H'D*J *3'GE H*-16 H*+J1 'D-3'3J). H8'&A 'D,G'2 'DEF'9J AJ 'D,D/ E+D 'D#96'! 'D#.1J AJ 'D,3E GJ %E' :J1 FH9J) #H FH9J). 'D,G'2 'DEF'9J 'DD' FH9J ( Non specific immune system ) 'D"DJ) 'DEF'9J) 'DD' FH9J) GJ 'D.7 'D#HD EF /A'9 'D,3E 9F/E' J*916 DDE3*6/. H*4ED: /A'9 AJ2J'&J JBHE (G 'D,D/. EA12'* 'D,3E ( 'DE.'7 @ 'D#G/'( AJ 'DE,'1J 'D*FA3J). 'D:// 'D/ GFJ) HEA12'*G'). .DHJ): GJ *F,2 (H'37) 'D('D9'* H'D.D'J' 'DB'*D) 'D7(J9J) (NK ) . 'D,G'2 'DEF'9J 'DFH9J (Specific immune system): G0' 'DFE7 DG /H1G 9F/E' JA4D 'D,G'2'DEF'9J 'DD'FH9J EF 'D*.D5 EF 'DE3*6/(Antigen) 'DEG',E. G0' 'D,G'2 J4ED 'DE1C('* 'D.DHJ) (Cellular) H'D.DJ7) (Humoral) 'D*J *EDC 0'C1) EF'9J) FEH0,J) -J+ # FG J-16 '3*,'() EF'9J) (*C1'1 'D*916 DFA3 'DE3*6/. H8'&A 'D,G'2 'DEF'9J 'DFH9J: 'D,G'2 'DEF'9J 'DFH9JI JF*, 'D.D'J' 'DEF'9J) HGJ .D'J' 'D('&J) "B"H'D.D'J' 'D*' &J) "T" (2/61)  'D.D'J' 'D*'&J): *3'GE AJ CD EF 'D'3*,'() 'DEF'9J) 'D.DHJG H'D.DJ7). 'D.D'J' 'D('&J): *F*, E,EH9'* #6/'/ ":DH(HDJF'*" EF'9J) E.*DA):" IgE , IgG H IgM, Ig A H"IgD". 'D*A'9D 'D#D1,J B/ J92I %DI 9H'ED /'.DJ) 'DEF4# #H.'1,J) 'DEF4#. ' @ 'DE3*6/"Antigen ": GH E'/) :1J() JECFG' #F *+J1 '3*,'() EF'9J). HG0' B/ J$/J %DI: *4CJD 'D#6/'/ "Antibodies". *:J1 A9'DJ) 'D.D'J' 'DDEA'HJ) 'DE91HA) ('3E 'D'3*,'() 'DE*H'37) ('D.D'J' "Cell mediated response" 'D5A'* 'DCJE'HJ) DDE3*6/'*: B/ *CHF 'DE3*6/'* 5:J1) 'DH2F 'D,2J&J #H C(J1) 'DH2F 'D,2J&J . 1 @ 'DE3*6/'* C(J1) 'DH2F 'D,2J&J (High molecular weight antigens): **4CD EF 'D#-E'6 'D#EJFJ) H'D((*J/'* 'D*J JECFG' #F *+J1 H*-16 *CHJF 'D#6/'/. 2 @ 'DE3*6/'* 5:J1) 'DH2F 'D01J(Low molecular weight antigens) : G0G 'D#FH'9 D'*3*7J9 #F *-16 *4CJD 'D#6/'/ E'DE *1*(7 E9 (1H*JF  G0G *91A ('3E ('DFH'4() Haptens HJECF #F *+J1 'D#6/'/ 'D.DJ7) Humoral #H 'DFE7 'DE*#.1 ('DE*H'37 ('D.D'J' :Delayed cell type ) EF 'D-3'3J) 'D*J *CHF FH9J) DDFH'4(. 'DE3*6/'* 'D*J *-33 'D#4.'5 (4CD #C+1 4JH9'K DD-3'3J) 'D'3*G/'AJ) (Anaphylactic) #H 'DFE7 'DE*#.1 HG0' J91A ('3E E3*R'1, "'D1J',JF" #H EHD/ 'D'1,JG(Allergen) . 'D#6/'/ (Antibodies) : GJ ,DH(HDFJ'* EF'9J) E5DJ) **4CD '3*,'() D*-1J6 'DE3*6/. H'D#6/'/ **4CD EF B(D 'D.D'J' 'D(D'2EJ) H**#DA EF 3D'3D 9/J/) EF (HDJ ((*'J/'*. 'DH-/) 'D1&J3J) DD6/ GJ ,2J& 'D,DH(HDJF 'DEF'9J (Ig ) . JH,/ 9/) ,DH(HDJF'* EF'9J) AJ 'DEA12'* 'D.'1,J) E+D 'DBF') 'DE9HJ) H'D71B 'D*FA3J). A4D #J ,2! EF ,G'2 'DEF'9) B/ J$G( DD*-33  #H %DI 'D'D*G'( #H %DI 'D#E1'6 'D.(J+). 'D*A'9D'* 'DEF'9J) 'DE.*DA): (2/62)  *A'9D 6/ @ E3*6/ : (Antigen-antibody reaction) 3H'! C'F *A'9D'K AH1J'K J-/+ (9/ 'D*916 DE3*6/ E9JF #H EF FE7 'D*A'9D 'DE*#.1. 'D*A'9D'* 'D#1,J) 'DAH1JG: (FE7 I, II, III) HGJ *E+D '3*,'() .D7J) "Humoral"H*4'(G .D'J' *'&J)" 'H B-lymphocytes "E+'1) HC0DC 'D.D'J' 'DE5H1J)(Plasma cells) 'D*J *F*, H*F47 'D,DH(HDJF'* 'DEF'9J) 'DE.*DA). 'D*A'9D 'D#1,J 'DE*#.1: (FE7 IV ) B/ J3*:1B 'D*A'9D 'D#1,J 9/) 3'9'* #H #J'E #H -*I #3'(J9 DJ8G1 EF HB* 'D*916 DDE3*6/. G0' 'DFE7 E*H'37 ('D.D'J'(Cell medited) (H'37) 'DDEA'HJ'* EF FH9 (T-lymphoctes) 'D*'&J) 'DE*-33). *A'9D'* A17 'D-3'3J) 'DE.*DA): -3( *5FJA ",JD HCHE(3"( Gell & Coombs) GJ: 1 @ 'DFE7 'DAH1J @ 'D'3*G/'AJ '$ 'D*#BJ: "Immediate or anaphylactic reaction ". B/ JCHF 'DE3*6/ EF 'D#79E)  -('* 'D7D9  'D:('1  'D1J4  #H :J1G'. 'D#6/'/: GJ 'D,DH(HDJF'* 'DEF'9J) IgE . *A'9D 6/ @ E3*6/: (Antigen-antibody reaction) J3(( 2H'D *-(( 'D.D'J' 'D/BDJ) #H 'D(/FJ)(Degranulation of Mast cells) -J+ J$/J 0DC %DI*-11 9/) H3'&7 .'5) E+D: 'DGJ3*'EJF  3J1H*HFJF  'D(1'/JCFJF H'DEH'/ 'D(7J&) (SRS) . 'DE8'G1 'DAJ2J'&J) 'D*41J-J) 'DE16J) 'D*J *-/+ F*J,) D0DC GJ : -*H39 'D#H9J) 'D/EHJ). -2J'/) 'DFAH0J) 'DH9'&J). -*BD5 'D96D'* 'DED3'!. 'DE8'G1 'D31J1J) DDFE7 I GJ: 41J @ H0E) H9'&J) @ 5/E) +'B() @ 1(H B5(J H'D*G'( #FA #1,J. 2 @ FE7 'D#6/'/ 'D3'E) DD.D'J' ('DFE7 Cytotoxic antibody II) 'DE3*6/: AJ 'D*A'9D 'D#1,J FE7 'D+'FJ GH (Hapten) 'DF'4( 'D0J J*13( 9DI ,/1 'D.DJ) #H 9DI 'D#:4J) 'D.DHJ) 'D*J *9ED CE3*6/. (2/63)  'D#6/'/: GJ #6/'/ 3'E) DD.D'J' EF 'D#5F'A" IgA , IgG HIgM ". J-/+ 'D*A'9D 'D#1,J CF*J,) D*A'9D 'D#6/'/ 'D,'1J) E9 'D/H1) 'D/EHJ) #H 'D#6/'/ 'D.DHJ) E9 'DE3*6/'* ('D,'1J)) 'D*J *$/J %DI '1*('7 'DE*EE) E9 E9B/ 'D6/ @ E3*6/ (Complement) E$/J'K %DI 'F-D'D 'D.D'J' 'DE3*G/A). *#+J1 CD *A'9D CG0' GH EF 'DFH9 ':D'D .DHJ (Cytolysis). 'DE8'G1 'D31J1J) DD*A'9D'* 'D3'E) DD.D'J' GJ : FB5 'D5AJ-'* . AB1 /E ':D'DJ (Hemolytic anemia @ A17 'DE-(('* Agranuloctosis). H#E1'6 'DEF'9) 'D0'*J) (Auto-immune diseases) . 3 @ E9B/ 6/ @ E3*6/ (Antigen-antibody immune complex) / 'DFE7/ III *A'9D "1+3 (Arthus reaction). 'DE3*6/: AJ G0' 'DFE7 JCHF /H'! @ E5D :1J( HE3*6/'* #.1I E+D 'D9B/J'* H'D#1H'E. 'D#6/'/: AJ 'DFE7 (III ) EF 'D*A'9D'* 'D#1,J) GH "'D,DH(HDJF 'DEF'9J: "IgG" H'DE*EE)". 'D*A'9D 'D#1,J (Complement)J-/+ CF*J,) D"DJ) E9B/). 'D*(/D'* 'DAJ2JHCJE'HJ) 'D*J B/ *-/+ F*J,) DG0' 'DFH9 EF 'D*A'9D: *13( E9B/'* 'D6/ @ E3*6/(Antigen-antibody reaction) 9DI ,/1'F 'D#H9J) 'D/EHJ) 'D491J). *A9JD F8'E 'DE*EE). 'F,0'( 'DC1J'* 'D(J6 HA17 'D('D9'* (Phagocytosing cells) DDE1C( 'DEF'9J (H'37) 'DC1J'* 'D(J6. 'F-D'D 'D('D9'*. *.1J( ,/1 'D.D'J' ('D#F2JE'* 'DDJ2H2HEJ). %F *#+J1'* G0G 'D*A'9D'* GJ 'D*G'( HF.1(Necrosis) 'D'F3,G. 'DE8'G1 'D31J1J) DD*A'9D'* 'D#1,J) AJ 'DFE7 III GJ: - *A'9D'* "1+3 ( 8'G1) "1*H3 - /'! 'DE5D). - 7A- 'D#/HJ). - 'F-D'D 'D(41) 'DF.1J 'D3EJ. - 'D-E'EJ 'DE*9//) 'D#4C'D (Erythema multiforme) H'D-E'EJ 'D9B/J)( Erythema nodosum ) 'D*A'9D 'DE*#.1 'DE3*6/: ('DFE7 IV) GHJ4ED #FH'9'K E.*DA) EF 'DEH'/ 'DCJE'HJ) H:J1G'. 'D#6/'/: GJ 'DDEA'HJ'* 'D*'&J). (2/64)  'D*A'9D 'D#D1,J JF,E 9F *A'9D E3*6/ @ DEA'HJ'* F',E 9F 9H'ED .DJ7) *$/J %DI 8GH1 (DJEAHCFJ'*Lymphokines ). *#+J1'* G0G 'D*A'9D'* GJ: *H39 H9'&J @ H0E) @ '1*4'- ('DH-J/'* H'DDEA'HJ'*. 'DE8'G1 'D31J1J) GJ: #C2JE' 'D*E'3 'D# D1,J) @ #C2JE' 'D6J'! 'D#D1,J) @ 'D7AH- 'D#D1,J) H1A6 'D#96'!. 'DE8'G1 B/ *CHF EH69J) AJ 'D,D/ #H *5J( 'D,D/ H'D#96'! 'D#.1I. 'DFE7 'D9',D H'D",D DD*A'9D'* 'D*-33J) GJ EGE) ,/'K AJ "DJ) 'D#C2JE'. 'D*A'9D 'D9',D: J-/+ (3(( 2H'D *-(( 'D.D'J' 'D(/FJ)(Mast cells) : (3(( 'D*-1J6 EF 'D6/ 'DE$/J D*-11 'DH3'&7 E+D: "'DGJ3*'EJF  'DJHCH*1JF  H'D9'ED 'DEA9D DD5AJ-'*  'D(1H*J'2 " H:J1G'. HG0' 'D*A'9D B/ J$/J %DI #E1'6 ,D/J) E+D 'DE1'-D 'D('C1G EF 'D#C2JE' 'D'3*41'&J)(Atopic dermatitis)  'D41J H'DH0E) 'D91BJ). '3B5'! G0' 'DFE7 GJ: '.*('1'* 'DH.2 @ *9JJF 9J'1 "IgE "H*,1() 'DE5D (RAST ). 'D*A'9D 'D",D: 'D*E'3 'DE*C11 DE3*6/ E9JF E9 'D.D'J' 'D*'&J) 'DE*-33) 3'(B'K J$/J %DI *-1J6 H*-1J1 " 'DDEAHCJF'*" 'D*J *+J1 '*A'9D' 'D*G'(J' H*A9D 'D('D9'* 'DC(J1) D*-11 'DH3'&7. G0' 'DFE7 EF 'D*A'9D E3$HD 9F 'DFH9 'DE*#.1 EF #C2JE' 'DED'E3)  'D#C2JE' 'D6H&J) 'D#1,J) H'DE1'-D 'DE*#.1) EF 'D#C2JE' 'D'3*41'&J) (Atopic dermatitis). 'D*A'9D'* 'DEF'9J) 'DE*H'37) ('D.D'J' DG' /H1 G'E AJ 'DEB'HEG 6/ 'DA7H1  H'DAJ1H3'* H'D'F*'F'* 'D-(J(J) DD,D/ H'D*A'9D'* 'DH3J7) DD/: 'D-41'*. '.*('1'* 'D(B9) H*A'9D *4CJD 'DDEA'HJ'* B/ *AJ/ AJ *-/J/ 'D9'ED 'DE3(( DD-3'3J). 'D#C2JE' Eczema GJ *A'9D ,D/J 'D*G'(J '3*,'() D*-1J6 E3*6/ E'. CDE) "#C2JE'": GJ E57D- %:1JBJ (JHF'FJ) *9FJ "'DAH1'F #H 'D:DJ'F". (2/65)  J5A 'D7(J( (J1 (Baer) 'D#C2JE': (#FG' *A'9D -7'7J -HJ5DJ -'C **1'AB AJ 7H1G' 'D-'/ E9 -E'EJ HH0E). HAJ 7H1G' 'DE2EF E9 *3EC H*-22(Lichenification) H*B41 E9 'D'-*A'8 ((96 E8'G1G' 'D-7'7J) 'D-HJ5DJ). *4CD #FH'9 'D#C2 JE' #C+1 EF 30% EF -'D'* 'D#E1'6 'D,D/J). *5FJA 'D#C2JE': JH,/ *5FJA'* E.*DA) DD'C2JE' 'D*J B/ *.*D7 #-J'F'K , D0DC E98E 'DE$DAJF JA6DHF CDE) 'D*G'( ,D/ "Dermatitis". H1:E %F CD -'D'* 'D#C2JE' B/ *-/+ *:J1'* 'D*G'(JG ('D,D/  %D' %FG DJ3 CD 'D*G'('* 'D,D/J) *9*(1 #C2JE' %0 #F 'D*G'( 'D,D/ J9FJ 9'/) 'D'D*G'('* 'D,D/ 'D,1+HEJ). *5FJA 'D#C2JE' #-J'F'K J9*E/ 9DI 'D9H'ED 'DE+J1) H'DE3((). HJECF *5FJA 'D#C2JE' %DI /'.DJ) 'DEF4# 'D*J *F,E 9F E3(( EF 6EF 'D,3E H%DI .'1,J) 'DEF4# 'D*J *CHF F*J,) 9H'ED .'1,J). 1 @ 'D#C2JE' 'D/'.DJ) 'DEF4#: G0' 'DE57D- J9FJ -'D) #C2JE'&J) D'*F,E 9F 9H'ED (J&J) .'1,J) 'DEF4# DCHFG' **H'37 (-/+J'* *F4# /'.D 'D,3E. AJ (96 'D-'D'* 9DI CD -'D JH,/ 9H'ED E$G() /'.DJ) H.'1,J): 'D#C2JE' 'D/'.DJ) 'DEF4# *4ED: 'D*G'( 'D,D/ 'D'3*41'&J)(Atopic dermatitis) . 'D*G'( 'D,D/ 'D2GEJ (Seborrheic dermatitis). 'D#C2JE' 'DB15J) (Discoid eczema) . #C2JE' 931 'D*91B 'DFA'6J) (Dyshydrotic eczema) . #C2JE' '3*BD'(J) #H 'DE1'AB) D#E1'6 ,G'2J) (Metabolic eczema or eczema associated wit systemic diseases) ,D'/'* 'D#.E5 'D4('(J) (Juvenile plantar dermatoses). 'F/A'9 /H'&J #C2JE'&J (Eczema due to drug reactions). 'D*G'( ,D/ 1CH/J(Stasis dermatitis) . 2 @ 'D#C2JE' .'1,J) 'DEF4#: 'D*G'( ,D/ *.1J4J (/&J (Primary irritant dermatitis) #C2JE' 'D*E'3 'D#1,J)(Allergic contact dermatitis) 'D*G'( 'D,D/ 'D6J'&J 'D#1,J (Photoallergic reaction) (2/66)  'D'F/A'9 'D6J'&J E*9// 'D#4C'D (Polymorphous light eruption) 'D*G'( ,D/ 'F*'FJ (Infective dermatitis) 3 @ 'D#4C'D :J1 'DE5FA) EF 'D'C2JE': 'D*G'( 'D,D/ 'D95(J:" 'D-2'2 'DE2EF 'D(3J7" (Neurodermatitis, Lichen simplex chronicus) 'D#C'D 'D9BJ/J "Nodular Prurigo." *5FJA 'D#C2JE' -3( 'D3J1 H'D5H1) 'D31J1J): 'D#C2JE' 'D-'/). 'D#C2JE' *-* 'D-'/). 'D#C2JE' 'DE2EF). 'DE1',9 Longley J, Braverman IM, Edelson RL. Immunology and the Skin: Ann NY Acad Sci 1988 1 Bos JD, Zonneveld I, Das PK et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88: 569-73 2 Bruynzeel-Koomen C. IgE on Langerhans cells: new insights into the pathogenesis of atopic dermatitis. Dermatologica 1986; 172: 181-3 3 Kim KM, Mayumi M, Iwai Y. IgE receptor-bearing lymphocytes in allergic and non-allergic children. Pediatr Res 1988; 24: 254-7 4 Streilein JW. Skin-associated lymphoid tissues (SALT): Origins and functions. J Invest Dermatol 1983; 80: 12s-15s 5 Zola H. The surface antigens of human B-lymphocytes. Immunology Today 1987; 8: 308-15 6 Chernielewski J, Vaigot P, Prunieras M. Epidermal Langerhans cells - a cycling cell population. J Invest Dermatol 1985; 84: 424-6 7 Wolff K, Stingl G. The Langerhans cell. J Invest Dermatol 1983; 80: 17s-21s 8 Weaver CT, Unanue ET. The costimulatory function of antigen-presenting cells. Immunology Today 1990; 11: 49-55 9 Quinti I, Brozek C, Wood N et al. Circulating IgG auto-antibodies to IgE in atopic syndromes. J Allergy Clin Immunol 1986; 77: 586-94 10 (2/67)  Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980 11 Sampson HA. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1983; 71: 473-80 12 Rudzki E, Grzywa A. Immediate reactions to Balsam of Peru, cassia oil and ethyl vanillin. Contact Derm 1976; 2: 360-1 13 Cronin E. Studies in contact dermatitis. 18. Dyes in clothing. Trans St John's Hosp Derm Soc 1960; 54: 156-64 14 Reynolds CW, Ortaldo JR. Natural killer activity: the definition of a function rather than a cell type.Immunology Today 1987; 8: 172-4 15 Maibach HI, Epstein WL. Plant dermatitis: fact and fancy. Postgrad Med 1964; 35: 571-4 16 Mitchell JC, Dupuis G, Geissman TA. Allergic contact dermatitis from sesquiterpenoids of plants. Br J Dermatol 1972; 87: 235-40 17 Mitchell JC, Geissmann TA, Dupuis G et al. Allergic contact dermatitis caused by Artemisia and Chrysanthemum species. J Invest Dermatol 1971; 56: 98-101 18 Mitchell JC, Rook AJ. Diagnosis of contact dermatitis from plants. Int J Dermatol 1977; 16: 257-66 19 Rothenborg HW, Menne T, St3/4lin K-E. Temperature dependent primary irritant dermatitis from lemon perfume. Contact Derm 1977; 3: 37-48 20 Powell SM, Barrett DK. An outbreak of contact dermatitis from Rhus verniciflua (Toxicondendron vernifluvum). Contact Derm 1986; 14: 288-9 21 Dahlquist I, Fregert S. Formaldehyde releasers. Contact Derm 1978; 4: 173 22 Menne T, Hjorth N. Routine patch testing with paraben esters. Contact Derm 1988; 19: 189-91 23 (2/68)  'DA5D 'D3'/3 941 'D*G'( 'D,D/ 'D'3*41'&J Atopic dermatitis GH 4CD E2EF E*C11 EF 'D#C2JE' 0H *#G( H1'+J  J5J( 'D169 HB/ J3*E1 DD7AHD) #H D3F 'D(DH:. 'D4CD 1BE 158: #C2JE' '3*41'&J) (3 #.H'* H#.HJF) 'D-'D) 'D'3*41'&J): GJ '3*9/'/ H1'+J D*CHJF CEJ) C(J1) EF 'D#6/'/ EF FH9 Ig E. 'D*A'9D B/ J*8'G1 (H'-/ #H #C+1 EF 'D*A'9D'* 'DEF'9J) E+D 'D#C2JE' @ 'D1(H @ -EI 'D9DA @ H'D*G'( 'DED*-E). AJ 9'E 1925 #/.D Coca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hite dermograhism) HGJ '(J6'6 'D,D/ AJ EHB9 61() 9F/ 'DE1J6 'DE5'( ('D'C2JE' 'D'3*41'&J). 'D'3*,'() 'D69JA) DD3J1H*HFJF -BF'K: -BF 'D3J1H*HFJF 9F/ 'D#4.'5 'D7(J9JF 3J$/J D-E'EJ(Erythema) (/HF '1*C'3 41HJ(Wheal raction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nfantile atopic dermatitis) 2@ 'D*G'( 'D,D/ 'D'3*41'&J 'D7ADJ (EF 4 @ 10 3FH'* (Childhood atopic dermatitis). 3@ 'D*G'( 'D,D/ 'D'3*41'&J 9F/ 'D('D:JF(Adult atopic dermatitis). 'D*G'( 'D,D/ 'D'3*41'&J 9F/ 'D169 (#C2JE' 'D16J9) Infantile atopic dermatitis #C2JE' 'D16J9 *4ED 'DFH9 'D#C+1 'F*4'1'K EF 'D#FH'9 'D#.1I EF -3'3J) 'D,D/. 'D4CD 1BE 159 ': -3'3J) 'D16J9 (FH9 F'/1 EF 'D*-33) Fig. 159a. Infantile eczema(Severe & uncommon type) 'D4CD 1BE 160: #C2JE' 16J9 (-'/)) 'D4CD 1BE 159( : FH9 F'/1 EF -3'3J) 'D16J9 'D4CD 1BE 159,: -3'3J) 'D16J9 (9/ 'DE9'D,) Fig. 160. After treatment Infantile eczema (Same patient above) after one week treatment with nonsteroid topical ointment(Flogocid),Antihistamine drops(Fenistil) and Erythromycin suspension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andruff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poxy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ntecubital area) @ .DA EF7B) 'D1C() (Popliteal area). 'D(B9 'D-E'EJ) *8G1 E9 -HJ5D'* 5:J1) H*5(- (9/ 0DC "A'*' E*B41) HF'2) H17(). HB/ *:2H 'DEF7BG 'D,1'+JE 'DE.*DAG,HJ*8'G1 'D'F*'F 'D+'FHJ ((+1'* HB4H1 HGJ 4'&9) -J+ J$G( D0DC 37- 'D,D/ 'DE*3-, H'D-C) 'D4/J/). J5(- 'D7AD 'DE5'( BDB'K  HJ(CJ HJA1C ,D/G /'&E'K H(4/). 'D-DB) 'DEA1:G EF "-C) @ *3-, @ -C)" B/ *$/J %DI '.*D'7'* #C+1 (9/ 'D4A'! E+D *F/( 'D,D/. G0G 'D"A) 'D,D/J) B/ *E*/ D*5J( EF7B) 7'BJ) 'DEG/ H'DA1H) E*8'G1) ((B9 -HJ5DJG F'2G H E*B41). 'DE8'G1 'D,G'2J): -E'EJ 'D,D/(Erythroderma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hildhood atopic dermatitis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hronic childhood atopic dermatitis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pH 'D,D/ -'E6J H2 BHJ J*1'H- E'(JF 4.2 @ 5.6 (JFE' 'D pH = 7*CHF E*9'/D) (D'-'E6 HD'BDHJ) 'DB1'!) AHB 'D@ 7 J4J1 %DI #F 'DE'/) BDHJ) H*-* 'D@ 7 -'E6). 'D@ pH *.*DA EF ,2! %DI ,2! ".1 -3( 'D9E1 H'D,F3. pH 'D0CH1 #C+1 -EH6G EF 'D%F'+ HG0' JD9( /H1'K G'E'K AJ %JB'A FEH 'D,1'+JE 9DI 37- 'D,D/. 'D5H'(JF H'D4'E(HF'* 'D#C+1 -EH6) #H BDHJ) .'5) *DC 'D*J *-HJ 9DI 97H1 HEDHF'* B/ *BD( pH 'D,D/ H*3(( ,A'A #C+1 J$G( DD*#C2E #H %DI 'D'D*G'('* . (2/75)  ,D/ 'D169 H'D#7A'D *-*', 9'/) AB7 %DI *F8JA D7JA (/HF 5'(HF 'D*J GJ EF8A'* 5F'9J) #H '3*9E'D E17('* 7(J9J) .AJA). 'DE71J'* GJ :DJ31J/'* +D'+J) .AJA) #H C-HD 7HJD 'D3D3D) (Cetyl - Stearyl) #H (HDJ %J+JDJF ,DJCHD #H :D'JCH2 #EJFH ,D'JC'F. 'D7AD 'D3DJE J,( #F J3*-E E1) CD JHEJF. A*1) 'D-E'E J,( #F D' **,'H2 'D@ 5 /B'&B DD16J9 H'D@ 10 /B'&B DD7AD. 'DF'-J) EF7B) 'D-A'&8 JECF *F8JAG' (D7A 9F/ 'D-',) (5H'(JF .AJA) H*,AJA 'DF'-J) #A6D (#BE4) B7FJ) F'9E) #H H1B EF'/JD F'9E .'D EF 'D97H1. H'D/G'F (9/G' (2J* 'DF('*'* E+D 2J* 'D2J*HF #H A'2DJF. JECF %6'A*G (1EF:F'* 'D(H*'3JHE 1/1000 CE7G1 DD,D/ 'DED*G( #H .D'5) 'D49J1 DD,D/ 'D-3'3 ,/'K. *F8JA 'DEHDH/ J,( #F JCHF (D7A H:J1 EG14. HEF 'DEGE 9/E '3*9E'D 'D4'E(HF'* 'DBHJ) H'DE.14) DCF 'DA1H) JECF *F8JAG' (4'E(H #7A'D .AJA ,/'K. 7'BJ) 'DEG/ 9F/ 'DH'D/'F JECF :3DG' (3GHD) HDCF %0' C'F* 'D7(B) 3EJC) AJECF %2'D*G' ('3*./'E 2J* F('*J /'AI! E+D 2J* 2J*HF /'AJ! JH69 9DI 'DEF7B) +E *2'D (D7A (*E4J7 'DEF7B) (D7A (E47 91J6 'D#3F'F. 'D#7A'D JEDCHF 4-HE H'BJ) #BD EF 'D('D:JF D0DC J,( '3*9E'D 'D5H'(JF 'DC1JEJ) .'5) 'D-'HJ) 9DI E71J'* E9 'DE3*-61'* 'D:J1 5'(HFJ). ('.*5'1: 'D5H'(JF 'DE3*9ED) 9F/ 'D169 H'D#7A'D J,( #F *CHF 0'* 5A'* GJ: J,( #F JCHF 'D5'(HF p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olloid baths) : GJ -E'E'* F'9E) *3*./E DD,D/ 'D-'C HJECF #F *E*5 'DEH'/ 'D,'D(G DD17H() #H 'DHDH9) ('D/3E. HGJ 9('1) 9F E3'-JB E+D /BJB 'D4HA'F" Oatmeal" 'DEE2H, ('DE'! HJ,( #F JCHF 0DC EE2H,'K ,J/'K H.'DJ'K EF 'D(DH1'* -*I D'J3(( 0DC *3-,'K 9DI ,D/ 'D7AD. FH9 'D5'(HF H'D4'E(H 'DE3*./E DD7AD H'D16J9 J,( #F JCHF .AJA'K H(5A'* .'5)(Tensid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olcom) JECF #F *7(B DD"A'* 'D,'A). %0' C'F* 'D-3'3J) 'F*'FJ) A%F E4'1C) 'D3*1H&J/'* E9 E6'/ -JHJ E+D ,F**'EJ3JF #H AH3J/'* 'D5H/JHE (Fucicort) #H AH3JCH1* JF5- (G D9/) #J'E. 'DE3*-61'* 'DEH69J) B/ *AB/ A9'DJ*G' 9F/E' *3*./E DA*1) 7HJD) #H 9F/E' *7(B (4CD E*C11 EF B(D 'DE1J6. G0' B/ JF,E 9F 'DEB'HE) 'DEC*3() 6/ 'D3H':'* #H (3(( 'D9'ED 'DFA3J -J+ #F 'DE1J6 H9'&D*G JAB/HF 'D+B) ('DE3*-61 (3(( 9/E %EC'FJ) 4A'! -'D*GE (4CD /1'E'*JCJ HE$C/. 'DE3*-61'* 'DEH69J) 'D-'HJ) 9DI E6'/'* GJ3*'EJF  #DFJHEJ3JF  #H 3DA' #H (F3DJF J,( 9/E '3*./'EG' (3(( '-*E'D 'F *3(( 'D-3'3J) 'DEH69J) .'5) 9F/E' *3*9ED DA*1) 7HJD). 'D#/HJ) 'D,G'2J): 'DE6'/'* 'D-JHJ): JECF %97'$G' %0' C'F GF'C 'F*'F ,1+HEJ +'FHJ 'D0J J*1'AB 9'/) E9 "A'* 'C2JE'&J) E*3-,): 'D'1J+1H3JF Zithromex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g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ataract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yrtec) : G0' 'D/H'! 0H BJE) AJ 'D-'D'* 'DE*1'AB) E9 *H*1 95(J DCFG J,( #F J97I (-01 -J+ #FG JHD/ F9'3 BDJD .'5) 9F/ *,'H2 'D,19) 'DEF5H5 (G'. (2/82)  #-J'F'K F-F F-*', DE6'9A) 'D,19) AJ E6'/'* 'DGJ3*'EJF #H E4'1C*G' E9 E6'/'* GJ3*'EJF #.1I EF E,EH9) #.1I. 'DE9'D,) 'DEH69J): 'D'C2JE' AJ 'D('D:JF *CHF 9'/) EF 'DFH9 'D,'A  D0DC 'DE1'GE 'D-'HJ) 9DI 3*J1H&J/ .AJA AJ #3'3 E71J B/ *CHF C'AJ) DD3J71) 9DI 'D"A'* 'DEH69J) 'D5:J1). E1'GE 'D3*J1HJ/'* 'DE4'1C) E9 -E6 'D5A5'A(Locosalene, Diprosalic) *3*./E DD"A'* 'D,D/JG 'D,'A). 'D-'D'* 'DE.*D7) ('D*G'( ,1+HEJ +'FHJ **7D( E6'/'* -JHJ) AEHJ'K E+D 'D'1J+1H3JF HC1JE 3*J1HJ/ E4'1C) E9 E6'/ -JHJ E+D 'D,F*'E3JF E9 'D(*J'EJ+'2HF A'DJ1'* #H :J1G' EF 'D3*J1HJ/'* 'DEADH1) (Clestoderm v, Decoderm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epot Medrol, Kenacort, 40mg) *97I 9EJB' AJ 'D96D #3(H9J'K DE/) 2 @ 4 #3'(J9 GH #C+1 '3*9E'D'K. B/ JA6D %97'! 'D-BF AJ (96 'D-'D'* (/D'K EF 'D,19'* ('DAE %0 D'J*1C 0DC #J 4C #H F3J'F 'D,19'* 'DAEHJ) 'DE,/HD) EF 'D#/HJ) 'D3*J1HJ/J). 'DE1',9 (2/83)  Gwynn CM, Morrison Smith J, Leon GL. Role of IgG4 subclass in childhood allergy. Lancet 1978; i: 910-11. 1 Svensson A, Edman B, M"ller H. A diagnostic tool for atopic dermatitis based on clinical criteria. Acta Derm Venereol 1985; 92 (Suppl. 114): 33-40. Br J Dermatol 1971; 84: 605-7. 2 Braathen LR. T-cell subsets in patients with mild and severe atopic dermatitis. Acta Derm Venereol 1985; 114 (Suppl.): 133-6. 3 Jensen JR. Reduction of active natural killer cells in patients with atopic dermatitis estimated at the single cell level. Acta Derm Venereol 1985; 114 (Suppl.): 105-8. 4 Rajka G. Essential Aspects of Atopic Dermatitis. Berlin: SpringerVerlag, 1989. 5 Svensson A, Edman B, M"ller H. A diagnostic tool for atopic dermatitis based on clinical criteria. Acta Derm Venereol 1985; 92 (Suppl. 114): 33-40. 6 Rajka G. Essential Aspects of Atopic Dermatitis. Berlin: SpringerVerlag, 1989. 7 Walker RB, Warin RP. The incidence of eczema in early childhood. Br J Dermatol 1956; 68: 1182. 8 Blumenthal MN, Yunis E, Mendell N et al. Preventive allergy: genetics of IgE mediated-diseases. J Allergy Clin Immunol 1986; 78: 962-67. 9 Rajka G. Essential Aspects of Atopic Dermatitis. Berlin: SpringerVerlag, 1989. 10 Taylor B, Wadsworth J, Wadsworth M et al. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984; ii: 1255-7. 11 Wuthrich B, Baumann E, Fries RA et al. Total and specific IgE (RAST) in atopic twins. Clin Allergy 1981; 11: 147-54. 12 Cookson WOCM, Hopkin JM. Dominant inheritance of atopic immunoglobulin-E responsiveness. Lancet 1988; i: 86-7. 13 (2/84)  Ring J, Dorsch W. Altered releasability of vasoactive mediator secreting cells in atopic eczema. Acta Derm Venereol 1985; 114 (Suppl.): 9-23. 14 'DA5D 'D3'(9 941 -3'3J) 'D79'E Food Allergy JH,/ 9/) #FE'7 EF 'D79'E 'D*J *3(( #C2JE' #H *9ED C9'ED E+J1 DD"A) 'D,D/J). #FH'9 -3'3J) 'D79'E GJ EF 'DFE7 "I" 'D0J JF,E 9F *-11 'DGJ3*'EJF EF 'D.D'J' 'D(/FJ) (Mast cells)  HJ$/J 0DC %DI 'D*G'( H2J'/) FAH0J) 'D#H9J) 'D/EHJ). ,2&J'* 'D79'E B/ *E1 9(1 ,/'1 'D#E9'! %DI 'D/H1) 'D/EHJ)  'DE1J6 'DE5'( (-3'3J) 'D79'E B/ JCHF D/JG #6/'/" IgE E9 IgG H Ig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gA " 'D9'(1 B/ JCHF #J6'K 9'ED E$+1. #J .DD AJ *1CJ2 "Ig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g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artrazine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ereals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it. A , D, E , K.. HJ,( #F *CHF G0G 'DAJ*'EJF'* .'DJ) EF 'DF4'! #+F'! *-6J1G'. 'D'-*J','* 'DJHEJ) EF G0G 'DAJ*'EJF'*: Pyridoxine 100 mg Nicotinamide 600 mg Ascorbic acid 300 mg Riboflavin 15 mg Thiamin hydrochloride 150 mg (2/92)  'A6D E5/1 DAJ*'EJF "/" GH #49) 'D4E3 D0' *91J6 ,D/ 'D7AD JHEJ'K D#49) 'D4E3 AJ 'D5('- DG A'&/G G'E). 71JB) 'D*79JE (E5D .'5 (F'! 9DI F*J,) '.*('1'* 'D-3'3JG B/ JCHF 0' A'&/) DDE5'(JF ('D-3'3J) 'D'3*41'&J) @ 'D1(H H-EI 'DB4. 'DE1',9 Andersson, JB. And Lessof, MH. : Diagnosis and treatment of food allergies. Proceedings of the nutrition society, 42, 257 (1983). 1 Atkins FM, Steinberg SS, Metcalfe DD. Evaluation of immediate adverse reactions to foods in adult patients II. A detailed analysis of reaction patterns during oral food challenge. J Allergy Clin Immunol 1985; 75: 356-63. 2 Bock SA, Lee W-Y, Remigro LK. Studies of hypersensitivity reactions to foods in infants and children. J Allergy Clin Immunol 1978; 62: 327-34. 3 Sampson HA. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Immunol 1988; 81: 635-45. 4 Barnetson R StC, Merrett TC. Food allergy and atopic eczema. Proc Nutr Soc 1983; 42: 247-56. 5 Jackson PG, Lessof MH, Baker RWR. Intestinal permeability in patients with eczema and food allergy. Lancet 1981; i: 1285-6. 6 Hausen BM, Hjorth N. Skin reaction to topical food exposure. Dermatol Clin 1984; 2: 567-78, 7 Sampson HA, Joli PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984; 311: 372-6. 8 Eagle, R. :Eating and allergy. Futura, London. 110 (1979) 9 Barnetson R StC, Merrett TC. Food allergy and atopic eczema. Proc Nutr Soc 1983; 42: 247-56. 10 (2/93)  Carini C. IgE immune complexes in food allergy; significance, pathogenicity and clinical consideration. Clin Allergy 1987; 17: 485-97. 11 Barnetson R StC, Merrett TC. Food allergy and atopic eczema. Proc Nutr Soc 1983; 42: 247-56. Atopic Dermatitis 12 Jackson PG, Lessof MH, Baker RWR. Intestinal permeability in patients with eczema and food allergy. Lancet 1981; i:1285-6. 13 Sampson HA. The role of food allergy and mediator release in atopic dermatitis. J Allergy Clin Dermatol 1989; 81: 635-45. 14 Barnetson R StC, Merrett TC. Food allergy and atopic eczema. Proc Nutr Soc 1983; 42: 247-56. 15 Carini C. IgE immune complexes in food allergy; significance, pathogenicity and clinical consideration. Clin Allergy 1987; 17: 485-97. 16 Gwynn CM, Morrison Smith J, Leon GL. Role of IgG4 subclass in childhood allergy. Lancet 1978; i: 910- 17 Satyawan I, Oranje AP, van Joost Th. Perioral dermatitis in a child due to rosin in chewing gum. Contact Derm 1990; 22:182-3. 18 Sampson HA. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1983; 71: 473-80. 19 Sampson HA, Joli PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984; 311: 372-6. 20 'DA5D 'D+'EF 941 'D*G'('* 'D,D/ 'D*.14J) 'D#HDJ) Primary irritant dermatitis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atch test) #-J'F'K JCHF EAJ/ ,/'K AJ H69 H*-/J/ 'D9'ED 'DE*GE. HEF 'DEGE #F FD'-8 #F '.*('1 'D(B9) J,( #F D'J,1J AJ 'D*G'( 'D,D/ 'D4/J/ H'DH'39 -*I **E 'D3J71) 9DI 'D"A'* .'5) 9F/ 'DE16J 'DE5'(JF (-3'3J) 4/J/)  %,1'! 'D(B9) J,( 'D*#C/ EF #F 'DE1J6 D'J*F'HD 'D3*J1H&J/'* 'DB41J) #H E6'/'* 'DGJ3*'EJF .'5) 7HJD) 'D#E/ EFG'. -J+ #F G0G 'D#/HJ) B/ *$/J D*A3J1 :J1 /BJB DD%.*('1. 'DEH'/ 'DE.*(1G 'DBHJ) AJ 'D(B9) J,( #F *.AA DCJ D'*3(( -3'3J) E('41) #H *-1J6 DD"A'* 'D#HDJ). -3'3JG 'HDJG *.1J4JG EF 'DE9'/F ( Fig. 173a.Primary irritant dermatitis (Metal) -3'3JG *.1J4JG EF 'D97H1 ( Fig. 173b.Primary irritant dermatitis (Perfumes) -3'3JG 'HDJG *.1J4JG EF 'D,H'1( ( Fig.173d. Primary irritant dermatitis(Stockings) -3'3JG *.1J4JG -D/G EF 'D,H'1( Fig. 173f.Acute irritant dermatitis 'DE1',9 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980 1 (2/97)  Holst R, M"ller H. One hundred twin pairs patch tested with primary irritants. Br J Dermatol 1975; 93: 145-9 2 Jackson EM, Goldner R, eds. Irritant Contact Dermatitis. New York: Marcel Dekker, 1990 3 Kligman AM, Wooding WM. A method for the measurement and evaluation of irritants on human skin. J Invest Dermatol 1967; 49: 78-94 4 Fregert S. Manual of Contact Dermatitis, 2nd edn. Copenhagen: Munksgaard, 1981 5 Symposium on Skin Cleansing. Trans St John's Hosp Dermatol Soc 1965; 51: 133-256 6 Van der Valk PGM, Crijns MC, Nater JP et al. Skin irritancy of commercially available soap and detergent bars as measured by water vapour loss. Dermatosen 1984; 32: 87-90 7 Wood DCF, Bettley FR. The effect of various detergents on human epidermis. Br J Dermatol 1971; 84: 320-5 8 Zesch A. Adverse reactions of externally applied drugs and inert substances. Dermatosen 1988; 36: 128-33 9 De Groot AC. Patch Testing. Test concentrations and vehicles for 2800 allergens. Amsterdam: Elsevier, 1986 10 Fisher AA. Contact Dermatitis, 3rd edn. Philadelphia: Lea and Febiger, 1986 11 Hurkmans JFGM, Bodde HE, van Driel LMJ et al. Skin irritation caused by transdermal drug delivery systems during long-term (5 days) application. Br J Dermatol 1985; 112: 461-7 12 'DA5D 'D*'39 941 'C2JE' 'D*E'3 9F/ 'D#7A'D -/J+J 'DHD'/) Neonatal Contact Dermatitis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ufexamac, Flogocid or Parfenac-Droxaryl " 9'/) C'AJ) DD3J71) 9DI 'D-'D'* 'D.AJA). 'D-'D'* 'D4/J/) B/ **7D( GJ/1HCH1*J2HF .AJA EH69J'K (Elocom cream) . (2/99)  E6'/'* 'DGJ3*'EJF B/ *3*9ED DEF9 'D-C) (Fenistil drops or syrup). /'! 'D+FJ'* 9F/ 'DH69 @ /'! 'D+FJ'* 'D7AJDJ Infantile Intertrigo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eborrehic Dermatitis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gE AJ 'DE5D B/ JAJ/ AJ 'D*4.J5 'D*A1JBJ. 5 @ /H'! 'DFH3,'* ('D.D'J' D'F:1G'3F (Langerhans cell hisliocytosis) B/ J8G1 ('F/A'9 0H E8'G1 4'&9) E9 'D*G'( 'D,D/ 'D2GEJ 'D7ADJ .'5) *H29G 9DI 'DA1H)  'D.'51*JF H'D'(7JF. 'D'F/A'9 AJ /'! 'DFH3,'* (.D'J' D'F:1G'3F J,*E9 (4CD 9F'BJ/ EF D7'.'* 4A'A) (DHF E*HG, E9 FE4'* AJ (96 'D-'D'*. (96 'DE8'G1 'D#.1I JECF *-/J/G' E+D "A'* 'DAE H'DF'-J) 'D41,J) 'D*F'3DJ) HC*D 71J) AJ 'DA1H) #H 6.'E) C(/J) 7-'DJ). .29) 'D,D/ B/ *$C/ *4.J5 /'! 'DFH3,'* (.D'J' D'F:1G'F3. 6 @ '671'('* 9H2 'DEF'9J) 'D#HDJ) (Primary immuno-defficiency disordrs) B/ J*8'G1 ('F/A'9 'C2JE'&J 0H EJHD F-H 'D37H- 'D9'7A) 'DB1J(). 'D"A'* 'D,D/J) (4CD .'5 GJ #H1'E -(J(J) E2EF). B/ *H,/ (FA3 'D7AH- AJ '671'('* 9H2 'DEF'9) 'D+'FHJ) E+D 'F*'F 'D%J/2 'DHD'/J. 71B 'DE9'D,): 'D-'D'* 'D.AJA): (2/102)  *,AJA 'DF'-J) 'DE:(FJ) H0DC (*7(JB E3-HB E6'/ ,1'+JE E9*/D EF'3( E+D "Zeasorb "(H/1) 'D*'DC J,( *,F(G #H '3*9E'D 'D(H/1) 'DE3-HBG ,J/'K H.'DJ) EF 'D(DH1'* 'D*J B/ *3-, 'D,D/ HJ-*ED #F *$/J %DI *A'BE 'D'F/A'9. 9'/) '3*./E E3*-61 E6'/ D'D*G'( .'DJ EF 'D3*J1HJ/ E+D "Pufexamac ,Droxaryl" DH-/) #H E4'1C) E9 E6'/ ,1+HEJ HE6'/ A71J E+D "Parfinac, Flogocid" C1JE'* AJ -'D'* 'D'.*D'7'* 'DA71J) H'D,1+HEJ) DDEF7B) 'DE5'(). G0G 'DE1C('* 9'/) A9'D) HGJ "EF) D#FG' .'DJ) EF 'D3*J1HJ/'* 'DB41J). AJ 'D-'D'* 'D#C+1 4/) J3*7( ('3*./'E 'D3*J1HJ/'* 'DB41J) 'DE9*/D) EH69J'K E4'1C) E9 E6'* DDE(J6'* #H E6'/'* 'D,1'+JE "Decoderm compound cream " C1JE DE/) -H'DJ #3(H9 -3( 4/) 'D-'D) E9 '3*9E'D E71J'* 2J*J)( Baby Vaseline, Moisturel cream, Alpha keri , (baby oil". 9F/E' *CHF 'D"A) E*3-,)  17() HF'2G  A%F 'DE9'D,) (CE'/'* 17() -'HJ) 9DI E-'DJD 69JA) E+D (1EF:F'* 'D(H*'3JHE 1/9000 #H 'DEFJHE '3*J'* B/ JCHF EAJ/'K ,/'K. (9/ '3*9E'D 'DCE'/'* JH69 'DC1JE 'DEF'3(. J,( 'D'F*('G (-01 D%5D'- 'D9H'ED 'DE$G() E+D 'D*GHJ) DDEF'7B 'DE:(FJ) H'D(/'F) ('D4'4 E+D 4'4 A'2JDJFJ #H 'D3HA1'*HD JECF #F J7(B 9DI 'DEF'7B 'DE:(FJ) DEF9 'D*E'3 'DE('41 E9 'D-A'&8. %F 0DC DG /H1 G'E ,/'K 9F/ 'D169 DEF9 'D*.1J4. 'D4'4 JECF '3*./'EG (9/ *7(JB 'DE3*-61'* 'DEH69J) 9DI 'DEF'7B 'DE:(FJ). 'D*G'( 'D,D/ E'-HD 'D41, ('D9,'FJ) 9F/ 'DHDJ/ 'DE3(('*: 'D*G'( ,D/ 'D9,'F #C+1 'F*4'1'K (JF 'D169 'D0JF J*:0HF ('D2,',) JF,E 9F 2J'/) 'D@" p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ufexamac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ratt AG. Perianal dermatitis of the newborn. Am J Dis Child 1951; 82: 429-32 1 Pratt AG, Reed WT. Influence of type of feeding on pH of stool, pH of skin and the incidence of perianal dermatitis in the newborn infant. J Pediatr 1955; 46: 539-43 2 Tanino J, Steiner M, Benjamin B. The relationship of perianal dermatitis to fecal pH. J Pediatr 1959; 54: 793-800 3 Boisits EK, McCormack JJ. In: Maibach H, Boisits EK, eds. Neonatal Skin. New York: Marcel Dekker, 1982: 191-204 4 Brookes DB, Hubbert RM, Sarkany I. Skin flora of infants with napkin rash. Br J Dermatol 1971; 85: 250-3 5 Brown BW. Fatal phenol poisoning from improperly laundered diapers. Am J Public Health 1970; 60: 901-2 6 Caplan RM. The irritant role of feces in the genesis of perianal itch. Gastroenterol 1966; 50: 19-23 7 Gall LS. Normal fecal flora of man. Am J Clin Nutr 1970; 23: 1457-65. Honig PJ, Gribetz B, Leyden JL et al. Amoxicillin and diaper dermatitis. J Am Acad Dermatol 1988; 19: 275-9 8 John Radcliffe Hospital Cryptorchidism Study Group. Effect of corticosteroid creams on descent of testes in infants. Br Med J 1990; 301: 214-15 9 Jordan WE, Blaney TL. In: Maibach H, Boisits EK, eds. Neonatal Skin. New York: Marcel Dekker, 1982: 205-221 10 (2/105)  Pratt AG, Reed WT. Influence of type of feeding on pH of stool, pH of skin and the incidence of perianal dermatitis in the newborn infant. J Pediatr 1955; 46: 539-43 11 Zimmerer RE, Lawson KD, Calvert CJ. The effects of wearing diapers on skin. Pediatr Dermatol 1986; 3: 95-101 12 Bonifazi E, Garofalo L, Lospalluti M et al. Granuloma gluteale infantum with atrophic scars: clinical and histological observations in eleven cases. Clin Exp Dermatol 1981; 6: 23-9 13 'DA5D 'D941HF 'D*G'( ,D/ EF7B) 'D-A'&8 Diaper Dermatitis (Napkin dematitis) GH *#C2E AJ 'DFH'-J 'DE:7') ('D-A'&8 F*J,) D9H'ED C+J1) #GEG': 'D*:7J) 'DE3*E1)  'D17H() H'D*97JF AJ EF7B) 'D-A'&8 B/ *3(( -'D) :J1 AJ2JHDH,J) -J+ %F 'D,D/ D' JECF *-ED 0DC. *.E1 'DEA12'* H'F7D'B 'D'EHFJ' B/ JCHF D*DC 'D9H'ED #+1 G'E. CE' %F 'D#7A'D 0H 'D*:0J) 'D,J/G H'DH2F 'D2'&/ EF 'D9H'ED 'DEGJ&) HGE #C+1 *916'K DD%5'() ('D*G'( 'D,D/ (EF7B) 'D-A'&8. 'DE3(('*: 1:E #F *DC 'D9H'ED 'DAJ2JHDH,J) H'DE-16) *D9( /H1'K EGE'K AJ 'DE3(('*  %D' %F 'DE$+1'* 'D*J JECF #F *G& 'DI -/H+ 'D"A) 'D,D/J) AJ 'D16J9 DJ3 ('D61H1) #F *CHF GJ FA3G' 9F/ 'D".1. 'D9H'ED 'DE$G(): 1 @ *97JF 'DF'-J) 'DE:(FJ): G0' J$/J 'DI *:JJ1 'D-'D) 'DAJ2JHDH,J) 'DE+'DJ) DG0G 'DEF7B). 2 @ *:7J) 'DF'-J) 'DE:(FJ): 'D*:7JG 'DE3*E1) DD,D/ JECF (-/ 0'*G' #F *3(( -E'EJ F',E) 9F A17 'D*91B H*1'CE 'DA6D'* 9DI 'DF'-J) 'DE:(FJ). 3 @ 'DE'!: GH 9'ED E.14 EGE .'5) 9F/E' JCHF E-*H'G EF 'D#ED'- #H 'DCDH1JF #9DI EF 'DE9/D CE' %F '3*./'E 'DE'! 'DEDH+ DG /H1 G'E C0DC. (2/106)  'D*17J( H'D'-*C'C B/ JCHF' E3$HDJF 9F (96 -'D'* 'D*G'( 'D,D/ 'D-A'8J, -J+ %F G0G 'D9H'ED *,9D 'D,D/ #C+1 B'(DJ) DDE.14'* CE' #F 'D*E'3 'DE3*E1 E9 'DE'! DH-/G B/ JA'BE 'D*G'( 'D,D/  -J+ J2J/ 0DC 'DFAH0J) 9(1 'D(41) H'D'-*C'C H('D*'DJ B/ JGJ! D-/H+ 'D'D*G'('* 'D,D/J) ('DEF7B). 4 @ 'D(HD: /H1 'D(HD AJ 'D*#G( DD"A'* 'D,D/J) B/ JCHF F',E'K 9F" pH "'D2'&/) #H E-*HJ 'D#EHFJ' 'D9'DJ. 'D(HD'*(Urease) *F*, 9F (96 'D,1'+JE 'D(1'2J) HDG' *#+J1 9DI 2J'/) 'D@ "p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p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istocytosis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queous cream HJ,AA B(D H69 G0G 'DE71J'*. #+F'! *C1'1 'D'D*G'('* (EF7B) 'D-A'8 HF*J,) DD,A'A JA6D #F J6'A DDE'! 9F/ '3*-E'E 'D7AD 2J* -E'E E+D" Alpha- Keri #H 2J* Oilatum #H Balneum " H'DE71J'* H'DC1JE'* 'DE'&J) (#CHJ3) JECF '3*./'EG' -JFE' JCHF 'D'F/A'9 *-* 'DE9'D,) H%,1'! 'D-E'E CD JHE. (2/112)  J,( 9/E 'D*4,J9 9DI '3*./'E 'DE3*-61'* 'DE('9) (/HF H5A) 7(J) H'.*J'1 'D#FH'9 'D:J1 -'HJ) 9DI E.14'* BHJ). *F8JA 'D16J9: 'DEF8A 'DE+'DJ DDEHDH/ 'D,/J/ H'D169 J,( #F J*EJ2 ('D5A'* 'D*'DJ): J,( #F JCHF .'DJ'K EF 'DE1C('* 'D*J B/ *O$0J 'D,D/. J,( #F JCHF +'(* AJ2JHCJEJ'&J'K J,( #F JCHF :J1 -'HJ 9DI 97H1'* J,( #F JCHF :J1 -'HJ 9DI 'DC-HD J,( #F D' J-*HJ EH'/ 0'* A9'DJ) E*5'D() E9 'DE$1,'* 'D#.1I J,( #F D' J-*HJ 9DI EH'/ JECF #F *3*BD( ('DADH1' 'D/BJB) 'D,D/J) EF 'DEGE #F *(BJ EF7B) 'D-A'8 EC4HA) H-1) JHEJ'K #-J'F'K (/HF -A'&8 DD*GHJ) 'D31'HJD 'D(D'3*JCJ) H'DE7'7J) 'D*J *D(3 AHB 'D-A'8 J,( #F *3*./E (-01 -J+ #FG' B/ *3(( *:7J) #C+1 H*GJ! DFEH 'D,1'+JE H'DA71J'*. 'DE3'-JB E+D (H/1) *'DC J,( *,F(G' %0' C'F* EF7B) 'D-A'8 E*B1-) HE*97F) HB/ *3(( *.1J4. 3- 'DE9'D,) 'DA9'D): *9*E/ 'DE9'D,) 9DI 4CD 'D"A) 'D*J *H,/ AJ EF7B) 'D-A'8: 'D"A) 'DF'2): (1EF:F'* 'D(H*'3JHE 1/9000 CE'/'* *3*./E H**7(B 9DI 'D"A) D*,AJAG'. JO:73 'D4'4 'D*F8JA AJ (1EF:F'* 'D(H*'3JHE H*3*./E (4CD CE'/'* *7(B (D7A 9DI 'D37- 'DF'2 DE/) /BJB)  HJECF *C1'1 0DC. 9DI 'D7(J( #F JCHF H'9J'K ,/'K AJ '.*J'1 'DE3*-61'* 'DEH69J) (3(( %EC'FJ) 'D*-33 'DEH69J ((96 'DC1JE'* #H 'DE-'DJD 'D-'HJ) 9DI E-33'* E+D 'DFJHEJ3JF  'DE./1'* 'DEH69J)  'DE6'/'* 'D-JHJ)  H'DE6'/'* 'DGJ3*'EJFJ) H:J1G'. 'D3*J1H&J/'* 'DB41J) 'DEH69J): 9DI 'D1:E EF #F (96 'D#7('! J3*./EHF 'D3*J1HJ/'* 'DB41J) AJ CD 'D-'D'* -*I 'D-'D'* 'D#.A H'DH'B9 #F 'D3*J1H&J/'* 'DB41J) EH69J'K H/'.D'K D'*3*7( (4CD 1H*JFJ AJ 'D*G'( 'D,D/ 'D-A'8J. 'DF'-J) 'DE*3E7) D/JG' 'D%EC'FJ) DD'E*5'5 'D31J9 DD3EHE H:J1G' E+D 'D3J*1HJ/'*. #9'D, 'D*G'( 'D,D/ 'D-A'8J CE' JDJ : (2/113)  1 - 'DF'-J) 'D-A'8J) 'DE*97F) H'D17(): #F5- 'D#E #F *3*./E: (1EF:F'* 'D(H*'3JHE CE'/'* 1/9000 E1*JF JHEJ'K D*F8JA 'DF'-J) EF 'DA6D'* H'D'A1'2'*. C1JE E6'/ :J1 3*J1H&J/J -'HJ 9DI E7G1'* E+D "Pufexamac)" Flococid) J7(B (9/ CE'/'* 'D(1EF,F'*. H69 'D4'4 AHB 'DE1GE  3H'! C'F 0DC 'D4'4 ,'A'K #H E:EH3'K (2J* 'D2J*HF #H ('DE6'/'* 'D-JHJ) :J1 E-33) E+D 'D3HA1'*HD #H 'DAH3J/JF  J7(B AHB 'DC1JE. 'D:16 EF H69 'D4'4 AHB 'DC1JE GH DEF9 'DED'E3G 'DE('41) (JF ,D/ 'D7AD E9 'D-A' 8 'D(D'3*JCJ D*BDJD 'D*.1J4 H'D*:7J) HC*E 'DEF7B). 2- 'D4CD 'D,'A: 'D*F8JA 'DD7JA DDEF7B) +E *7(JB E1GE E+D 'D@ (Flogocid) 'D.'DJ EF 'D3*1HJ/'* 'DB41J) H4'4 *-* 'D-A'8. AJ 'D-'D'* 'D,'A) (4/): J,( '3*9E'D 'DE71J'* AJECF '3*./'EG' HE1GE 'D3*J1H&J/ 'D.AJA ,/'K E+D (Elocom) #H (Eumovote) J3*./E D9/) #J'E AB7 HJ,( #F *9DE 'D#E #F *HBA 'DE1GE HD'*3*./EG #C+1 EF #3(H9 H'-/ 3- 'D"A'* 'DE.*D7): /'! 'DE(J6'* JECF #F J9'D, (E3*-61 EH69J .AJA E+D E1GE (Flogocid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anstene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erpetiform napkin dermatitis: napkin dermatitis simulating an acute herpes simplex infection. Br J Dermatol 1986;114: 746-7 1 Keswick BH, Seymour JL, Milligan MC. Diaper area skin microflora of normal children and children with atopic dermatitis. J Clin Microbiol 1987; 25: 216-21 2 Zimmerer RE, Lawson KD, Calvert CJ. The effects of wearing diapers on skin.Pediatr Dermatol 1986; 3: 95-101 3 Stein H. Incidence of diaper rash when using cloth and disposable diapers. J Pediatr 1982; 101: 720-3 4 Buckingham KW, Berg RW. Etiologic factors in diaper dermatitis: the role of feces. Pediatr Dermatol 1986; 3: 107-12 5 Jordan WE, Lawson KD, Berg RW et al. Diaper dermatitis: frequency and severity among a general infant population. Pediatr Dermatol 1986; 3: 198-207 6 (2/115)  Munz D, Powell KR, Pai CH. Treatment of candidal diaper dermatitis: a double blind controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr 1982; 101: 1022-5 7 Berg RW, Buckingham KW, Stewart RL. Etiologic factors in diaper dermatitis: The role of urine. Pediatr Dermatol 1986; 3: 102-6 8 Buckingham KW, Berg RW. Etiologic factors in diaper dermatitis: The role of feces. Pediatr Dermatol 1986; 3: 107-12 9 Campbell RL, Bartlett AV, Sarbargh FC et al. Effect of diaper types on diaper dermatitis associated with diarrhoea and antibiotic use in children and day-care centres. Pediatr Dermatol 1988; 5: 83-7 10 Jordan WE, Lawson KD, Stewart R et al. Diaper dermatitis: Frequency and severity among a general infant population. Pediatr Dermatol 1986; 3: 198, 207 11 'DA5D 'D-'/J H'D941HF -3'3J) EH'/ 'D*,EJD Cosmetic Dermatitis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ragrance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ntioxidant ) (2/117)  *4ED G0G 'D#5(': 'D96HJ) @ DD'FHDJF @ E'5'* #49) 'D4E3. (96 EH'/ 'D*,EJD 'D*J B/ *3(( 'D-3'3JG 'DC1JE'* 'DE3*./E) AJ E17('* 'D,D/  'DEH'/ 'D-'HJ) 9DI 'D2&(B 'DF4'/1J B/ *3(( -3'3J) ,D/J). C1JE'* 'DH,G E+D #5(:) 'D@" Azo"  H'DD'FHDJF H'D('1'(JF  'DEJ1'FHD'*" Bronopol , Dowicil 200 , Germall II , Germal H Euxyl K4oo "H#ED'- AFJD 'D2&(B B/ *-/+ 'D*G'( ,D/ *E'3J #1,J HJCHF -'/'K E9 *-H5D HAB'9'* AJ EHB9 'D*E'3 .'5) 9F/ 'D#7A'D 'D5:'1. E'5'* #49) 'D4E3  'D5'(HF  'DEF8A'* H#H1'B 'D*H'DJ* H9// EF 'DEF*,'* 'D5F'9J) E+D 4E9 'D#16 @ H'DC1JE'* B/ *3(( C0DC 'D-3'3J) 'D,D/J). 'DC1JE'* 'D5J/D'FJ) #J6'K B/ *-HJ 97H1 *1JF*JF CHDHAHFJ (1'*F,) E3'-JB 'DH,G 5(: AZO H'D('1'(JF'* "Dowicil 200 Germal" 'D4CD 1BE 177: -3'3J) EH'/ 'D*,EJD (('D,AF) 'D4CD 1BE 178: -3'3J) EH'/ 'D*,EJD 'D4CD 1BE 179: -3'3J) EH'/ 'D*,EJD ('D4CD 'D9/J HFB5 *5(:) 'D4CD 1BE 180: 'D*G'( ,D/ *E'3J AB'9J 'D4CD 1BE 181: 'C2JE' *E'3J 'D4AHJ 'D4CD 1BE 182: 'D*G'( ,D/ (EH'/ 'D*,EJD 'D4CD 1BE 183: -3'3J) 'D97H1 (Berloque) E-'DJD 'DJ/: 9/) C1JE'* *-*HJ 9DI" 'DD'FHDJF". "/J %+J' FHD'EJ/"  ,H2 'DGF/  E1C('* 'D#EHFJHE 'D1('9J)  'D(1HFH(HD  'D5H'(JF 'D3'&D)  DH1'JD 'J+1 3DAJ*  H/J 'J+'FHD 'E'J/ HB/ *3(( *DC 'DEH'/ -3'3J) *D'E3J). 'D5'(HF H'D4'E(H: 'D5H'(JF H'D4'E(HF'* 'D-'HJ) 9DI 'D97H1 H(F2JD 3'D3JD'* B/ *3(( #J6'K '1*C'3 'C2JE'&J .'5) 9F/ 'DE16J 0HJ 'D,D/ 'D-3'3. E6'/'* 'D*91B: #ED'- 'D2FC H'D#DEFJHE HE3*-61'* 'D@ " Zirconinum"'DEH,H/) AJ E2JD'* 1'&-) 'D91B B/ *+J1 H1E'K -(J(J'K #1,J'K. (2/118)  E2JD'* 'D91B 'D-'HJ) C0DC 9DI E6'/'* -JHJ) E+D "'DFJHEJ3JF "#H 'D#DEFJHE  AFJFHD'* E+D" 'DGJC3'CDH1AJF" H "Irgasan " H "GJ/1HC3J CJFHDHF" B/ *3(( #J6'K '1*C'3'K 'C2JE'&J EH69J'K. 'D4CD 1BE 184: -3'3J) 'D97H1 E3*-61'* 'D491: 9// EF E3*-61'* 'D491 B/ *D9( /H1'K G'E'K CE-33 DD,D/ HEFG': 5(:) 'D491: 'DAFJDJF /J'EJF @ 'D*HDHJF /J'EJF. F*1H "PPD "('1' 'E'JFH/'J AJF'D'EJF  'D1J3H13FHD H'D('J1H:'DHD. C1JE'* 'D491: 'D4JD'C @ 'D(F2H&JF. C1JE'* H,D 'D491: D'FHDJF @ ('1'(JF "Germall Ambrette Musk." E-'DJD 'D491: 'DCJFJF @ 1J3H13JFHD @ GJC3'EJ/ JF 'J2J +JHF'*. EF8A'* 'D491: 5(:'F "AZO "  GJ/1HC3 CJFHDJF'*  (J1+JHE 'D2FC  'DE3C1) (#BD'E 'D-',(JF) H#5(:*G' H'DC-HD GJ EH'/ 4'&9) B/ *3(( 'D-3'3J) 'D,D/J). 4'E(HF'* 'D491: 'DE971)  'DB71'FJ)  -E6 'D5A5'A  1J2H13JFHD  CFJF 3DA'*  (J1J+HE 'D2FC" Cinchona" D'FHDJF @ ('1'(JF ." P - AFJD /J'EJF". #5(:) 'D491 'D-'HJ) 9DI *HDHJF /J'EJF . 1JH13JFHD 'D*G'( ,D/ (EH'/ 'D*,EJD 'D(J1JB'DHD 'D@ "Musk "B/ *9ED CE-33'* ,D/J) (GD'E E5AA 'D491). 'D4CD 1BE 185: -3'3J) E1C('* A1/ 'D491 10'0 'D491 (Spray): 'D-'HJ) 9DI D'FHDJF" Shellac" #H 'D5E: 'D91(J B/ *3(( 'D-3'3J) (A1H) 'D1#3. E3*-61'* 'D#8'A1: 'DEF*,'* 'D-'HJ) 9DI AH1E'D/G'J/ H'D3DAHF'EJ/ *9*(1 3(( 4'&9 D'D*G'( ,D/ 'D9FB H'D#,A'F 9F/E' *CHF 9DI *E'3 E9 'D,D/. E3*-61'* 'D9JF: B/ *-*HJ 9DI 'D97H1 @ 'DE3C1) @ E.77'* 'D#,A'F HE8DD 'D#,A'F H'D9JF. 'D2JH*: E+D 2JH* 'DDH2 @ B/ *3(( 'C2JE' *E'3 #H -3'3J) 6J'&J). E3*-61'* 'D4A'G: #5(:) -E1) 'D4A'G "AZO" H'DCFJ'2HDJF B/ *3(( *A'9D', *E'3J'K #1,J'K. (2/119)  'DE3*-61'* 'DEDHF) #H 'DEFCG) B/ *3(( 'D*G'( ,D/ *E'3 E+D 'DD'FHDJF C-HD #HDJD @ 2J* 'D.1H9 @ ,JD'F (1H(JD. EHFH *1'J (H*JD CJFHF 'EJD /J EJ+JD "PABA". 'DDH2  'D97H1 @ 'DEH'/ 'DEDHF) #H 'DEH'/ 'D%6'AJ)  #H +F'&J @ #H +D'+J (1HEHADH1H3JF B/ *3(( 'D*G'( ,D/ 'D4A) 'D*E'3J HB/ J$/J D4BHB E$DE) AJ 'D4A'G. 'D9H'ED 'DEFCG): -3'3J) 'D*E'3 DD*H'(D *-/+ (4CD 1&J3J EF 'D*916 'DEGFJ DCF 'D-3'3J) EF 'DE'3*1/ @ 'DB1A)  'DA'FJDJ'  HCD 'D(G'1'*  2J* 'D9191 H'DB1FAD E-33'* DJ3* :J1 4'&9) -*I (JF 'DE3*GDCJF. AJ 5F'9) 'D79'E 'D-/J+) JH,/ 9// C(J1 EF 'DEFCG'* 'D*1CJ(J). 'DD'5B'* Adhesive Tape: *-*HJ 9DI 5E: 'D5FH(1 'DCDHDHAHFJ @ 'D/'E'1 @ 'DEH'/ 'DE7'7J) @ 'DD' FHDJF @ 'D#C1JD'* @ /'J AJFJD +JH1J' H'D(96 'D".1 EF 'DEH'/ B/ *-HI 9DI 1'*F, 'D@ Epoxy. 'D#/HJ) 'DEH69J): E98E 'DEH'/ 'DEH69J) B/ *3(( 'D-3'3J). HEF G0G E' JDJ: E1C('* 'D(F2JHD (J1HC3'J/ H'D(1'(F. 'DE7'7 H'DCJE'HJ'* 'DE7'7J) AJ #:7J) B71'* 'D9JF B/ *3(( 'D-3'3J) C0DC. 4E9 'DF-D (Propolis) *9*(1 (4CD C(J1 HE*2'J/ (#FG' E'/) *3(( 'D*-33 AJ 'DE1'GE 'D7(J9J). 'DD'JD +JH1J' H9D( H'D1HJ'D ,DJ B/ *-33 'D,D/ #J6'K. EH'/ *,EJD E-33) #.1I 'DEG/&'* 'D95(J): AJFH+J'2JF E-33 'D,D/ 9F/E' J3*9ED C41'( #H #B1'5 E3-HB) *5(- 9DI *E'3 E9 'DJ/JF. 'DGJ/1HC3J CJFHDHF: (Hydroxyquinolines) *3*9ED (4CD 1&J3J AJ 'D#/HJ) 'DEH69J) H**H',/ C0DC AJ EH'/ 'D*,EJD H'D#/HJ) 'DE6'/) DDB41) H'DEF8A'* BDJD) 'DE'!  H:3HD'* 'DAE  H:J1G'. HJH,/ 7JA E*5'D( H'39 EFG' J3(( 'D-3'3J). 'DAH1E'D/GJ/: (Formaldehyde) (2/120)  'DAH1E'D/GJ/ 'D-1 JH,/ AJ 1'*F,'* 'DAH1E'D/GJ/ E+D 'DBE'4 Textiles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ecoderm cream) #HE6'/ -JHJ AEHJ E+D '1J+1HEJ3JF E9DB #H" Z ithromax". 'D"A'* 'D,'A) *3*,J( DDE71J'* HE1GE 'D3*J1HJ/ EH69J. E6'/'* 'DGJ3*'EJF AEHJ'K B/ *CHF EAJ/)K AJ EF9 'D-C). 'DE1',9 (2/121)  Adams RM, Maibach HI. A five-year study of cosmetic reactions. J Am Acad Dermatol 1985; 13: 1062-9 1 De Groot AC. Adverse Reactions to Cosmetics. Groningen, The Netherlands: State University of Groningen, 1988 2 Nater JP, de Groot AC. Unwanted Effects of Cosmetics and Drugs Used in Dermatology, 2nd edn. Amsterdam: Elsevier,1983 3 Bardazzi F, Misciali C, Borrello P et al. Contact dermatitis due to antioxidants. Contact Derm 1988; 19: 385-6 4 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980: 264-5 5 Nater JP, de Groot AC. Unwanted Effects of Cosmetics and Drugs Used in Dermatology, 2nd edn. Amsterdam: Elsevier,1983 6 De Groot AC. Labelling cosmetics with their ingredients. Br Med J 1990; 300: 1636-8 7 De Groot AC, Beverdam E. Tjong Ayong C et al. The role of contact allergy in the spectrum of adverse effects caused by cosmetics and toiletries. Contact Derm 1988; 19: 195-201 8 Suyai T, Takahashi Y, Takagi T. Pigmented cosmetic dermatitis and coal tar dyes. Contact Derm 1977; 3: 249 9 Nakayama H, Harada R, Toda M. Pigmented cosmetic dermatitis. Int J Dermatol 1976; 15: 673-5 10 Koch SE, Mathias T, Maibach HI. Chloracetamide: an unusual cause of cosmetic dermatitis. Arch Dermatol 1985; 121: 172-3 11 Taylor JS. Adhesives, gums and resins. In: Fisher AA. Contact Dermatitis, 3rd edn. Philadelphia: Lea and Febiger, 1986: 667-74 12 Calnan CD. Unusual hydroxycitronellal perfume dermatitis. Contact Derm 1979;5: 123 13 Dooms-Goossens A, Dubelloy R, Degreef H. Contact and systemic contact-type dermatitis to spices. Dermatol Clin 1990; 8: 89-93 14 (2/122)  Larsen WG. Perfume dermatitis. J Am Acad Dermatol 1985; 12: 1-9 15 Shelley WB, Hurley HJ. The allergic origin of zirconium deodorant granulomas. Br J Dermatol 1958; 70: 75-101 16 'DA5D 'D+'FJ H'D941HF -3'3J) 'D#D(3) Clothing dermatitis 'D-1'1) H'D17H() EF 'D9H'ED 'DG'E) 'DE+J1) DD-3'3J) HDG0' 'D3(( EF 'D61H1J 'D-A'8 9DI /1,) -1'1) ,3E 'D7AD (H69G' 'D7(J9J 3H'! AJ 'D5JA #H AJ 'D4*'! HD'J9FJ 0DC C*E ,D/ 'D7AD .'5) AJ A5D 'D4*'! EE' B/ JH/J 0DC %DI 'D*GJ&) D2J'/) 'D-3'3J) F*J,) D2J'/) 'D*91B HC0DC *$G( DD'D*G'('* 'D,D/J) 3H'! 'DA71J) #H 'D,1+HEJ). 'D4CD 1BE 186# : -3'3J) 'DED'(3 'D4CD 1BE 186(: -3'3J) 'DED'(3 'D4CD 1BE 186, : -3'3J) 'DED'(3 'DE'/) 'DE$1,) #H 'DE+J1) DD-3'3J) AJ 'D#D(3) %E' #F *CHF FA3 FH9 'DBE'4 #H 'DEH'/ 'DCJE'HJ) #H 'D#5(': #H 'DE9'/F E+D 'D3-'('* #H *DC 'D*J AJ 'D#-2EG H:J1G'. 'D#BE4): 'DB7F: 9'/) D'J+J1 'D-3'3J) HGH #BD #FH'9 'D#BE4G 'DEGJ&) DD-3'3J). 'D5HA: 9'ED EGE AJ %+'1) 'D-3'3J)  D0DC JD'-8 %F (96 #FH'9 'D-3'3J) *2/'/ AJ A5D 'D4*'! F*J,) D'3*9E'D 'DED'(3 'D5HAJG HF*J,) #J6'K D,A'A 'D,D/. HJ,( ED'-8) %F (B'J' EH'/ 'D:3JD 'D*J *9DB AJ 'DED'(3 F*J,) 9/E 47AG' ,J/'K B/ *CHF 9'ED'K EGE'K DD-3'3J) HJ,( 'D'F*('G DG0G 'DED'-8G %0 F5'/A (96 #FH'9 'D-3'3J) 'D,D/J) 'D*J 51A* DG' 'D9/J/ EF 'D9D','* /HF A'&/) H9F/E' *E 'D*1CJ2 9DI 47A 'DED'(3 '.*A* G0G 'DE4CDG FG'&J'K (%0F 'DDG. 'D-1J1: F'/1'K E'J$/J %DI 'D-3'3J). 'D(HDJ3*1 H'DF'JDHF: EH'/ 'DF'JDHF H'D'C1JDC HE'/) 'D3('F/C3 'DE3*9ED) AJ 5F9 -A'&8 'D'7A'D H'D#-2E) DG' ,EJ9'K #+1 G'E AJ -/H+ 'D-3'3J). H'D3(( 'D#HD 'DE$+1 B/ JCHF E'/) 'DBE'4 #H 'D'5(':. (2/123)  E'/) 'D3('F/C3: G0G E'/G :J1 E7'7JG B'(DG DD4/ EF 'D(HDJH1J+JF *3*9ED AJ 5F'9) 'D,H'1( H'D#1(7) H'D#-2E) H'D5/1J'*. 'DE'/) 'DE$1,) #H 'DE+J1) DD-3'3J) AJ *DC 'D#FH'9 GI EJ1C'(*H(F2H+'J2HD. AH1E'D/JG'J/: *3*9ED G0G 'DE'/G 9DI F7'B H'39 AJ 'D5F'9'* .'5) AI 'DED'J3 @ EF'/JD 'DH1B @ H1B 'D*H'DJ* HE'/) DEF9 'DC1E4) AJ 'DED'(3 HCH) 'D1B(G. 'DCH) 'D*J *3*9ED DD#7A'D H'D*J *H69 -HD 'D1B(G H#9DI 'D5/1 .'5) 9F/ *:0J) 'D7AD :'D('K E'*CHF E5FH9) EF EH'/ E+J1) DD-3'3J) D0DC EF 'D61H1J '.*J'1 FH9 B7FJ :J1 E$+1. 'D#-0J): 'DEH'/ 'DE3*9ED) AJ 5F'9) 'D#-0JG E+D 'D,D/ @ AH1E'D/ JG'J/ @ C1EJ* @ *FJF GJ 9H'ED E+J1) DD-3'3J). 'DA1'!: E'/) 'D,D/ #H 'DEH'/ 'DE3*9ED) AJ /(':) H*,GJ2 'DA1'! E+D ('1'AFDJF /'J'EJF ,EJ9G' EH'/ B/ *+J1 'D-3'3J). (96 #FH'9 'DBE'4 B/ *3(( 'D-3'3J) H9DI 'DE1J6 #F D'J3*./E G0' 'DBE'4 3H'! AI 'DED'(3 #H 'D,H'1( #H :J1G' D9/) #J'E  %0' *-3F* 'D-'D) AJ-'HD D(3 0DC 'DBE'4 +'FJ) %0' 9'/* 'D-C) AG0' J9FJ 0DC %F *DC 'DEH'/ GJ 'D3(( AJ 'D-3'3J). 'D9H'ED 'DEGJ&) D-3'3J) 'DBE'4: 1 @ 'D,D/ 'D71J H'D-3'3 CE' GH 'D-'D D/I 'D'7A'D. 2 @ 'D3EFG. 3 @ 2J'/) 'D*91B B/ J$/J 0DC %DI %0'() (96 'D#5(': #H 'DEH'/ 'DCJE'HJ) ('DBE'4. 4 @ 'D17H(): 2J'/) 'D17H() *3'9/ 9DI *17J( 'D(41) EE' JGJ! %DI 2J'/) 'E*5'5 'DEH'/ EF 9DI 37- 'D,D/. 5 @ 2J'/) F3() 'D/GHF ('D,D/. 6 @ 'DED'(3 'D6JB) H'DC'*E) D37- 'D,D/. 7 @ 'DC/E'* 9'ED EGE C0DC. 8 @ -'D) 'D,D/ 'D9'E): 'D'-*C'C 'DE*C11 @ 'D%5'('* 'D,D/J) H*.1J4 'D,D/. 9 @ 'DE16I 'DE5'(HF ('D-3'3J) #C+1 '3*9/'/'K D-3'3J) 'DED'(3 EF :J1GE. 10 @ ECHF'* 'D,D/ ('DEF7B) 'DE5'(): EF'7B 'D,D/ 'D:FJ) ('D:// 'D/GFJ) #H 'D,D/ 'D1BJB E+D 'D,AHF #C+1 916) DD%5'(). (2/124)  'DE8'G1 'D31J1J) D-3'3J) 'D#D(3): -3'3J) 'DED'(3 GJ EF 'DFH9 'D0J J-/+ E*'.1'K F*J,) ED'E3) 'DE'/) 'DE-33) ('DBE'4. HB/ JCHF 'D*#+J1 EF 'DFH9 'DE+J1 'D#HDJ H0DC E('41) (9/ D(3 'DFH9 'DE$+1. *(/# 'D#91'6 (-C) H%-E1'1 (,D/ 'DEF7BG 'DE916). B/ *CHF 'D#91'6 #4/ (JF 0HJ 'D(41) 'D-3'3) .'5) D/I 'D'7A'D %0 *8G1 (+H1 HAB'BJ9 . -3'3J) 'DED'(3 B/ *8G1 AJ A5D E9JF EF 'D9'E CE' GH 'D-'D AJ 'D-3'3J) EF 'DED'(3 'D5HAJG 'D*J *CHF #4/ AI EH3E 'D(1/ HB/ *D'-8 'D#E 0DC 9F/E' J*916 7ADG' DDED'(3 'D5HAJ) #H 'D#:7J). 'D-3'3J) EF 'D,H'1( *-/+ (C+1) (JF 'D'7A'D -J+ JCHF 'D*-33 8'G1'K 9DI 'DEF7B) 'DE916). HFA3 'D4J! JF7(B 9DI 'D#FH'9 'D#.1I EF 'DED(H3'* E+D 'D31'HJD H'D#-2E). ED'-8'* 9'E): J,( ED'-8) %F (B'J' 'D5'(HF AJ 'DED'(3 'D*I DE *47A ,J/'K B/ JCHF DG' /H1 G'E #H 'DEH'/ 'DCJE'HJ) 'D#.1I E+D AH1E'D/(G'J/ GJ EH'/ EF 'DEECF #F *3(( 'D-3'3J) 'D*D'E3J). 'D*91B 'D2'&/ H9/E 'D'G*E'E (F8'A) 'D,3E H'D*/A&) 'D2'&/) AJ 'DE3CF .'5) AJ A5D 'D4*'! EF 'D9H'ED 'DG'E) C0DC DD*GJ&) DD-3'3J). C*E 'D,D/ (9/) 7(B'* EF 'DED'(3 #H 'D#:7J) DA*1) 7HJD) .'5) 9F/ 'D'7A'D B/ J$/J 'D*-33 'D,D/. 'D17H() 'D2'&/) H'D'-*C'C GJ 9H'ED G'E) C0DC. 'D'5(': @ 'DCJE'HJ'* H'DEH'/ 'DEDHF) DDED'(3 *D9( #-J'F'K /H1'K G'E'K 9DI *-33 'D,D/. (96 #FH'9 'D#BE4) E+D 'DC'CJ H'D,JF2 B/ *3(( -3'3J) HC0DC (B9 /EHJ) ('D,D/ ('D(J1(J1'). 3(( G0' 'DFH9 EF 'D-3'3J) B/ *CHF 'D'5(': ('2H/'J2 #H AH1ED/JG'J/) #H EF 'DEH'/ 'DCJE'HJ) 'DE3*9ED) #+F'! *,GJ2 'DED'(3. J8G1 'D7A- 'D,D/J 9'/) 9DI EF'7B 'D37- 'D/'.DJ DDA.0JF #H 'D#019 HJF*41 (9/ 0DC %DI EF'7B #.1I. 71B *4.J5 -3'3J) 'D#BE4): (2/125)  1@ 'DE8'G1 'D31J1J): 8GH1 'D-3'3J) 9DI 'DEF'7B 'DE:7'G ('DED'(3 H**-3F 'D#91'6 9F/ .D9G'. 2@ *,1() 'DD7'.G(Patch test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ronin E. Studies in contact dermatitis. 18. Dyes in clothing. Trans St John's Hosp Derm Soc 1960; 54: 156-64 1 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980 2 Edman B. Sites of contact dermatitis in relationship to particular allergens. Contact Derm 1985; 13: 120-35 3 Hodgson CA, Hellier FF. Dermatitis caused by shirts in B.L.A. J Roy Army Med Corps 1946; 87: 110-17 4 (2/126)  Epstein E, Maibach HI. Ethylenediamine allergic contact dermatitis. Arch Dermatol 1968; 92: 476-7 5 Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chm 1977; 28: 197-209 6 Christophersen J, Mennщ TM, Tanghof P et al. Clinical patch test data evaluated by multivariate analysis. Contact Derm 1989; 21: 291-9 7 Kirton V, Wilkinson DS. Sensitivity to cinnamic aldehyde in a toothpaste. Contact Derm 1975; 1: 77-80 8 Berger C, Muscleman M, Meekness Brand?o F et al. Thin layer chromatography search for Disperse Yellow 3 and Disperse 9 Orange 3 in 52 stockings and pantyhose. Contact Derm 1984; 10: 154-7 10 Cronin E. Formal in textile dermatitis. Br J Dermatol 1963; 75: 267-73 11 Cronin E. Studies in contact dermatitis: XVIII. Dyes in clothing. Trans St John's Hosp Derm Soc 1968; 54: 156-64 12 Fregert S, Greenberger B, Grandson K et al. Allergic contact dermatitis from chromate in military textiles. Contact Derm 1978; 4: 223-4 13 Hjorth N, M"ller H. Phototoxic textile dermatitis (`Bikini dermatitis'). Arch Dermatol 1976; 112: 1445-7 14 Jordan WP. Clothing and shoe dermatitis. Postgrad Med 1972; 52: 143-8 15 Lundkofoed M. Contact dermatitis from formaldehyde in fabric softeners. Contact Derm 1984; 11: 254 16 Dahl MV. Allergic dermatitis from footwear. Minnesota Med 1975; 58: 871-4 17 De Groot AK, Gerkens F. Contact urticaria from a chemical textile finish. Contact Derm 1989; 20: 63-4 18 Farli M, Gasperini M, Giorgini S et al. Clothing dermatitis. Contact Derm 1986; 14: 316-17 19 (2/127)  Fisher AA. How to obtain shoes free of common sensitizers. Cutis 1973; 12: 678 20 Fisher AA, Kanof NB, Bionchi EM. Free formaldehyde in textiles and paper. Arch Dermatol 1962; 36: 753-6 21 Foussereau J, Dallara JM. Purity of standardized textile dye allergens - a thin layer chromotography study. Contact Derm 1986; 14: 303-6 22 Hatch KL, Maibach HI. Textile chemical finish dermatitis. Contact Derm 1986; 14: 1-13 23 HODGSON G. & HELLIER F. (1946) J. roy. Army. Med. Corps. 87, 110 24 Hatch KL, Maibach HI. Textile fiber dermatitis. Contact Derm 1985; 12: 1-11 25 Hjorth N, M"ller H. Phototoxic textile dermatitis (`Bikini dermatitis'). Arch Dermatol 1976; 112: 1445-7 26 Jordan WP. Clothing and shoe dermatitis. Postgrad Med 1972; 52: 143-8 27 Lundkofoed M. Contact dermatitis from formaldehyde in fabric softeners. Contact Derm 1984; 11: 254 28 Hatch KL, Maibach HI. Textile chemical finish dermatitis. Contact Derm 1986; 14: 1-13 29 Hatch KL, Maibach HI. Textile fiber dermatitis. Contact Derm 1985; 12: 1-11 30 Cronin E. Studies in contact dermatitis. 18. Dyes in clothing. Trans St John's Hosp Derm Soc 1960; 54: 156-64 31 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980 32 Hodgson CA, Hellier FF. Dermatitis caused by shirts in B.L.A. J Roy Army Med Corps 1946; 87: 110-17 33 Epstein E, Maibach HI. Ethylenediamine allergic contact dermatitis. Arch Dermatol 1968; 92: 476-7 34 Osmundsen P.E. (1968) Br. J. Derm 81, 789 35 Osmundsen P.E. (1970) Br. J. Derm 831, 296 36 (2/128)  'DA5D 'D+'D+ H'D941HF 'D-3'3J) 'DF',E) 9F 'DEF8A'* Detergent dermatitis 'DA5D 'D*'DJ 'DA5D 'D3'(B (-+ -3'3J) 'DEF8A'* #C+1 4JH9'K (JF 'DA*J'* 'D('D:'* H*O3EI C0DC "-3'3J) 1() 'D(J*". F81'K D'F*4'1 G0' 'DFH9 EF 'D-3'3J) B/ JCHF EF 'DEAJ/ %97'! DE-) E.*51) .'5) H%F 'D#9/'/ EF 'D'7A'D 'D0JF J9EDHF AI 'D(JH* #H 'DE7'9E H'D#E'CF 'D#.1I AJ '2/J'/ AJ G0G 'D#J'E. '9*('1'* 9'E): J*4'1C 'D91B H'D2GE E9 (96GE' 9DI 37- 'D,D/ HJ4CD'F 41J-) -E6J) H4'- -E6J "Acid Mantle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ygroscopic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p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llerderm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agnusson B, Gilje 0. Allergic contact dermatitis from a dishwashing liquid containing laurel ether sulphate. Acta DermVenereol 1973; 53: 136-40. 1 White IR, Lewis J, El Alami A. Possible adverse reactions to an enzyme-containing washing powder. Contact Derm 1985;13: 175-9. 2 Wilkinson DS, Bandmann H-J, Calnan CD et al. The role of contact allergy in hand eczema. Trans St JohnСs Hosp Derm Soc 1970; 56: 19-25. 3 (2/132)  Wilkinson DS. Nursing and Management of Skin Diseases 4th edn. London, Faber & Faber, 1977. 4 Calnan CD. Nickel dermatitis. Br J Dermatol 1956; 60: 229-36. 5 Christensen OB, Moller H. Nickel allergy and hand eczema. Contact Derm 1975; 1: l29-35. 6 Cronin E. Clinical prediction of patch test results. Trans St John's Hosp Derm Soc 1972; 58: 153-62. 7 Edman B. Sites of contact dermatitis in relationship to particular allergens. Contact Derm 1985; 13: 129-35. 8 Fisher AA. Metal dermatitis - some questions and answers. Cutis 1977; 19: 156, 158, 164, 165 and 169. 9 Fregert S. Occupational dermatitis in a 10-year material. Contact Derm 1975; 1: 96-107. 10 Husain SL. Contact dermatitis in the West of Scotland. Contact Derm 1977; 3: 327-32. 11 Mennщ T, Brandrup F, Thestrup-Pedersen K et al. Patch test reactivity to nickel alloys. Contact Derm 1987; 16: 255-9. 12 Moller H. Intradermal testing in doubtful cases of contact allergy to metals. Contact Derm 1989; 20: 120-3. 13 'DA5D 'D1'(9 H'D941HF 'D*-33 'DF('*J (#C2JE' 'DF('*'*) Plant Dermatitis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hus"@ 'D(DH7 'D3'E @ H'DC'4JH @ (01) 'D.D('( (Ivy) @ H'DE'F,H @ 'D5E: H4,1 'D7D- B/ *9ED CEH'/ E-33). 'DE'/) 'DE-33) AJ 4E9 93D 'DF-D J4*B EF 1'*F, 'D@ "Poplar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ig.190. Hyperpigmentation( Photosensetization by Furocumarine in figs trees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ecoderm cream). 'D3*J1H&J/'* 'DB41J) /'.D'K J-*A8 (G' DD-'D'* 'DE.*D7) (E8'G1 ,G'2J) 4/J/). %0' C'F* 'D3*J1H&J/'* 'D,G'2J) 61H1J) A%FG JA6D '3*./'E 'D@ "Depot Medrol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rass Dermatitis) G0' 'DFH9 EF 'D*G'( 'D,D/ 4'&9 9F/ 'D#7A'D 'D0JF JD9(HF AJ 'D-/JB) 'DEF2DJ) #H 'DED'9( #H ED'9( C1) 'DB/E 'DE:7') ('D94(. B/ J-/+ 0DC .D'D 'D@ 24 3'9) 'D#HDJ AJ 'DEF'7B 'D*J *CHF 9DI *E'3J E9 'D94(. '.*('1 'D(B9) DD94( %J,'(J (2/135)  E1C('* F('*J) E-33) 9/) EF*,'* F('*J) B/ *3(( -3'3J) ,D/J). 1 @ 2JH* #5DJ): JH,/ AJ B4H1 'D-E6J'* H'DAH'CG 'D-'E6J) @ #H1'B 'DF9F'9 HD-'! 4,1) 'DB1A). 2 @ 2J* 'DB1A): J3*./E CE'/) EFCG) AJ '-E1 'D4A'!  'D9DC) @ E9,HF 'D#3F'F HAJ #A1'F 'D9,JF. 3 @ 2J* 'DB1FAD: 'D#H,JFHD J3*./E AJ 7( 'D#3F'F. 4 @ 2J* 'DDJEHF: JH,/ AJ 4,1) 'DDJEHF HB4H1 'DDJEHF. 5 @ (D3E 'D(J1H: J-*HJ 9DI 2J* #5DJ  'D0J J3(( -3'3J) 'D*E'3. 6 @ 'DA'FJDJ': J4*B EF F('* 'DA'FJDJ' HJ3*./E CE'/) EFCG) AJ 9/) #79E) E+D 'DE+D,'* 'DC9C  'D9DC)  H(96G' J-HJ 'DA'FJDJ' B/ *3(( #C2JE' *E'3 AJ 'D,D/ #H 'D#:4J) 'DE.'7J). 7 @ AJH1HCHE'1JF: JH,/ AJ (96 'DF('*'* E+D 'D*JF H'D(B/HF3  'DE'3*1/ HB/ J3(( 0DC -3'3J) 6J'&J). B/ J8G1 'F/A'9 -E'EJ -HJ5DJ HAB'9J 9DI 'DEF'7B 'D*J 9DI *E'3 E9 G0G 'DEH'/. HG0' 'D'F/A'9 J8G1 (9/ *916 3'(B DDEF7B) 'D*J 9DI *E'3 'DE-33 'D6J'&J D#49) 'D4E3. 8 @ -('* 'D7D9 "Pollens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indane) H Pyrithrum "GH 'DE(J/ 'D#4J9 %-/'+'K DD-3'3J). 'DE(J/'* 'DAH3AH1J) 'D96HJ) #-J'F'K *9*(1 CE-33'*. -3'3J) 1'*F, (2/136)  Epoxy Resin Dermatitis 1'*F,'* "Epoxy "GJ EF 'DEH'/ 'D#C+1 *-33'K 'D*J */.D AJ 'D5F'9) -/J+'K. *3*9ED AJ 'D9H'2D 'DCG1('&J) #H 'DBHD() ('D2,',J 'DDJAJ. *3*./E #J6'K AJ 'D*:DJA H*5AJ- 'DE9'/F H*:DJA 'DE9'/F HEDJ! 'DA1':'* AJ 'D#9E'D 'D#3EF*J). JH,/ #/D) C'AJ) (#F 'DE9'/F H'DE7'7 H'D(HDJ '3*1 H'D3J1'EJC AJ F'8E 'D.7J 'DBD(J (Cardiac pace-makers) H#(1 'D-BF *-* 'D,D/ EF 'D9H'ED 'DE+J1) DD-3'3J). 'D4CD 1BE 191 ': -3'3J) 1'*F, Fig. 191a. Epoxy resin dermatitis 1'*F, "Epoxy " J3*./E AJ 5F'9) 'D(D'3*C E+D 'D-B'&( 'D(D'3*JCJ)  'DBA'2'*  'D5E: H'D/G'F'*. 'D1'*F, 'DE3*./E AJ .JH7 'D(HDJ '3*1 E+D 'D/C1HF HD5B'* 'D(HDJ '3*1 B/ J3*./E AJ 5F'9) 'D-A'8'* HJ9ED C9'ED E-33 J3(( #C2JE'. -3'3J) 'D3E'B Rhus Dermatitis GJ #C2JE' 'DF('*'* *F,E 9F 'D*E'3 'D,D/J E9 (96 'DF('*'* E+D 'D(DH7 @ F('* 'D.D('( H'D*JF H:J1G'. 'DE8'G1 'D31J1J): *8G1 'D#91'6 E('41) (9/ 'D*916 #H B/ J3*:1B 0DC A*1) #7HD -*I J8G1. 'D"A'* 'D,D/J) *(/H (4CD -C) 4/J/) AJ EC'F 'D*E'3 E9 -E'EJ  HH0E) EH69J). 'D-HJ5D'* H'DAB'9'* *-/+ H9'/) .7J) HE*,E9). 'D4CD 1BE 191 (: -3'3J) 'D3E'B Fig.191b. Rhus dermatitis 'D#E'CF 'D#C+1 %5'() GJ 'DEF'7B 'DEC4HA) EF 'D,3E E+D 'DH,G @ 'D#71'A  H'DEF'7B 'DE:7') (#D(3) 1BJB) H'D#,A'F H'D4A'G B/ *5(- E*H0E) *$/J %DI 'D'1*C'3'* 'D#1,J) 'D4/J/) H%DI %:D'B C'ED DD#,A'F. %F *1CJ( 'D-HJ5D'* (4CD .7J 9'/) GH 9D'E) E4.5) D-3'3J) 'D3E'B . GF'C #FH'9 #.1I EF 'D*G'( 'D,D/ E*9DBLacquer Rhus  'D*J *-/+ (H'37) /G'F 'DEA1H4'*  'D.4( Cashew 'D/G'F  'D5EH: 'D5F'9J)  'DH1FJ4 H'D'-E'6 'DE*HA1) AJ 4,1) Ginkgo . (2/137)  B/ *-/+ 'D#C2JE' #J6'K EF (96 'DH1H/ E+D 2G1) 'D1(J9 @ #2G'1 "Chrysanthemum " H2GH1 "Prairie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eaweed Dermatitis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epot Medrol 40mg.) B/ J-*', DG AJ 'D-'D'* 'D4/J/) H'D"A'* 'DEF*41). 6 @ E6'/'* 'DGJ3*'EJF *3*./E DEF9 'D-C). 7 @ 'DAB'9'* B/ *A*- H*3*./E CE'/'* (1EF:F'* 'D(H*'3JHE 1/ 9000 D*,AJAG'. 8 @ 'D9D', (71JB) 'D*79JE 'D*-33J (Desinstization) . 'DE1',9 REFERENCE Kligman AM. Poison ivy (Rhus) dermatitis. Arch Dermatol 1958; 77: 149-80 Malten KE. Tracing back a positive to epoxy resins. Contact Derm 1977; 3: 217. Malten KE. Tracing back a positive to epoxy resins. Contact Derm 1977; 3: 217. Holst R, Kirby J, Magnusson B. Sensitization to tropical woods giving erythema multiforme-like eruphons. Contact Derm 1976; 2: 295 Woods B. Irritant plants. Trans St JohnСs Hosp Dermatol Soc 1962; 48: 75-82. Maibach HI, Epstein WL. Plant dermatitis: fact and fancy. Postgrad Med 1964; 35: 571-4. Mitchell JC, Dupuis G, Geissman TA. Allergic contact dermatitis from sesquiterpenoids of plants. Br J Dermatol 1972; 87: 235-40. Mitchell JC, Geissmann TA, Dupuis G et al. Allergic contact dermatitis caused by Artemisia and Chrysanthemum species. JInvest Dermatol 1971; 56: 98-101. Mitchell JC, Rook AJ. Diagnosis of contact dermatitis from plants. Int J Dermatol 1977; 16: 257-66. Rothenborg HW, Menne T, St3/4lin K-E. Temperature dependent primary irritant dermatitis from lemon perfume. Contact Derm 1977; 3: 37-48. Maibach HI, Epstein WL. Plant dermatitis: fact and fancy. Postgrad Med 1964; 35: 571-4. Mitchell JC, Dupuis G, Geissman TA. Allergic contact dermatitis from sesquiterpenoids of plants. Br J Dermatol 1972; 87: 235-40. (2/139)  Mitchell JC, Geissmann TA, Dupuis G et al. Allergic contact dermatitis caused by Artemisia and Chrysanthemum species. J Invest Dermatol 1971; 56: 98-101. Powell SM, Barrett DK. An outbreak of contact dermatitis from Rhus verniciflua (Toxicondendron vernifluvum). Contact Derm 1986; 14: 288-9. Rook A. Plant dermatitis. Br Med J 1960; 2: 1771-4. Rudzki E, Grzywa A. Immediate reactions to Balsam of Peru, cassia oil and ethyl vanillin. Contact Derm 1976; 2: 360-1 Thune PO, Solberg YJ. Photosensitivity and allergy to aromatic lichen acids and compositae oleoresins and other plant substances. Contact Derm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lloy ('DA6) #H 'DF-'3 E9 'D2&(B) D-4H'* 'D#3F'F HAJ 'D#/H'* 'D3F'FJ). B/ JO-/+ 7AH- E9EE) AJ 'D#4.'5 'DE5'(JF (-3'3J) EF 'D*1CJ('* DD#3F'F #H EH'2JF 'D-1'1) 'DEC3H1). 'D2&(B 'DE9/FJ GH 3(( F'/1 DD-(J(HE 'D,D/J(Cutaneous granuloma) . #ED'- 'D2&(B 'DD'96HJ) -'DJ'K #BD '3*./'E'K C#/HJ) EH69J). (2/141)  'DE1C('* 'D96HJ) *3*./E CE(J/'* H9H'ED E6'/) DD,1'+JE @ AJ 'D2JH* @ 'D/G'F'* H5F'9) 'D#BE4) @ 5F'9) 'DH1B HAJ *(7JF 'D#-0J). #-J'F'K 'DE1C('* 'D96HJ) *3*./E CE'/) -'A8) AJ 'DE-'DJD 'DE9/) DD-BF E+D .D'5'* 'D,'E':DH(JF H'D#6/'/ #H AJ 'DEB49'*  'DC1JE'*  'DE7G1'* 'D,D/J)  'DB71'* 'D9JFJ) HE-'DJD 'D9/3'* 'DD'5B). (H1'* AFJD 'D2&(B (Merfen) E'2'D J3*9ED (C+1) AJ 'DE(J/'* DDA7H1. '3*J'* AFJD 'D2&(B J3*./E AJ (96 B'*D'* 'DF7A 'DEG(DJ) 'D*J B/ *3(( '1*C'3 #1,J. 3DA'J/ 'D2&(B 'D#-E1 (Cinnabar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urrows D. Adverse chromate reactions on the skin. In: Burrows D, ed. Chromium: Metabolism and Toxicity. Boca Raton, Florida: CRC Press, 1983: 137-63 2 Hambly EM, Wilkinson DS. Contact dermatitis to butyl acrylate in spectacle frames. Contact Derm 1978; 4: 115 3 Kirton V, Wilkinson DS. Sensitivity to cinnamic aldehyde in a toothpaste. Contact Derm 1975; 1: 77-80 4 Calnan CD. Nickel dermatitis. Br J Dermatol 1956; 60: 229-36 Christensen OB, M?ller H. Nickel allergy and hand eczema. Contact Derm 1975; 1: l29-35 5 6 Shelley WB, Hurley HJ. The allergic origin of zirconium deodorant granulomas. Br J Dermatol 1958; 70: 75-101. 7 Volden C, Kiokan H, Kauli G et al. Phototoxic and contact toxic reactions to the exocarp of sweet oranges: a common cause of cheilitis? Contact Derm 1983; 9: 201-4. 8 Cronin E. Clinical prediction of patch test results. Trans St JohnСs Hosp Derm Soc 1972; 58: 153-62. 9 Edman B. Sites of contact dermatitis in relationship to particular allergens. Contact Derm 1985; 13: 129-35. 10 Fisher AA. Metal dermatitis - some questions and answers. Cutis 1977; 19: 156, 158, 164, 165 and 169. 11 Fregert S. Occupational dermatitis in a 10-year material. Contact Derm 1975; 1: 96-107. 12 Husain SL. Contact dermatitis in the West of Scotland. Contact Derm 1977; 3: 327-32. 13 MennщЖT, Brandrup F, Thestrup-Pedersen K et al. Patch test reactivity to nickel alloys. Contact Derm 1987; 16: 255-9. 14 Meller H. Intradermal testing in doubtful cases of contact allergy to metals. Contact Derm 1989; 20: 120-3. (2/143)  15 Berger C, Muslmani M, Menezes Brandao F et al. Thin layer chromatography search for Disperse Yellow 3 and Disperse Orange 3 in 52 stockings and pantyhose. Contact Derm 1984; 10: 154-7. 16 Cronin E. Formalin textile dermatitis. Br J Dermatol 1963; 75: 267-73. 17 Cronin E. Studies in contact dermatitis: XVIII. Dyes in clothing. Trans St JohnСs Hosp Derm Soc 1968; 54: 156-64. 18 De Groot AK, Gerkens F. Contact urticaria from a chemical textile finish. Contact Derm 1989; 20: 63-4. 19 Farli M, Gasperini M, Giorgini S et al. Clothing dermatitis. Contact Derm 1986; 14: 316-17. 20 Fisher AA, Kanof NB, Bionchi EM. Free formaldehyde in textiles and paper. Arch Dermatol 1962; 36: 753-6. 21 Fisher AA. The notorious poison ivy family of Anacardiaceae plants. Cutis 1977; 20: 570-95. 22 Mitchell JC, Rook AJ. Diagnosis of contact dermatitis from plants. Int J Dermatol 1977; 16: 257-66. 23 Rothenborg HW, Menne T, Stlin K-E. Temperature dependent primary irritant dermatitis from lemon perfume. Contact Derm 1977; 3: 37-48. 24 Powell SM, Barrett DK. An outbreak of contact dermatitis from Rhus verniciflua (Toxicondendron vernifluvum). Contact Derm 1986; 14: 288-9. 25 Rook A. Plant dermatitis. Br Med J 1960; 2: 1771-4. Rudzki E, Grzywa A. Immediate reactions to Balsam of Peru, cassia oil and ethyl vanillin. Contact Derm 1976; 2: 360-1. 26 27 Thune PO, Solberg YJ. Photosensitivity and allergy to aromatic lichen acids and compositae oleoresins and other plant substances. Contact Derm 1980; 6: 64-71. 28 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980. (2/144)  Edman B. Sites of contact dermatitis in relationship to particular allergens. Contact Derm 1985; 13: 120-35. 29 30 Hodgson CA, Hellier FF. Dermatitis caused by shirts in B.L.A. J Roy Army Med Corps 1946; 87: 110-17. 31 Epstein E, Maibach HI. Ethylenediamine allergic contact dermatitis. Arch Dermatol 1968; 92: 476-7. 32 Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chm 1977; 28: 197-209. 33 Christophersen J, MennE TM, Tanghof P et al. Clinical patch test data evaluated by multivariate analysis. Contact Derm 1989; 21: 291-9. 'DA5D 'D3'/3 H'D941HF 'D*-33 'D,D/J 'DF',E 9F 'DE.14'* 'D#.1I Skin Sensitization due to Other Irritants #C2JE' 'D*E'3 H'D*.1J4 #C+1 4JH9'K 9F/ 'D('D:JF. 1:E #F (96 #FH'9 'DE.14'* J(/H #FG' *3*./E EF B(D 'D('D:JF AB7 H-*I 'D#7A'D AJ 'DHB* 'D-'DJ J4'1CHF 'D('D:JF AJ #9E'D E9FJ). JB/1 #F -H'DJ 250 EDJHF 7AD AJ 'D9'DE J9EDHF (4CD :J1 B'FHFJ AJ 9/) 5F'9'* HJBHEHF (9/) #9E'D .'5) C'D*J JH/JG' 'D('D:HF. F-F FH',G AJ #+F'! EE'13*F' DDEGF) #7A'D'K D/JGE #C2JE' *E'3 EF 'D#3EF*  'D/J2D  'DEF8A'* H(96 'D#FH'9 'D#.1I. HDG0' 'D3(( *E 0C1 G0G 'D#FH'9 EF 'D-3'3J). (96 'DE.14'* 'D#.1I 'DE*HA1) HDG' 'DB/1) 9DI %-/'+ #C2JE' *E'3 H*.1J4 GJ: Fig.195.a,b,c,d."The youngest welder" : 10 years old child misused as a metal welder without the minimal protective safety measures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usol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hoe Dermatitis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loom,s shoes" . 3 @ '3*./'E ,H'1( E5F9) EF 'DB7F E'5 DD91B. 4 @ E9'D,) A17 'D*91B. 'DE9'D,) 'DA9'D) GJ FA3G' 'DE7(B) AJ 'D#FH'9 'D#.1I EF #C2JE' 'D*E'3. -3'3J) 'D,H'1( Stocking Dermatitis #5(:) 'D@ Azo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ermacil, Sterr Strip" H(D'3*1 "Band AID. 'DE1',9 Raesaenen L, Lehto M, Reunala T. Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis. Arch Dermatol Res 1987; 279: 215-18. 1 Zesch A. Adverse reactions of externally applied drugs and inert substances. Dermatosen 1988; 36: 128-33. 2 Hezemans-Boer M, Toonstra J, Meulenbelt J et al. Skin lesions due to exposure to methyl bromide. Arch Dermatol 1988; 124: 917-21. 3 Hostynek JJ, Patrick E, Younger B et al. Hypochlorite sensitivity in man. Contact Derm 1989; 20: 32-7. 4 Jackson EM, Goldner R, eds. Irritant Contact Dermatitis. New York: Marcel Dekker, 1990. 5 Middleton JD. The mechanism of action of surfactants on the isolated stratum corneum. J Soc Cosmet Chem 1969; 20:399-412. 6 (2/149)  Pryce DW, White J, English JSC et al. Soluble oil dermatitis: a review. J Soc Occup Med 1989; 39: 93-8. 7 Rycroft RJG. Soluble Oil as a Major Cause of Occupational Dermatitis. Cambridge: University of Cambridge, 1982 (dissertation). 8 Verbeck SJA, Buise-van Unnik EMM, Malten KE. Itching in office workers from glass fibres. Contact Derm 1981; 7: 354. 9 Fisher AA. Contact Dermatitis, 3rd edn. Philadelphia: Lea and Febiger, 1986. 10 Foussereau J, Benezra C, Maibach HI. Occupational Contact Dermatitis. Copenhagen: Munksgaard, 1982. 11 Fregert S. Manual of Contact Dermatitis, 2nd edn. Copenhagen: Munksgaard, 1981. 12 Caron GA, Calnan CD. Studies in contact dermatitis XIV. Resorcin. Trans St JohnСs Hosp Dermatol Soc 1962; 48: 149-56. 13 Correia S, Menezes Brand?o F. Contact dermatitis of the feet. Dermatosen 1986; 34: 102-5. 14 Sugai T, Yamamoto S. Decrease in the incidence of contact sensitivity to formaldehyde. Contact Derm 1980; 6: 154. 15 Cronin E. Studies in contact dermatitis: XIX. Nylon stocking dyes. Trans St JohnСs Hosp Derm Soc 1968; 54: 165-9. 16 Dahl MV. Allergic dermatitis from footwear. Minnesota Med 1975; 58: 871-4. 17 Fisher AA. How to obtain shoes free of common sensitizers. Cutis 1973; 12: 678. 18 (2/150)  'DA5D 'D3'(9 H'D941HF 'D*G'( 'D,D/ 'D2GEJ Seborrheic dermatitis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xfoliative dermatitis) #H -E'EJ E9EE) (Erythroderma) *91A ('3E /'! (Leiner's disease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nfantile seborrheic dermatitis 'D*G'( 'D,D/ 'D2GEJ 'D7ADJ GH E57D- J3*./E DH5A (96 'D#E1'6 'D,D/J) 'D2GEJ) 'DE.*DA) E+D B(9) 'DEG/ (Cradle cap)  "A'* 'D+FJ'* @ 'D5/'A 'D7ADJ H*F'01 "D'JFJ1". E9/D -/H+ 'D-3'3J) 'D'3*41'&J)(Atopic dermatitis) E9 'D*G'( 'D,D/ 'D2GEJ 9'DJ ,/'K EE' J*HB9 #F (96 'D#7A'D 'DE5'(JF ('D*G'( ,D/ 2GEJ EF 'DEECF #F JCHF D/JG B'(DJ) DD-3'3J) 'D'3*41'&J). 'D,1'+JE 'DA71J) " P. ovale " GJ ,2! EF ADH1' 'D,D/ 'D7(J9J) B/ JCHF DG' /H1 AJ -/H+ 'DE16 HG0' JD'-8 F*J,) D'3*,'() 'D'D*G'( 'D,D/ 'D2GEJ DDCJ*HCHF'2HD EH69J'K. (3/2)  E9'D,) 'D*G'( 'D,D/ 'D2GEJ: 9F/ 'DHD/'F H'D#7A'D 'D5:'1 B/ **7D( AB7 #/HJ) .AJA) ('DEB'1F) E9 'D('D:JF. "A'* 'D,D/: "A'* .AJA) AJ 'D,D/ *.A 9'/) (H'37) E1GE 'DGJ/1HCH1*J2HF. 'D-'D'* 'DE9*/D): E1GE GJ/1H CH1*J2HF E4'1C) E9 (Lococorten vioform , Pufexamac, flogocid)) #H 'DE1C('* 'D-/J+) E+D E1C('* "'D#2HD". 'D-'D'* 'D4/J/): 'D3*J1HJ/'* 'DEADH1) B/ *3*9ED ".0JF (9JF 'D'9*('1 'D*#+J1'* 'D,'F(J). 'DE3*-61'* 'DEH69J) ('DE4'1C) E9 E6'/'* 'D-JHJ) #H 'D'J*1'CHF'2HD JECF #F J3*./E AJ 'D-'D'* 'DE.*D7) ('F*'F A71J #H ,1+HEJ +'FHJ. AJ E98E 'D-'D'* EF 'D*G'( 'D,D/ 'D2GEJ 9F/ 'D169 H'D#7A'D JECF '3*./'E: "Pufexamac ," "Flogocid cream. G0' 'DE1C( .'DJ EF 'D3*J1HJ/'* HGH A9'D #J6'K CE6'/ A71J HE6'/ ,1+HEJ. HG0' 'D/H'! "EF HA9'D HJ97J F*'&, ,J/). "A') 'DA1H): 'D-'D'* 'D.AJA): B/ *-*', 4'E(H (3J7 H.AJA E+D :"Nizoral or zincon shampoo" HJ3*9ED E1) CD JHEJF #H -3( 'D-'D). 'D-'D'* 'DE*H37): E-DHD GJ/1HCH1*J2HF (Lococorten lotion , Locoid scalp lotion) E9 4'E(H .AJA. 'D-'D'* 'D4/J/): CH1J*CH 3*J1HJ/ EADH1 (4CD E-DHD B/ F-*', DG DE9'D,) 'D-'D'* 'DE*C11) H'DE2EF) HB/ *3*AJ/ C0DC EF 'D4'E(H 'D-'HJ 9DI 'DB71'F E+DPolytar or zincon shampoo)). 'D*G'( 'D,D/ 'D2GEJ AJ 'D#,A'F: 4'E(H .AJA E+D 4'E(H 'D#7A'D 9/) E1'* HJ7(B E1GE 9JFJ GJ/1HCH1*J2HF E1*JF JHEJ'K DA*1) B5J1). JECF '3*./'E 4'E(H (Nizoral) DD#7A'D 'D#C(1 H'D('D:JF DA*1) B5J1) HB/ J97J F*'&, ,J/)  3DA'* 'D3DJFJHE 4'E(H (Selsun) GH A9'D AJ 'D*G'( 'D,D/ 'D2GEJ. 'D'3*./'E 'DE*C11 DE+D *DC 'D4'E(HF'* B/ J3(( *3'B7 491 HJ,( 'D'F*('G DD9JF #+F'! :3JD 'DA1H) D#F 'D4'E(H B/ J$/J D-/H+ -3'3J) '$ 'D*G'('* ('D9JF H'D,AHF. (3/3)  'D*G'( 'D,D/ 'D2GEJ AJ 'DA1H) 9'/) J.*D7 ('F*'F ,1+HEJ +'FHJ E+D 'D*G'( 'D#,1(). E-DHD E6'/ -JHJ E+D 'D'1J+1HE'J3JF (Eryderm) #H 'DCDJF/'E'J3JF (Dalacin T lotion) JECF #F J7(B E1*JF JHEJ'K 9DI 'DA1H). 'D'F*'F'* 'D,1+HEJ) DDA1H) J,( E9'D,*G' B(D '3*9E'D 'D3*J1H&J/'* 'DB41J) -J+ #F G0G 'DE1C('* B/ *$/J %DI *A'BE 'D-'D). 'D3J71) 9DI 'D'F*'F'* 'D,1+HEJ) ('3*9E'D 'D5'/'* 'D-JHJ) AEHJ'K E+D 'D3JA'DH3(H1JF  'D'1J+1H3JF #H "Zithromax" B/ *3*7( AJ 'D'F*'F'* 'DH'39) H'D4/J/). 'D/HC3J 3CDJF @ 'DEJFH3CDJF H'D**1'3CDJF D'*97J DD#7A'D DCF GJ 0'* *#+J1 ,J/ 9F/ 'D('D:JF. B(9) 'DEG/ (7'BJ) 'DEG/ ) Cradle cap GJ 4CD .AJA EF 'D*G'( 'D2GEJ  J5J( 'D169 'D-/J+J 'DHD'/). *(/H 'DE8'G1 'D,D/J) (4CD B4H1 /GFJ) ED*5B) *5J( BE) 'DA1H)  **1'AB 9'/) E9 'D/.FJ'* (Milia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exalocal , Locosalon) JECF *7(JBG (D7A HB/ J97J F*'&, ,J/). 'D-'D'* 'DE.*D7) ('F*'F ,1+HEJ #H A71J +'FHJ JECF E9'D,*G' ('3*./'E 'DE6'/'* 'D,1+HEJ) 'DEH69J) E+D "Muperacin " C1JE #H E6'/ A71J EH69J E+D 'D'J*1'CHF'2HD C1JE . /'! D'JFJ1 (#-E1J) D'JF1) Leiner's disease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ig.208 Leiner's disease J*EJ2 'DE16 ('DE8'G1 'D*'DJ): 1 @ 'D*G'( ,D/ 2GEJ E9EE. 2 @ %3G'D 4/J/ E9F/. 3 @ G2'D 4/J/ HF-HD. 4 @ 'F*'F'* EH69J) H,G'2J) E*C11). 5 @ /'! D'JFJ1 'D9'&DJ E9 3H! H8JA) C5 J9*(1 E16'K .71'K B/ JG// -J') 'D7AD. 'DE9'D,): E98E 'D-'D'* 4/J/) *-*', %DI '3*4A'!. *H'2F 'D3H'&D H'D4H'1/. (D'2E' 7'2,). 3*J1HJ/'* H5'/'* -JHJ). %6'A'* :0'&J) DDAJ*'EJF B 'DE1C( (E' AJG 'D(JH*JF EGE. 'DE1',9 Bonifazi E. Infantile seborrheic dermatitis: pathogenetic considerations and nosological aspects. Pediatr Dermatol News 1988; 7: 16-21 1 (3/5)  Yates VM, Kerr Rei, Mackie R. Early diagnosis of infantile seborrheic dermatitis and atopic dermatitis-clinical features. Br J Dermatol 1983; 108: 6338 2 Prince GE. Erythroderma desquamativa of the newborn infant. J Pediatr 1955; 47: 475-80 3 Miller ME, Koblenzer PJ. Leiner's disease and deficiency of C5. J Pediatr 1972; 80: 879-80 4 Evans DIK, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner's disease). Arch Dis Child 1977; 52: 691-5 5 'DA5D 'D+'EF H'D941HF #FH'9 #.1I EF -3'3J) 'D,D/ 'D'C2JE' 'D'F*'FJ) Infective Dermatitis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lantar eczema) : 9F/ 'D#7A'D J,( *EJJ2 G0G 'D-'D) 9F 'D,D'/ 'D-E6J 'D4('(J(Juvenile plantar dermatoses) . 39A) 'DB/E (T. pedis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iscoid eczema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ocasalene or Diprosalic ointment" (4CD E1GE .'5) AJ 'D"A'* 'D,D/J) 'D,'A) (Diprosalic ointment) H(,( ED'-8) %F G0' 'DE1GE BHJ ,/'K HD'J51A DD#7A'D CE' %FG J,( 9/E H69G 9DI EF'7B 'D,D/ 'D1BJB) E+D 'DH,G  +F'J' 'D,D/ H'DEF7B) 'D*F'3DJ) %0 B/ J3(( E6'9A'* :J1 E1:H(). E3*-61'* E6'/'* 'DGJ3*'EJF E+D: (Cetrizine,Zyrtec tablets or syrup) *97J D9/) #J'E HJA6D B(D 'DFHE -J+ *CHF 'D-C) #4/. AJ (96 'D#-J'F ('D%6'A) 'DI 'DFH9 'D#HD B/ F97J E6'/'* EF FH9 ".1 EF 'DGJ3*'EJF AJ -'D'* 'D-C) 'D4/J/) 'D*J D'*3*,J( DD9D', 'D#HD. 'D3*J1HJ/'* 'DB41J) AEHJ'K #H ('D96D F'/1'K E'JD2E AJ 'D#C2JE' 'DB15J). #C2JE' 931 'D*91B (AB'9'* 'D#71'A) Dyshydrotic eczema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uvenile plantar dermatoses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etrolum " #H 'DA'2DJF DA*1) 7HJD) 9DI 'D,D/. 4 @ 3*J1HJ/'* B41J) EH69J'K .AJA) DH-/G' #H ('DE4'1C) E9 -E6 'D5A5'A *3*./E DA*1) B5J1) HB/ J97J F*'&, ,J/). 5 @ 'DADH1HJH1'3JD JECF #F *97J (:6 'DF*'&, 9F/ 'D#7A'D 'DC('1. 6 @ AJ*'EJF A 'D-'E6J "Retonic Acid" EH69J 'DAJ*'EJF" A " AEHJ'K DA*1) B5J1). (3/10)  'D'C2JE' 'D1CH/J) (Stasis Dermatitis) GJ #C2JE' .'1,J) 'DEF4# *1*(7 ('671'('* H9'&J) E9 B5H1 H1J/J HGJ #C+1 4JH9'K 9F/ 'D#9E'1 'DC(J1). 'DE8'G1 'D,D/J) 9'/) *8G1 9DI #3AD 'D3'B AJ 'DH,G 'D/'.DJ AHB 'DC9( 'D#F3J. 'D4CD 1BE 219: #C2JE' 1CH/J) *8G1 'D"A) (4CD -E'EJ #H H0EJ #H E21B (3(( 'D'-*B'F 'DEH69J HB/ **1'AB E9 -C) .AJA)  *-22  *B1- HA17 *5(:. 'DE1',9 Parish WE, Welbourn E, Champion RH. Hypersensitivity to bacteria in eczema. IV: Cytotoxic effect of antibacterial antibody on skin cells acquiring bacterial antigens. Br J Dermatol 1976; 95: 493-506 1 Parish WE, Welbourn E, Champion RH. Hypersensitivity to bacteria in eczema. Titre and immunoglobulin class of antibodies to staphylocci and micrococci. Br J Dermatol 1976; 95: 285-93 2 Weismann K, Hjorth N. Microbial eczema of the feet. Br J Dermatol 1982; 107: 330-7 3 Welbourn E, Champion RH, Parish WE. Hypersensitivity to bacteria in generalized eczema. I: Bacterial culture, skin tests, and immunofluorescent detection of immunoglobulins and bacterial antigens. Br J Dermatol 1976; 94: 619-25 4 Bendl BJ. Nummular eczema of stasis origin: a morphological pattern of diverse etiology. Int J Dermatol 1979; 18: 129-35 5 Calnan CD, Meara RH. Discoid eczema - dry type. Trans St John's Hosp Dermatol Soc 1956; 37: 26-8 6 Cowan MA. Nummular eczema - a review, follow-up and analysis of 325 cases. Acta Derm Venereol 1961; 41: 453-60 7 Rollins TG. From xerosis to nummular dermatitis. J Am Med Assoc 1968; 206: 637 8 Ashton RE, Griffiths WA. Juvenile plantar dermatosis - atopy or footwear? Clin Exp Dermatol 1986; 11: 529-34 9 (3/11)  Graham RM, Verbov JL, Vickers CFH. Juvenile plantar dermatosis. Clin Exp Dermatol 1987; 12: 468 10 Jones SK, English JSC, Forsyth A et al. Juvenile plantar dermatosis - an eight year follow-up of 102 patients. Clin Exp Dermatol 1987; 12: 5-7 11 Mackie RM. Juvenile plantar dermatosis. Semin Dermatol 1982; 1: 67-75 M"ller H.Atopic winter feet in children. Acta Derm Venereol 1972; 52: 401-5 12 Shrank AB. Aetiology of juvenile plantar dermatosis. Br J Dermatol 1979; 100: 641-6 13 Stankler L. Juvenile plantar dermatosis in identical twins. Br J Dermatol 1978; 99: 585-6 14 Hersle K, Mobacken H. Hyperkeratotic dermatitis of the palms. Br J Dermatol 1982; 107: 195-202 de Boer EM, Bruynzeel DP, Van Ketel WG. Dyshidrotic eczema as an occupational dermatitis in metal workers. Contact Derm 1988; 19: 184-8 15 Duhra P, Ryatt KS. Haemorrhagic pompholyx in bullous pemphigoid. Clin Exp Dermatol 1988; 13: 342-3 16 Burton JL. Venous `stasis' ulcers, stasis dermatitis and mothers' political ambitions for their offspring: Reply Br J Derm 1990; 122: 715-16 17 Fraki JE, Peltonen L, Hopsu-Havu VK. Allergy to various components of topical preparations in stasis dermatitis and leg ulcers. Contact Derm 1979; 5: 97-100 18 Breit R. Allergen change in stasis dermatitis. Contact Derm 1977; 3: 309-11 19 Ryan TJ. Venous stasis ulcers, stasis dermatitis and mothers' political ambitions for their offspring. Br J Dermatol 1990; 122: 715 (letter) 20 (3/12)  'DA5D 'D*'39 H'D941HF 'D41J H'D#E1'6 'D-E'EJ) Erythemas And Urticaria 'D-E'EJ Erythema 'D-E'EJ *9FJ %-E1'1 'D,D/ 'DF',E 9F *H39 'D#H9J) 'D/EHJ)  HG0' B/ J$/J %DI '-*B'F AJ EF7B) E9JF) EF 'D,D/ '3*,'() D9H'ED /'.DJ) 'DEF4# #H .'1,J) 'DEF4#. 'D-E'EJ GJ #HD E8'G1 'D#E1'6 'D,D/J) HB/ *CHF EH69J) #H E9EE). 'D#4C'D 'D31J1J) DD-E'EJ: 1 @ 'D-E'EJ 'DEH69J): G0' 'D4CD J5J( (96 'DEF'7B H*F,E 9F 9H'ED E.*DA). GF'C 9/) #3E'! 31J1J) *5A 'D-E'EJ 'DEH69J) EFG': 'D-E'EJ 'D1'-J)(Eryhema palmare) : AJ 'D1'-*JF  B/ *8G1 (3(( *4E9 'DC(/. -E'EJ 'D#1A'9(Erythema intertrigo) : -E'EJ AJ EF'7B 'D+FJ'* ('DE:(FJ)) F',E) 9F A17 'D'-*C'C H'D*91B. -E'EJ 'D41+(Erythema pernio) : F',E) 9F 'D*916 DD(1/ H*5J( 'D#5'(9. 'D-E'EJ 'D-1'1J) (Erythema caloricum): -E'EJ 'D'57D'! *-/+ (3(( 'D*916 D#J FH9 EF 'D-1'1). -E'EJ 'D4E3(Erythema solare) : -E'EJ F',E) 9F 'D*916 D#49) 'D4E3. #FH'9 #.1I EF 'D-E'EJ B/ *8G1 C'3*,'() D#FH'9 E9JFG EF 'D79'E  'DEH'/ 'DCJE'HJ) 'D#/HJ)  'DDB'-'* @ '671'('* 'DE9/J) 'DE9HJ) H9/E +('* 'DE-1C 'DH9'&J 'D/EHJ (Vasomotor instability) . 2 @ 'D-E'EJ 'DE9EE): G0' 'D4CD E9EE J5J( EF'7B H'39) EF 'D,D/ *F,E 9F 9H'ED ,G'2J). *8G1 'D-E'EJ 'DE9EE) (9/ #4C'D E.*DA). 'D-E'EJ 'D*3EEJ) 9F/ 'DHDJ/ Toxic erythema of the new born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ncontinentia Pigmenti) . *BJ- 'D,D/ 'D(+1J 9F/ 'DHDJ/: *(/J 'D(+1'* .D'J' (J6'! E9*/D'*  (JFE' 'D(+1'* AJ 'D-E'EJ 'D3EJ) 9F/ 'DHDJ/ EEDH!) ('D-E6J'* H*CHF ,1'(J) HE'-HD ,1'(J). 'DD7'.'* 'D-E'EJ) *(/J '1*4'- E'-HD 'D#H9J) .AJA EF 'D-E6'*. 'DE9'D,): 'D71B 'D/'9E) H'D916J) -J+ #FG D'JH,/ E9'D,) FH9J)  9'/) 'D"A'* 'D,D/J) *2HD .D'D 9/) #J'E. 'D-E'EJ 'D7A-J) Exanthematous erythema 9/) #4C'D EF 'D#E1'6 'D7A-J) **8'G1 (-E'EJ E*FH9) HFH9J) DCD E16. 'D#E1'6 'D,1+HEJ) H'DAJ1H3J) GJ 3(( 4'&9 DD-E'EJ 9F/ 'D169 H'D#7A'D 'D5:'1 @ 'D-5() @ 'D-E'EJ 'D'F*'FJ) ('DE16 'D.'E3) 'DH1/J) @ 'D-EJ 'DA1A1J) @ H(96 'D#FH'9 'D-E'EJ 'DE9EE). 'D-E'EJ 'D'F*'FJ) ('DE16 'D.'E3) (/'! E'1:'1JF) Erythema infectiosum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rythema multiforme GJ *F'01 A17 'D*-33 JF,E 9F *A'9D 6/ @ E3*6/ (Antigen antibody reaction) HB/ J5J( 'D,D/ H'D#:4J) 'DE.'7J) H'D#96'! 'D/'.DJ). *F'01 3*JAF ,HF3HF GH 4CD 31J1J 4/J/ H-'/ EF 'D-E'EJ 9/J/) 'D#4C'D. 'D4CD 1BE 220# : -E'EJ E*9// 'D#4C'D 'D4CD 1BE 220, : -E'EJ E*9// 'D#4C'D 'D4CD 1BE 220( : -E'EJ E*9// 'D#4C'D Fig.219 Erythema multiforme 'D4CD 1BE 220/ : -E'EJ E*9// 'D#4C'D Fig.219 Erythema multiforme 'DE8'G1 'D31J1J): *(/H 'D"A'* 'D,D/J) (4CD D7'.'* E/H1) E1*4-) BDJD'K (DHF #1,H'FJ :'EB #H #21B A'*-  E*F'81)  0'* EJD DD'F*4'1 E-J7J'K. B/ J8G1 #4C'D E.*DA) EF 'D-E'EJ 9/J/) 'D#4C'D H0DC J9*E/ 9DI 4CD H4/) 'D*A'9D: B/ JCHF 'D"A'* D7'.J)  -7'7J)  9B/J)  -HJ5DJ) #H AB'9J) E4CD) #4C'D'K E.*DA) E+D 'D-DBJ @ 'DE/H1 @ "A'* E/A3J) 'D4CD H#4C'D A1A1J) H41HJ). 'D"A) 'DG/AJ) 'D4CD ('DB2-J)) 'D,2! 'DE1C2J EF 'D"A) J(/I 9'/) 'F.A'6'K AJ H37G' H*CHF 0'* DHF 1E'/J E21B J91A ('3E "'D"A) 'DB2-J) 'D4CD "(Iris lesion) HGJ 9'/) EEJ2) D-E'EJ 9/J/) 'D#4C'D. -E'EJ E*9// 'D'4C'D 'D#E'CF 'D#C+1 %5'() GJ 'D8G1 'DJ/JF H'D#5'(9 H'DB/EJF. 'D4CD :Hebra J*EJ2 ('1*C'3'* -E'EJ) -7'7J)  41HJ)  AB'9J) H-*I F2AJ) *8G1 9DI 'DEF'7B 'D,D/J) 'DE916) DD4E3  H'D"A'* 'D,D/J) *#.0 4CD 'DB2-JG 'DEEJ2. 'D#:4J) 'DE.'7J) 9'/) *5'(  HG0' 'D4CD E*C11 HJ3(B 9'/) ('D9B(HD 'D(3J7 'D4AHJ B(D (/! 'D-E'EJ. 'D4CD 'DD7'.J 'D-7'7J: (3/15)  -E'EJ D7'.J) -7'7J). H'6-) 'D-H'A *F*41 F-H 'DE-J7 E4CD) (B9 9/J/) 'D-DB'* E9 4A'! E1C2J H*CHF 'D#4C'D 'DB2-J) 'DE.*DA) H'6-) AJ G0' 'DFH9. 'D4CD 'DAB'9J: B/ *(/J 'D"A'* 'D,D/J) AB'9'* F2AJ) 9DI B'9/) -E'EJ). 'D4CD 'DAB'9J 'D-HJ5DJ: -HJ5D'* E*F'+1) #H E*,E9) E-'7) (B'9/) -E'EJ) B/ *4.5 .7# 9DI #FG' "A'* 9B(HDJ). 'D4CD 'DD7'.J 'D-7'7J: "A'* 'D,D/ *8G1 (4CD D7'.'* -E1'! E21B) E*H0E) #H D7'.'* E37-) 0'* EJD DD'F*4'1 F-H 'DE-J7. *F'01 3*JAF ,HF3HF Steven's-Johnson syndrrome J9*(1 G0' 'DFH9 4CD 4/J/ EF 'D-E'EJ 9/J/) 'D#4C'D HJ*8'G1 (#91'6 ,D/J) H('D#:4J) 'DE.'7J) H'D#-4'! 'D/'.DJ). 'DE8'G1 'D9'E): B/ J(/J 'DE16 (E8'G1 (FHJ) 4/J/)  -J+ #F 'D4/) H'D%F0'1 J9*E/ 9DI 'D9E1 H3(( 'DE16 H'D9D', 'DE(C1. 'D#91'6 'D(FHJ): -EI @ 5/'9 @ /9+ H#DE -'/ AJ 'DAE H'D(D9HE. B/ J*8'G1 'DE16 (E8'G1 4/J/) E+D *319 'DF(6 @ 69A 9'E @ *319 'D*FA3 @ #DE ('DEA'5D H'D*91B. B/ JCHF G0' 'D*F'01 B'*D'K. 'D#:4J) 'DE.'7J): 'D*G'( 'DAE HGH E8G1 ('C1 HB/ JCHF E4.5'K. *8G1 'D#:4J) 'DE.'7J) *B1-'K HF2A'K HF2HD 'DD9'( HH0E) EE' B/ J*/.D 0DC AJ 'D41( H'D*:0J). 'D*G'( 'DED*-E)  *B1- 'DB1FJ) H'D*G'( 'D#FA H'D19'A GJ E8'G1 'D#:4J) 'DE.'7J) 'D4'&9). 'DE8'G1 'D,D/J): *8G1 'D"A'* 'D,D/J) (4CD -E'EJ 9/J/) 'D#4C'D D7'.J) E9 '1*C'3 -HJ5DJ #H -7'7J #H B2-J 'D4CD. *E2B 'DAB'9'* J$/J %DI 37- ,D/ E*B1- E*"CD H*2/'/ B'(DJ*G DD'F*'F'* 'D+'FHJ). 'DF2HA *-* 'D#8'A1 4'&9). 'D(1A1J'* E8G1 4'&9 DD4CD 'D4/J/. B/ *CHF 'D-C) 4/J/) ,/'K. 'DE3(('*: 9/) 9H'ED *$/J 'DI *F'01 3*JAF @ ,HF3HF. 'DC+J1 EF 'D-'D'* E,GHD) 'D3((. (96 EE'JDJ B/ J3(( 'D*F'01: 1 @ 'D'F*'F'* 'D,1+HEJ): /A*1J' @ (1H3JD' @ 'D*/1F @ -EI 'D*JAJH&J/ H0'* 'D1&). (3/16)  2 @ 'D'F*'F'* 'DAJ1H3J): 'D-5() @ 'D9B(HD @ DB'- 'D,/J1J @ 0'* 'D1&) 'DAJ1H3J) #H 'D'FADHF2' 'D"3JHJ). 3 @ 'D'F*'F'* 'DA71J): 'DA7'1 'DC1H'FJ @ /'! 'DEF3,'*. 4 @ 'D'F*'F'* ('D#H'DJ: 'DED'1J' H'D*1JCHEHF'3. 5 @ #E1'6 'D:1'!: 'DF/() 'D-E'EJ) 'D,G'2J) H'DB1J5J). 6 @ 'DDB'-'* : BCG @ 'D,/J1J @ 4DD 'D#7A'D. 7 @ 'D#/HJ): (F3DJF @ 3DAHF'EJ/'* @ *1JE+H(1JE @ 'D3DD'3JD'*. 'DAJFH('1(J*'D @ 'D('1(J*H1'* @ .'A6'* 'D-1'1) H'DGJ/1'2JF. 8 @ *F'01 DHAD1 B/ J*1'AB E9 'D-E'EJ 9/J/) 'D#4C'D. 9 @ *:J1'* G1EHFJ). 10 @ 'D*E'3'* 'D,D/J) 'D#1,J): #C2JE' (Rhus)'D3E'B H'D'AF, 'DF'1J (Fire Sponges) . 11 @ 'D#E1'6 'D.(J+): DEAHE'* @ C'13JFHE'* @ %-E1'1 'D/E ('DC8) 'D/EHJ)) H'DH1E 'DFBHJ H/'! GH/,CF2. 'D*41J- 'DE16J: '1*4'- 'D*G'(J AJ #9DI 'D#/E). 'F*A'. HH0E) AJ 'D(41) H'D#/E). '1*4'- 'D*G'(J -HD 'D#H9J) 'D/EHJ) 'DE*H39). C1J'* -E1'! .'1, 'D#H9J). 'D*4.J5 'D*A1JBJ: 'F-D'D 'D(41) 'DF.1J 'D3EJ. #C2JE' 'D*E'3 'DAB'9J). 'DAB'9 H'D/'! 'DAB9'FJ. 'D0&() 'D-E'EJ) 'D,G'2J) 'DAB'9J). 'DE9'D,): *9*E/ 'DE9'D,) 9DI 'D3(( H4/) 'DE8'G1 'D31J1J). 'D-E'EJ 'DE1*A9) 'D/'&E) Erythema elevatum diutinum **EJ2 (9BJ/'* E/H1) -E1'! E1*A9) E$DE) **1*( (#4C'D -DBJ). 'D#E'CF 'D#C+1 %5'() GJ 'D37H- 'D('37) EF 'D#71'A H'DJ/JF. 'D9BJ/'* 0'* 37- #ED3 0H 'F.A'6 E1C2J  H'D' F/A'9 0H 3J1 E2EF B/ JF*41 %DI 'DAE  HD'*-/+ %5'() ('D#:4J) 'DE.'7J) H'D-'D) 'D9'E) DDE1J6 D'**#+1. 'D-E'EJ 'D9B/) Erythema nodosum **EJ2 (9BJ/'* -E1'! A'*-) HE$DE) HE*F'81) E.*DA) 'D#-,'E  #4J9 E'*CHF 9DI 'D37H- 'D('37) DD3'BJF  B/ J3(B 8GH1 'D'F/A'9 (96 'D#91'6 'D(FHJ) 'D.AJA) E+D 'D-EI  'D/9+ H'D#DE 'D96DJ H'DEA5DJ H'DE16 E-// DFA3G. (3/17)  ('D-E'EJ 'D9B/) B/ FHB4* AJ A5HD #.1I) 'D-E'EJ 'DE2EF) 'DG',1) Erythema chronicum migrans G0' 'D4CD JF,E 9F D/: 'D-41'* E+D 'DB1'/. J8G1 'D'1*C'3 'D-E'EJ (4CD .H'*E EF*41) F-H 'DE-J7 E9 -H'A E1*A9) HE1C2 4'-(. 'D4CD 1BE 221# : 'D-E'EJ 'DE2EF) 'DG',1) 'D-E'EJ 'D-DBJG 'D1+HJ) Erythema annulare rheumaticum G0' 'DFH9 4'&9 9F/ 'D#7A'D 'DE5'(JF ('D-EI 'D1+HJ) H'D*G'( 'D4A'A 'DBD(J 'D1+HJ. *8G1 'DE8'G1 'D,D/J) (4CD .H'*E (DHF #-E1 4'-( (-,HE E.*DA) H#4C'D E.*DA). 'D#E'CF 'D#C+1 %5'() GJ 'DA./JF  'D(7F H'D5/1 H'D8G1. 'D-E'EJ 'D-DBJ) 'DF'(0) Erythema annulare centrifugum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rythrodema 'D#-E1J) 'D,D/J) *9FJ %-E1'1 'D,D/ E9 *B41 ,D/J HB/ *CHF (/'&J) #H +'FHJ) *-/+ AJ 3J'B #E1'6 ,D/J) E.*DA). 'D#-E1J) 'D(/'&J): 'D#-E1J) 'D*B41J) (/'! D'JF1) (3/18)  'D#-E1J) 'DE*1'AB) E9 'DDEAHE'*  /'! GH/,CF @ 'DA7'1 'DA71'FJ (Mycosis fungoides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menn's ". 'D#C2JE' 'D*#(*J) 'D#-E1J). 'D5/'A. 'D41I Urticaria (3/19)  GH '1*C'3 ,D/J H9'&J 4'&9 J*EJ2 (8GH1 DH-) 'D41I/ Wheals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gE ". GF'C 9/) 9H'ED E.*DA) JECF #F *3(( 'D41I 'DEF'9J H#GEG': 'D79'E J3(( '6/'/ FH9J). 'D/J/'F 'DE9HJ). 9H'ED AJ2J'&J) F',E) 9F #49) 'D4E3 @ 'D-1'1) @ 'DE'! @ 'D6:7. 'DH0E) 'DH9'&J) 'D9'&DJ). 2 @ 'D41I 'DD'EF'9J: G0' 'D4CD F',E 9F EH'/ *$+1 E('41) E-/+) %2'D) *-(( 'D.D'J' 'D(/ JF)(Mast cells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erum protein electrophoresis) . H8'&A 'D:/) 'D/1BJ). 9J'1 IgE . '.*('1 RAST . 'D(HD DC4A 'F*'F E*HB9. H8'&A 'DC(/. 'DE3*6/ 'D37-J D'D*G'( 'DC(/ B . 'D#6/'/ 'D0'*J). *-1J 'DE*EE) (E' AJG' E+(7)" C1 " '3*1J2. *-DJD 'D(1'2 DC4A #J 7AJDJ'*. 5H1) 'D5/1 H'D,JH( 'D#FAJ) D*-/J/ #J ($1) 'D*G'(J). '.*('1'* 'D*-14 ('D*'1*1'2JF @ H#6/'/ 'DE(J6'* B/ *CHF 0'* BJE) 9F/ 'D#7A'D 'DC('1. #FH'9 'D41I JH,/ 9/) #FH'9 EF 'D41I: 'D41I 'DCHDJFJ 'DA9D(Cholinergic) . 'D41I 'DFA3J. 'D41I 'D9'&DJ. 'D41I 'D0'*J (E,GHD 'D3((). 'DH0E) 'DH9'&J) 'D95(J). 'D41I 'D5(':J(Urticaria pigmentosa) . 'D41I 'D-7'7J(Papular urticaria) . 'D41I 'DAB'9J. 41I 'D'3*F4'B. 'D41J 'DAJ2J'&J (3/21)  'D9H'ED 'DAJ2J'&J) E+D 'D(1/ H'D-1'1) H'D4E3 B/ *+J1 G0' 'DFH9 EF 'D41I. 41I 'D(1/: B/ JF*BD H1'+J'K C5A) ,3EJ) E3J71). *8G1 'D"A'* 'D,D/J) (4CD 41I (Wheal02npъ·№д╩:!J!L!Р'о'╓'·'d(о(╓(ф(ц(Ў()^)╓)Ў)*8*Ж,д,к,ўс╨║зЩГrЩeЩГTЩeЩeЩeЩeЩeЩeЩeЩeЩeЩ!jиhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!jhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ$hЁqphЁqp5БCJ$ZБ\Б^JaJ$o(*hЁqphЯ[╓5БB*CJ$ZБ\Б^JaJ$ph !hЁqphЯ[╓5БCJ$ZБ\Б^JaJ$*hЁqphЯ[╓5БB*CJ4ZБ\Б^JaJ4ph hЯ[╓hЯ[╓ZБ pю·■>!J!N!о,║,╛,999ФEаEдE@QLQPQ└]╠]╨]єт╧┼т╧┼т╧┼т╧┼т╧┼т╧┼т╧┼ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓ $ДДa$gdЁqp`r¤к,║,╝,8.\.8/А/╝0╚0╩0№0╕1┌1║3╪3999╪9ъ9№;<ю<Ё<*=@=▄=ь=ю=■=@&@lAКAD$DРEаEвE└E╪E2FPFКFмFG$GnGКGаG┬G╘HъHFIzI8JLJ▓K╚KbLzL╬Lъ┘╦╛╦╛╦╛╦╛╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъЬ╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦!jаhЯ[╓hЯ[╓CJU^JaJ!j°hЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jPhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph =╬LьLM2MЎMNzPЦPжВ▓Р▓Ф▓ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓ v v4АDА°А Б Б╪Б┌Б╞В8Г:Г╬ГЎГ/Д0ДwД{Д}ДНД╚Д╩Д╙Д╫ДхДэДЕЕЕЕJЕ[ЕЛЕПЕСЕЯЕ▀ЕрЕщЕэЕяЕёЕєЕ√Е*Ж+ЖEЖIЖKЖMЖOЖXЖoЖqЖлЖ╡ЖяЖЁЖЎЖ°ЖЗ#З9З;ЗЖЗЗЗ╘З╒ЗЁЗюр╙р╜мр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙!jшhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j@hЯ[╓hЯ[╓CJU^JaJDЁЗЇЗЎЗ°З·ЗИИИbИfИhИvИИАИБИ╔И╩ИЙЙЙ$Й]Й^Й`ЙaЙdЙiЙйЙкЙЁЙЇЙЎЙКCКDК`КdКfКhКjКpКККХК╬К┘КЛЛ"Л'ЛWЛXЛгЛ╣ЛьЛюЛ;М<МaМeМgМsМЖМЗМ╧М╤МЁМёМН*Н\Н^НО╢П╚Пёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬!jРhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJI╚П╩ПdЫvЫxЫФе╛е(ж:ж<жXпtп~▓Р▓Т▓ж╕┬╕╞╕╓╕╬╣┌╣6╛H╛J╛^└z└Т╚д╚ж╚╚╘┌╘▄╘r╒~╒z╓юр╩╣рмр╩Ырмр╩Крмрмрмр╩yрмр╩hр╩Wрмр!j( hЯ[╓hЯ[╓CJU^JaJ!jА hЯ[╓hЯ[╓CJU^JaJ!j╪ hЯ[╓hЯ[╓CJU^JaJ!j0 hЯ[╓hЯ[╓CJU^JaJ!jИhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!jрhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ!j8hЯ[╓hЯ[╓CJU^JaJ"Ф▓:╛H╛L╛Ц╚д╚и╚╠╘┌╘▐╘`сnсrсЮэмэ░эj∙x∙|∙ЦдиЎю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓z╓Ж╓°╓╫^╫j╫╪*╪8┘F┘в┘░┘ъ┘Ї┘*┌8┌Ш┌в┌Ж▄Т▄о▐╕▐B▀X▀╪▀ц▀JрXрррюр\сnсpсАсЮст.тpт~т>уRу*ф:фКфЪфЄх■хАцМц"ч4чzчОчьч■ч\шhш▄шЄшbщzщъъ╘ъъъ>ыHы╠ы┌ыь(ьШьоь8эJэЪэєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!j╨ hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKЪэмэоэ└э╬эRюxюf∙x∙z∙|∙· ·F·J·L·Y·Ч·Ш·с·Ї·*√+√t√u√├√─√╠√╨√╥√╙√╒√р√№№N№V№Z№^№b№v№░№▓№ ¤(¤,¤┌¤■¤ТджюЇЖ Ъ & 6 ДвЄъ┘╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъЬ╦╛╦╛╦╛╦╛╦ъ!j╚ hЯ[╓hЯ[╓CJU^JaJ!j hЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jx hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph <$*к─·BRTj┤─@X╘·Ив(.2DF╥╪ц ╬ ╘ b!h!╥%ъ%ь%Ў%@(R(T(╓)■)и,╛,F-Z-T1h1▓4─4╞4:&:юр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╜Ыр╙р╙р╙р╙р╜Кр╙!jhhЯ[╓hЯ[╓CJU^JaJ!j└hЯ[╓hЯ[╓CJU^JaJ!jhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jphЯ[╓hЯ[╓CJU^JaJ66DHD(R(V(╢4─4╚4.?*??ТAжAиA░A°BC D.DДKЦKШK╞KцKlW~WАWЇYZ|\Ф\` `0`6`Zbpbtb|b╩b╘bЪcмcоc░c╕ceBe>hThVhthкi┬iXj\jёфёфёфё╬╜ёфёфёфёфё╬мёфё╬Ыёфёфёфёфёфёфёфё╬Кёфёфёфёфёфёф!jhЯ[╓hЯ[╓CJU^JaJ!j`hЯ[╓hЯ[╓CJU^JaJ!j╕hЯ[╓hЯ[╓CJU^JaJ!jhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ6\j╞k┌kNlzlАlмlnmВm▐mЄmЇmnрnolo~oВoФoЦo╠oцoЮp▓pКt╕t"wwPwbx╨x╥xpyШyzzOzPzЮzЯzзzлzнz╣z┬z├z─z{#{X{Y{x{|{~{А{В{М{г{д{├{╟{╔{╠{╬{╫{ю{я{·{ёфёфёфёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфё╬мёфёфёфёфёфёфёфёфёфёфёф!jXhЯ[╓hЯ[╓CJU^JaJ!j░hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJDШo╗z┬z─zаАзАйА&Ж-Ж/ЖZЛhЛlЛnЧ|ЧАЧЦгдгигмп║п╛пL╗Z╗^╗ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓·{■{||| |8|9|w|{|}|Л|└|┴|╤|╒|╫|с|}}L}M}Й}Л}Т}Ц}╠}╬}ы}Ї}~~b~c~k~o~q~|~е~ж~├~╟~╔~╩~╠~╫~ш~щ~57?CENz|╔┌ААGАKАMА[АФАЮАзАиАйАЁАёАББ!Б#Бёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬╜ёфёфёфё!jhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJ#Б%Б0Б8Б:БkБoБqБtБvБАБФБХБ╖Б╕Б╪Б▄Б▐БрБтБюБ°Б·Б%В)В+В-В/В:ВAВCВКВОВРВЮВ▌В▐В ГГГГГ Г'Г)ГgГkГmГ|Г╖Г╣Г╓Г▀ГДДДДДД!Д+ДGДIДШДЪДиДмДоД░Д▓Д╝ДрДтД0ЕFЕyЕzЕЕАЕбЕкЕ─Е┼ЕхЕюЕ Ж ЖЖЖЖЖєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхhЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJZЖЖ$Ж-Ж.Ж/Ж{Ж|Ж╦Ж═ЖЗ З ЗЗRЗSЗnЗqЗzЗГЗХЗЧЗ╓ЗсЗИИ(И,И.И/И1И<ИiИjИзИлИнИ╕И°И∙И?ЙPЙОЙПЙ╟Й╪Й$К&К╕К╝К╥К┌К▐КтКцКXЛhЛjЛjЧ|Ч~ЧТгєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧нх╧Ьх!j°hЯ[╓hЯ[╓CJU^JaJ!jPhЯ[╓hЯ[╓CJU^JaJ!jиhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ=Тгдгжгип║п╝п<║p║H╗Z╗\╗&╟8╟:╟▐╦т╦ф╦ш╦ъ╦ь╦└╠┬╠╞╠╪╠ ╧╧╧$╧<╨>╨ц╨°╨·╨ф╫■╫┘F┘Д┌Ъ┌Ю┌а┌╞┌°┌P█В█h▄z▄ъ┘╦ъ║╦н╦ъЬ╦ъЛ╦н╦н╦н╦н╦н╦н╦н╦н╦ъz╦н╦н╦н╦н╦н╦н╦ъ!j@hЯ[╓hЯ[╓CJU^JaJ!jШhЯ[╓hЯ[╓CJU^JaJ!jЁhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!jHhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jаhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph .^╗*╟8╟<╟ъ╨°╨№╨l▄z▄~▄┬ш╨ш╘шfЇtЇxЇь·■┬ ╨ ╘ ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓z▄|▄╕▌ш▌▐$▐b▀Ь▀└▀╘▀6тPт╛т▄туHуц0цЖцШц╛ш╨ш╥ш▄шЁшщLщЎэ$ю,ю@ювєоє(Ї:Ї@ЇFЇbЇtЇvЇ:ЎzЎоў╩ў"°l°p°Ж°К°в°∙&∙О∙в∙√√Ц■ж■к■╠■ш·юр╙р╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╜Ыр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜!j8hЯ[╓hЯ[╓CJU^JaJ!jРhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jшhЯ[╓hЯ[╓CJU^JaJ=·№ЄЇж▓   2 ╛ ╨ ╥ <╪▐№0`b╞╠NPXZ╨▐р■Є"■"j$|$~$Ў+,Р/к/▐/Ё/р0Є0юр╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙╜Ыр╙р╜Кр╙р╙р╙р╜!j╪hЯ[╓hЯ[╓CJU^JaJ!j0hЯ[╓hЯ[╓CJU^JaJ!jИhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jрhЯ[╓hЯ[╓CJU^JaJ/n$|$А$ф0Є0Ў0╪;ц;ъ;bHpHtH╪TцTъTЖ`Ф`Ш`кl╕l╝lyyyю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓Є0Ї01&1╥2т2 363V3d3╚3┌3А4М4╚4╬4*5:5Ф6░6 7(7B7H7n7|7о7└78(8&989Ш9и9ш9:J:n:╓:ю:;2;`;n;░;╬;╘;ц;ш;ь;■;>>2>>>|>О>┬>╓>?$?тFG^HpHюр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╜!j( hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jАhЯ[╓hЯ[╓CJU^JaJ@pHrH2IDILMИM№QRDRLRNRhRXS`S╘TцTшT─U▄UVVv[И[\\$\(\H\\\в\╝\n]А]Ж]Р]^,^2^<^`.`4`>`B`F`В`Ф`Ц`└dтdШfЄfJghg╚g■g8hJh─hЇhiiюр╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜Ыр╙р╙р╙р╙р╙р╙р╙!j "hЯ[╓hЯ[╓CJU^JaJ!jx!hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j╨ hЯ[╓hЯ[╓CJU^JaJ=iИi║iжl╕l║l`qhqjq~qnrКrМrаr╥r■r6s`s╛sрsJvPv─v╠v№xyyPfhrЦБиБ╘БВ.ДXДЕ.Е0Е@ЖZЖ┌Й▐Й╞ЛюЛюМ НrПДПЖП▐ФЎФЫ.Ыёфё╬╜ёфёфёфёфёфёфёфёфёфё╬мёфёфёфёфёфё╬Ыёфёфёфёфё╬Кёфёф!j└$hЯ[╓hЯ[╓CJU^JaJ!j$hЯ[╓hЯ[╓CJU^JaJ!jp#hЯ[╓hЯ[╓CJU^JaJ!j╚"hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ6y Е.Е2ЕvПДПИПЇЫЬЬиииb┤p┤t┤┤└┬└╞└╪╠ц╠ъ╠*┘8┘<┘ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓.ЫЁЫЬЬJЬ^ЬfЬxЬа,ата&б(б>бFбdбVвlв║ж╘ж(з@зиии|пЬп4░L░P│r│^┤p┤r┤╕<╕╝╕╠╕╛╣ф╣░└┬└─└·├─╥╞·╞╘╠ц╠ё█╩ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё█мё╜ё╜ё╜ё█Ыё╜ё╜ё╜ё█Кё╜ё╜ё█!j`'hЯ[╓hЯ[╓CJU^JaJ!j╕&hЯ[╓hЯ[╓CJU^JaJ!j&hЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!jh%hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ0ц╠ш╠0╥f╥╙H╙╛╘т╘╛╓·╓&┘8┘:┘▓с─с╚с┌с~тктFфОфdхvхxхц(ц ю(ю*ю>ю╬юямЁ╞Ё▓ё─ё╞ёюёЄмЄ─ЄВєвєЬЇ─Ї■ЎўD√Д√.¤<¤■■юр╙р╙р╙р╙р╜мр╙р╙р╙р╙р╜Ыр╙р╙р╙р╙р╙р╜Кр╙р╙р╙р╙р╙р╙р╙р╜!j*hЯ[╓hЯ[╓CJU^JaJ!jX)hЯ[╓hЯ[╓CJU^JaJ!j░(hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j(hЯ[╓hЯ[╓CJU^JaJ4<┘hхvхzх╢ё─ё╚ё ■■■\ j n R`d"""&"Ю.м.░.┬:╨:╘:ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓■■ж║X j l °  ╞┌Ъ╩N`bЁ▓!┌!"""$"$*$T$n$Ю$╪$Ї$ %*%T%К%╬%&D&z&Ц&Ш&м&┌&'А'и'Ё'((z(Ц(Ш(в(ж(┤(╢(╞(юр╙р╜мр╙р╙р╙р╜Ыр╙р╙р╜Кр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙!jа,hЯ[╓hЯ[╓CJU^JaJ!j°+hЯ[╓hЯ[╓CJU^JaJ!jP+hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jи*hЯ[╓hЯ[╓CJU^JaJ6╞(╚(╨(╘(Ў(b.К.М.Ъ.м.о.:4b4$7V7X7`7d7f7j7║7╛7╞7╩788 8╛:╨:╥:В<О<Р<к<─>Є>Ї>■>?? ?L?|B░BC*CPCdCвC╞C(G:GGS"S&Sд_▓_╢_╪f▀fсflqzq~qZ}h}l}"Й0Й4ЙFХTХXХю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓S"S$SЦTоTV,VМYТYфYъYЦZ┤Zf\|\░\╢\а_▓_┤_вabb bbbbb bObPbobsbШbЩbЯbгbеbзbйb│b╪b┌b■bcccc#c^c_clcqcйcкc┴c┼cтcцcшcїc5d6dAdEdGdJdRdSdъ┘╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦!jш/hЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j@/hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph DSdVd`ddБd╜d┴d├d╥deeZe^e`eoeкeлe┴e┼e╟e╚e╩e╥eяeёe2f6f8fEfДfЖf┬f╞f╚f╓f▀fрfсfg1gdgeg{ggБgГgЕgПgмgнg┌g▐gрgуgыg·gphrhЮhжhкh░h└h┬h╚h▐hЇh·hДiЖi└i╨i▄i"j0j╪mєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!jР0hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJK╪m■m.nTnАnдn╨nцnшnЎnhqzq|q^ulunuvutwФwx,x.x6x@{R{|@|4}R}V}h}j}d~В~А8А|ГШГ(ЗNЗЙ0Й2ЙФНвНФП└ПЖС▓СХ@ХBХTХVХШєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєх╧нхєхєхєхєх╧Ьхєхєхєхєх╧Лх!j03hЯ[╓hЯ[╓CJU^JaJ!jИ2hЯ[╓hЯ[╓CJU^JaJ!jр1hЯ[╓hЯ[╓CJU^JaJ!j81hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ6Ш0Ш2Ш@Ш╕Щ▐Щ╝Ъ╥ЪмЫ╪ЫшЬ Э&Ю<ЮTаИа@б`бИбмб╚б┌б▄б0вJвLвfв2гXг▓г▐гргЁгОдкдЁж"зxй~йBлRл@мPмЪм╕мрн№н\оnоpоn░Ф░Ц░▒$▒0▒4▒>▒P▒─▒╞▒▓▓▓ ▓ ▓▓*▓+▓єхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєх╧нхєхєхєхєхєхєхєхєхєх!jА4hЯ[╓hЯ[╓CJU^JaJ!j╪3hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJDXХ╠б┌б▐б`оnоrо1╢8╢:╢Ь└к└о└╠&╠*╠Ю╫м╫░╫2у@уDуяяяю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓+▓b▓f▓h▓x▓╖▓╕▓╫▓█▓р▓щ▓№▓■▓M│N│Ь│░│ц│ч│┤┤┤┤┤$┤0┤2┤{┤Р┤╢┤╖┤╚┤╩┤с┤ъ┤╡╡╡╡2╡4╡6╡8╡9╡>╡\╡]╡а╡д╡н╡о╡┌╡▐╡р╡т╡ф╡ё╡ў╡°╡╢╢!╢#╢%╢/╢8╢9╢:╢Г╢Д╢в╢ж╢и╢к╢м╢╕╢єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєх!j(5hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJK╕╢╠╢═╢╖╖B╖F╖H╖X╖^╖_╖к╖л╖ў╖°╖╕ ╕$╕(╕,╕Р╕─╕°╕ ╣╣╣Є║╗·╝╜4╛B╛D╛N╛ └<└Ш└к└м└0┬@┬╩├┌├B┼V┼X┼h┼└╟▄╟О╚Ш╚к╦т╦╠&╠(╠Ю╧╢╧╕╧╠╧╨ ╨р╨Ё╨Ж╤к╤H╥\╥╛╘єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєх╧нхєхєхєхєхєхєх!jx6hЯ[╓hЯ[╓CJU^JaJ!j╨5hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJD╛╘╓╘Ъ╫м╫о╫t▄М▄.у@уBуму▓увхмх$ц8ц:цHцЬч└ч$щ8щ*ю4ю№юяя╘Ё┌ЁИёЮёТ°Ь°√√√Ї¤ ■ ■O■R■t■x■z■|■~■З■Ц■Ч■▄■р■т■я■  єх╧╛хєх╧нхєхєхєхєхєхєхєх╧Ьхєхєхєх╧Лхєхєхєхєхєхєхєхєхєх!j9hЯ[╓hЯ[╓CJU^JaJ!jp8hЯ[╓hЯ[╓CJU^JaJ!j╚7hЯ[╓hЯ[╓CJU^JaJ!j 7hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ6я √√√╗┬─·   `nr╝"╩"╬"А.О.Т.Ю:м:░:■F GGю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓    " ) * z { Е Й Л Н П Щ ┬ ├ Є Ў ° · №  \oгд├╟╔╠╬╪юя*,9C|}ЧЫЭавл╞╟є■  XYд╣┬├─ї∙√ HJQUZeТУйнєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєх!j└9hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKнп▓┤┐┘█*cd~ВДЗЙУлн√№(-<=ehvВД╩╠щь√(DЎ   .║╨№ВЦ .F\\npШвв╓╪89[_єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєх╧нхєхєхєхєх!j;hЯ[╓hЯ[╓CJU^JaJ!jh:hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJD_aegoz|╚╔▀ухчщЄ WXЙНbxzО─■0╕"╩"╠"О(Ь(ж)╩)H*V*╬*+J+v+Ў+ ,T,p,~,Ш,╕-╪-$.:.|.О.Р.p/v/^0n0╬2┌2м4╢4Ъ:м:єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєх╧нхєхєхєхєх╧!j`<hЯ[╓hЯ[╓CJU^JaJ!j╕;hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJCм:о:╕;╛;z=Д=т=ъ=&@8@T@h@z@Ю@д@╝@╪@ъ@A$A*ABAbDАDzEРE·F GGxHДHJ8JФKоKОMжMдO╝O>RPRRRЖZТZ\$\H]`]╨^т^ф^lata|aВaюр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╜Ыр╙р╙р╙р╜Кр╙р╙!j?hЯ[╓hЯ[╓CJU^JaJ!jX>hЯ[╓hЯ[╓CJU^JaJ!j░=hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j=hЯ[╓hЯ[╓CJU^JaJ6GBRPRTR╘^т^ц^pj~jВjЦvдvиv"Г2Г6Г▓П┬П╞П~ЫОЫТЫюз■зию█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓ВaHe\e╩e┌e▄eЁeTfffjfАf╬fЎfNjhjlj~jАjl,l╥nЄnМo║oтs■sТvдvжvt}~}А}Т}╥А▐АрАшА╩БтБкВ╕ВГ2Г4Г╚ГфГцДЕ╛З╓ЗVЙhЙjЙ|ЙдЛоЛ░Л┬Л~НИНтНОёфёфёфёфёфёфёфё╬╜ёфёфёфёфё╬мёфёфёфёфёфёфё╬Ыёфёфёфёфёфёфёфёфёф!j°@hЯ[╓hЯ[╓CJU^JaJ!jP@hЯ[╓hЯ[╓CJU^JaJ!jи?hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ=ОоП┬П─ПtСАСВСМСtУzУ Ф<ФfХЬХъЧ№Ч°ЩЪzЫОЫРЫЁЫЬЬ"Ь&ЬRЬмг╝гHе`ежжзJзPзvз╞з╚з╠зшзъз■зиии│D│д│╕│║│ъ│№│L╕N╕ё█╩ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё█мё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё█Ыё╜ё╜ё█Кё╜ё╜!jШChЯ[╓hЯ[╓CJU^JaJ!jЁBhЯ[╓hЯ[╓CJU^JaJ!jHBhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!jаAhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ6ии│╕│╝│Z┐j┐n┐|╦М╦Р╦И╫Ш╫Ь╫┬у╥у╓у"Ё2Ё6ЁШ№и№м№░└─ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓N╕r╕Т╕╕╣╠╣T╗j╗И╗Ь╗Є╗╝╜@╜h╜t╜V┐j┐l┐Z─^─x╦М╦О╦ ═*═╬J╬f╬z╬Д╫Ш╫Ъ╫Z╪z╪┌╪№╪ ррlс~с╛у╥у╘у ъ(ъ@ъNъ э.э0э:эЁ2Ёёфёфёфёфёфёфёфё╬╜ёфё╬мёфёфёфё╬Ыёфёфёфёфё╬Кёфёфёфёфё╬!j8FhЯ[╓hЯ[╓CJU^JaJ!jРEhЯ[╓hЯ[╓CJU^JaJ!jшDhЯ[╓hЯ[╓CJU^JaJ!j@DhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ42Ё4Ё~ЁМЁdўВў ∙∙А√Ш√о√╞√ь√№√F№`№d№О№Ф№и№к№t■М■м└┬К ж ь№■╛ь*0ьЁvЖИД"в"╩"Ё"(#L#N#\#юр╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╜Ыр╙р╜Кр╙р╙р╙р╜yр╙р╙р╙р╙!jАIhЯ[╓hЯ[╓CJU^JaJ!j╪HhЯ[╓hЯ[╓CJU^JaJ!j0HhЯ[╓hЯ[╓CJU^JaJ!jИGhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jрFhЯ[╓hЯ[╓CJU^JaJ/─Ё№zЖКh)t)x)м1╕1╝1╘=р=ф=2J>JBJ▄UшUьU╠a╪a▄aю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓\#d)t)v)Р.а.V/^/d/h/j/Ш/Ю/╓/╪/\0и1╕1║1╢<▐<р<ц<╨=р=т=>d>f>l>ш>Ї>Ў> ?°DE°F№FH$HЁIJJ,J.J>J@JЬK┬K╢N┌NrQ─QFSvSё█╩ё╜ё╜ё╜ё╜ё╜ё╜ё█мё╜ё╜ё█Ыё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё█Кё╜ё╜ё╜ё╜!j LhЯ[╓hЯ[╓CJU^JaJ!jxKhЯ[╓hЯ[╓CJU^JaJ!j╨JhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!j(JhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ6vS╪UшUъU╩Y╨Yф\Ў\ ]&]╚a╪a┌aМdоd┤d╕d└d╞dJlZl\lЖnКnОpиp q:qx&x(x:yJy·z{z}И},р№ЎБ°БtВОВТВЦВЪДмДё█╩ё╜ё╜ё╜ё█мё╜ё╜ё╜ё█Ыё╜ё╜ё╜ё█Кё╜ё╜ё╜ё╜ё╜ё╜ё╜ё╜ё█!j└NhЯ[╓hЯ[╓CJU^JaJ!jNhЯ[╓hЯ[╓CJU^JaJ!jpMhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!j╚LhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ0▄aNlZl^lx&x*xЮДмД░ДцРЇР°РЭЭЭТйайдй°╡╢ ╢╞└╘└╪└ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓мДоД▓ДтДкЕ╓Е╛И╘ИLЙxЙтРЇРЎРФЧвЧдЧ░Ч▄Ш°ШЇЫЬ№ЬЭЭОйайвй\кИккк┤к╢к╞кЦл╚л▐ньн│$│Ї╡╢╢т╕Ё╕┬└╘└юр╙р╙р╙р╙р╜мр╙р╙р╙р╙р╜Ыр╜Кр╙р╙р╙р╙р╙р╙р╜yр╙р╜!jRhЯ[╓hЯ[╓CJU^JaJ!j`QhЯ[╓hЯ[╓CJU^JaJ!j╕PhЯ[╓hЯ[╓CJU^JaJ!jPhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jhOhЯ[╓hЯ[╓CJU^JaJ-╘└╓└<├`├>─R─T─d─┤╠╞╠╚╠~═М═▓╤└╤┬╤╥╤┘&┘(┘°┘ ┌p▀а▀ДтФтDф|ф~фОфх$х&хRхrхФц╝ц~чФчЦчдч°шщъBъ4ыZыЬь╛ьюэюLяzяМёЮёюр╙р╙р╙р╜мр╙р╙р╙р╜Ыр╙р╙р╙р╙р╙р╜Кр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜!jиThЯ[╓hЯ[╓CJU^JaJ!jThЯ[╓hЯ[╓CJU^JaJ!jXShЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j░RhЯ[╓hЯ[╓CJU^JaJ6╪└╕╠╞╠╩╠┘&┘*┘х$х(хРёЮёвёt¤В¤Ж¤┤ ┬ ╞ FTX┬"╨"╘"ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓Юёаё░Є─Є╞ЄрЄмў▄ў°°Ў°№°╛√╠√о№╝№ ¤¤p¤В¤Д¤╓¤ф¤Р■Ц■║■└■┌■р■К Р ▓╕06j.─╩┬╓ЖМtzкрH О ░ ┬ ─ ╚ т Т ║ юр╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜Ыр╙р╙!jаVhЯ[╓hЯ[╓CJU^JaJ!j°UhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jPUhЯ[╓hЯ[╓CJU^JaJ=║ ╓  ╕╥BTVhВ8HJRь2HШи !4!╛"╨"╥"D#Z# (B(Ў./ /B0J0:2b2в5┤5В7ж7.9<9╪9ъ9ь9:D;V;X;V<b<d<А<▐<т<ёфёфё╬╜ёфёфёфёфёфёфёфё╬мёфёфё╬Ыёфёфёфёфёфёфёфё╬Кёфёфёф!j@YhЯ[╓hЯ[╓CJU^JaJ!jШXhЯ[╓hЯ[╓CJU^JaJ!jЁWhЯ[╓hЯ[╓CJU^JaJ!jHWhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ6╘"·./ /H;V;Z;xGЖGКGмN║N╛NфZЄZЎZтfЁfЇf.rhNhhi|i╝i╨iмk lll!lWlXl`lallГlЕlРlЬlЮl╤lхl m#mRmVmXm8nHn*rrжx╛xЮz└zT{h{Ю|и|к|╕|6~H~J~|ЖШЖЇИЙ"Й$ЙfМюр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╜Ыр╙р╙╜Кр!j╪]hЯ[╓hЯ[╓CJU^JaJ!j0]hЯ[╓hЯ[╓CJU^JaJ!jИ\hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jр[hЯ[╓hЯ[╓CJU^JaJ6L~Й"Й&Й0Х>ХBХфаЄаЎашлЎл·л8╕F╕J╕ж─┤─╕─Р╨Ю╨в╨H▄V▄Z▄ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓fМИМLПnП,Х>Х@ХLЩVЩ^ЩhЩ╞ЬфЬЮЮиЮ▓Ю╓ЮрЮNЯbЯраЄаЇа·в>гjг~гмг╞гддBд\дРдод┤ж╘ж╓жЁжzйойркюкЬл╛лфлЎл°л4пFп ▒(▒*▒>▒@▒J▒D│Z│╩╖ш╖╕єхєх╧╛хєхєхєхєхєхєхєх╧нхєхєхєхєхєхєхєхєхєхєхєх╧Ьхєхєхєхєхєхєх!j╨_hЯ[╓hЯ[╓CJU^JaJ!j(_hЯ[╓hЯ[╓CJU^JaJ!jА^hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ=╕╕╕╕4╕F╕H╕X╣n╣F╜`╜Ж╜Ц╜р┬°┬├0├в─┤─╢─К╟а╟╞╔Ў╔ ╦H╦М╨Ю╨а╨^╥|╥╙.╙n╙z╙|╙В╙А╘Ф╘F╒Z╒ф╫·╫в┘╕┘█$█&█4█,▄@▄D▄V▄X▄В▐єхєх╧╛хєхєхєхєхєх╧нхєхєхєх╧Ьхєхєхєхєхєхєхєхєхєхєхєх╧Лх!jpbhЯ[╓hЯ[╓CJU^JaJ!j╚ahЯ[╓hЯ[╓CJU^JaJ!j ahЯ[╓hЯ[╓CJU^JaJ!jx`hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ6В▐а▐др╕р т,т2тDт╠т╪т┌трт╕у┬у$х6х8хFхtцЦцЮч╚ч╥чфчtшЖшИшОъ╛ъ└ъюъЎъ·ъыыыPыRы╩ы╥ы╓ыЇыhьЦь№ьэээ э╢я╩я╓ётёцё°ёЇ>ЇPЇRЇмЇ╝Її,ї°>°&∙0∙F∙X∙єхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхє╧нхєхєхєхєхє!j└chЯ[╓hЯ[╓CJU^JaJ!jchЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJDZ▄xшЖшКшBЇPЇTЇИЦЪъ ° № p~ВЙРТA%H%J%─0╥0╓0ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓X∙√ √╩¤╥¤6■P■2 \ ДЦШ bdtvД┌фъьЁВЮФдц ° · ОЮак┌ю "l~АТ  *RSЗЛНПСЪЭёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфё╬мёфёфёфёфё╬Ыёфёфёфёфёфёфёфёф!j╕ehЯ[╓hЯ[╓CJU^JaJ!jehЯ[╓hЯ[╓CJU^JaJ!jhdhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ=ЭЮ╓┌▄щ'):>@JrtГМЫЯбм╕╣3ANP}БГЕЗРЧЩ╣╜┐┬─╦рс°№■ $%DHJKMWln╛┐▌сухчЄTUimoqsvxАЮЯьэЎ·№■ 7ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJZ78wЗРСТ▐рЁЇЎ∙√ # ' ) 7 v К м ░ ▓ └ √ № ! !?!@!_!c!e!f!h!r!З!Й!╒!┘!)"*"Z"^"q"r"Ш"Ь"Ю"а"б"в"е"▒"╣"╗" # ##)#3#7#9#;#=#G#Q#S#а#б#│#╡#╫#ш#ёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё!j`fhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJш#&$($A$E$G$S$m$n$з$л$н$║$Ї$ї$+%/%1%?%H%I%J%Ц%Ч%▀%р%∙%¤% %&&\'l'М'Ъ'Ў'(╚(╓(8)J)·)*`*r*t*М*,,,,,└0╥0╘0╘6т6L9\9^9p9╕9╬9 ;;;,;&<@<╠<єхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧нхєхєхєхєхєхєхєх!j░ghЯ[╓hЯ[╓CJU^JaJ!jghЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJD╓0╨<▐<т<I$I(IТUаUдUцaЇa°aЦmдmиmьy·y■y8ЖFЖJЖМТЪТЮТю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓╠<▐<р<╬>ш>4ABAоD║DI$I&I┌JшJ L&LдM▄MZQrQRNRSSОUаUвU┤]╩]тaЇaЎaЎhi2iDibirijjТmдmжm╠uцuрvЎv╬yшyъ┘╦╛╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦ъЬ╦╛╦ъЛ╦╛╦╛╦╛╦╛╦ъz╦╛╦╛╦╛!j°jhЯ[╓hЯ[╓CJU^JaJ!jPjhЯ[╓hЯ[╓CJU^JaJ!jиihЯ[╓hЯ[╓CJU^JaJ!jihЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jXhhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 0шy·y№y@Е\Е4ЖFЖHЖ╝Ж╩Ж.ЗPЗЖИаИ"К6КbПjПpПЦПОС╢С║С╞СИТЪТЬТvФМФжФ╢ФфХ°ХЦЦЭ ЭвЭ└Э ЯЯ ЯpикимициюиЄиЇи°ийDйFй╛й╞йъ┘╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъЬ╦╛╦╛╦╛╦╛╦╛╦╛╦ъЛ╦╛╦╛╦╛╦╛╦╛╦╛╦!jШmhЯ[╓hЯ[╓CJU^JaJ!jЁlhЯ[╓hЯ[╓CJU^JaJ!jHlhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jаkhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 6ЮТЯЯ"Я|кГкЕкw░~░А░и╖╢╖║╖╚├╓├┌├ь╧·╧■╧4█B█F█\чjчnчю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓╞й╩йрйкк1к3кgкkкmкoкqкzкГкДкЕкнк▒к╢к╕к╬к╨клл3л7л9л<л>лGлOлQллГлЕлИлКлРлЯлблчлылэл¤л7м8мqмuмwмДм╗м╜м╬м╤м┌м▐мрмчмнн н$н&н(н*н0нMнNнsнwнyн{н}нЖнРнТнєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!j@nhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKТн▌нён(о)оfоpойокоыоэоЎо°оппп'п@пAпzп~пАпСп╧п╨п░░░░Y░Z░c░g░i░j░l░u░~░░А░└░─░╞░╙░ї░∙░√░¤░ ░▒ ▒ ▒=▒A▒C▒E▒G▒Q▒W▒X▒Ш▒Ь▒Ю▒о▒ъ▒ы▒ё▒ї▒ў▒°▒·▒▓0▓1▓F▓J▓єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!jшnhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKJ▓L▓M▓O▓Z▓y▓z▓╩▓╦▓╓▓┌▓▄▓▀▓с▓ь▓││M│N│b│c│j│n│p│{│й│к│─│╚│╒│▀│Ё│ё│┤┤┤┤ ┤+┤7┤9┤Г┤Е┤б┤в┤╔┤╘┤ ╡ ╡╢Д╢Т╢Ф╢─╢д╖╢╖╕╖Р╗Ш╗╚╗╬╗ ╜6╜^╛Т╛К└О└╞└╓└╪└Є└К┴Ш┴Є┴┬┬єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєх!jРohЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJK┬(┬Ц├Ш├└├┬├─├╓├╪├ц─°─■─┼┼┼╝┼╩┼n╞В╞╟6╟8╟H╟H╚P╚R╚Д╚f╔А╔В╔а╔Z╩h╩ж╩┤╩╦"╦°╦╠Ъ╠к╠─╠╪╠T╬X╬ш╧·╧№╧&╨X╨:╤N╤В╤Р╤└╤┌╤╥0╥╬╥╥╥╕╙╨╙╘ ╘╢╘╛╘─╘╨╘0╒єхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧нхєхєхєхєхєхєхєхєхєхєх!jрphЯ[╓hЯ[╓CJU^JaJ!j8phЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJD0╒H╒J╒t╒B╓H╓t╓ж╓■╓4╫Є╫°╫<┘>┘ ┌6┌О┌Ъ┌0█B█D█Ь█о█▓█╕█▌▌╝▌╬▌n▐О▐о▐╩▐▀(▀Z▀Ш▀о▀┤▀╬▀┌▀▄▀ь▀╕р╛р с&с`сtс^тРтJуpуДфФфхх·х цHцhцоц▓цXчjчlч&ш<шыєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧нхєх!j0rhЯ[╓hЯ[╓CJU^JaJ!jИqhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJDы.ы┬ьфь~эДэдэмэ"ЁDЁЄ(Є єє єBєJє&ЇDЇЎЎ║·▄·√"√$√8√b√~√╛√т√B№╕№ь№"¤V¤p¤r¤О¤╢¤╪¤H■~■о■ф■" N P b d ж ▄ .╓(LjF┤╢тЁFH╬╨єхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧нхєхєхєхєхєхєхєхєхєх!jАshЯ[╓hЯ[╓CJU^JaJ!j╪rhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJDnчєє"єT b f ╥┘█─ ╦ ═ в░┤и&╢&║&Ї233┌>ш>ь>ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓╨#%2pqжкм╣Ўў'+-9{|ЩЭЯбгезйкн└┴єў∙ABw{}Й├╧╤╙╘╫  6:<>@HPRЪЫ╜┴├┼╟╨┘┌█#]^ШЬЮмєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєх!j(thЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKмхч     % - / N P } ~ В Ж И К М Ц ╞ ╚     X Z g k m o q z Ь Ю щ ¤ 8 9 Д Щ ╬ ╧ ы я ё є ї       a b x | ~  Б К м н Ї ў       ; < T X Z [ ] d Д Е п │ ╡ ╖ ╣ ┬ єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхhЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJX┬ ╦ ╠ Rt"$&"*@АР╢╨Ю░▓8д─╞┌0HJ^╚┌▄■DJdXbh╚╩8 : ╝ ╛ ╥ д&╢&╕&))Ц.Ш.|/Ж/Ё23ъ┘╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъЬ╦╛╦╛╦╛╦ъ!j vhЯ[╓hЯ[╓CJU^JaJ!jxuhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j╨thЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph <33и9╚9Ї9:╨=ш=╓>ш>ъ>ЄC(DЬIтI KKKjV|V~V _$_>_@_М_Ц_V`Z`▓`╢`bbЖbШbЪbЄcdьkЁkЪnмnюр╙р╙р╙р╜мр╙р╙р╜Ыр╜Кр╙р╙р╙р╙р╙р╙р╜yр╙р╙р╜!jhyhЯ[╓hЯ[╓CJU^JaJ!j└xhЯ[╓hЯ[╓CJU^JaJ!jxhЯ[╓hЯ[╓CJU^JaJ!jpwhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j╚vhЯ[╓hЯ[╓CJU^JaJ)ь>KK KnV|VАVКbШbЬbЮnмn░nАzОzТz°ЖЗ ЗфТЄТЎТюЮ№ЮЯю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓мnоnt.t8uFuоv║v|zОzРzЇЖЗЗXЙdЙdКtК$П6ПрТЄТЇТмЧ▓Ч,Э<ЭъЮ№Ю■ЮЇкллв╡о╡╛╢╨╢юр╙р╙р╙р╜мр╜Ыр╙р╙р╙р╜Кр╙р╙р╜yр╜hр╙р╜!jX}hЯ[╓hЯ[╓CJU^JaJ!j░|hЯ[╓hЯ[╓CJU^JaJ!j|hЯ[╓hЯ[╓CJU^JaJ!j`{hЯ[╓hЯ[╓CJU^JaJ!j╕zhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jzhЯ[╓hЯ[╓CJU^JaJ$Я°кл л┬╢╨╢╘╢Ї┬├├├╔╩╔╠╔Ё╘■╘╒юр№рс^эlэpэD∙R∙V∙ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓╨╢╥╢N╣z╣2╗^╗╞╝╩╝┴B┴F┴J┴Ё┬├├├f├j├Ф├Ц├╢├╛├╚├▄├──Z─[─d─h─j─m─u─x─{─А─Р─Ф─Ц─г─▀─р─┼ ┼ ┼┼┼#┼)┼*┼y┼z┼▒┼╡┼╖┼╗┼┴┼╬┼╞╞╞╞O╞P╞Х╞Щ╞Ы╞Я╞ж╞юр╙р╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙!jи~hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j~hЯ[╓hЯ[╓CJU^JaJDж╞й╞м╞╡╞ф╞ц╞■╞╟+╟,╟U╟Y╟[╟]╟_╟g╟t╟v╟┼╟╟╟▐╟т╟ф╟ц╟ш╟Є╟╚╚;╚D╚Y╚[╚к╚л╚п╚╖╚├╚╟╚═╚╪╚Ї╚ї╚;╔?╔A╔P╔З╔И╔░╔┤╔╣╔┴╔╩╔╦╔╠╔(╩*╩А╩И╩М╩Ф╩а╩·╩╦Ё╦Є╦X╠l╠░═╢═╛═─═╩═╥═ь╘ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфё!jPhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJь╘■╘╒▄ ▄И▄О▄ър№р■рZэlэnэVю\ютўЎў@∙R∙T∙▓ └ ■   м ╛ └  . 0 ^' А' L( b( ъ┘╦╛╦╛╦ън╦ъЬ╦╛╦╛╦ъЛ╦╛╦ъz╦ъi╦ъX╦╛╦╛!jшГhЯ[╓hЯ[╓CJU^JaJ!j@ГhЯ[╓hЯ[╓CJU^JaJ!jШВhЯ[╓hЯ[╓CJU^JaJ!jЁБhЯ[╓hЯ[╓CJU^JaJ!jHБhЯ[╓hЯ[╓CJU^JaJ!jаАhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j°hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph "V∙   ░ ╛ ┬  . 2 ) .) 2) b0 i0 k0 8 $8 (8 LD ZD ^D ╠N ┌N ▐N ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓b( j( n( p( К( Т( Ц( Ш( ┤( ╝( └( ┬( ╪( ▐( т( ф( Є( Ї( ) ) ) .) 0) + x+ z+ ц+ ъ+ ю+ , B, C, У, Ф, ╨, ╘, ╓, ф, - - a- e- g- u- ▒- ▓- ▄- р- т- ф- ц- Ё- √- №- ;. ?. A. O. Л. М. ║. ╛. ├. ═. ╙. ╘. / / / +/ i/ j/ ▒/ ┼/ Ї/ ёфёфёфёфёфёфёфёфёфёф╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёф!jРДhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJЇ/ 0 B0 C0 L0 P0 R0 T0 V0 `0 i0 j0 k0 ╢0 ╖0 р0 ф0 ц0 ш0 ъ0 ї0 1 1 @1 D1 F1 H1 J1 R1 c1 g1 У1 Ф1 ╥1 ╪1 ┌1 х1 !2 "2 M2 Q2 S2 U2 W2 b2 k2 l2 н2 ▒2 │2 ┬2 ■2 3 73 ;3 =3 L3 |3 ~3 Й3 К3 д3 и3 н3 ╡3 ╧3 ╨3 4 4 #4 '4 )4 64 X4 Y4 ёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё!j8ЕhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJY4 в4 г4 л4 п4 ▒4 │4 ╡4 └4 х4 ц4 ,5 -5 F5 J5 L5 O5 6 x6 о6 8 $8 &8 HD ZD \D ╚N ┌N ▄N XT lT JX TX ZX вX ▄X цX ьX :Y ВY КY РY ╢Y ╕Y рY "Z ,Z 2Z RZ TZ hZ zZ ▐Z рZ ·Z [ [ єхєхєхєхєхєхєхєхєхєх╧╛х╧нх╧Ьхєхєхєхєхєхєхєхєхєхєхєхєхєх╧!j0ЗhЯ[╓hЯ[╓CJU^JaJ!jИЖhЯ[╓hЯ[╓CJU^JaJ!jрЕhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ8▐N [ [ [ рa юa Єa pn ~n Вn цz Ўz ·z З ,З 0З nТ ~Т ВТ мЭ ╝Э └Э к "к &к ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓[ [ [ в[ д[ ╓[ ▐[ т[ ц[ ъ[ ·[ \ \ O\ V\ `\ b\ п\ ░\ ╚\ ╠\ ╬\ ╨\ ╥\ ┌\ Ў\ ў\ ] ] $] +] <] =] j] n] p] r] t] ~] Е] Ж] ╙] ╘] ^ ^ ^ +^ j^ k^ Д^ И^ К^ М^ О^ Ц^ │^ ┤^ ю^ Є^ Ї^ _ A_ G_ g_ o_ Б_ В_ О_ П_ ╢_ ╛_ ╦_ ═_ ,` .` t` x` ║` ┬` ╞` Va Мa ▄a юр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙рhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j╪ЗhЯ[╓hЯ[╓CJU^JaJR▄a юa Ёa >m Оm Nn fn ln ~n Аn ╥n o ^o Жo тz Ўz °z юЕ Ж Ж Ж З ,З .З >М DМ ▐М №М ■М Н jР xР zР ░Р jТ ~Т АТ У У ТФ ╕Ф Х >Х 6Ч XЧ ZЧ dЧ цЧ юЧ ъ┘╦╛╦╛╦ън╦╛╦╛╦ъЬ╦╛╦╛╦ъЛ╦╛╦╛╦╛╦╛╦╛╦ъz╦╛╦╛╦╛╦╛╦╛╦╛!j ЛhЯ[╓hЯ[╓CJU^JaJ!jxКhЯ[╓hЯ[╓CJU^JaJ!j╨ЙhЯ[╓hЯ[╓CJU^JaJ!j(ЙhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jАИhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 0юЧ ЁЧ RШ VЭ ZЭ иЭ ╝Э ╛Э $ж 6ж к "к $к |м шм ъм Ўм ■м н н н н zн |н о о #о 'о )о +о -о 6о Sо Tо Цо Ъо Ьо ко то фо п п п п &п (п tп Зп ╖п ╕п ▐п тп фп цп шп Ёп ■п  п E░ I░ K░ W░ К░ О░ Р░ Э░ ┘░ ┌░ ∙░ ёфёфё╬╜ёфё╬мёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёф!jpМhЯ[╓hЯ[╓CJU^JaJ!j╚ЛhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJD∙░ ¤░  ░ ▒ ▒ ▒ "▒ #▒ s▒ t▒ Й▒ Н▒ П▒ Т▒ Ф▒ Э▒ ╛▒ ┐▒ √▒ ▓ ▓ ▓ ▓ a▓ b▓ м▓ └▓ ·▓ √▓ │ !│ #│ $│ &│ 0│ D│ E│ Х│ Ц│ ╫│ █│ ┤ f┤ r┤ t┤ И┤ М┤ м┤ т╗ Ў╗ °╗ д╛ и╛ ┐ ┐ А┐ Д┐ L─ P─ V╚ j╚ l╚ ёфёфёфёфёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфё╬мёфёфёфёфё╬Ы!jhОhЯ[╓hЯ[╓CJU^JaJ!j└НhЯ[╓hЯ[╓CJU^JaJ!jНhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ=&к ▓ ▓ ▓ ц╗ Ў╗ ·╗ Z╚ j╚ n╚ \╘ l╘ p╘ ╞р ╓р ┌р 6э Fэ Jэ К° Ъ° Ю° ╘ ф ш ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓l╚ X╘ l╘ n╘ ┬р ╓р ╪р Ўр ■р >с Dс ис ║с ц $ц 2э Fэ Hэ Ж° Ъ° Ь° О и о ╕ ╝ ─ ╘ т ъ ° ╨ ф ц < P R ╨ т ш ° ё█╩ё█╣ёмёмёмёмё█Ыё█Кёмёмёмёмёмё█yё█hёмём!jXТhЯ[╓hЯ[╓CJU^JaJ!j░СhЯ[╓hЯ[╓CJU^JaJ!jСhЯ[╓hЯ[╓CJU^JaJ!j`РhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJ!j╕ПhЯ[╓hЯ[╓CJU^JaJ!jПhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJ(ш @ P T О Ю в У& Ы& Э& n/ ~/ В/ Ё; < < ^G nG rG S S S F^ V^ Z^ ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓° ▄ ь   " 2 v Ж И Ш К Ю а (# r# t# $ $ $ $ S$ T$ Э$ ░$ ъ$ ы$ % % % % % % 3% 4% j% k% s% w% y% Ж% ─% ╞% ъ% ю% Ё% ё% є% №% & & Z& [& & Г& Е& Ж& И& С& Ы& Ь& Э& щ& ъ& 9' ;' E' I' K' ёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬мёфёфёфёф!jиУhЯ[╓hЯ[╓CJU^JaJ!jУhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJDK' N' P' Y' {' }' ╚' ┌' ( ( >( B( D( E( G( P( X( Y( и( й( Ў( °( ) ) ) ) ) ) ?) A) М) О) Я) г) е) ж) и) л) * d* К* j/ ~/ А/ ╩4 ▄4 ╥; ш; ь; < < ┤= ║= > 0> 8> b> h> v> x> |> A "A @A PA XA dA ЪC кC ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬╜ёфёфё╬мёфёфёфёфёфёфёфёфёф!j°ФhЯ[╓hЯ[╓CJU^JaJ!jPФhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJDкC ╠F рF ZG nG pG HH VH J J K DK ЁK ЎK ЦM жM ╘M ╓M ░N ╕N tO ~O оO ╝O ЬR вR ■R S S 8T @T ВW ЬW ╬X ╪X \Z lZ А\ в\ (^ @^ B^ V^ X^ ╬^ ▐^ оh ╩h "i 6i j 4j 6j 8j ╚j ёфё╬╜ёфёфёфёфёфёфёфёфёфёфё╬мёфёфёфёфёфёфё╬Ыёфёфёфё╬Кёф!jШЧhЯ[╓hЯ[╓CJU^JaJ!jЁЦhЯ[╓hЯ[╓CJU^JaJ!jHЦhЯ[╓hЯ[╓CJU^JaJ!jаХhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ6Z^ $j 4j 8j Hq Pq Rq м| ╝| └| "Й 2Й 6Й (Х 8Х <Х ▌а ха ча  ж з з ─н ╘н ╪н ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓╚j ╩j ▄j фj шj ьj Ёj k Xk \k ╥k рk ъk ьk Bl El al hl Нl Оl ╟l ╦l ═l ┘l m 'm _m `m {m |m Шm Яm зm иm сm хm чm їm 6n 7n Дn Жn Уn Чn Щn Ыn Эn зn ╨n ╤n o o o o Vo Wo `o do fo ho jo so Сo Уo ┌o юo "p $p 8p 9p `p pp иp кp ╖p ╗p ╝p ╜p ┐p ╞p эp яp 5q 9q ;q Fq ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJUFq Pq Qq Rq Дq Иq Кq Хq ╓q ╫q ёq їq ўq ∙q √q Vr |r и| ╝| ╛| Й 2Й 4Й $Х 8Х :Х Ц &Ц вЮ ЇЮ №Ю \Я dЯ hЯ lЯ pЯ ВЯ ОЯ РЯ а а а а ]а ^а cа gа iа kа mа vа ва га ╔а ═а ъ┘╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ън╦ъЬ╦ъЛ╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦!j8ЪhЯ[╓hЯ[╓CJU^JaJ!jРЩhЯ[╓hЯ[╓CJU^JaJ!jшШhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j@ШhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 6═а ╧а ╤а ╙а █а ха ца ча /б 0б 9б =б ?б Aб Cб Kб yб zб ┬б ╓б в в Mв Qв Sв _в Ьв Эв ╢в ║в ╝в ╜в ┐в ╟в цв чв -г /г 2г 3г ;г >г Eг Gг Jг Mг sг wг yг Жг ╝г └г ┬г ╨г д д 0д 4д 6д 8д :д Dд Mд Oд Ьд Эд ╜д ┴д ├д ─д ╞д ╧д сд уд &е *е єхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!jрЪhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJK*е ,е ;е qе uе wе Де └е ┴е ┘е ▌е ▀е се уе ъе ж ж $ж (ж *ж ,ж .ж 7ж Vж Wж Ож Тж Фж аж █ж ▌ж ъж юж Ёж Єж Їж ¤ж з з з Jз Nз Pз [з Эз Юз │з ╖з ╣з ╗з ╜з ╞з цз чз 0и 2и ?и Cи Eи Gи Iи Rи xи yи Щи Эи Яи би ги ли ┤и ╕и ┐и └и ─и ╚и єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!jИЫhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJK╚и фи ци ши яи й й ,й 0й 2й 4й 6й >й Nй Oй Хй Щй Ый кй рй фй цй єй /к 0к Hк Lк Nк Pк Rк Yк vк wк ак дк жк ик кк ▓к ║к ╝к як єк їк л *л ,л >л @л ^л bл dл rл Гл Дл ▓л ║л ═л ╬л м "м &м Bм ░м ▓м цм юм Єм Ўм ·м н ,н 4н Bн Fн Pн Tн Xн fн Жн Он кн ░н ┤н └н єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхhЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJT└н ╘н ╓н >о Pо Rо fо X▒ n▒ ╪╡ ю╡ Z╣ n╣ p╣ ╓║ ┌║ Т─ ж─ и─ `╠ r╠ ╘═ ш═ ъ═ №╓ "╫ $╫ l╫ n╫ №╫ ╪ ╪ ╪ Q╪ R╪ Б╪ Е╪ Ж╪ И╪ К╪ У╪ Ь╪ Э╪ ъ╪ ь╪ ┘ ┘ ┘ ┘ ┘ ┘ &┘ ъ┘╦╛╦╛╦╛╦╛╦ън╦╛╦ъЬ╦╛╦ъЛ╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъ!j(ЮhЯ[╓hЯ[╓CJU^JaJ!jАЭhЯ[╓hЯ[╓CJU^JaJ!j╪ЬhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j0ЬhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 3╪н ^╣ n╣ r╣ Ц─ ж─ к─ ╪═ ш═ ь═ ┘ &┘ (┘ Фр др ир э э "э О∙ Ю∙ в∙    ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓&┘ '┘ (┘ ^┘ _┘ t┘ w┘ ~┘ Ж┘ ▓┘ ╢┘ ╕┘ ╞┘ ■┘ ┌ ┌ ┌ ┌ ┌ ┌ ┌ F┌ G┌ s┌ w┌ y┌ {┌ }┌ З┌ О┌ Р┌ ▄┌ ▌┌ т┌ ц┌ ш┌ ъ┌ ь┌ Ў┌ &█ '█ 6█ :█ <█ >█ @█ C█ E█ H█ J█ M█ O█ S█ W█ ^█ g█ i█ Ж█ И█ е█ й█ л█ ╣█ ў█ °█ ¤█ ▄ ▄ ▄ ▄ "▄ ~▄ В▄ ь▄ Ї▄ °▄ ▌ И▌ К▌ ╩▌ ╥▌ ╓▌ ┌▌ ▐▌ юр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!j╨ЮhЯ[╓hЯ[╓CJU^JaJS▐▌ b▐ В▐ Рр др жр ▄т фт :у @у ф ф pь xь ~ь ╠ь ╬ь Єь Їь э э э э BЄ RЄ TЄ ^Є vє Ає Вє Оє дў ─ў К∙ Ю∙ а∙ F T   ( :     F Z d д ╩ n x ~ Ъ ёфё╬╜ёфёфёфёфёфёфёфё╬мёфёфёфёфёфё╬Ыёфёфёфё╬Кёфёфёфёфёф!jpбhЯ[╓hЯ[╓CJU^JaJ!j╚аhЯ[╓hЯ[╓CJU^JaJ!j аhЯ[╓hЯ[╓CJU^JaJ!jxЯhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ6Ъ Ь ░ └ ╩ В а > F L p ┬ ┌ . : ▓ ╛ ┬ ╓ ╪ V p Д Т < ` в ╢ ╕  * . 2 ╞ т ·   5 6 ? C E G I P В Д С Х Ч Ш Ъ Я ╩ ╦ р ф ц ч щ ю ! ! U! W! d! h! j! ёфёфёфёфёфёфёфёфё╬╜ёфёфёфё╬мёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёф!j└вhЯ[╓hЯ[╓CJU^JaJ!jвhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJD ╞ ╓ ┌ ж ╢ ║ ў$  $ % Z/ j/ n/ ж; ╢; ║; 6H FH JH \O dO fO РU ШU ЪU ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓j! k! m! q! Я! а! н! ▒! │! ╡! ╖! ╛! ь! э! " " " " " " 8" :" Е" Ч" ╥" ╙" # 0# j# k# В# Ж# И# К# М# Ф# о# ▒# ┤# ╡# ■# $ $ $ $ $ $ $ K$ L$ d$ h$ j$ l$ n$ u$ Ч$ Щ$ ф$ ї$  $ % % N% O% Й% Н% П% Ы% ▌% ▐% & & & & ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬╜ёфёфёфёфёфёфё!jhгhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJ& & && *& +& I& M& O& P& R& Z& w& x& ┴& ╨& ' ' ( V/ j/ l/ Z9 d9 ; &; в; ╢; ╕; P> \> |? М? 2H FH HH ╩H ╪H ┌H fI jI ▄I фI шI ·I GJ HJ ]J aJ cJ dJ fJ lJ ТJ УJ ├J ╟J ╔J ╩J ╠J ╘J ▌J ▀J єхєхєхєхєхєхєхєхєх╧╛хєхєх╧нхєхєх╧Ьхєхєхєхєхєхєхєхєхєхєхєхєхєх!j`еhЯ[╓hЯ[╓CJU^JaJ!j╕дhЯ[╓hЯ[╓CJU^JaJ!jдhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ=▀J K K K K K K 'K (K )K +K XK \K ^K _K bK lK sK tK ╛K ┐K ╚K ╠K ╬K ╨K ╥K ▄K L L XL YL qL uL wL xL zL ГL гL дL ╓L ┌L ▄L ▐L рL ъL яL ЁL ?M @M EM IM KM MM OM ZM КM ЛM ЪM ЮM аM вM дM зM йM мM оM ▒M │M ╖M ╗M ├M ╠M ╬M ыM эM N N N N \N ]N bN fN hN iN kN vN дN жN █N ▀N єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхhЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJZ▀N сN уN хN яN ;O =O JO NO PO RO TO ZO dO eO iO ▒O ▓O ═O ╧O уO хO шO ыO °O ∙O P P P P P %P ?P @P ZP ^P `P bP dP oP ЛP МP ╧P ╙P ╒P фP %Q &Q ;Q ?Q AQ CQ EQ NQ qQ rQ ШQ ЬQ ЮQ аQ вQ нQ ╜Q ╛Q R R R R [R ]R cR gR iR kR mR xR єхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх!jжhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJKxR вR гR ╩R ╬R ╨R ╥R ╘R ▀R ьR юR >S ?S US YS [S \S ^S hS КS ЛS ╥S ╒S тS цS шS ъS ьS ЎS T T T *T oT pT СT ХT ЧT ШT ЪT зT ╕T ╣T U U 6U :U ╣ `║ j║ ▐└ ю└ Ё└ М┴ ╢┴ ╨┬ т┬ А├ а├ *┼ ,┼ Ю┼ а┼ ╚ ╚ ╚ 8╚ М╔ О╔ ъ╩ ь╩ 8╦ к╦ м╦ ╠ ╠ ╠ $╠ єхєх╧╛хєхєхєхєхєхєхєх╧нхєхєхєхєхєх╧Ьхєхєхєхєхєхєхєхєхєхєхєхєх!j@нhЯ[╓hЯ[╓CJU^JaJ!jШмhЯ[╓hЯ[╓CJU^JaJ!jЁлhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJ=Hи В┤ О┤ Т┤ т└ ю└ Є└ &╠ ,╠ .╠ |╓ И╓ М╓ ╪т фт шт `я lя pя ш√ Ї√ °√ 6 D H ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓$╠ ,╠ -╠ .╠ s╠ t╠ ╢╠ ║╠ ╝╠ ╚╠ ═ ═ ═ ═ ═ ═ ═ !═ N═ O═ ^═ _═ k═ o═ q═ s═ u═ ~═ С═ У═ т═ у═ 6╬ >╬ B╬ ф╬ ╧ x╓ И╓ К╓ ш┌ █ А█ ╢█ ╓█ ╪█ ▄█ ц█ &с Bс ╘т фт цт \я lя ъ┘╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ън╦╛╦╛╦╛╦╛╦╛╦ъЬ╦ъ!j8пhЯ[╓hЯ[╓CJU^JaJ!jРоhЯ[╓hЯ[╓CJU^JaJhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jшнhЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 6lя nя DЁ ЖЁ ▄Ё ё ЪЄ ▄Є "ї Fї ф√ Ї√ Ў√ Ж  ╝  т Є ░ ▓ ╞ ▐   2 D F n Р  " & ┬ ─ 1 2 = A C E G Q s u ╛ ┐ ў √ ¤ K _ Ц Ч ▄ ▌ ( ) 2 6 8 : < юр╙р╙р╙р╙р╜мр╙р╙р╙р╙р╙р╜Ыр╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙р╙!j0▒hЯ[╓hЯ[╓CJU^JaJ!jИ░hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jрпhЯ[╓hЯ[╓CJU^JaJ=< E r s н ▒ │ └         # G I c g Б Е З Ф ╙ х   A E G I K S \ ] ^ ж з ░ ┤ ╢ ╕ ║ ┴ ё Є " & A S Й Щ ╘ ш   + / 1 4 6 ? i j Й Н П С У Ь ░ ▓ ш ь ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё╬╜ёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфёфё!j╪▒hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJJH U \ ^ №   # *# .# t/ В/ Ж/ p; ~; В; фG ЄG ЎG @T NT RT x` Ж` К` ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓ь ю ё є √ ¤ ■ H I s w y { } Ж Н П ┘ ь $ % g k m | │ ┤         I K X \ ^ _ a k Р С ▀ Ё Ў ·   f А В Ф ж ╢ о ╠ < b  " Ш ╝ B R T ` ъ  J Ж # *# єхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєхєх╧╛хєхєхєхєхєхєхєхєхєхєхєх╧!jА▓hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph hЯ[╓hЯ[╓CJZБ^JaJhЯ[╓hЯ[╓CJ^JaJJ*# ,# n& Ъ& 8) R) T) d) к+ ╥+ p/ В/ Д/ :1 `1 ╛1 Ё1 ┬3 ╩3 ╥3 °3 D4 L4 T4 z4 X8 n8 b9 l9 l; ~; А; ? 6? рG ЄG ЇG J "J (L 0L `L xL P @P BP RP ~R ОR РR ЮR ╜ L╜ P╜ ╪╚ ц╚ ъ╚ ╬╘ ▄╘ р╘ №р с с ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ю█╤ $ДДgdЯ[╓$ДДдdдd[$\$a$gdЯ[╓$ДДдdдd[$\$gdЯ[╓~Д РД ТД └Е ╩Е ж ·м &н Ён Ўн nо xо ┌░ ь░ ю░ ▓ 2▓ т▓ │ 0┤ 2┤ V┤ j┤ ┌┤ ь┤ а╡ ╢╡ °╢ (╖ Ш╖ Ъ╖ V╝ X╝ ~╝ А╝ И╝ К╝ :╜ L╜ N╜ в╜ д╜ ╛ $╛ ▄╛ ┐ Ъ╚ ▓╚ ╘╚ ц╚ ш╚ Ш╩ Ъ╩ Є╩ Ї╩ ъ┘╦╛╝╦╛╦╛╦╛╦ъл╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦╛╦ъЪ╦╛╦╛╦╛╦╛╦ъЙ╦╛╦╛!j`║hЯ[╓hЯ[╓CJU^JaJ!j╕╣hЯ[╓hЯ[╓CJU^JaJ!j╣hЯ[╓hЯ[╓CJU^JaJUhЯ[╓hЯ[╓CJ^JaJhЯ[╓hЯ[╓CJZБ^JaJ!jh╕hЯ[╓hЯ[╓CJU^JaJ*hЯ[╓hЯ[╓6БB*CJZБ]Б^JaJph 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ermographic urticaria GH FH9 4'&9 EF 'D41I. J*EJ2 (41I E1*A9 'D-H'A .7J  J8G1 (9/ *.1J4 'D,D/ (#/'). HJ*1'AB E9 2J'/) 'D@ IgE 'DE*,HD ('D/H1)'D/EHJ). 'D61( 9DI 'D,3/ J$/J D8GH1 '3*,'() Lewis 'D+D'+J) E9 41I H %-E1'1 E*HG, B/ J8G1 0DC AJ 25@50% EF 'D(41 'D9'/JJF. 'D4CD 1BE 229: 41I 'DC*'() 'DE8'G1 'D31J1J): B/ J+'1 G0' 'DFH9 EF 'D41I ('D6:7 'DF',E EF 'D+J'( 'DE4/H/) #H (9/ 61( #H C-* 'D,D/ ('DBDE #H #J #/') #.1I -J+ #FG (9/ 9/) +H'FJ J8G1 'F/A'9 41HJ E-'7 (*HG, -E'EJ E-5H1 AJ 'DEC'F 'DE*#+1. (3/22)  HB/ J*1'AB 0DC E9 'D-C). 'D*.1J4 #J6'K J$/J %DI 8GH1 E+D G0G 'D.7H7 'D%-E1'1J). 'DE9'D,): 'D'E*F'9 9F *F'HD 'D79'E 'DE*HB9 #H 'D/H'! 'DE*GE. (Atarax- Hydroxyzine) J9*(1 EF 'D9D','* 'DA9'D) AJ CD #FH'9 'D41I. E6'/'* 'DGJ3*'EJF 'D,JD 'D,/J/  3*1J2JF (Zyrtec- Cetrizine) #J6'K 0H BJE). 'D3*J1H&J/'* EH69J'K D'JF5- (GE' /'&E'K. 'D3*J1H&J/'* AEHJ'K #H .D'DJ'K A9'D) (4CD E$B* HF'/1'K E' *3*9ED 9F/ 'D169 H'D#7A'D. -'51'* H2 E+D 'D3JEJ*/JF (Cimetidine) B/ *,1( AJ 'D-'D'* 'DE9F/) H'DE2EF). 'D3'J(1HG(*'/JF (Periactin) B/ *97J DD#7A'D 'DC('1 HDJ3 DD#7A'D 'D5:'1. HG0' 'D/H'! B/ JCHF A9'D .'5) ('DE4'1C) E9 (Hydroxazine) #-J'F'K. E4'1C) E6'/JF DDGJ3*'EJF EF E,EH9*JF E.*DA*JF B/ *CHF 61H1J 9F/ 'D#7A'D 'DC('1 AJ (96 'D-'D'* 'D*J D'*3*,J( DD9D','* 'D*BDJ/J). 'D41I 'DH1'+J 'D9'&DJ Heridofamilial urticaria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anazol " #F/1H,JF 69JA J+(7 'D,HF'/H*1AJF 'DF.'EJ CD'GE' #+(* #FG A9'D C/H'! HB'&J. 'D41I 'D5(':J Urticaria pigmentosa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steoporosis ) H*5D(. ED'-8): (3/24)  'DE16J J,( #F JF*(GH' D9/E A1C 'D,D/ (4/) .'5) #+F'! #H (9/ 'D-E'E ('DE'! 'D3'.F -J+ #F G0' JF47 'D.D'J' 'D(/FJ) AJ 'D,D/ H'D71B 'D*FA3J) EE' B/ J$/J %DI HG, HG(H7 6:7  H*4F, B5('* H-*I EH* EA',& . 'DE9'D,): -'51'* H1 H'D3J1HG(*'/JF B/ *(/J (96 'D*-3F. -'51'* H2 J9*B/ #F DG' *#+J1 (3J7 9DI *.AJA 'D#91'6 AJ 'D41I 'D5(':J. 'DE8'G1 'D,G'2J) JECF #F *9'D, CD 9DI -/). 'DE1',9 Gollhausen R, Kligman AM. Human assay for identifying substances, which induce non-allergic contact urticaria: the NICU-test. Contact Derm 1985; 13: 98-106 1 De Groot AK, Gerkens F. Contact urticaria from a chemical textile finish. Contact Derm 1989; 20: 63-4 2 Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981; 104: 369-81 3 Michaelsson G, Juhlin L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 1973; 88: 525-32 4 Parish WE. Possible relevance of changes in mast cells and neutrophils to perpetuation of chronic urticaria In: Champion 5 RH, Greaves MW, Kobza Black A et al., eds. The Urticarias. Edinburgh/ New York: Churchill Livingstone, 1985: 70-85 6 Kobza Black A, Greaves MW, Champion RH et al. Urticaria. Br J Dermatol 1991; 124: 100-8 7 Lagunoff D. The mechanism of histamine release from mast cells. Biochem Pharmacol 1972; 21: 1889-96 8 MacDonald SM, Lichtenstein LM, Proud LM et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987; 139: 506-12 9 Parish RP Champion RH. Urticaria. London: W.B. Saunders, 1974 10 (3/25)  Parish WE Possible relevance of changes in mast cells and neutrophils to perpetuation of chronic urticaria. In: Champion RH, Greaves MW, Black AK, Pye RJ, eds. The Urticarias. Edinburgh: Churchill-Livingstone, 1985: 70-85 11 Carini C. IgE immune complexes in food allergy; significance, pathogenicity and clinical consideration. Clin Allergy 1987; 17: 485-97 12 Heavey DJ, Kobza-Black A, Barrow SE et al. Prostaglandin D2 and histamine release in cold urticaria. J Allergy Clin Immunol 1986; 78: 459-61 13 Michaelsson G, Juhlin L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 1973; 88: 525-32 14 Thompson HL, Burbelo PD, Segui-Real B et al. Laminin promotes mast cell attachment. J Immunol 1989; 143: 2323-7 15 Freeman RG, Spiller R, Knox JM. Histopathology of erythema toxicum neonatorum. Arch Dermatol 1960; 82: 586-9 16 Harris R, Schick B. Erythema neonatorum. Am J Dis Child 1956; 92: 27-33 Keitel HG, Yadav V. Etiology of toxic erythema. Am J Dis Child 1963; 106: 306-9 17 Levy HL, Cothran F. Erythema toxicum neonatorum present at birth. Am J Dis Child 1962; 103: 617-19 18 Wakeel RA, Gavin MP, Keefe M. Severe toxic erythema caused by diltiazem. Br Med J 1988; 296: 1071 19 Hasan T, Jansen CT. Erythroderma: a follow-up of 50 cases. J Am Acad Dermatol 1983; 8: 836-40 20 Zoon JJ, Mali JWH. The influence of erythroderma on the body. Arch Dermatol 1957; 75: 573 21 Harris DWS, Spencer M-J, Tidman MJ. Papulo-erythroderma - clinical and ultrastructural features. Clin Exp Dermatol 1990; 15: 105-6.13 22 (3/26)  Uvnas B. Chemistry and storage function of mast cell granules. J Invest Dermatol 1978; 71: 76-80 23 Vella Briffa D, Eady RAJ, James MP et al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 1983; 109: 67-75 24 Poynard T, Nataf C, Messing B et al. Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis. New Engl J Med 1982; 307: 186 .(Letter) 25 Omerod AD, Herriot R, Davidson RJL et al. Adult mastocytosis, an immunophenotypic and flow cytometric investigation. Br J Dermatol 1990; 122: 737-44 26 Rasmussen JE. Xanthelasmoidea: an unusual case of urticaria pigmentosa. Arch Dermatol 1976; 112: 1270-1 27 Sutter MC, Beaulieu G, Birt AR. Histamine liberation by codeine and Polymyxin B in urticaria pigmentosa. Arch Dermatol 1962; 86: 217-21 28 Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. New Engl J Med 1979; 301: 465-9 29 'DA5D 'D+D'+HF 'D'F/A'9'* 'D/H'&J) Drug Reactions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tabrine" #H 'DDHF 'D1E'/J 'D:'EB 'DF',E 9F *F'HD E1C('* 'DA6). A17 'DAJ*'EJF A B/ J$/J %DJ *H1E -HD 'D3E'B "Periosteal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poxy AJ EH'/ -4H 'D#3F'F B/ *$/J %DI -3'3J) 9DI 'D:4'! 'DE.'7J DDAE. /'! 'DE5D: B/ JCHF 3((G 'D(F3DJF HE4*B'*G. 'D#C2JE' 'D*H3AJ): 'DE-33'* 'DEH69J)  'DE9'/F 'D+BJD) H'DE6'/'* 'D-JHJ). 'D'F/A'9 'D/H'&J 'D+'(*: 'D3DAHF'EJ/'*  'D('1(J*H1'* @ 'DAJFHD A*'D&JF. 'D*A'9D 'D7A-J: 'DE6'/'* 'D-JHJ)  AJFJD (H*'2HF  'D+J'2J/  ('1(*JH1J*. 'D-E'EJ 9/J/ 'D#4C'D: 3DAHF'EJ/'* H:J1G'. F.1 (41HI: 'D('1(J*H'*  'DAFJD (H*'2HF H'D3DAHF'EJ/'*. 'D(1A1J): 'D(F3DJF H3'E'* 'D.D'J'. 'DH1E 'D-(J(J :"Zirconium" E6'/'* 'D*91B HEH'/ 'D*,EJD 'DE3*./E) EH69J'K .'5) DD7J'* 'D#(7J)  'D(1HE H'DJH/. 'F/A'9 J4(G 'D0&() 'D-E'EJ): GJ/1'D'2JF @ 'D(1HC' JJF #EJ/. (3/28)  A17 *5(:: ACTH @ CDH1(1HE'2JF  (JH3DA'F @ 'DE9'/F EH69J'K (4CD F*1'* 'DA6) AJ 'D#/HJ) 'DEH69J) CE' GH 'D-'D AJ 'D#/HJ) 'DEH69J) 'DE3*9ED) DE9'D,) 'D-1HB E+D "'DAD'E'2JF". 2J'/) 491 'D,3E: 'F/1H,JF. CH1*JCH3*J1HJ/ H*3*H3*J1HF. -'5) (+9D()): 3'E'* 'D.D'J' ('D#/HJ) 'DE3EE) DD.D'J') @ GJ('1JF. H3*J1H*J/'* 'DB41J). '1*C'3 6J'&J 3EJ: F',E 9F #/HJ) 'DED'1J' @ 'DCHE'1JF H'DAJFH+J'2JF. 'D#/HJ) 'D#C+1 4JH9'K 'D*J *3(( '1*C'3'* ,/DJ) GJ: E6'/'* 'D,1'+JE: 'DE6'/'* 'D-JHJG AEHJ'K #H EH69J'K B/ *3(( -3'3J). 'DE6'/'* 'D-JHJ) 'DEH69J) 'D#C+1 4JH9'K 'D0J *3(( #C2JE' *E'3 #1,J) GJ 'DFJHEJ3JF @ A1'EJ3*JF  AJ1,JFJ'E'J3JF  H'D('3J*1'3JF. 'D3'D3JD'FJ/ 'DCDH1J #H 'D(1HEJ  E1C('* 'D2&(B 'D96HJ)  'D(F2JD @ 'DC-HD  'D3DAHF'EJ/'*. +'JH1'E 3DA'*. 'DJH/ @ ('JH+JF 'D0J B/ JH,/ AJ (96 'D4'E(HF'* B/ *3(( '1*C'3 /H'&J. 'DE6'/'* 'D-JHJ) 'D,G'2J) E+D: 'DEHFH3CDJF @ 'DCDH1'E AJFCHD @ 'D(F3DJF H'D**1'3CDJF B/ *3(( #FH'9 31J1J) E.*DA) EF 'D'1*C'3 'D/H'&J. 'D#E(3DJF HE4*B'*G B/ *8G1 7A- -5(J 'D4CD E9 (/'J) 9DI 'D#71'A B/ JO5(- E9EE'K HJ-/+ 0DC 9F/ 'DE16J 'DE9'D,JF ('D'E(3JDJF H9'/) J-/+ (9/ #3(H9 H'-/ EF (/'J) 'DE9'D,). 'D*916 'D*'DJ DG$D'! 'DE16J DD#E(J3DJF HE4*B'* 'D(F3DJF 'D#.1I B/ *3(( 'D7A- 'D,D/J. 'D#E(3DJF B/ J3(( '1*C'3 *#BJ(Anaphylactic reaction) . @ 'D#EHC3J3DDJF: J$/J D'F/A'9'* ,D/J) *4ED 'D41I @ 'D7AH- 'D-5(J) 'D4CD H'D-7'7J) 'DD7'.J). 'F/A'9 /H'&J +'(*  H/'! 'DE5D. (3/29)  'DGJ/1HC3J CJFHDHF ( Sterosan) H (Chinoform)Vioform ('D%6'A) %DI '3*1'* -E6 'DGJ/1HC3J (F2H&JC  'D@ (Parabans,Nipagins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orticosteroids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riparanol) *$/J %DI '671'( AJ 'D*B1F. 'D#8'A1: 'D/JCDHE'J3JF B/ J3(( *48J 'D#8'A1. 'D491: 'DE9'D,) 'DCJE'HJ) E+D 'DEJ+H*1C3'* B/ *3(( *3'B7 9'E DD491 . A17 *F'HD 'DAJ*'EJF A B/ J-+ *3'B7 491. 'DE1',9 Korkij W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol 1984; 120: 520-4. 1 Hurwitz S. Cutaneous disorders of the newborn. In: Clinical Pediatric Dermatology. Philadelphia; WB Saunders, 1981; 14-15. 2 Meyrick Thomas RH, Munro DD. Fixed drug eruption due to paracetamol. Br J Dermatol 1986; 115: 357-9. 3 Hughes BR, Holt PJA, Marks R. Trimethoprim associated fixed drug eruption. Br J Dermatol 1987; 116: 241-2. 4 Feinstein A, Sofer E, Trau H et al. Urticaria and fixed drug eruption in a patient treated with griseofulvin. J Am Acad Dermatol 1984; 10: 915-17. 5 Commens C. Fixed drug eruption. Aust J Dermatol 1983; 24: 1-8. 6 Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-7. 7 Guin JD, Haynie LS, Jackson D et al. Wandering fixed drug eruption: A mucocutaneous reaction to acetaminophen. J Am Acad Dermatol 1987; 3: 399-402. 8 Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-7. 9 Andersen KE, Maibach HI. Allergic reaction to drugs topically. Clin Toxicol 198 0; 16: 415-65. Angelini C, Vena CA, Meneghini CL. Contact allergy to antiviral agents. Contact Derm 1986; 15: 114-15. 10 Bandmann H-J, Calnan CD, Cronin E et al. Dermatitis from applied medicaments. Arch Dermatol 1972; 106: 335-7. 11 (3/33)  Beck MH, Burrows D, Fregert S et al. Allergic contact dermatitis to epoxy resin in ostomy bags. Br J Surg 1985; 72: 202-3. 12 Burry JN, Hunter CA. Photocontact dermatitis from Jadit. Br J Dermatol 1970; 82: 224-9. 13 Calnan CD. Diethyldithiocarbamate in adhesive tape. Contact Derm 1978; 4: 61. 14 Calnan CD, Cronin E. False positive reaction to mercaptobenzo-thiazole from rubber in eyedrop bottle. Contact Derm 1981; 7: 283-4. 15 Calnan CD, Frain-Betl W, Cuthbert JW. Occupational dermatitis from chlorpromazine. Trans St John's Hosp Dermatol Soc 1962; 48: 49-74. 16 Clark EW, Blondeel A, Cronin E et al. Lanolin of reduced sensitizing potential. Contact Derm 7: 80-3. 17 Colver CB, Inglis JA, McVithe E et al. Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction? Br J Dermatol 1990; 122: 217-24. 18 Coopman S, Dooms-Coossens A. Cross-reactions in topical corticosteroid contact dermatitis. Contact Derm 1960; 19: 145-6. 19 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone 1980: 192-278. 20 Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980: 805-13 and 832-8. 21 Curley RK, Macfarlane AW, King CM. Contact sensitivity to the amide anaesthetics lidocaine, prilocaine, and mepivacaine. Arch Dermatol 1986; 122: 924-6. 22 Dahlquist I, Fregert S, Cruvberger B. Detection of formaldehyde in corticoid creams. Contact Derm 1980; 6: 494. 23 Shoss RG, Rayhanzadeh S. Toxic epidermal necrolysis following measles vaccination. Arch Dermatol 1974; 110: 766-70. 24 (3/34)  Roujeau J-C, Guillaume J-C, Fabre J-P et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France 1981-1985. Arch Dermatol 1990; 126: 37-42. 25 Revuz J, Roujeau J-C, Guillaume J-C et al. Treatment of toxic epidermal necrolysis. Cretail's experience. Arch Dermatol 1987; 123: 1156-8. 26 Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome). Br J Dermatol 1979; 100: 69-86. 27 Heimbach DM, Engrav LH, Marvin JA. Toxic epidermal necrolysis. A step forward in treatment. J Am Med Assoc 1987; 257: 2171-5. 28 Barnes RL, Wilkinson DS. Epidermal necrolysis from clothing impregnated with paraffin. Br Med J 1973; iv: 466-7. 29 De Groot AC, Conemans JMH. Contact allergy to furazolidone. Contact Derm 1990; 22: 202-5. 30 Deschamps D, Carnier R, Savoye J et al. Allergic and irritant contact dermatitis from diethyl-betachloroethylamine. Contact Derm 1988; 18: 103-5. 31 Van Dijk E, Neering H, Vit?nyi BEJ. Contact hypersensitivity to sesame oil in patients with leg ulcers and eczema. Acta Derm Venereol 1973; 53: 133-5. 32 Dohn W. Beitrag zur Frage der Chloramphenicol-Kontaktallergien. Hautarzt 1965; 16: 174-7. 33 Allergenicity prediction and pharmacopoeial requirements. Contact Derm 1983; 9: 175-85, and 352-9. 34 Dooms-Goosens A, Degreef H, Coopman S. Corticosteroid contact allergy: a reality. In: Frosch 35 PJ, Dooms-Coossens A, Lachapelle J-M et al., eds. Current Topics in Contact Dermatitis. Berlin: Springer, 1989: 233-7. 36 (3/35)  Dooms-Coossens A, Degreef H, Vanhee J et at. Chlorocresol and chloracetamide: allergens in medications, glues and cosmetics. Contact Derm 1981; 7: 51-2. 37 Fisher AA. Contact Dermatitis, 3rd edn. Philadelphia: Lea and Febiger, 1986: 141-257. 38 Fisher AA. Unnecessary addition of ethylenediamine hydrochloride to 'generic' nystatin creams. J Am Acad Dermatol 1989; 20: 129-30. 39 Fregert S, M?ller H. Photo cross-sensitization among halogen-hydroxybenzoic acid derivatives. J Invest Dermatol 1964; 43: 271-4. 40 Fregert S, Trulson L, Zimerson E. Contact allergic reactions to diphenylthiourea and phenylisothiocyanate in PVC adhesive tape. Contact Derm 1982; 8: 38-42. 41 Gelfarb M, Leider M. Allergic eczematous contact dermatitis. Report of a case caused by sensitization to undecylenic acid and its zinc salt. Arch Dermatol 1960; 82: 642-3. 42 Gellin GA, Maibach HI, Wachs CN. Contact allergy to tolnaftate. Arch Dermatol 1972; 106: 43 Goh CL. Contact sensitivity to proflavine. Int J Derm 1986; 25: 449-51. 44 Cola M, Francalanci S, Brusi C et at. Contact sensitization to acyclovir. Contact Derm 1989; 20: 45 C?ransson K, Lidщn S. Contact allergy to sorbic acid and unguentum Merck. Contact Derm 1981; 277. 46 Harris GL, Maibach HI. Allergic contact dermatitis potential of 3 pyridostigmine bromide transdermal drug delivery formulations. Contact Derm 1989; 2l: 189-93. 47 Hannuksela M, Piril? V, Salo OP. Skin reactions to propylene glycol. Contact Derm 1975; 1: 48 Hausen BM, Heesch B, Kiel U. Studies on the sensitizing capacity of imidazole derivatives. Am J Contacf Derm 1990; 1: 25-33. 49 (3/36)  Hausen BM, Wollenweber E, Senff H et al. Propolis allergy (1) Origin, properties, usage and literature review. Contact Derm 1987; 17: 163-70. 50 Hjorth N, Trolle-Lassen C. Skin reactions to ointment bases. Trans St John's Hosp Dermatol Soc 49: 127-40. 51 Holdiness M. A review of contact dermatitis associated with transdermal therapeutic systems. Contact Derm 1989; 20: 3-9. 52 Jelen C, Tennstedt D. Contact dermatitis from topical imidazole antifungals: 15 new cases. Contact Derm 1989; 21: 6-11. 53 Jordan WP. Cross-sensitization patterns in acrylate allergies. Contact Derm 1975; 1: 13-15. 54 Dooms-Goossens A, Degreef H. Contact allergy to petrolatums. (I) Sensitizing capacity of different brands of yellow and white petrolatums. (II) Attempts to identify the nature of the allergens. 55 Jones SK, Kennedy CTC. Contact dermatitis from tioconazole. Contact Derm 1990; 22: 122-3. 56 Katz BE, Fisher AA. Bacitracin: a unique topical antibiotic sensitizer. J Am Acad Dermatol 1987; 1016-24. 57 Kinnunen T, Hannuksela M. Skin reactions to hexylene glycol. Contact Derm 1989; 21: 154-8. 58 Kligman AM. Lanolin allergy: crisis or comedy? Contact Derm 1983; 9: 99-107. 59 Lachapelle JM, Lamy F. On allergic contact dermatitis to virginia-mycin. Dermatologica 1973; 320-2. 60 Larsen WG. Allergic contact dermatitis to the perfume in Mycolog cream. J Am Acad Dermatol 1: 131-3. 61 Levine BB. Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin C and its degradation products. J Exp Med 1960; 112: 62 (3/37)  Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. J Am Med Arsoc 1979; 242: 63 Lovell CR, Staniforth P. Contact allergy to benzalkonium chloride in plaster of Paris. Contact Derm 1981; 7: 343-4. 64 Meneghini CL, Rantuccio F, Lomuto M. Additives, vehicles and active drugs of topical medicaments as causes of delayed-type allergic dermatitis. Dermatologica 1971; 143: 137-47. 65 Mennщ T, Hjorth N. Rouhne patch testing with paraben esters. Contact Derm 1988; 19: 189-91. 66 Nater JP, de Groot A.C. Unwanted Effects of Cosmetics and Drugs used in Dermatology, 2nd edn. Amsterdam: Elsevier, 1985: 44-108 and passim. 67 Neumann RA, Knobler RM, Lindemayr H. Tiaprofenic acid induced photosensitivity. Contact Derm 1989; 20: 270-3. 68 Patruno C, Auricchio L, Mozzillo R et at. Allergic contact dermatitis due to tromantadine hydrochloride. Contact Derm 1990; 22: 187. 69 Puig L, Abadias M, Alomar A. Erythroderma due to ribostamycin. Contact Derm 1989; 21: 70 Rajka C, Pallin 0. Sensitization to locally applied Antastene. Acta Derm Venereol 1964; 44: 71 Reitamo S, Lauerma AI, F?rstr?m L. Detection of contact hypersensitivity to topical corticosteroids with hydrocortisone-l7-butyrate. Contact Derm 1989; 21: 159-65. 72 Reynolds NJ, Harman RRM. Allergic contact dermatitis from chlorhexidine diacetate in a skin swab. Contact Derm 1990; 22: 103-4. 73 Takahashi M, Matsuo I, Ohkido M. Contact dermatitis due to honeybee royal jelly. Contact Derm 1983; 9: 452-5. 74 Salo OP, Piril? V, Viljanen E. Sensitivity to topical dequaline. Acta Allergol 1968; 23: 490-6. 75 (3/38)  Schwartz BK, Glendenning WE. Allergic contact dermatitis from hydroxypropyl cellulose in a transdermal estradiol patch. Contact Dermatitis 1988; 18: 106-7. 76 Shelley WB, Heaton CL. Minocycline sensitivity. J Am Med Assoc 1973; 224: 125-6. 77 Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Baltimore: Williams & Wilkins, 1986. 78 Lenz W. Malformations caused by drugs in pregnancy. Am J Dis Child 1966; 112: 99-106. 79 Miller ME, Seals J, Kaye R et al. A familial, plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-3. 80 Vujasin J, Petrovic D. Biotin in some erythemato-squamous dermatoses of babies. Dermatologica 1952; 105: 180-3. 81 Shono M, Hayashi K, Sugimoto R. Allergic contact dermatitis from croconazole hydrochloride. Contact Derm 1989; 21: 225-7. 82 Tennstedt D, Lachapelle J-M. Allergic contact dermatitis to 5-fluorouracil. Contact Derm 1987; 279-80. 83 Valsecchi R, Cainelli T. Contact dermatitis from ibuproxam. A case with cross-reactivity with ketoprofen. Contact Derm 1990; 22: 51. 84 Van Ketel WC. Systemic contact-type dermatitis by derivatives of adamantane. Dermatosen 1988; 23-24. 85 Wasilewski C. Allergic contact dermatitis from nystatin. Arch Dermatol 1970; 102: 216-17. 86 Crotty RQ. Erythroderma desquamativum (Leiner's disease). Arch Dermatol 1955; 71: 587-90. 87 Den Tandt W, Eggermont E, Bourgeois N. Erythroderma desquamativum. Acta Paediatr Belg 1967; 21: 433-50. 88 (3/39)  Evans DIK, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner's disease). Arch Dis Child 1977; 52: 691-5. 89 Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8. 90 'DA5D 'D-'/J H'D+D'+HF E8'G1 #E1'6 FB5 'DEF'9) 'D#HDJ) Manifestations of primary immuno-defficiency diseases 9/) E8'G1 31J1J) *-/+ (3(( 9H2 'D,DH(HDJF'* 'DEF'9J). HB/ *CHF *DC 'DE8'G1 :J1 FH9J) #H FH9J) **9DB (FE7 E9JF EF 'D,DH(HDJF'* 'DEF'9J). 'DE8'G1 'D,D/JG :J1 'DFH9J): *-/+ (3(( 9/) 9H'ED E.*DA) GJ (4CD 1&J3J: 'D'F*'F'* H'D*B1-'*. 'D/E'ED 'DE*C11) #H 'D.1','*. 'DBH('! 'DAB'9J) E9 9FJ('* 1'&B). 'D*B1-'* 'D,D/J) B/ *$/J %DI 'F*'F +'FHJ ('DAJ1H3'* E+D 'D9B(HD 'D(3J7 HAJ1H3 'D-D# 'DF7'BJ @ CDG' *$/J %DI .DD AJ 'DDEA'HJ'* 'D*'&J). 'D+"DJD 'DAJ1H3J). 'D"A'* 'D-HJ5DJ) 'DAB'9J). 'D8GH1 'D-HJ5DJ DD*F'01 A17 Ig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gA 'D'F*B'&J @ 9H2 IgM 'D'F*B'&J H1F- *H39 'D#H9J) 'D491J) Ataxia telengectasia. 'D0&() 'D-E'EJ): JH,/ E9/D E*2'J/ DD0&() 'D-E'EJ) 'D,G'2J) 9F/ 'DE16J 'DE5'(JF (9H2 IgA 'D'F*B'&J  H'D"A'* 'D,D/J) *4(G *B1J('K 'D0&() 'D-E'EJ) 'DB1J5J). 'D*F'01'* 'DE*1'AB) E9 #E1'6 9H2 'DEF'9J) Syndromes associated with immuno-defficiency diseases 1 @ :J'( ,'E':DH(JF 'D/E (/'! (1H*HF) GH 9H2 EF'9J F'/1 @ J5J( 'D0CH1 @ J-/+ C5A) E1*(7) ('D,F3 EBGH1) .D'D 6 4GH1 'D#HDI  JCHF 'D7AD 9'/) E-EJ (H'37) 'D#6/'/ 'D"*JG DG EF #EG #+F'! 'D-ED. 'DE8'G1 'D31J1J): #C2JE' D' JECF *A1JBG' 9F 'D#C2JE' 'D'3*41'&J) B/ *8G1 9F/ 'D16J9 E9 E3*HJ'* EF.A6) EF IgE 'D,'&D. 'D#7A'D 'DE5'(HF JCHF 9F/GE '3*9/'/ DCJ JCHF D/JGE "A'* 'F*'FJ) BJ-J) *5J( .'5) 'D#0F 'DH37J  'D,JH( H'D1&*JF. 'D'F*'F'* 'D,D/J) 'DBJ-J) #J6'K 4'&9) H*4ED 'D/E'ED H'D.1','* H'D*G'( 'DF3J, 'D.DHJ. G0G 'D#4C'D EF 'D'F*'F'* :'D('K E' *-/+ ('D9FBH/J'* 'DE0G() H'D9B/J'* E,EH9) A . #E1'6 1&HJ) E2EF) FB5 3E9 A4D 'DFEH 2 @ 9H2 IgA 'D'F*B'&J 'DE8'G1 'D31J1J): -E'B (Varicella) B'*D. H1E -(J(J E2EF ('DE(J6'* 'D(J6. 'C2JE' *#(*J) #H '3*41'&JG H1(H. 'F*'F'* ,1+HEJ) E*C11) AJ 'D71B 'D*FA3J). B/ *CHF '671'('* 'DEF'9) 'D0'*J) '.*D'7'K D9H2 IgA .'5) 'D0&() 'D-E'EJ) 'D,G'2J) (SLE) 'D*G'( 'DEA'5D 'D1+H'FJ @ 'D*G'( 'D,D/ H'D96D'*  AB1 'D/E 'D.(J+  'D(GB H(1A1J) FB5 'D5AJ-'* 'D#3'3J). 'D'1*C'3'* 'D*#BJ) 'D*'DJ) DFBD 'D/E #H %97'! 'D,DH(HDJF'* 'DEF'9J)  *F,E 9F H,H/ 'D@ IgE H#6/'/ IgA . 3 @ 9H2 IgM 'D'F*B'&J 'DE8'G1 'D31J1J): #C2JE'. +"DJD AJ1H3J) 6.E). (3/41)  'F*'F'* ('D1&HJ'* H'DECH1'* 'D3-'&J). 4 @ *F'01 A17 IgM GH E16 H1'+J E1*(7 ('D,F3 J5J( 'D0CH1 (4CD E3J71. 'DE8'G1 'D9'E): 'D'F*'F'* 'D,1+HEJ) 'DE*C11)  .'5) 'D*G'( 'DDH2*JF  'D*G'( 'D#0F 'DH37J H0'* 'D1&) .'5) #+F'! 'D3F) 'D#HDI #H 'D+'FJ) EF 'D-J'). 'DE8'G1 'D,D/J): +"DJD AJ1H3J) C+J1). E8'G1 'D#:4J) 'DE.'7J): 'D*G'( 'DAE  'D*G'( 'DD+) H*B1- AEHJ J-/+ (4CD +'FHJ DFB5 'D9/D'*. 5H1) 'D/E: J1*A9 Ig M HJF.A6 IgA , IgG H IgE HFB5 'D9/D'* . 5 @ 9H2 'D*#J'* (*F'01 /J ,H1, @ 931 *5F9 'D*JEH3) G0' 'D*F'01 J9C3 'D*7H1 'D4'0 AJ 'DBH) 'D:D5EJ) #H 'D.J4HEJG (Branchial pouches) 'D+'D+ H'D1'(9 ('D(D9HEJ)). 'DE8'G1 'D31J1J): 'DE8'G1 'D,D/J): 'D#7A'D 'DE5'(HF JCHF D/JGE "A) ,D/J) "*4(G 'D*G'( 'D,D/ 'D2GEJ" H'D#C2JE' 'D*#(*J) H'D7AH- 'DD7'.J) 'D-7'7J). /'! 'DE(J6'* 'DAEHJ 'DE3*E1 GH E8G1 4'&9 9F/ 'D#7A'D 'D0JF *9/H' 'DE1-D) 'DHDJ/J). 'DE8'G1 'D9'E): :J'( 'D:// E,'H1'* 'D/1B. *4HG'* BD(J) HAJ 'D#H9J) 'DC(J1). *4HG'* AJ 'D1#3 H'D9FB HFB5 *5(: 'D*JEH3 *$/J %DI .DD .D'J' T .DBJ. 6 @ 9H2 'DEF'9) 'DE.*D7) 'D4/J/ J4J1 G0' 'DE57D- %DI *F'01 J(/J 9/) '671'('* H1'+J) EEJ2) (FA3 'DE8'G1 'D31J1J) H'DEF'9J). G0' 'D*F'01 J*8'G1 ('671'('* '3*BD'(J) E9 9H2 'D'/FJH2JF /J'EJF'F  H(JH1JF FJCDJH2J/ AH3AH1JD'2  9H2 AJ 'D(1H*JF'* 'D1'(7 DD@ DNA H.DD AJ %F*', 'D'F*1DHCJF @ 2 . 'DEH* 4'&9 AJ 'D#4G1 'D#HDI EF 'D9E1. 'DE8'G1 'D31J1J): J8G1 'DE1J6 9H2 4/J/ H'6- AJ H8'&A CD EF 'DDEA'HJ'* 'D*'&J) H'D('&J). 'DE8'G1 AJ 'D#:4J) 'DE.'7J): /'! 'DE(J6'* 'D,G'2J H'D,D/J 'DE.'7J GJ 'D*8'G1'* 'D#C+1 4JH9'K  'F*'F'* 'DA7H1 'D,D/J) B/ *-/+ HB/ *(/H (4CD 'D*G'( ,D/ -A'8J E2EF. (3/42)  'D#-E1J) 'D3E'CJ) E9 -'5) H:J'( 491 'D-',(JF H'D,AFJF #H 931 *5F9 'D#/E) (Ectodermal dysplasia ). "A'* *4(G 'F-D'D 'D(41) 'DF.1J 'D3EJ. 'F*'F'* AJ1H3J) **8'G1 (*B1-'* 'D,D/ .'5) AJ F'-J) 'D9,'F #H 'D:4'! 'DE.'7J DDAE H'DD3'F. 'F*'F'* 'D-D# 'DF7'BJ 'D4/J/) B/ *-/+. 'DE8'G1 'D9'E): 'F*'F'* E*C11) .'5) 0'* 'D1&). 'F*'F'* AJ1H3J) F',E) 9F 'D-E) 'DE6.E) DD.D'J' (Cytomegalic virus)  'D-5() H'D*CJ3 'D1&HJ 'DC'1JFJ. 'D%3G'D 'DE2EF ((3(( 'D1H*' AJ1H3 :'D('K #H 'DCHE(JDH('C*1 #H 'D7AJDJ'* E+D 'D,J'1/ J'D'E(J'). 'DE9'D,): 219 FBJ 'D98E GJ 'DE9'D,) 'DA9'D) AB7 . 7 @ *F'01 'DDEA'HJ'* 'D@" Bare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menn's GH *F'01 9'&DJ (5A) ,3EJ) EBGH1)  #:D( 'D*8'G1'* ,D/J) HJ(/J '671'( J9C3 *C'+1 'DDEA'HJ'* 'D*'&J) H9DI -3'( 'DDEA'HJ'* 'D('&J). 'DE16 0H 3J1 31J9 HB'*D  E9 A4D FEH H'F*'F E*C11. 'DE8'G1 'D,D/J): 7A- E*B41 H%-E1J) ,D/J) E*EH,). 'DE8'G1 'D9'E): 6.'E) C(/J) 7-'DJ) H'9*D'D 9B/ DEAJ) E9EE). %3G'D E2EF. B/ J-/+ DEAHE' AJ (96 'D-'D'*. A17 'DDEA'HJ'* H'D-E6'*. 6J'9 'D.D'J' 'D('&J) HE3*HJ'* E*F'B5) EF CD 'D,DH(HDJF'* 'DEF'9J) E'9/' Ig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gE H'F.A'6 IgG . :J'( 'D#6/'/ 'D1'5)(Isohaemaglutinins) . J671( 9'/) 'D,DH(HDJF *-* 'D5FA IgG2 . **#+1 (4CD #BD 4/) 'D'3*,'('* DDE3*6/'* 'D(1H*JFJ) ('D#6/'/. 'D.D'J' 'DDEA'HJ): 5:J1) H0'* *4HG'* 4CDJ) E*EJ2). 'DE9'D,): FBD 'D5AJ-'* 'D7'2,): DDF2A 'D-'/. '3*&5'D 'D7-'D: J.AA .71 'DF2JA  J2J/ 9// 'D5AJ-'* HJ-3F H8JA*G' HJ2JD .71 'F*'F 'D/E 'DB'*D DCF G0' 'D.71 JECF *BDJDG ('D%97'! 'DHB'&J 'DE/J/ DDE6'/'* 'D-JHJ) .'5) 'D3DA' E+D (CO - Trimoxazol). 'D,DH(HDJF'* :'E': 'D%97'! 'DH1J/J DD,DH(HDJF'* 'DEF'9J) 0H /H1 E-/ / DD3J71) 9DI 'D'F*'F 9F/E' *CHF 'DE6'/'* 'D-JHJ) :J1 C'AJ) DH-/G'. ,'E',DH(HDJF'* D'J97I 96DJ'K H(0DC A%FG E6'/ '3*7('( (3(( .71 'DF2A EC'F 'D-BF. 219 'DFBJ 'D98E: 'D/1'3) 'DH1'+J) DD#GD H'DF3'! 'D-'ED'* DDE16 AJ 'D9'&D) 4J! EGE ,/'K. 10 @ 1F- *H39 'D491J'* Ataxia telengectasia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gA H.DD 'D*'&J'* 4'&9) ,/'K. 'DE9'D,): 'DE9'D,) ('D(JH*JF 10 @ 40 ED: JHEJ'K. 11 @ 9H2 'D(JH*JF/J2(Biotinidase defficiency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riscili's Syn (3/45)  GH '671'( F'/1  J-*ED #FG JF*BD H1'+J'K C5A) -,EJ) EBGH1)  HAJG J*1'AB 9H2 'DEF'9) 'DE4*1C E9 EGB ,2&J(Albinism) H:J'( .D'J' "D'F:1G'F3" 'D,D/J). 491 'D-',(JF H'D#,A'F *8G1 (DHF 1E'/J A6J EF0 'D7AHD) 'D('C1). 13 @ #E1'6 'D9/D'*(Neutrophil disorders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oli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olony stimulating factor" J(/H #FG' E4,9G AJ 'D9D',. FB5 'D9/D'* H'D*F'01'* 'DE1'AB) DG' FB5 'D9/D'* *-/+ #J6'K C,2! EF 9/) *F'01'*: FB5 'DC1J'* 'D4'ED CE' AJ "AB1 /E A'FCHFJ". 931 'D*B1F 'D.DBJ. *F'01 "4/J'B GJ,'4J". *F'01 ":1J3JDDJ". -/+ +'FHJ AJ #9H'2 'DEF'9) 'D(/&J). 14 @ AB1 /E A'FCHFJFanconi's anemia 'D*F'01 JH1+ C5A) ,3EJ) EBGH1). 'D#7A'D 'DE5'(HF 9'/) JCHFHF 5:'1'K HF'B5J 'DH2F 9F/ 'DHD'/). HB/ *-/+ 'DHA') 9'/) .D'D 9/) 3FH'* H#HD 9D'E) DDE6'9A'* 'D.7J1) GJ A4D FBJ 'D98E. 'DE8'G1 'D31J1J): 'DE8'G1 'D,D/J): 8GH1 'DC/E'* 'D/EHJ) (3GHD) GH 916 ('C1 HJ8G1 9'/) (9E1 4 @ 10 3FH'*. A17 'D*5(: 'D,D/J H'D*4HG'* 'DGJCDJ) GJ 5A'* EEJ2) #J6'K. 'D*5(: 'D(FJ 'D(B9J 3H'! J4(G (Freckles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lkylating agents) AJ -'D'* E'B(D 'D219. 15 @ 931 'D*B1F 'D.DBJ GJ B5H1 FBJ 'D98E E1*(7 E*1BJ. C'F AJ 'DE'6J J.*D7 ('D*4.J5 E9 AB1 /E A'FCHFJ. 'DE8'G1 :J1 'D/EHJ) E*EJ2) (4CD C'ED. 16 @ *F'01 A17 IgE GH -'D) 9H2 EF'9J) (/'&J) *H1+ (5A) ,3EJ) B'G1)  H**EJ2 (%F*'F'* E*C11) ('D9FBH/J'* H'1*A'9 4/J/ (E3*HJ'* Ig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gE 9'DJ) ,/'K (4CD +'(* -*I 9F/ 'D169. '1*A'9 E3*HJ'* IgD . E3*HJ'* IgA , IgG H IgM :J1 8'G1). 2J'/) C(J1) ,/'K AJ IgE 'DCDJ 'D,'&D. (3/48)  J(/J 'DE1J6 '3*,'('* %J,'(J) BHJ) %DI *B'9D 'D@ Flare H Wheal AJ '.*('1'* 'D,D/ ('DH.2 "Prick" ('D#79E) 'DE$1,) H('D'3*F4'B DDE$1,'* 'D4'&9) H'D,1'+JE H'DA7H1. 'DDEA'HJ'* AJ 'D/E 'DE-J7J 9'/) 7(J9J) HD'JH,/ 40H0'* AJ 'D.D'J' 'D*'&J). 'DE9'D,): 'DHB'J) ('DE6'/'* 'D-JHJ). J97J 'D3JE*J/JF DDE16J 0HJ 'D'3*,'() 'D69JA) DDE6'/'* DH-/G'. J,( E9'D,) 'F*'F'* 'DE(J6'* (4CD EH69J (E1C('* CJ*HCHF'2HD AEHJ #H E3*-61'* E6'/'* 'DA7H1 'D-/J+) E+D 'D'J*1'CHF'2HD. 'DBJD) #H 'D#CJ'3 'DGH'&J) 'D1&HJ) J,( #F *4B. 17 @ 9H2 'D*5'B 'DC1J'* 'D(J6 Leukocyte adhesion deficiency JH1+ G0' 'D'671'( (5A) ,3EJ) 0'*J) EBGH1)  HJ*5A (3H! H8JA) 'DC1J'* 'D(J6 HG0' J$/J %DI "A'* BJ-J) AJ 'D#F3,) 31J1J'K HF3,J'K. 'D40H0'* AJ H8JA) 'DC1J'* 'D(J6 EH,H/) #J6'K .'5) 'F.A'6 H8JA) 'D.D'J' 'D7(J9J) 'DB'*D) (Natural killer-cells)-(NK) HH8'&A 'D*'&J'* 'D3'E) DD.D'J'. 'DE8'G1 'D31J1J): 'D*G'( 'DF3J, 'D.DHJ  'D.1','* H*B1-'* 'D#F3,) 'D1.H) 'DE*C11) GJ 'DE8'G1 'D1&J3J). 'D96HJ'* 'D*J *92D 9'/) EF G0G 'D.1','* GJ %E' 'D9FBH/J'* 'DE0G() #H 'D,1'+JE 3D(J) 'D:1'E E+D E.coli #H 'D2H' &A (3H/HEHF'3). 'D*G'( 'D#0F 'DH37J 'DE*C11 H69A 'D*&'E 'D,1H- B/ *CHF E8'G1 EGE). 'F*'F'* 'DE(J6'* 'D37-J) 4'&9). 'D*G'( 'DAE 'D*B1-J H'DE16 (E'-HD 'D#3F'F) 'D4/J/ 'D0J B/ J$/J %DI 6J'9 ('C1 ('D#3F'F GH E4CD) 4'&9). 'D*G'( 'D(1J*HF 4'&9 H3(( E*C11 D'.*D'7'* .7J1). *#.1 3BH7 'D31) H'D*G'( E'-HD 'D31). 'D*4.J5: 'D*4.J5 'DE.(1J 'DE$C/ J9*E/ 9DI %8G'1 'D9D'E'* 'D37-J) :J1 'DC'AJ) EF: CD11a, CD11b,&CD11c H9DI 9/J/) 'D#4C'D EF 'DDEA'HJ'* H'DH-J/'*. 'D*4.J5 E' B(D 'DHD'/) E*HA1 HJ-*', D9JF) EF /E 'D,FJF. 'DE9'D,): 'DE6'/'* 'D-JHJ). *31J( 'D9/D'*. (3/49)  219 FBJ 'D98E. 18 @ 'D/'! 'D-(J(J 'DE2EF Chronic granulomatous disease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gE 2'&/ #H 7(J9J. 'DE9'D,): 'D9F'J) 'D5-J) ('D,D/. J,( '3*B5'! A17 'D-1'1) ('F*('G D%8G'1 EHB9 'D'F*'F H'D96HJ'* 'DE3$HD). J,( '.*J'1 'DE6'/'* 'D-JHJ) ('F*('G HJ,( #F *CHF 'DE9'D,) E1C2). 'DE9'D,) 'DE3*E1) ('DE6'/'*  ('D*1'J E+H(1JF @ 3DA'EJ+HC3'2HD (Bactrim, septrin fort) #H 'D*1JEJ*H(1JE DH-/G  GH 'D.7 'DE9J'1J DDE9'D,) 'D"F. 'DE9'D,) 'DE3*E1) (E6'/'* 'DA7H1 E+D 'DCJ*HCHF'2HD D'J(/H #FG' A9'D) AJ 'DHB'J) EF 'D14'4J'* DCF J$ED #F J97J 'D%J*1'CHF'2HD A'&/) E' HGH *-* 'D*BJJE H#+(* #FG A9'D ,/'K. 'D'F*1AJ1HF *-* 'D,D/. ,'E',DH(HDJF B/ JCHF 0H F*'&, ,J/). FBD 'D/E B/ JCHF E7DH('K DE9'D,) AB1 'D/E. 'D3*J1H&J/'* 'DB41J) ,G'2J) DD%F3/'/ 'DE9HJ. 219 FBJ 'D98E. 19 @ *F'01 4H'4E'F Schwachman syndrome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r H C1s 'DE8'G1 GJ: E8'G1 4(G 'D0&() 'D-E'EJ) 'D,G'2J). 'D*G'( CDJ) :4'&J. 'F*'F'* 1&HJ) H.1','* C(/J). 6 @ 9H2 C4 'DE8'G1 'D31J1J): 0&() -E'EJ) ,G'2J) #H *F'01 'D0&() 'D-E'EJ) 'D,G'2J). E8'G1 E+D (1A1J) GJFHC @ 4HFD'(F #H *F'01 3,H,1F. 'F*'F'*. 7 @ 9H2 C2 J(/H #FG #4J9 E*EE)  H*(JF -'DJ'K #FG J*1'AB E9 *FH9 AJ 'D#E1'6 DCF 'D#4.'5 'DE5'(HF JCHFHF #5-'! *E'E'K. 'DE8'G1 'D31J1J): B/ *4(G 'DE8'G1 #E1'6' E.*DA) E+D: #E1'6 'D:1'!: E+D 'D0&() 'D-E'EJ) 'D,G'2J). 'D0&() 'D-E'EJ) 'DB15J)  'D*G'( 'DCDJ) 'D:4'&J  'D*G'( 'DEA'5D 'D1+H'FJ H'D*G'( 'D,D/ H'D96D. (1A1J) GJFHC @ 4HFD'JF. /'! C1HF. (1A1J) FB5 'D5AJ-'* 'D#3'3J). 'F*'F'* ,1+HEJ) B/ *-/+ #J6'K .'5) ('D1&HJ'* H'DE3*/ JE'* 'DF2DJ) H'D3'&J'*. 8 @ 9H2 C3 'D'F*'F'* GJ 'DE.'71 'D1&J3J) D9H2 C3  'D*G'( 'D3-'J' ('D3-'&J'* H0'* 'D1&) ('D1&HJ'* GJ 'DE4'CD 'D1&J3J). 'D5H1) 'D31J1J): *4(G *DC 'D.'5) (FB5 ,'E',DH(JF 'D/E. 7AH- -7'7J) D7'.J) 9'(1) E*1'AB) E9 'F*'F'*. E8'G1 #.1I E+D 'D0&() 'D-E'EJ) 'D,G'2J) H'D*G'( 'DCDJ) 'D:4'&J. 9 @ 9H2 'DE*EE) 'D'F*G'&J) (C5 , C6 , C7 , C8 , C9) 'DE8'G1 'D31J1J): 'D*G'( 3-'J' ('D3-'&J'* E*C11. 'F*'F'* EF*41) ('DECH1'* 'D(FJ). 'F*'F'* ,D/J) H.1','* *E* ,D/J) AJ (96 'D-'D'*. #E1'6 'D:1'!: 'D0&() 'D-E'EJ) 'D,G'2J) H'D0&() 'D-E'EJ) 'DB15J) H/'! 3,H:1JF 'D/'! 'D1+H'FJ 'D4('(J @ *5D( 'D#5'(9 @ 8'G1) 1JFH @ H'D*G'( 'DAB'1 'DEB37 ('DD'5B). 'DE1',9 Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6 1 (3/53)  Gilson IH, Banett JH, Conant MA et al. Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 20: 637-42 2 Gretzula J, Penneys NS. Complex viral and fungal skin lesions of patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1987; 16: 1151-4 3 Miller ME, Seals J, Kaye R et al. A familial, plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-3 4 Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30 5 Patrizi A, Masina M, Tassoni P et al. Erythroderma in infancy: a sign of immunodeficiency? J Am Acad Dermatol 1987; 17: 694-5 6 Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent `cold' abscesses. Lancet 1974; ii: 617-19 7 Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job's) syndrome. Medicine 1983; 62: 195-208 8 Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job's) syndrome. Medicine 1983; 62: 195-208 9 Buckley RH, Sampson HA. The hyperimmunoglobulin E syndrome. In: Franklin ED, ed. Clinical Immunology Update. New York: Elsevier 1981: 147-67 10 Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978; 41: 288-314 11 Mawhinney J, Killen M, Fleming WA et al. The hyperimmunoglobulinemia E syndrome: a neutrophil chemotactic defect reversible by histamine H2 receptor blockade. Clin Immunol Immunopathol 1980; 17: 483-91 12 (3/54)  Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20 13 Zachary CB, Atherton DJ. Hyper-IgE syndrome. Clin Exp Dermatol 1986; 11: 403-8 14 Evans DIK, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner's disease). Arch Dis Child. 1977; 52: 691-5 15 Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8 16 Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30 17 Svejcar J, Homolka J. Experimental experiences with biotin in babies. Ann Paediatr 1950; 174: 175-93 18 Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8 19 Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30 20 Svejcar J, Homolka J. Experimental experiences with biotin in babies. Ann Paediatr 1950; 174: 175-93 21 Super M, Thiel S, Lu J et al. Association of low levels of mannanbinding protein with a common defect of opsonisation. Lancet 1989; ii: 1236-9 22 Miller ME, Nilsson UR. A familial deficiency of the phagocytosisenhancing activity of serum related to a dysfunction of the fifth component of complement (C5). New Engl J Med 1970; 282: 354-8 23 Vujasin J, Petrovic D. Biotin in some erythemato-squamous dermatoses of babies. Dermatologica 1952; 105: 180-3 24 (3/55)  Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6 25 Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent `cold' abscesses. Lancet 1974; ii: 617-19 26 Karol RA, Eng J, Cooper JB et al. Imbalances in subsets of T lymphocytes in an inbred pedigree with Omenn's syndrome. Clin Immunol Immunopath 1983; 27: 412-27 27 Dreskin SC, Goldsmith PK, Gallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection syndrome. J Clin Invest 1985; 75: 26-34 28 Blum R, Geller G, Fish LA. Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia and divergent chemotactic responses in two generations. J Pediatr 1977; 90: 607-9 29 Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job's) syndrome. Medicine 1983; 62: 195-208 30 Walsh GA, Richards KL, Douglas SD et al. Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients. J Clin Microbiol 1981; 13: 1046-8 31 Buckley RH, In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 320-6 32 Kamei R, Honig PJ. Neonatal Job's syndrome featuring a vesicular eruption. Pediatr Dermatol 1988; 5: 75-82 33 Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent `cold' abscesses. Lancet 1974; ii: 617-19 34 (3/56)  Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in 35 Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20 36 Walsh GA, Richards KL, Douglas SD et al. Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients. J Clin Microbiol 1981; 13: 1046-8 37 Miller ME, Seals J, Kaye R et al. A familial, plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-3 38 Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6 39 Zachary CB, Atherton DJ. Hyper-IgE syndrome. Clin Exp Dermatol 1986; 11: 403-8 40 Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in 41 Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20 42 Glover MT, Atherton DJ, Levinsky RJ. Syndrome of erythroderma, failure to thrive and diarrhea in infancy: a manifestation of immunodeficiency. Pediatrics 1988; 81: 66-72 43 Archer E, Chuang T-Y, Hong R. Severe eczema in a patient with DiGeorge's syndrome. Cutis 1990; 45: 455-9 44 DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: occurrence with congenital hypoparathyroidism. Birth Defects 1968; 4: 116-23 45 Bastian JF, Williams RA, Ornelas W et al. Maternal isoimmunisation resulting in combined immunodeficiency and fatal graft-versus-host disease in an infant. Lancet 1984; 1: 1435-7 46 (3/57)  Weinberg K, Parkman R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. New Engl J Med 1990; 322: 1718-23 47 Gelfand EW, Dorsch HM. Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects 1983; 19: 65-72 48 Schuurman HJ, Huber J, Zegers BJM et al. Placental diagnosis of the bare lymphocyte syndrome. New Engl J Med 1985; 313: 757-8 49 Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30 50 Soothill JF, Harvey BAM. Defective opsonization: a common immunity deficiency. Arch Dis Child 1976; 51: 91-9 51 De Grouchy J, Turleau C. Clinical Atlas of Human Chromosomes. New York: John Wiley, 1984 52 Buckley RH, Sampson HA. The hyperimmunoglobulin E syndrome. In: Franklin ED, ed. Clinical Immunology Update. New York: Elsevier 1981: 147-67 53 Dreskin SC, Goldsmith PK, Gallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection syndrome. J Clin Invest 1985; 75: 26-34 54 Buckley RH, In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 320-6 55 Mawhinney J, Killen M, Fleming WA et al. The hyperimmunoglobulinemia E syndrome: a neutrophil chemotactic defect reversible by histamine H2 receptor blockade. Clin Immunol Immunopathol 1980; 17: 483-91 56 Miller ME, Koblenzer PJ. Leiner's disease and deficiency of C5. J Pediatr 1972; 80: 879-80 57 (3/58)  Ochs HD, Davis SD, Mickelson E et al. Combined immunodeficiency and reticuloendotheliosis with eosinophilia. J Pediatr 1974; 85: 463-5 58 Auerbach AD, Min Z, Ghosh R et al. Clastogen-induced chromosomal breakage as a marker for first trimester prenatal diagnosis of Fanconi anemia. Hum Genet 1986; 73: 86-8 59 Gluckman E, Berger R, Dutreix J. Bone marrow transplantation for Fanconi anemia. Semin Hematol 1984; 21: 20-6 60 Jouan H, Le Diest F, Nezelof C. Omenn's syndrome: pathologic arguments in favor of a graft-versus-host pathogenesis. Hum Pathol 1987; 18: 1101-8 61 Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann New York Acad Sci 1972; 201: 437-44 62 Blaese RM, Strober W, Waldmann TA. Immunodeficiency in the Wiskott-Aldrich syndrome. Birth Defects: Original Article Series 1975; XI(I): 250-4 63 Kwan S-P, Kandkuyl LA, Blaese M et al. Genetic mapping of the Wiskott-Aldrich syndrome with two highly linked polymorphic DNA markers. Genomics 1988; 3: 39-43 64 Mauer AM. X-linked recessive disorders: chronic granulomatous disease and Wiskott-Aldrich syndrome. J Invest Dermatol 1973; 60: 522-8 65 Peacocke M, Siminovitch KA. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X-chromosome. Proc Natl Acad Sci USA 1987; 84: 3430-3 66 Rosen FS. T cell: B cell collaboration - the response to polysaccharide antigens. Semin Immunol 1989; 1: 87-91 67 (3/59)  Standen GR, Lillicrap DP, Matthews N et al. Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Quart J Med 1986; 59: 401-8 68 Ammann AJ, Hong R. Disorders of the T-cell system. In: Stiehm ER, ed. Immunological Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 280-5 69 Epstein WL, Reed W, Boder E et al. Dermatologic aspects of ataxia telangiectasia. Cutis 1968; 4: 1324-32 70 Peterson RDA, Funkhouser JD. Ataxia telangiectasia: an important clue. New Engl J Med 1990; 322: 124-5 71 Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8 72 Thoene J, Baker H, Yoshino M et al. Biotin-responsive carboxylase deficiency associated with subnormal plasma and urinary biotin. New Engl J Med 1981; 304: 817-23 73 Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New Engl J Med 1989; 320: 1574-80 74 Kostmann R. Infantile genetic agranulocytosis; a review with presentation of ten new cases. Acta Paediatr Scand 1975; 64: 362-8 75 (3/60)  'DA5D 'D+'FJ H'D+D'+HF 'D,D'/'* 'DH1'+J) Genodermatoses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ocus"" 9F/ 'D%F'+ JH,/ 46 5(:J (4CD #2H', E*B'(D) 'DEH'B9 (Homologus) HC0DC JH,/ F3.*JF EF CD EH1+): 'D#HDI EF 'D#E H'D+'FJ) EF 'D#( -3( 'DEF4#. H0DC FA3G 9F/ 'D0CH1 E'9/' 'D'.*D'A AJ 'D5(:J 'D,F3J A% FG" X H Y ". (3/61)  'DEH1+'* 'DE*('/D) AJ EHB9 H'-/ *3EJ 'DE*E'+D'F (Alleles) CD 4.5 JEDC E*E'+D'F E.*DA'F AJ EHB9 .'5 J3EJ E*.'DA 'DDH'B- "Heterezygous". %0' C'F CD' 'DE*E'+DJF E-//'F J3EJ 'D4.5 E*E'+D 'DDH'B- (Homozygous) . #FH'9 'DEH1+'*: 'DEH1+) 'DB'G1) :(Dominent) : B'(D) D%8G'1 C'ED *#+J1G' 9F/E' *H,/ AJ 96H H'-/ AB7 EF 'D#2H', 'D5(:J) (-'D) E*.'DA 'DDH'B-). 'DEH1+'* 'DEBGH1) (Recessive): *H,/ 'DEH1+) AJ CD' 'DEHB9JF 'DE3$HDJF E*E'+D 'DDH'B- B(D #F JECFG' %8G'1 *#+J1G' 'DC'ED. 'DEH1+'* 'D*J **9DB ('D5(:J'* :J1 'D,F3J) X #H Y *3EJ "'D,3EJ) 'D0'*J)". 'D5A'* 'DE6(H7) ('DEH1+' * 'DE*9DB) ('D5(:J'* 'D,F3J) X #H Y GJ E1*(7) ('D,F3 'D5(:J Y 'D0J GH #5:1 (C+J1 EF 'D5(:J X . 'DH1'+) 'DE1*(7) ('D,F3: GJ 0'* #GEJ) AB7 H'-/) AJ 'D8H'G1 'D31J1J)  E98E H1(E' CD 'DEH1+'* 'DE1*(7) ('D,F3 *H,/ 9DI 'D5(:J X . 'D7A1'* (Mutation ) AJ 'D'-H'D 'D7(J9JG '3*F3'. DNA JCHF /BJB'K H(4CD C'ED  DCF #.7'! #H 7A1'* JECF #F *-/+ (4CD E*#.1 94H'&J'K. B/ *-/+ 'D7A1'* CF*J,) D*('/D FB7) %3*(/'D EF FJCDJH*J/J H'-/ #H %/.'D #H 47( H'-/) #H %+F'F AJ 'D#2H', 'D#3'3J). 9F/E' *-/+ 'D7A1) AJ .DJ) ,3EJ) (7A1) ,3EJ)) AB7 'D.D'J' 'DF'*,) AJ G0G 'D.DJ) *5'( H3HA D'JCHF GF'C 'F*B'D'K DD40H0 DD#,J'D 'DB'/E). #E' AB7 AJ 'D7A1'* 'D*J *-/+ AJ 'D9P13QJG "gametes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enetic counselling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aplotype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enetic linkage B/ JB*1( HLA EF EH1+) #.1J AJ FA3 'D5(:J 'D*J JF*, 'DE16  3H'! E('41) (E+'D: 'D9H2 'D#F2JEJ) #H (4CD E$/J) %DI *#+J1 9DI 'D'3*,'() 'DEF'9J) 'D*J B/ *CHF %E' 2J'/) 4'0) E$/J) %DI EF'9) 0'*J) #H FB5'F 4'0 J$/J %DI 'F*'F. *#+J1'* 'DE3O*BR(PD Receptor effects (96 'DEH'/ 'DCJE'HJ) (E' AJG' 'D#/HJ) H'D3EHE  *1*(7 %DI 'D37- 'D.DHJ B(D #F */.D %DI 'D3J*H(D'3E'. H-J+ #F HLA EH,H/) 9DI 37- 'D.DJ) A%FG' B/ *-H1 '1*('7 G0G 'DEH'/ 'D3'E) (4/). 'D*1'AB (JF HLA H(96 'D#E1'6 DJ3 E7DB'K. 'D'671'('* 'D5(:J) Chromosomal disorders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lastosis Perforoms H Syringomata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dward's syndrome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atu syndrome 'DE8'G1 'DEEJ2) DD*F'01 GJ: 'DE8'G1 'D9'E): *.DA 9BDJ. ,(G) E37-) EF-/1). *4HG'* 9JFJ) *4ED 5:1 9JF H:J'( 'D9JF. 4B -FC @ 4B 4A) H#0F'F E*E1C2*'F (4CD H'7J! . B/E E+D 95' 'DE61(. *4HG'* BD(J) H9// EF 'D*4HG'* 'D-4HJ). 'D-J') D#C+1 EF 6 4GH1 :J1 4'&9). 'DE8'G1 'D,D/J): #H1'E H9'&J) H/EHJ)  .'5) 9DI 'D,(G)  'D#8'A1 EA17 'D'F-F'! H*4HG'* EH69J) DDA1H). ,D/ 'D9FB JCHF #C+1 E7'7J). (5E) 'DCA *8G1 *A19 +D'+J AJ 'D71A 'D(9J/. *F'01 *J1F1 Turner's syndrome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onan's syndrome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linefelter's syndrome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aurodontism" . 'D4CD 253(. *F'01 CDJFAD*1 E9 'D3E'B 'D4CD 253 ,. *F'01 CDJFAD*1 'D*4.J5: *1'AB 'D+/J 'DE*6.E 'D('12 E9 .5J*JF 5:J1*JF E9 H,H/ #96'! *F'3DJ) 7(J9J) J$C/ 'D*4.J5 J$C/ 0DC (H,H/ 2J'/) 'D%A1'2 'D(HDJ DD,HF'/H*1HAJF (G1EHF 'DEF47 'D*F'3DJ  EF47 'DBF/) DD-'+'* 'DBF/J). 'D*4.J5 J$C/ C0DC ('D/1'3'* 'D5(:J). 'DE9'D,): 'DE9'D,) (%97'! 'D*H3*H3*J1HF %0 J$/J 0DC %DI *-3F 'D5A'* 'D,F3J) 'D+'FHJ) DCF DJ3 'D9BE /'! 'DH1E 'D95(J 'DDJAJ @ 'DFE7 1 @ /'! AHF 1JCDF G'H2F Von Recklen Hausen's disease GH 931 *5F9 .DBJ J*EJ2 (E8'G1 ,D/J) H95(J) H96DJ) H98EJ). 'DE8'G1 'D31J1J): 'DE8'G1 'D,D/J): 'DE8'G1 'D,D/J) 'DEEJ2) *4ED (B9 (DHF 'DBGH) (-DJ( (Cafщ au lait) HGJ (B9 E37-) HE/H1) E9 FB7 (FJ) /'CF). 9F/E' *CHF 9//G' 3*) #H #C+1 (-,E 1.5 @ 2 3E B71'K 9DI 'D#BD  A%F *4.J5 'DH1E 'D95(J 'DDJAJ JCHF 9'/) E$C/'K. (B9 'DBGH) (-DJ( GJ #HD E8'G1 'DE16 AJ CD 'D#7A'D. EF 'DE8'G1 'D#.1I DDE16: H-E'* E491) H2J'/) %5(':G' (DHF (1HF2J @ FE4 #(7J HA17 491 9DI #3AD 'D8G1. 'D4CD 1BE 252: 'DH1'E 'D95(J 'DDJAJ ((B9 BGH) (-DJ( H#CJ'3) 'D4CD 1BE 253: H1'E 95(J DJAJ CE' #F #H1'E 95(J) DJAJ) E*9//) *-/+ 9DI 7HD 'D#95'( 'DE-J7) ('D%6'A) %DI #CJ'3 71J) (HG0' E' JEJ2G' 9F -(H( 'D4('( 'D*J *CHF B'3J) HE8'G1 #.1I EEJ2)) HE9FB)  #C+1G' 9DI 'D,09 H'D#71'A HB/ **H',/ ('DE&'*. **1'